BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 041345
(340 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 204 bits (520), Expect = 4e-53, Method: Compositional matrix adjust.
Identities = 116/300 (38%), Positives = 174/300 (58%), Gaps = 11/300 (3%)
Query: 5 LKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQG-IVEFKN 63
LK F + + A+DNFS N LG+GGFG VYKG+L DG +A+KRL + QG ++F+
Sbjct: 25 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQT 84
Query: 64 EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKEL-LDWKKRFNI 122
E ++I+ H NL+RL G + ERLLVY Y+ N S+ + + + + LDW KR I
Sbjct: 85 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 144
Query: 123 IEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI 182
G +GL YLH + ++IHRD+KA+NILLD++ + DFG+A+ + +
Sbjct: 145 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-V 203
Query: 183 VGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLN-----LVGYA 237
GT G+++PEY+ G S K+DV+ +GV++LE+I+ ++ +D R N L+ +
Sbjct: 204 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR---AFDLARLANDDDVMLLDWV 260
Query: 238 WQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMA 297
L E K L+D L + +EV + I V LLC Q +RP MS+V ML D +A
Sbjct: 261 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 320
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 201 bits (511), Expect = 5e-52, Method: Compositional matrix adjust.
Identities = 114/300 (38%), Positives = 172/300 (57%), Gaps = 11/300 (3%)
Query: 5 LKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQG-IVEFKN 63
LK F + + A+DNF N LG+GGFG VYKG+L DG +A+KRL + QG ++F+
Sbjct: 17 LKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQT 76
Query: 64 EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKEL-LDWKKRFNI 122
E ++I+ H NL+RL G + ERLLVY Y+ N S+ + + + + LDW KR I
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 123 IEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI 182
G +GL YLH + ++IHRD+KA+NILLD++ + DFG+A+ + +
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-V 195
Query: 183 VGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLN-----LVGYA 237
G G+++PEY+ G S K+DV+ +GV++LE+I+ ++ +D R N L+ +
Sbjct: 196 RGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR---AFDLARLANDDDVMLLDWV 252
Query: 238 WQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMA 297
L E K L+D L + +EV + I V LLC Q +RP MS+V ML D +A
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 164 bits (415), Expect = 6e-41, Method: Compositional matrix adjust.
Identities = 97/274 (35%), Positives = 161/274 (58%), Gaps = 6/274 (2%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 75
AT+NF +G G FG VYKG L DG ++A+KR + S QGI EF+ E + ++ +H +
Sbjct: 37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPH 96
Query: 76 LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKEL-LDWKKRFNIIEGIVQGLLYLH 134
LV L+G ++ E +L+Y+Y+ N +L ++ S + + W++R I G +GL YLH
Sbjct: 97 LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV-GTHGYMSPEY 193
+ +IHRD+K+ NILLD+ PKI+DFG+++ G + + +V GT GY+ PEY
Sbjct: 157 TRA---IIHRDVKSINILLDENFVPKITDFGISKK-GTELGQTHLXXVVKGTLGYIDPEY 212
Query: 194 VMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT 253
+ G ++ KSDVYSFGV++ E++ ++ +NL +A + N G+ +++D
Sbjct: 213 FIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN 272
Query: 254 LHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDV 287
L + P+ + + + C+ + DRP+M DV
Sbjct: 273 LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 164 bits (415), Expect = 6e-41, Method: Compositional matrix adjust.
Identities = 97/274 (35%), Positives = 161/274 (58%), Gaps = 6/274 (2%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 75
AT+NF +G G FG VYKG L DG ++A+KR + S QGI EF+ E + ++ +H +
Sbjct: 37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPH 96
Query: 76 LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKEL-LDWKKRFNIIEGIVQGLLYLH 134
LV L+G ++ E +L+Y+Y+ N +L ++ S + + W++R I G +GL YLH
Sbjct: 97 LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV-GTHGYMSPEY 193
+ +IHRD+K+ NILLD+ PKI+DFG+++ G + + +V GT GY+ PEY
Sbjct: 157 TRA---IIHRDVKSINILLDENFVPKITDFGISKK-GTELDQTHLXXVVKGTLGYIDPEY 212
Query: 194 VMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT 253
+ G ++ KSDVYSFGV++ E++ ++ +NL +A + N G+ +++D
Sbjct: 213 FIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN 272
Query: 254 LHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDV 287
L + P+ + + + C+ + DRP+M DV
Sbjct: 273 LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 149 bits (377), Expect = 2e-36, Method: Compositional matrix adjust.
Identities = 106/304 (34%), Positives = 155/304 (50%), Gaps = 25/304 (8%)
Query: 8 FDFQTIAAATDNFSP------GNRLGQGGFGPVYKGKLLDGQEIAIKRLSK----SSGQG 57
F F + T+NF GN++G+GGFG VYKG ++ +A+K+L+ ++ +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 73
Query: 58 IVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWK 117
+F E K++AK QH NLV LLG S + LVY Y+PN SL + L W
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 118 KRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEA 177
R I +G G+ +LH+ IHRD+K++NILLD+ KISDFG+AR
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 178 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERH----LNL 233
+RIVGT YM+PE + G ++ KSD+YSFGV++LEII+ G + H L L
Sbjct: 191 MXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIIT-----GLPAVDEHREPQLLL 244
Query: 234 VGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
E + ID ++++ S V V C+ +K RP + V +L
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMNDADST-SVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
Query: 294 DTMA 297
T +
Sbjct: 304 MTAS 307
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 149 bits (375), Expect = 3e-36, Method: Compositional matrix adjust.
Identities = 106/302 (35%), Positives = 153/302 (50%), Gaps = 21/302 (6%)
Query: 8 FDFQTIAAATDNFSP------GNRLGQGGFGPVYKGKLLDGQEIAIKRLSK----SSGQG 57
F F + T+NF GN++G+GGFG VYKG ++ +A+K+L+ ++ +
Sbjct: 9 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 67
Query: 58 IVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWK 117
+F E K++AK QH NLV LLG S + LVY Y+PN SL + L W
Sbjct: 68 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 127
Query: 118 KRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEA 177
R I +G G+ +LH+ IHRD+K++NILLD+ KISDFG+AR
Sbjct: 128 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 184
Query: 178 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTER--HLNLVG 235
RIVGT YM+PE + G ++ KSD+YSFGV++LEII+ D R L L
Sbjct: 185 MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLP---AVDEHREPQLLLDI 240
Query: 236 YAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDT 295
E + ID ++++ S V V C+ +K RP + V +L T
Sbjct: 241 KEEIEDEEKTIEDYIDKKMNDADST-SVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 299
Query: 296 MA 297
+
Sbjct: 300 AS 301
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 148 bits (374), Expect = 3e-36, Method: Compositional matrix adjust.
Identities = 106/302 (35%), Positives = 153/302 (50%), Gaps = 21/302 (6%)
Query: 8 FDFQTIAAATDNFSP------GNRLGQGGFGPVYKGKLLDGQEIAIKRLSK----SSGQG 57
F F + T+NF GN++G+GGFG VYKG ++ +A+K+L+ ++ +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 73
Query: 58 IVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWK 117
+F E K++AK QH NLV LLG S + LVY Y+PN SL + L W
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 118 KRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEA 177
R I +G G+ +LH+ IHRD+K++NILLD+ KISDFG+AR
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 178 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTER--HLNLVG 235
RIVGT YM+PE + G ++ KSD+YSFGV++LEII+ D R L L
Sbjct: 191 MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLP---AVDEHREPQLLLDI 246
Query: 236 YAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDT 295
E + ID ++++ S V V C+ +K RP + V +L T
Sbjct: 247 KEEIEDEEKTIEDYIDKKMNDADST-SVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
Query: 296 MA 297
+
Sbjct: 306 AS 307
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 144 bits (362), Expect = 1e-34, Method: Compositional matrix adjust.
Identities = 105/302 (34%), Positives = 149/302 (49%), Gaps = 21/302 (6%)
Query: 8 FDFQTIAAATDNFSP------GNRLGQGGFGPVYKGKLLDGQEIAIKRLSK----SSGQG 57
F F + T+NF GN+ G+GGFG VYKG ++ +A+K+L+ ++ +
Sbjct: 6 FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 64
Query: 58 IVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWK 117
+F E K+ AK QH NLV LLG S + LVY Y PN SL + L W
Sbjct: 65 KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 118 KRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEA 177
R I +G G+ +LH+ IHRD+K++NILLD+ KISDFG+AR
Sbjct: 125 XRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 178 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTER--HLNLVG 235
+RIVGT Y +PE + G ++ KSD+YSFGV++LEII+ D R L L
Sbjct: 182 XXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLP---AVDEHREPQLLLDI 237
Query: 236 YAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDT 295
E + ID +++ S V V C+ +K RP + V +L T
Sbjct: 238 KEEIEDEEKTIEDYIDKKXNDADST-SVEAXYSVASQCLHEKKNKRPDIKKVQQLLQEXT 296
Query: 296 MA 297
+
Sbjct: 297 AS 298
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 112 bits (279), Expect = 4e-25, Method: Compositional matrix adjust.
Identities = 85/271 (31%), Positives = 137/271 (50%), Gaps = 23/271 (8%)
Query: 24 NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
RLG G FG V+ G + ++A+K L K + F EA L+ LQH LVRL
Sbjct: 19 KRLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 77
Query: 84 LQKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
++ ++ EY+ SL DF D K LL K + I +G+ Y+ R I
Sbjct: 78 TREEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNYI 132
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
HRDL+A+N+L+ + + KI+DFG+AR NE A + +PE + G ++K
Sbjct: 133 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGCFTIK 191
Query: 203 SDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDE 262
SDV+SFG+L+ EI++ K Y + +++ ++G + + E+C PDE
Sbjct: 192 SDVWSFGILLYEIVTYGKIP--YPGRTNADVM----TALSQGYRMPRV-----ENC-PDE 239
Query: 263 VTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
+ + +C ++KA +RPT + S+L +
Sbjct: 240 LYDIMK---MCWKEKAEERPTFDYLQSVLDD 267
>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
pdb|3PPZ|B Chain B, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
Length = 309
Score = 111 bits (277), Expect = 6e-25, Method: Compositional matrix adjust.
Identities = 65/214 (30%), Positives = 118/214 (55%), Gaps = 6/214 (2%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
++G G FG V++ + G ++A+K L + + + EF E ++ +L+H N+V +G
Sbjct: 44 KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
Q +V EYL SL + S +E LD ++R ++ + +G+ YLH + ++
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIV 161
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
HRDLK+ N+L+D + K+ DFG++R L + GT +M+PE + + + K
Sbjct: 162 HRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKX--AAGTPEWMAPEVLRDEPSNEK 219
Query: 203 SDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGY 236
SDVYSFGV++ E+ + ++ G + + + VG+
Sbjct: 220 SDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF 253
>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
pdb|3P86|B Chain B, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
Length = 309
Score = 110 bits (276), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 64/214 (29%), Positives = 119/214 (55%), Gaps = 6/214 (2%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
++G G FG V++ + G ++A+K L + + + EF E ++ +L+H N+V +G
Sbjct: 44 KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
Q +V EYL SL + S +E LD ++R ++ + +G+ YLH + ++
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIV 161
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
HR+LK+ N+L+D + K+ DFG++R L + + GT +M+PE + + + K
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS--AAGTPEWMAPEVLRDEPSNEK 219
Query: 203 SDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGY 236
SDVYSFGV++ E+ + ++ G + + + VG+
Sbjct: 220 SDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF 253
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 106 bits (265), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 82/270 (30%), Positives = 135/270 (50%), Gaps = 23/270 (8%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
+LG G FG V+ G + ++A+K L K + F EA L+ LQH LVRL
Sbjct: 19 KLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 85 QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
++ ++ E++ SL DF D K LL K + I +G+ Y+ R IH
Sbjct: 78 KEEPIYIITEFMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNYIH 132
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL+A+N+L+ + + KI+DFG+AR NE A + +PE + G ++KS
Sbjct: 133 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGCFTIKS 191
Query: 204 DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEV 263
+V+SFG+L+ EI++ K Y + +++ Q + + E+C PDE+
Sbjct: 192 NVWSFGILLYEIVTYGKIP--YPGRTNADVMSALSQGYRMPR---------MENC-PDEL 239
Query: 264 TRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
+ +C ++KA +RPT + S+L +
Sbjct: 240 YDIMK---MCWKEKAEERPTFDYLQSVLDD 266
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 106 bits (264), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 89/284 (31%), Positives = 141/284 (49%), Gaps = 30/284 (10%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
RLG G FG V+ G ++A+K L + S F EA L+ +LQH LVRL
Sbjct: 28 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 86
Query: 85 QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
Q+ ++ EY+ N SL DF S K ++ K ++ I +G+ ++ + + IH
Sbjct: 87 QE-PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIH 140
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL+A+NIL+ D ++ KI+DFG+AR NE A + +PE + G ++KS
Sbjct: 141 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKS 199
Query: 204 DVYSFGVLVLEIISSKK--NNGCYDTERHLNL-VGYAWQLWNEGKALELIDTTLHESCSP 260
DV+SFG+L+ EI++ + G + E NL GY ++C P
Sbjct: 200 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR--------------MVRPDNC-P 244
Query: 261 DEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQP 304
+E+ + + LC +++ DRPT + S+L + A QP
Sbjct: 245 EELYQLMR---LCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 285
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 106 bits (264), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 89/284 (31%), Positives = 141/284 (49%), Gaps = 30/284 (10%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
RLG G FG V+ G ++A+K L + S F EA L+ +LQH LVRL
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 85 QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
Q+ ++ EY+ N SL DF S K ++ K ++ I +G+ ++ + + IH
Sbjct: 79 QE-PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIH 132
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL+A+NIL+ D ++ KI+DFG+AR NE A + +PE + G ++KS
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKS 191
Query: 204 DVYSFGVLVLEIISSKK--NNGCYDTERHLNL-VGYAWQLWNEGKALELIDTTLHESCSP 260
DV+SFG+L+ EI++ + G + E NL GY ++C P
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR--------------MVRPDNC-P 236
Query: 261 DEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQP 304
+E+ + + LC +++ DRPT + S+L + A QP
Sbjct: 237 EELYQLMR---LCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 277
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 105 bits (263), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 89/284 (31%), Positives = 141/284 (49%), Gaps = 30/284 (10%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
RLG G FG V+ G ++A+K L + S F EA L+ +LQH LVRL
Sbjct: 30 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 88
Query: 85 QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
Q+ ++ EY+ N SL DF S K ++ K ++ I +G+ ++ + + IH
Sbjct: 89 QE-PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIH 142
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL+A+NIL+ D ++ KI+DFG+AR NE A + +PE + G ++KS
Sbjct: 143 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKS 201
Query: 204 DVYSFGVLVLEIISSKK--NNGCYDTERHLNL-VGYAWQLWNEGKALELIDTTLHESCSP 260
DV+SFG+L+ EI++ + G + E NL GY ++C P
Sbjct: 202 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR--------------MVRPDNC-P 246
Query: 261 DEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQP 304
+E+ + + LC +++ DRPT + S+L + A QP
Sbjct: 247 EELYQLMR---LCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 287
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 105 bits (263), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 89/284 (31%), Positives = 141/284 (49%), Gaps = 30/284 (10%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
RLG G FG V+ G ++A+K L + S F EA L+ +LQH LVRL
Sbjct: 26 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVT 84
Query: 85 QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
Q+ ++ EY+ N SL DF S K ++ K ++ I +G+ ++ + + IH
Sbjct: 85 QE-PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIH 138
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL+A+NIL+ D ++ KI+DFG+AR NE A + +PE + G ++KS
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKS 197
Query: 204 DVYSFGVLVLEIISSKK--NNGCYDTERHLNL-VGYAWQLWNEGKALELIDTTLHESCSP 260
DV+SFG+L+ EI++ + G + E NL GY ++C P
Sbjct: 198 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR--------------MVRPDNC-P 242
Query: 261 DEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQP 304
+E+ + + LC +++ DRPT + S+L + A QP
Sbjct: 243 EELYQLMR---LCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 283
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 105 bits (262), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 89/284 (31%), Positives = 141/284 (49%), Gaps = 30/284 (10%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
RLG G FG V+ G ++A+K L + S F EA L+ +LQH LVRL
Sbjct: 29 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 87
Query: 85 QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
Q+ ++ EY+ N SL DF S K ++ K ++ I +G+ ++ + + IH
Sbjct: 88 QE-PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIH 141
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL+A+NIL+ D ++ KI+DFG+AR NE A + +PE + G ++KS
Sbjct: 142 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKS 200
Query: 204 DVYSFGVLVLEIISSKK--NNGCYDTERHLNL-VGYAWQLWNEGKALELIDTTLHESCSP 260
DV+SFG+L+ EI++ + G + E NL GY ++C P
Sbjct: 201 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR--------------MVRPDNC-P 245
Query: 261 DEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQP 304
+E+ + + LC +++ DRPT + S+L + A QP
Sbjct: 246 EELYQLMR---LCWKERPEDRPTFDYLRSVLEDFFTATEGQFQP 286
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 105 bits (262), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 85/273 (31%), Positives = 136/273 (49%), Gaps = 30/273 (10%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
RLG G FG V+ G ++A+K L + S F EA L+ +LQH LVRL
Sbjct: 22 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVT 80
Query: 85 QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
Q+ ++ EY+ N SL DF S K ++ K ++ I +G+ ++ + + IH
Sbjct: 81 QE-PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIH 134
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL+A+NIL+ D ++ KI+DFG+AR NE A + +PE + G ++KS
Sbjct: 135 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKS 193
Query: 204 DVYSFGVLVLEIISSKK--NNGCYDTERHLNL-VGYAWQLWNEGKALELIDTTLHESCSP 260
DV+SFG+L+ EI++ + G + E NL GY + P
Sbjct: 194 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY---------------RMVRPDNCP 238
Query: 261 DEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
+E+ + + LC +++ DRPT + S+L +
Sbjct: 239 EELYQLMR---LCWKERPEDRPTFDYLRSVLED 268
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 105 bits (262), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 86/273 (31%), Positives = 138/273 (50%), Gaps = 30/273 (10%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
RLG G FG V+ G ++A+K L + S F EA L+ +LQH LVRL
Sbjct: 21 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVT 79
Query: 85 QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
Q+ ++ EY+ N SL DF S K ++ K ++ I +G+ ++ + + IH
Sbjct: 80 QE-PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIH 133
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL+A+NIL+ D ++ KI+DFG+AR NE A + +PE + G ++KS
Sbjct: 134 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKS 192
Query: 204 DVYSFGVLVLEIISSKK--NNGCYDTERHLNL-VGYAWQLWNEGKALELIDTTLHESCSP 260
DV+SFG+L+ EI++ + G + E NL GY ++C P
Sbjct: 193 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR--------------MVRPDNC-P 237
Query: 261 DEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
+E+ + + LC +++ DRPT + S+L +
Sbjct: 238 EELYQLMR---LCWKERPEDRPTFDYLRSVLED 267
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 105 bits (262), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 85/273 (31%), Positives = 136/273 (49%), Gaps = 30/273 (10%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
RLG G FG V+ G ++A+K L + S F EA L+ +LQH LVRL
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 85 QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
Q+ ++ EY+ N SL DF S K ++ K ++ I +G+ ++ + + IH
Sbjct: 79 QE-PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIH 132
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL+A+NIL+ D ++ KI+DFG+AR NE A + +PE + G ++KS
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKS 191
Query: 204 DVYSFGVLVLEIISSKK--NNGCYDTERHLNL-VGYAWQLWNEGKALELIDTTLHESCSP 260
DV+SFG+L+ EI++ + G + E NL GY + P
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY---------------RMVRPDNCP 236
Query: 261 DEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
+E+ + + LC +++ DRPT + S+L +
Sbjct: 237 EELYQLMR---LCWKERPEDRPTFDYLRSVLED 266
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 105 bits (262), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 85/273 (31%), Positives = 136/273 (49%), Gaps = 30/273 (10%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
RLG G FG V+ G ++A+K L + S F EA L+ +LQH LVRL
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 85 QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
Q+ ++ EY+ N SL DF S K ++ K ++ I +G+ ++ + + IH
Sbjct: 79 QE-PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIH 132
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL+A+NIL+ D ++ KI+DFG+AR NE A + +PE + G ++KS
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKS 191
Query: 204 DVYSFGVLVLEIISSKK--NNGCYDTERHLNL-VGYAWQLWNEGKALELIDTTLHESCSP 260
DV+SFG+L+ EI++ + G + E NL GY + P
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY---------------RMVRPDNCP 236
Query: 261 DEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
+E+ + + LC +++ DRPT + S+L +
Sbjct: 237 EELYQLMR---LCWKERPEDRPTFDYLRSVLED 266
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 105 bits (262), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 86/273 (31%), Positives = 138/273 (50%), Gaps = 30/273 (10%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
RLG G FG V+ G ++A+K L + S F EA L+ +LQH LVRL
Sbjct: 26 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVT 84
Query: 85 QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
Q+ ++ EY+ N SL DF S K ++ K ++ I +G+ ++ + + IH
Sbjct: 85 QE-PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIH 138
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL+A+NIL+ D ++ KI+DFG+AR NE A + +PE + G ++KS
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKS 197
Query: 204 DVYSFGVLVLEIISSKK--NNGCYDTERHLNL-VGYAWQLWNEGKALELIDTTLHESCSP 260
DV+SFG+L+ EI++ + G + E NL GY ++C P
Sbjct: 198 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR--------------MVRPDNC-P 242
Query: 261 DEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
+E+ + + LC +++ DRPT + S+L +
Sbjct: 243 EELYQLMR---LCWKERPEDRPTFDYLRSVLED 272
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 105 bits (261), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 86/273 (31%), Positives = 138/273 (50%), Gaps = 30/273 (10%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
RLG G FG V+ G ++A+K L + S F EA L+ +LQH LVRL
Sbjct: 25 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVT 83
Query: 85 QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
Q+ ++ EY+ N SL DF S K ++ K ++ I +G+ ++ + + IH
Sbjct: 84 QE-PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIH 137
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL+A+NIL+ D ++ KI+DFG+AR NE A + +PE + G ++KS
Sbjct: 138 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKS 196
Query: 204 DVYSFGVLVLEIISSKK--NNGCYDTERHLNL-VGYAWQLWNEGKALELIDTTLHESCSP 260
DV+SFG+L+ EI++ + G + E NL GY ++C P
Sbjct: 197 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR--------------MVRPDNC-P 241
Query: 261 DEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
+E+ + + LC +++ DRPT + S+L +
Sbjct: 242 EELYQLMR---LCWKERPEDRPTFDYLRSVLED 271
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 104 bits (260), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 86/273 (31%), Positives = 135/273 (49%), Gaps = 30/273 (10%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
RLG G FG V+ G ++A+K L + S F EA L+ +LQH LVRL
Sbjct: 15 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 73
Query: 85 QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
Q+ ++ EY+ N SL DF S K L K ++ I +G+ ++ + + IH
Sbjct: 74 QE-PIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEERN---YIH 127
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL+A+NIL+ D ++ KI+DFG+AR NE A + +PE + G ++KS
Sbjct: 128 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKS 186
Query: 204 DVYSFGVLVLEIISSKK--NNGCYDTERHLNL-VGYAWQLWNEGKALELIDTTLHESCSP 260
DV+SFG+L+ EI++ + G + E NL GY + P
Sbjct: 187 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY---------------RMVRPDNCP 231
Query: 261 DEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
+E+ + + LC +++ DRPT + S+L +
Sbjct: 232 EELYQLMR---LCWKERPEDRPTFDYLRSVLED 261
>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine
Length = 267
Score = 103 bits (256), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 86/273 (31%), Positives = 137/273 (50%), Gaps = 30/273 (10%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
RLG G FG V+ G ++A+K L + S F EA L+ +LQH LVRL
Sbjct: 16 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 74
Query: 85 QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
Q+ ++ EY+ N SL DF S K L K ++ I +G+ ++ + + IH
Sbjct: 75 QE-PIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEERN---YIH 128
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
R+L+A+NIL+ D ++ KI+DFG+AR NE A + +PE + G ++KS
Sbjct: 129 RNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKS 187
Query: 204 DVYSFGVLVLEIISSKK--NNGCYDTERHLNL-VGYAWQLWNEGKALELIDTTLHESCSP 260
DV+SFG+L+ EI++ + G + E NL GY ++C P
Sbjct: 188 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY--------------RMVRPDNC-P 232
Query: 261 DEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
+E+ + + LC +++ DRPT + S+L +
Sbjct: 233 EELYQLMR---LCWKERPEDRPTFDYLRSVLED 262
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 102 bits (254), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 84/288 (29%), Positives = 136/288 (47%), Gaps = 42/288 (14%)
Query: 26 LGQGGFGPVYKGKLL------DGQEIAIKRLS-KSSGQGIVEFKNEAKLIAKLQHTNLVR 78
LG+ FG VYKG L Q +AIK L K+ G EF++EA L A+LQH N+V
Sbjct: 34 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFIF-------------DSSKKELLDWKKRFNIIEG 125
LLG + +++ Y + L F+ D + K L+ +++
Sbjct: 94 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR-TFGMNELEANTNRIVG 184
I G+ YL S V+H+DL N+L+ D++N KISD G+ R + + + N ++
Sbjct: 154 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 210
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG 244
+M+PE +M G S+ SD++S+GV++ E+ S C GY+ Q
Sbjct: 211 IR-WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC----------GYSNQ----- 254
Query: 245 KALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPTMSDVASML 291
+E+I C PD+ ++ ++ C + + RP D+ S L
Sbjct: 255 DVVEMIRNRQVLPC-PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 301
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 102 bits (254), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 84/288 (29%), Positives = 136/288 (47%), Gaps = 42/288 (14%)
Query: 26 LGQGGFGPVYKGKLL------DGQEIAIKRLS-KSSGQGIVEFKNEAKLIAKLQHTNLVR 78
LG+ FG VYKG L Q +AIK L K+ G EF++EA L A+LQH N+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFIF-------------DSSKKELLDWKKRFNIIEG 125
LLG + +++ Y + L F+ D + K L+ +++
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR-TFGMNELEANTNRIVG 184
I G+ YL S V+H+DL N+L+ D++N KISD G+ R + + + N ++
Sbjct: 137 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG 244
+M+PE +M G S+ SD++S+GV++ E+ S C GY+ Q
Sbjct: 194 IR-WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC----------GYSNQ----- 237
Query: 245 KALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPTMSDVASML 291
+E+I C PD+ ++ ++ C + + RP D+ S L
Sbjct: 238 DVVEMIRNRQVLPC-PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 100 bits (249), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 87/284 (30%), Positives = 139/284 (48%), Gaps = 30/284 (10%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
RLG G G V+ G ++A+K L + S F EA L+ +LQH LVRL
Sbjct: 20 RLGAGQAGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 85 QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
Q+ ++ EY+ N SL DF S K ++ K ++ I +G+ ++ + + IH
Sbjct: 79 QE-PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YIH 132
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL+A+NIL+ D ++ KI+DFG+AR E A + +PE + G ++KS
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIK-WTAPEAINYGTFTIKS 191
Query: 204 DVYSFGVLVLEIISSKK--NNGCYDTERHLNL-VGYAWQLWNEGKALELIDTTLHESCSP 260
DV+SFG+L+ EI++ + G + E NL GY ++C P
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY--------------RMVRPDNC-P 236
Query: 261 DEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQP 304
+E+ + + LC +++ DRPT + S+L + A QP
Sbjct: 237 EELYQLMR---LCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 277
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 98.6 bits (244), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 65/204 (31%), Positives = 109/204 (53%), Gaps = 17/204 (8%)
Query: 23 GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
G R+G G FG VYKGK + + ++ + Q + FKNE ++ K +H N++ +G
Sbjct: 17 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
S K + +V ++ SL + S K + KK +I +G+ YLH S +I
Sbjct: 77 S-TKPQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKS---II 130
Query: 143 HRDLKASNILLDDQMNPKISDFGMA----RTFGMNELEANTNRIVGTHGYMSPEYVM--- 195
HRDLK++NI L + KI DFG+A R G ++ E + I+ +M+PE +
Sbjct: 131 HRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSIL----WMAPEVIRMQD 186
Query: 196 NGIVSMKSDVYSFGVLVLEIISSK 219
+ S +SDVY+FG+++ E+++ +
Sbjct: 187 SNPYSFQSDVYAFGIVLYELMTGQ 210
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 98.6 bits (244), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 65/204 (31%), Positives = 109/204 (53%), Gaps = 17/204 (8%)
Query: 23 GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
G R+G G FG VYKGK + + ++ + Q + FKNE ++ K +H N++ +G
Sbjct: 29 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
S K + +V ++ SL + S K + KK +I +G+ YLH S +I
Sbjct: 89 ST-KPQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKS---II 142
Query: 143 HRDLKASNILLDDQMNPKISDFGMA----RTFGMNELEANTNRIVGTHGYMSPEYVM--- 195
HRDLK++NI L + KI DFG+A R G ++ E + I+ +M+PE +
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL----WMAPEVIRMQD 198
Query: 196 NGIVSMKSDVYSFGVLVLEIISSK 219
+ S +SDVY+FG+++ E+++ +
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQ 222
>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With
Staurosporine
Length = 283
Score = 97.8 bits (242), Expect = 8e-21, Method: Compositional matrix adjust.
Identities = 80/281 (28%), Positives = 128/281 (45%), Gaps = 22/281 (7%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
RLG G FG V+ G ++AIK L K F EA+++ KL+H LV+L +
Sbjct: 16 RLGNGQFGEVWMGTWNGNTKVAIKTL-KPGTMSPESFLEEAQIMKKLKHDKLVQLYAV-V 73
Query: 85 QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHR 144
+ +V EY+ SL F+ D + L K N+++ Q + R+ IHR
Sbjct: 74 SEEPIYIVTEYMNKGSLLDFLKDGEGRAL----KLPNLVDMAAQVAAGMAYIERMNYIHR 129
Query: 145 DLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSD 204
DL+++NIL+ + + KI+DFG+AR NE A + +PE + G ++KSD
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIK-WTAPEAALYGRFTIKSD 188
Query: 205 VYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVT 264
V+SFG+L+ E+++ + V Y N + LE ++ C D
Sbjct: 189 VWSFGILLTELVTKGR-------------VPYPGM--NNREVLEQVERGYRMPCPQDCPI 233
Query: 265 RCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPA 305
+ + C + +RPT + S L + A QP
Sbjct: 234 SLHELMIHCWKKDPEERPTFEYLQSFLEDYFTATEPQYQPG 274
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 97.1 bits (240), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 108/204 (52%), Gaps = 17/204 (8%)
Query: 23 GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
G R+G G FG VYKGK + + ++ + Q + FKNE ++ K +H N++ +G
Sbjct: 29 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
S + +V ++ SL + S K + KK +I +G+ YLH S +I
Sbjct: 89 STAP-QLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKS---II 142
Query: 143 HRDLKASNILLDDQMNPKISDFGMA----RTFGMNELEANTNRIVGTHGYMSPEYVM--- 195
HRDLK++NI L + KI DFG+A R G ++ E + I+ +M+PE +
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL----WMAPEVIRMQD 198
Query: 196 NGIVSMKSDVYSFGVLVLEIISSK 219
+ S +SDVY+FG+++ E+++ +
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQ 222
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 96.7 bits (239), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 67/210 (31%), Positives = 109/210 (51%), Gaps = 29/210 (13%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRLSKSS----GQGIVEFKNEAKLIAKLQHTNLVRLLG 81
+G GGFG VY+ + G E+A+K Q I + EAKL A L+H N++ L G
Sbjct: 15 IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 82 CSLQKGERLLVYEYLPNKSLDFFIFDSSKKE----LLDWKKRFNIIEGIVQGLLYLHKYS 137
L++ LV E+ L+ + S K+ L++W + I +G+ YLH +
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQ------IARGMNYLHDEA 125
Query: 138 RLRVIHRDLKASNILLDDQMNP--------KISDFGMARTFGMNELEANTNRIVGTHGYM 189
+ +IHRDLK+SNIL+ ++ KI+DFG+AR + G + +M
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH----RTTKMSAAGAYAWM 181
Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
+PE + + S SDV+S+GVL+ E+++ +
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGE 211
>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure
pdb|2GCD|B Chain B, Tao2 Kinase Domain-Staurosporine Structure
Length = 309
Score = 96.3 bits (238), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 69/207 (33%), Positives = 108/207 (52%), Gaps = 19/207 (9%)
Query: 20 FSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVEFKN---EAKLIAKLQHTN 75
FS +G G FG VY + + E+ AIK++S S Q ++++ E + + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 76 LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
++ GC L++ LV EY + D + + KK L + + + G +QGL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQE-VEIAAVTHGALQGLAYLHS 133
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
++ +IHRD+KA NILL + K+ DFG A + A N VGT +M+PE ++
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPYWMAPEVIL 184
Query: 196 ---NGIVSMKSDVYSFGVLVLEIISSK 219
G K DV+S G+ +E+ K
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERK 211
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 96.3 bits (238), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 19/205 (9%)
Query: 23 GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
G R+G G FG VYKGK + + ++ + Q + FKNE ++ K +H N++ +G
Sbjct: 18 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 83 SLQKGERLLVYEYLPNKSLDFFI-FDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
S K + +V ++ SL + +K E++ K +I QG+ YLH S +
Sbjct: 78 S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---I 130
Query: 142 IHRDLKASNILLDDQMNPKISDFGMA----RTFGMNELEANTNRIVGTHGYMSPEYVM-- 195
IHRDLK++NI L + + KI DFG+A R G ++ E + I+ +M+PE +
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL----WMAPEVIRMQ 186
Query: 196 -NGIVSMKSDVYSFGVLVLEIISSK 219
S +SDVY+FG+++ E+++ +
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQ 211
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 96.3 bits (238), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 19/205 (9%)
Query: 23 GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
G R+G G FG VYKGK + + ++ + Q + FKNE ++ K +H N++ +G
Sbjct: 33 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 83 SLQKGERLLVYEYLPNKSLDFFI-FDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
S K + +V ++ SL + +K E++ K +I QG+ YLH S +
Sbjct: 93 S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---I 145
Query: 142 IHRDLKASNILLDDQMNPKISDFGMA----RTFGMNELEANTNRIVGTHGYMSPEYVM-- 195
IHRDLK++NI L + + KI DFG+A R G ++ E + I+ +M+PE +
Sbjct: 146 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL----WMAPEVIRMQ 201
Query: 196 -NGIVSMKSDVYSFGVLVLEIISSK 219
S +SDVY+FG+++ E+++ +
Sbjct: 202 DKNPYSFQSDVYAFGIVLYELMTGQ 226
>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5Q|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
Length = 348
Score = 96.3 bits (238), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 69/207 (33%), Positives = 108/207 (52%), Gaps = 19/207 (9%)
Query: 20 FSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVEFKN---EAKLIAKLQHTN 75
FS +G G FG VY + + E+ AIK++S S Q ++++ E + + KL+H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 76 LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
++ GC L++ LV EY + D + + KK L + + + G +QGL YLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQE-VEIAAVTHGALQGLAYLHS 172
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
++ +IHRD+KA NILL + K+ DFG A + A N VGT +M+PE ++
Sbjct: 173 HN---MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPYWMAPEVIL 223
Query: 196 ---NGIVSMKSDVYSFGVLVLEIISSK 219
G K DV+S G+ +E+ K
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERK 250
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 95.9 bits (237), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 19/205 (9%)
Query: 23 GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
G R+G G FG VYKGK + + ++ + Q + FKNE ++ K +H N++ +G
Sbjct: 15 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 83 SLQKGERLLVYEYLPNKSLDFFI-FDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
S K + +V ++ SL + +K E++ K +I QG+ YLH S +
Sbjct: 75 S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---I 127
Query: 142 IHRDLKASNILLDDQMNPKISDFGMA----RTFGMNELEANTNRIVGTHGYMSPEYVM-- 195
IHRDLK++NI L + + KI DFG+A R G ++ E + I+ +M+PE +
Sbjct: 128 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL----WMAPEVIRMQ 183
Query: 196 -NGIVSMKSDVYSFGVLVLEIISSK 219
S +SDVY+FG+++ E+++ +
Sbjct: 184 DKNPYSFQSDVYAFGIVLYELMTGQ 208
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 95.9 bits (237), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 19/205 (9%)
Query: 23 GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
G R+G G FG VYKGK + + ++ + Q + FKNE ++ K +H N++ +G
Sbjct: 13 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 83 SLQKGERLLVYEYLPNKSLDFFI-FDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
S K + +V ++ SL + +K E++ K +I QG+ YLH S +
Sbjct: 73 S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---I 125
Query: 142 IHRDLKASNILLDDQMNPKISDFGMA----RTFGMNELEANTNRIVGTHGYMSPEYVM-- 195
IHRDLK++NI L + + KI DFG+A R G ++ E + I+ +M+PE +
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL----WMAPEVIRMQ 181
Query: 196 -NGIVSMKSDVYSFGVLVLEIISSK 219
S +SDVY+FG+++ E+++ +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQ 206
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 95.9 bits (237), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 19/205 (9%)
Query: 23 GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
G R+G G FG VYKGK + + ++ + Q + FKNE ++ K +H N++ +G
Sbjct: 13 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 83 SLQKGERLLVYEYLPNKSLDFFI-FDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
S K + +V ++ SL + +K E++ K +I QG+ YLH S +
Sbjct: 73 S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---I 125
Query: 142 IHRDLKASNILLDDQMNPKISDFGMA----RTFGMNELEANTNRIVGTHGYMSPEYVM-- 195
IHRDLK++NI L + + KI DFG+A R G ++ E + I+ +M+PE +
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL----WMAPEVIRMQ 181
Query: 196 -NGIVSMKSDVYSFGVLVLEIISSK 219
S +SDVY+FG+++ E+++ +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQ 206
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 95.9 bits (237), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 19/205 (9%)
Query: 23 GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
G R+G G FG VYKGK + + ++ + Q + FKNE ++ K +H N++ +G
Sbjct: 40 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 83 SLQKGERLLVYEYLPNKSLDFFI-FDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
S K + +V ++ SL + +K E++ K +I QG+ YLH S +
Sbjct: 100 S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---I 152
Query: 142 IHRDLKASNILLDDQMNPKISDFGMA----RTFGMNELEANTNRIVGTHGYMSPEYVM-- 195
IHRDLK++NI L + + KI DFG+A R G ++ E + I+ +M+PE +
Sbjct: 153 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL----WMAPEVIRMQ 208
Query: 196 -NGIVSMKSDVYSFGVLVLEIISSK 219
S +SDVY+FG+++ E+++ +
Sbjct: 209 DKNPYSFQSDVYAFGIVLYELMTGQ 233
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 95.9 bits (237), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 19/205 (9%)
Query: 23 GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
G R+G G FG VYKGK + + ++ + Q + FKNE ++ K +H N++ +G
Sbjct: 41 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 83 SLQKGERLLVYEYLPNKSLDFFI-FDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
S K + +V ++ SL + +K E++ K +I QG+ YLH S +
Sbjct: 101 S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---I 153
Query: 142 IHRDLKASNILLDDQMNPKISDFGMA----RTFGMNELEANTNRIVGTHGYMSPEYVM-- 195
IHRDLK++NI L + + KI DFG+A R G ++ E + I+ +M+PE +
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL----WMAPEVIRMQ 209
Query: 196 -NGIVSMKSDVYSFGVLVLEIISSK 219
S +SDVY+FG+++ E+++ +
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQ 234
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 95.9 bits (237), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 19/205 (9%)
Query: 23 GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
G R+G G FG VYKGK + + ++ + Q + FKNE ++ K +H N++ +G
Sbjct: 18 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 83 SLQKGERLLVYEYLPNKSLDFFI-FDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
S K + +V ++ SL + +K E++ K +I QG+ YLH S +
Sbjct: 78 S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---I 130
Query: 142 IHRDLKASNILLDDQMNPKISDFGMA----RTFGMNELEANTNRIVGTHGYMSPEYVM-- 195
IHRDLK++NI L + + KI DFG+A R G ++ E + I+ +M+PE +
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL----WMAPEVIRMQ 186
Query: 196 -NGIVSMKSDVYSFGVLVLEIISSK 219
S +SDVY+FG+++ E+++ +
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQ 211
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 95.9 bits (237), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 19/205 (9%)
Query: 23 GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
G R+G G FG VYKGK + + ++ + Q + FKNE ++ K +H N++ +G
Sbjct: 41 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 83 SLQKGERLLVYEYLPNKSLDFFI-FDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
S K + +V ++ SL + +K E++ K +I QG+ YLH S +
Sbjct: 101 S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---I 153
Query: 142 IHRDLKASNILLDDQMNPKISDFGMA----RTFGMNELEANTNRIVGTHGYMSPEYVM-- 195
IHRDLK++NI L + + KI DFG+A R G ++ E + I+ +M+PE +
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL----WMAPEVIRMQ 209
Query: 196 -NGIVSMKSDVYSFGVLVLEIISSK 219
S +SDVY+FG+++ E+++ +
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQ 234
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 95.5 bits (236), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 88/312 (28%), Positives = 149/312 (47%), Gaps = 55/312 (17%)
Query: 26 LGQGGFGPVYKGKLLDGQE-----IAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVRL 79
LG G FG VYKG + E +AIK L++++G + VEF +EA ++A + H +LVRL
Sbjct: 23 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
LG L +L V + +P+ L ++ + + LL+W + I +G++YL +
Sbjct: 83 LGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 135
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
R++HRDL A N+L+ + KI+DFG+AR +E E N + +M+ E +
Sbjct: 136 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 192
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT 253
+ +SDV+S+GV + E+++ K +G E L +G+ L
Sbjct: 193 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP--------DLLEKGERLP----- 239
Query: 254 LHESCSPDEVTRCIHVGLL-CVQDKATDRPTMSDVASMLT--------------NDTMAL 298
P T +++ ++ C A RP ++A+ + +D M L
Sbjct: 240 -----QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGDDRMKL 294
Query: 299 PTPRQPAFFINI 310
P+P FF N+
Sbjct: 295 PSPNDSKFFQNL 306
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 95.1 bits (235), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 67/202 (33%), Positives = 113/202 (55%), Gaps = 20/202 (9%)
Query: 26 LGQGGFGPVYKGKLLDGQE-----IAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVRL 79
LG G FG VYKG + E +AIK L++++G + VEF +EA ++A + H +LVRL
Sbjct: 46 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
LG L +L V + +P+ L ++ + + LL+W + I +G++YL +
Sbjct: 106 LGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 158
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
R++HRDL A N+L+ + KI+DFG+AR +E E N + +M+ E +
Sbjct: 159 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 215
Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
+ +SDV+S+GV + E+++
Sbjct: 216 YRKFTHQSDVWSYGVTIWELMT 237
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 95.1 bits (235), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 63/197 (31%), Positives = 104/197 (52%), Gaps = 7/197 (3%)
Query: 24 NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
+G G FG V+ G L+ ++AIK + + +F EA+++ KL H LV+L G
Sbjct: 13 QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
L++ LV+E++ + L ++ +++ L + + + +G+ YL + S VIH
Sbjct: 72 LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAS---VIH 126
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL A N L+ + K+SDFGM R F +++ ++ + SPE S KS
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 185
Query: 204 DVYSFGVLVLEIISSKK 220
DV+SFGVL+ E+ S K
Sbjct: 186 DVWSFGVLMWEVFSEGK 202
>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase
pdb|3COK|B Chain B, Crystal Structure Of Plk4 Kinase
Length = 278
Score = 94.7 bits (234), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 65/208 (31%), Positives = 108/208 (51%), Gaps = 11/208 (5%)
Query: 13 IAAATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS--GQGIVE-FKNEAKLI 68
I ++F GN LG+G F VY+ + + G E+AIK + K + G+V+ +NE K+
Sbjct: 6 IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 69 AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ 128
+L+H +++ L LV E N ++ ++ + K + + F + I+
Sbjct: 66 CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF--MHQIIT 123
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
G+LYLH + ++HRDL SN+LL MN KI+DFG+A M + T + GT Y
Sbjct: 124 GMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNY 178
Query: 189 MSPEYVMNGIVSMKSDVYSFGVLVLEII 216
+SPE ++SDV+S G + ++
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLL 206
>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src
pdb|2SRC|A Chain A, Crystal Structure Of Human Tyrosine-protein Kinase C-src,
In Complex With Amp-pnp
Length = 452
Score = 94.4 bits (233), Expect = 8e-20, Method: Compositional matrix adjust.
Identities = 79/283 (27%), Positives = 132/283 (46%), Gaps = 26/283 (9%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
+LGQG FG V+ G +AIK L K F EA+++ KL+H LV+L +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 248
Query: 85 QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ +V EY+ SL DF ++ K L + ++ I G+ Y+ R+ +H
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL+A+NIL+ + + K++DFG+AR NE A + +PE + G ++KS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKS 362
Query: 204 DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEV 263
DV+SFG+L+ E+ + + V Y + E L+ ++ C P E
Sbjct: 363 DVWSFGILLTELTTKGR-------------VPYPGMVNRE--VLDQVERGYRMPCPP-EC 406
Query: 264 TRCIH-VGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPA 305
+H + C + + +RPT + + L + + QP
Sbjct: 407 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQPG 449
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 94.4 bits (233), Expect = 9e-20, Method: Compositional matrix adjust.
Identities = 64/205 (31%), Positives = 109/205 (53%), Gaps = 19/205 (9%)
Query: 23 GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
G R+G G FG VYKGK + + ++ + Q + FKNE ++ K +H N++ +G
Sbjct: 13 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 83 SLQKGERLLVYEYLPNKSLDFFI-FDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
S + +V ++ SL + +K E++ K +I QG+ YLH S +
Sbjct: 73 STAP-QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---I 125
Query: 142 IHRDLKASNILLDDQMNPKISDFGMA----RTFGMNELEANTNRIVGTHGYMSPEYVM-- 195
IHRDLK++NI L + + KI DFG+A R G ++ E + I+ +M+PE +
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL----WMAPEVIRMQ 181
Query: 196 -NGIVSMKSDVYSFGVLVLEIISSK 219
S +SDVY+FG+++ E+++ +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQ 206
>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An
Inhibitor
Length = 452
Score = 94.4 bits (233), Expect = 9e-20, Method: Compositional matrix adjust.
Identities = 79/283 (27%), Positives = 132/283 (46%), Gaps = 26/283 (9%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
+LGQG FG V+ G +AIK L K F EA+++ KL+H LV+L +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 248
Query: 85 QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ +V EY+ SL DF ++ K L + ++ I G+ Y+ R+ +H
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL+A+NIL+ + + K++DFG+AR NE A + +PE + G ++KS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKS 362
Query: 204 DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEV 263
DV+SFG+L+ E+ + + V Y + E L+ ++ C P E
Sbjct: 363 DVWSFGILLTELTTKGR-------------VPYPGMVNRE--VLDQVERGYRMPCPP-EC 406
Query: 264 TRCIH-VGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPA 305
+H + C + + +RPT + + L + + QP
Sbjct: 407 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 449
>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor
Length = 535
Score = 94.4 bits (233), Expect = 9e-20, Method: Compositional matrix adjust.
Identities = 79/283 (27%), Positives = 132/283 (46%), Gaps = 26/283 (9%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
+LGQG FG V+ G +AIK L K F EA+++ KL+H LV+L +
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 331
Query: 85 QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ +V EY+ SL DF ++ K L + ++ I G+ Y+ R+ +H
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 386
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL+A+NIL+ + + K++DFG+AR NE A + +PE + G ++KS
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKS 445
Query: 204 DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEV 263
DV+SFG+L+ E+ + + V Y + E L+ ++ C P E
Sbjct: 446 DVWSFGILLTELTTKGR-------------VPYPGMVNRE--VLDQVERGYRMPCPP-EC 489
Query: 264 TRCIH-VGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPA 305
+H + C + + +RPT + + L + + QP
Sbjct: 490 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQPG 532
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 94.0 bits (232), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 62/197 (31%), Positives = 103/197 (52%), Gaps = 7/197 (3%)
Query: 24 NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
+G G FG V+ G L+ ++AIK + + +F EA+++ KL H LV+L G
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
L++ LV+E++ + L ++ +++ L + + + +G+ YL + VIH
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 124
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL A N L+ + K+SDFGM R F +++ ++ + SPE S KS
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 204 DVYSFGVLVLEIISSKK 220
DV+SFGVL+ E+ S K
Sbjct: 184 DVWSFGVLMWEVFSEGK 200
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 94.0 bits (232), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 62/197 (31%), Positives = 103/197 (52%), Gaps = 7/197 (3%)
Query: 24 NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
+G G FG V+ G L+ ++AIK + + +F EA+++ KL H LV+L G
Sbjct: 13 QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
L++ LV+E++ + L ++ +++ L + + + +G+ YL + VIH
Sbjct: 72 LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 126
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL A N L+ + K+SDFGM R F +++ ++ + SPE S KS
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 185
Query: 204 DVYSFGVLVLEIISSKK 220
DV+SFGVL+ E+ S K
Sbjct: 186 DVWSFGVLMWEVFSEGK 202
>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly
Mutant) In Complex With N6-Benzyl Adp
Length = 452
Score = 94.0 bits (232), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 79/283 (27%), Positives = 132/283 (46%), Gaps = 26/283 (9%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
+LGQG FG V+ G +AIK L K F EA+++ KL+H LV+L +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 248
Query: 85 QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ +V EY+ SL DF ++ K L + ++ I G+ Y+ R+ +H
Sbjct: 249 SEEPIYIVGEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL+A+NIL+ + + K++DFG+AR NE A + +PE + G ++KS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKS 362
Query: 204 DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEV 263
DV+SFG+L+ E+ + + V Y + E L+ ++ C P E
Sbjct: 363 DVWSFGILLTELTTKGR-------------VPYPGMVNRE--VLDQVERGYRMPCPP-EC 406
Query: 264 TRCIH-VGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPA 305
+H + C + + +RPT + + L + + QP
Sbjct: 407 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQPG 449
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 94.0 bits (232), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 62/197 (31%), Positives = 103/197 (52%), Gaps = 7/197 (3%)
Query: 24 NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
+G G FG V+ G L+ ++AIK + + +F EA+++ KL H LV+L G
Sbjct: 16 QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
L++ LV+E++ + L ++ +++ L + + + +G+ YL + VIH
Sbjct: 75 LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 129
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL A N L+ + K+SDFGM R F +++ ++ + SPE S KS
Sbjct: 130 RDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 188
Query: 204 DVYSFGVLVLEIISSKK 220
DV+SFGVL+ E+ S K
Sbjct: 189 DVWSFGVLMWEVFSEGK 205
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 93.6 bits (231), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 63/197 (31%), Positives = 104/197 (52%), Gaps = 7/197 (3%)
Query: 24 NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
+G G FG V+ G L+ ++AIK + + S +F EA+++ KL H LV+L G
Sbjct: 33 QEIGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
L++ LV+E++ + L ++ +++ L + + + +G+ YL + VIH
Sbjct: 92 LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 146
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL A N L+ + K+SDFGM R F +++ ++ + SPE S KS
Sbjct: 147 RDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 205
Query: 204 DVYSFGVLVLEIISSKK 220
DV+SFGVL+ E+ S K
Sbjct: 206 DVWSFGVLMWEVFSEGK 222
>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDF|B Chain B, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDJ|A Chain A, Src Kinase In Complex With Inhibitor Ap23464
Length = 279
Score = 93.6 bits (231), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 79/283 (27%), Positives = 132/283 (46%), Gaps = 26/283 (9%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
+LGQG FG V+ G +AIK L K F EA+++ KL+H LV+L +
Sbjct: 18 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 75
Query: 85 QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ +V EY+ SL DF ++ K L + ++ I G+ Y+ R+ +H
Sbjct: 76 SEEPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 130
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL+A+NIL+ + + K++DFG+AR NE A + +PE + G ++KS
Sbjct: 131 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKS 189
Query: 204 DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEV 263
DV+SFG+L+ E+ + + V Y + E L+ ++ C P E
Sbjct: 190 DVWSFGILLTELTTKGR-------------VPYPGMVNRE--VLDQVERGYRMPCPP-EC 233
Query: 264 TRCIH-VGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPA 305
+H + C + + +RPT + + L + + QP
Sbjct: 234 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 276
>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
pdb|1YI6|B Chain B, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
Length = 276
Score = 93.6 bits (231), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 77/271 (28%), Positives = 129/271 (47%), Gaps = 26/271 (9%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
+LGQG FG V+ G +AIK L K F EA+++ KL+H LV+L +
Sbjct: 15 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 72
Query: 85 QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ +V EY+ SL DF ++ K L + ++ I G+ Y+ R+ +H
Sbjct: 73 SEEPIXIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 127
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL+A+NIL+ + + K++DFG+AR NE A + +PE + G ++KS
Sbjct: 128 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIK-WTAPEAALYGRFTIKS 186
Query: 204 DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEV 263
DV+SFG+L+ E+ + + V Y + E L+ ++ C P E
Sbjct: 187 DVWSFGILLTELTTKGR-------------VPYPGMVNRE--VLDQVERGYRMPCPP-EC 230
Query: 264 TRCIH-VGLLCVQDKATDRPTMSDVASMLTN 293
+H + C + + +RPT + + L +
Sbjct: 231 PESLHDLMCQCWRKEPEERPTFEYLQAFLED 261
>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
pdb|1MQB|B Chain B, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
Length = 333
Score = 92.8 bits (229), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 75/278 (26%), Positives = 133/278 (47%), Gaps = 37/278 (13%)
Query: 26 LGQGGFGPVYKG--KLLDGQE---IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
+G G FG VYKG K G++ +AIK L + + V+F EA ++ + H N++RL
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
G + +++ EY+ N +LD F+ + K + ++ GI G+ YL + +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYL---ANM 166
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------YMSPEY 193
+HRDL A NIL++ + K+SDFG++R LE + T G + +PE
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRV-----LEDDPEATYTTSGGKIPIRWTAPEA 221
Query: 194 VMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTT 253
+ + SDV+SFG+++ E+++ Y + W+L N + ++ I+
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMT-------YGERPY-------WELSNH-EVMKAINDG 266
Query: 254 LHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
D + + + C Q + RP +D+ S+L
Sbjct: 267 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 304
>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain
pdb|1YOJ|B Chain B, Crystal Structure Of Src Kinase Domain
pdb|1YOM|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
pdb|1YOM|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
Length = 283
Score = 92.4 bits (228), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 79/283 (27%), Positives = 132/283 (46%), Gaps = 26/283 (9%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
+LGQG FG V+ G +AIK L K F EA+++ KL+H LV+L +
Sbjct: 22 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 79
Query: 85 QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ +V EY+ SL DF ++ K L + ++ I G+ Y+ R+ +H
Sbjct: 80 SEEPIYIVTEYMNKGSLLDFLKGETGK--YLRLPQLVDMSAQIASGMAYVE---RMNYVH 134
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL+A+NIL+ + + K++DFG+AR NE A + +PE + G ++KS
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIK-WTAPEAALYGRFTIKS 193
Query: 204 DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEV 263
DV+SFG+L+ E+ + + V Y + E L+ ++ C P E
Sbjct: 194 DVWSFGILLTELTTKGR-------------VPYPGMVNRE--VLDQVERGYRMPCPP-EC 237
Query: 264 TRCIH-VGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPA 305
+H + C + + +RPT + + L + + QP
Sbjct: 238 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 280
>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
pdb|1YOL|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
Length = 283
Score = 92.4 bits (228), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 79/283 (27%), Positives = 132/283 (46%), Gaps = 26/283 (9%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
+LGQG FG V+ G +AIK L K F EA+++ KL+H LV+L +
Sbjct: 22 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 79
Query: 85 QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ +V EY+ SL DF ++ K L + ++ I G+ Y+ R+ +H
Sbjct: 80 SEEPIYIVTEYMNKGSLLDFLKGETGK--YLRLPQLVDMSAQIASGMAYVE---RMNYVH 134
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL+A+NIL+ + + K++DFG+AR NE A + +PE + G ++KS
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKS 193
Query: 204 DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEV 263
DV+SFG+L+ E+ + + V Y + E L+ ++ C P E
Sbjct: 194 DVWSFGILLTELTTKGR-------------VPYPGMVNRE--VLDQVERGYRMPCPP-EC 237
Query: 264 TRCIH-VGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPA 305
+H + C + + +RPT + + L + + QP
Sbjct: 238 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 280
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 92.0 bits (227), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 62/197 (31%), Positives = 102/197 (51%), Gaps = 7/197 (3%)
Query: 24 NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
+G G FG V+ G L+ ++AIK + + +F EA+++ KL H LV+L G
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
L++ LV E++ + L ++ +++ L + + + +G+ YL + VIH
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 127
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL A N L+ + K+SDFGM R F +++ ++ + SPE S KS
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 186
Query: 204 DVYSFGVLVLEIISSKK 220
DV+SFGVL+ E+ S K
Sbjct: 187 DVWSFGVLMWEVFSEGK 203
>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc4b
pdb|3U51|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
pdb|3U51|B Chain B, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
Length = 275
Score = 92.0 bits (227), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 64/197 (32%), Positives = 103/197 (52%), Gaps = 9/197 (4%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
+LGQG FG V+ G +AIK L K F EA+++ KL+H LV+L +
Sbjct: 14 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 71
Query: 85 QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ +V EY+ SL DF + K L + ++ I G+ Y+ R+ +H
Sbjct: 72 SEEPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 126
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL+A+NIL+ + + K++DFG+AR NE A + +PE + G ++KS
Sbjct: 127 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKS 185
Query: 204 DVYSFGVLVLEIISSKK 220
DV+SFG+L+ E+ + +
Sbjct: 186 DVWSFGILLTELTTKGR 202
>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg-
1009247
Length = 270
Score = 92.0 bits (227), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 74/271 (27%), Positives = 131/271 (48%), Gaps = 24/271 (8%)
Query: 24 NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
+LG G FG V+ ++A+K + K + F EA ++ LQH LV+L
Sbjct: 21 KKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV- 78
Query: 84 LQKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
+ K ++ E++ SL DF D K+ L K + I +G+ ++ + + I
Sbjct: 79 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRN---YI 133
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
HRDL+A+NIL+ + KI+DFG+AR NE A + +PE + G ++K
Sbjct: 134 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGSFTIK 192
Query: 203 SDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDE 262
SDV+SFG+L++EI++ + Y + ++ +ALE P+E
Sbjct: 193 SDVWSFGILLMEIVTYGRIP--YPGMSNPEVI----------RALERGYRMPRPENCPEE 240
Query: 263 VTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
+ ++ + C +++ +RPT + S+L +
Sbjct: 241 L---YNIMMRCWKNRPEERPTFEYIQSVLDD 268
>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 92.0 bits (227), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 69/206 (33%), Positives = 99/206 (48%), Gaps = 17/206 (8%)
Query: 26 LGQGGFGPVYKGKL------LDGQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVR 78
LG G FG VY+G++ ++A+K L + S Q ++F EA +I+KL H N+VR
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLH 134
+G SLQ R ++ E + L F+ ++ S+ L ++ I G YL
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 135 KYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
+ IHRD+ A N LL KI DFGMAR + +M P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS 217
E M GI + K+D +SFGVL+ EI S
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255
>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma
Kinase Catalytic Domain
Length = 327
Score = 92.0 bits (227), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 69/206 (33%), Positives = 99/206 (48%), Gaps = 17/206 (8%)
Query: 26 LGQGGFGPVYKGKL------LDGQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVR 78
LG G FG VY+G++ ++A+K L + S Q ++F EA +I+KL H N+VR
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLH 134
+G SLQ R ++ E + L F+ ++ S+ L ++ I G YL
Sbjct: 99 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 135 KYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
+ IHRD+ A N LL KI DFGMAR + +M P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS 217
E M GI + K+D +SFGVL+ EI S
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241
>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|D Chain D, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 277
Score = 91.7 bits (226), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 64/197 (32%), Positives = 103/197 (52%), Gaps = 9/197 (4%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
+LGQG FG V+ G +AIK L K F EA+++ KL+H LV+L +
Sbjct: 16 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 73
Query: 85 QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ +V EY+ SL DF + K L + ++ I G+ Y+ R+ +H
Sbjct: 74 SEEPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 128
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL+A+NIL+ + + K++DFG+AR NE A + +PE + G ++KS
Sbjct: 129 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKS 187
Query: 204 DVYSFGVLVLEIISSKK 220
DV+SFG+L+ E+ + +
Sbjct: 188 DVWSFGILLTELTTKGR 204
>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|2OIQ|B Chain B, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|3D7T|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3DQX|A Chain A, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3DQX|B Chain B, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3EN4|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN4|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN5|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN5|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN6|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN6|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN7|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EN7|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EL7|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 3
pdb|3EL8|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3EL8|B Chain B, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3F6X|A Chain A, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|B Chain B, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|C Chain C, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|D Chain D, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3G6G|A Chain A, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|3G6G|B Chain B, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|4AGW|A Chain A, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|4AGW|B Chain B, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|3UQF|A Chain A, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQF|B Chain B, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQG|A Chain A, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|3UQG|B Chain B, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|4DGG|A Chain A, C-Src Kinase Domain In Complex With Rm-1-176
pdb|4DGG|B Chain B, C-Src Kinase Domain In Complex With Rm-1-176
Length = 286
Score = 91.7 bits (226), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 64/197 (32%), Positives = 103/197 (52%), Gaps = 9/197 (4%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
+LGQG FG V+ G +AIK L K F EA+++ KL+H LV+L +
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 85 QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ +V EY+ SL DF + K L + ++ I G+ Y+ R+ +H
Sbjct: 83 SEEPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL+A+NIL+ + + K++DFG+AR NE A + +PE + G ++KS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKS 196
Query: 204 DVYSFGVLVLEIISSKK 220
DV+SFG+L+ E+ + +
Sbjct: 197 DVWSFGILLTELTTKGR 213
>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
pdb|3SVV|B Chain B, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
Length = 286
Score = 91.7 bits (226), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 64/197 (32%), Positives = 103/197 (52%), Gaps = 9/197 (4%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
+LGQG FG V+ G +AIK L K F EA+++ KL+H LV+L +
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 85 QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ +V EY+ SL DF + K L + ++ I G+ Y+ R+ +H
Sbjct: 83 SEEPIYIVCEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL+A+NIL+ + + K++DFG+AR NE A + +PE + G ++KS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKS 196
Query: 204 DVYSFGVLVLEIISSKK 220
DV+SFG+L+ E+ + +
Sbjct: 197 DVWSFGILLTELTTKGR 213
>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|B Chain B, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|C Chain C, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|D Chain D, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
Length = 286
Score = 91.7 bits (226), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 64/197 (32%), Positives = 103/197 (52%), Gaps = 9/197 (4%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
+LGQG FG V+ G +AIK L K F EA+++ KL+H LV+L +
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 85 QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ +V EY+ SL DF + K L + ++ I G+ Y+ R+ +H
Sbjct: 83 SEEPIYIVIEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL+A+NIL+ + + K++DFG+AR NE A + +PE + G ++KS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIK-WTAPEAALYGRFTIKS 196
Query: 204 DVYSFGVLVLEIISSKK 220
DV+SFG+L+ E+ + +
Sbjct: 197 DVWSFGILLTELTTKGR 213
>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
pdb|3G6H|B Chain B, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
Length = 286
Score = 91.7 bits (226), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 64/197 (32%), Positives = 103/197 (52%), Gaps = 9/197 (4%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
+LGQG FG V+ G +AIK L K F EA+++ KL+H LV+L +
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 85 QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ +V EY+ SL DF + K L + ++ I G+ Y+ R+ +H
Sbjct: 83 SEEPIYIVIEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL+A+NIL+ + + K++DFG+AR NE A + +PE + G ++KS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKS 196
Query: 204 DVYSFGVLVLEIISSKK 220
DV+SFG+L+ E+ + +
Sbjct: 197 DVWSFGILLTELTTKGR 213
>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In
Complex With An Mk-2461 Analog With Specificity For The
Activated Receptor
pdb|3R7O|A Chain A, Structure Of Dually Phosphorylated C-Met Receptor Kinase
In Complex With An Mk-2461 Analog
Length = 307
Score = 91.3 bits (225), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 80/275 (29%), Positives = 135/275 (49%), Gaps = 28/275 (10%)
Query: 26 LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLL 80
+G+G FG VY G LLD G++I A+K L++ + G + +F E ++ H N++ LL
Sbjct: 37 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 81 G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
G C +G L+V Y+ + L FI + + + F + + +G+ YL +
Sbjct: 97 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 151
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG--THGYMSPEYVMNG 197
+ +HRDL A N +LD++ K++DFG+AR E + N+ +M+ E +
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQ 211
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
+ KSDV+SFGVL+ E+++ + Y ++ Y Q G+ L L
Sbjct: 212 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ----GRRL------LQPE 259
Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
PD + V L C KA RP+ S++ S ++
Sbjct: 260 YCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 291
>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CTJ|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CE3|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolopyridinepyridone Based Inhibitor
pdb|3F82|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
N-
(4-(2-Amino-3-Chloropyridin-4-Yloxy)-3-Fluorophenyl)-4-
Ethoxy-1-(4-Fluorophenyl)-2-Oxo-1,2-Dihydropyridine-3-
Carboxamide
pdb|3L8V|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepat Growth Factor Receptor C-Met In Complex With A
Biarylamine Inhibitor
Length = 314
Score = 91.3 bits (225), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 79/275 (28%), Positives = 136/275 (49%), Gaps = 28/275 (10%)
Query: 26 LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLL 80
+G+G FG VY G LLD G++I A+K L++ + G + +F E ++ H N++ LL
Sbjct: 38 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 81 G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
G C +G L+V Y+ + L FI + + + F + + +G+ +L +
Sbjct: 98 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL---ASK 152
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG--THGYMSPEYVMNG 197
+ +HRDL A N +LD++ K++DFG+AR E ++ N+ +M+ E +
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 212
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
+ KSDV+SFGVL+ E+++ + Y ++ Y Q G+ L L
Sbjct: 213 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ----GRRL------LQPE 260
Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
PD + V L C KA RP+ S++ S ++
Sbjct: 261 YCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 292
>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
The Microbial Alkaloid K-252a
pdb|1R1W|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met
Length = 312
Score = 91.3 bits (225), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 79/275 (28%), Positives = 136/275 (49%), Gaps = 28/275 (10%)
Query: 26 LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLL 80
+G+G FG VY G LLD G++I A+K L++ + G + +F E ++ H N++ LL
Sbjct: 36 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 81 G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
G C +G L+V Y+ + L FI + + + F + + +G+ +L +
Sbjct: 96 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL---ASK 150
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG--THGYMSPEYVMNG 197
+ +HRDL A N +LD++ K++DFG+AR E ++ N+ +M+ E +
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 210
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
+ KSDV+SFGVL+ E+++ + Y ++ Y Q G+ L L
Sbjct: 211 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ----GRRL------LQPE 258
Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
PD + V L C KA RP+ S++ S ++
Sbjct: 259 YCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 290
>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972
pdb|3QTI|B Chain B, C-Met Kinase In Complex With Nvp-Bvu972
Length = 314
Score = 91.3 bits (225), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 79/275 (28%), Positives = 136/275 (49%), Gaps = 28/275 (10%)
Query: 26 LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLL 80
+G+G FG VY G LLD G++I A+K L++ + G + +F E ++ H N++ LL
Sbjct: 38 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 81 G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
G C +G L+V Y+ + L FI + + + F + + +G+ +L +
Sbjct: 98 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL---ASK 152
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG--THGYMSPEYVMNG 197
+ +HRDL A N +LD++ K++DFG+AR E ++ N+ +M+ E +
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 212
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
+ KSDV+SFGVL+ E+++ + Y ++ Y Q G+ L L
Sbjct: 213 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ----GRRL------LQPE 260
Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
PD + V L C KA RP+ S++ S ++
Sbjct: 261 YCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 292
>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family-
Selective Tyrosine Kinase Inhibitor
pdb|2C0I|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0I|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0O|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0O|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0T|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-641359
pdb|2C0T|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-641359
Length = 454
Score = 91.3 bits (225), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 74/271 (27%), Positives = 131/271 (48%), Gaps = 24/271 (8%)
Query: 24 NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
+LG G FG V+ ++A+K + K + F EA ++ LQH LV+L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV- 251
Query: 84 LQKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
+ K ++ E++ SL DF D K+ L K + I +G+ ++ + + I
Sbjct: 252 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YI 306
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
HRDL+A+NIL+ + KI+DFG+AR NE A + +PE + G ++K
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGSFTIK 365
Query: 203 SDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDE 262
SDV+SFG+L++EI++ + Y + ++ +ALE P+E
Sbjct: 366 SDVWSFGILLMEIVTYGRIP--YPGMSNPEVI----------RALERGYRMPRPENCPEE 413
Query: 263 VTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
+ ++ + C +++ +RPT + S+L +
Sbjct: 414 L---YNIMMRCWKNRPEERPTFEYIQSVLDD 441
>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With
6-Benzyloxyquinoline Inhibitor
Length = 319
Score = 91.3 bits (225), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 79/275 (28%), Positives = 136/275 (49%), Gaps = 28/275 (10%)
Query: 26 LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLL 80
+G+G FG VY G LLD G++I A+K L++ + G + +F E ++ H N++ LL
Sbjct: 43 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 81 G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
G C +G L+V Y+ + L FI + + + F + + +G+ +L +
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL---ASK 157
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG--THGYMSPEYVMNG 197
+ +HRDL A N +LD++ K++DFG+AR E ++ N+ +M+ E +
Sbjct: 158 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 217
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
+ KSDV+SFGVL+ E+++ + Y ++ Y Q G+ L L
Sbjct: 218 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ----GRRL------LQPE 265
Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
PD + V L C KA RP+ S++ S ++
Sbjct: 266 YCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 297
>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1
pdb|3DKF|A Chain A, Sgx Clone 5698a65kfg1h1
Length = 317
Score = 91.3 bits (225), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 79/275 (28%), Positives = 136/275 (49%), Gaps = 28/275 (10%)
Query: 26 LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLL 80
+G+G FG VY G LLD G++I A+K L++ + G + +F E ++ H N++ LL
Sbjct: 39 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 81 G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
G C +G L+V Y+ + L FI + + + F + + +G+ +L +
Sbjct: 99 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL---ASK 153
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG--THGYMSPEYVMNG 197
+ +HRDL A N +LD++ K++DFG+AR E ++ N+ +M+ E +
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 213
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
+ KSDV+SFGVL+ E+++ + Y ++ Y Q G+ L L
Sbjct: 214 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ----GRRL------LQPE 261
Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
PD + V L C KA RP+ S++ S ++
Sbjct: 262 YCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 293
>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase
Length = 453
Score = 90.9 bits (224), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 78/283 (27%), Positives = 129/283 (45%), Gaps = 26/283 (9%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
+LGQG FG V+ G +AIK L K F EA+++ KL+H LV+L +
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGNMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 249
Query: 85 QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ +V EY+ SL DF + K L + ++ I G+ Y+ R+ +H
Sbjct: 250 SEEPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 304
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL+A+NIL+ + + K++DFG+ R NE A + +PE + G ++KS
Sbjct: 305 RDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKS 363
Query: 204 DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEV 263
DV+SFG+L+ E+ + + V Y + E L+ ++ C P E
Sbjct: 364 DVWSFGILLTELTTKGR-------------VPYPGMVNRE--VLDQVERGYRMPCPP-EC 407
Query: 264 TRCIH-VGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPA 305
+H + C + +RPT + + L + + QP
Sbjct: 408 PESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQXQPG 450
>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OEZ|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OF0|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3OF0|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3QLF|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLF|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLG|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
pdb|3QLG|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
Length = 286
Score = 90.9 bits (224), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 63/197 (31%), Positives = 103/197 (52%), Gaps = 9/197 (4%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
+LGQG FG V+ G +AIK L K F EA+++ K++H LV+L +
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKIRHEKLVQLYAV-V 82
Query: 85 QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ +V EY+ SL DF + K L + ++ I G+ Y+ R+ +H
Sbjct: 83 SEEPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL+A+NIL+ + + K++DFG+AR NE A + +PE + G ++KS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKS 196
Query: 204 DVYSFGVLVLEIISSKK 220
DV+SFG+L+ E+ + +
Sbjct: 197 DVWSFGILLTELTTKGR 213
>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
pdb|3GEQ|B Chain B, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
Length = 286
Score = 90.9 bits (224), Expect = 9e-19, Method: Compositional matrix adjust.
Identities = 64/197 (32%), Positives = 102/197 (51%), Gaps = 9/197 (4%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
+LGQG FG V+ G +AIK L K F EA+++ KL+H LV+L +
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 85 QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ +V EY+ SL DF + K L + ++ I G+ Y+ R+ +H
Sbjct: 83 SEEPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL A+NIL+ + + K++DFG+AR NE A + +PE + G ++KS
Sbjct: 138 RDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKS 196
Query: 204 DVYSFGVLVLEIISSKK 220
DV+SFG+L+ E+ + +
Sbjct: 197 DVWSFGILLTELTTKGR 213
>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
pdb|3F66|B Chain B, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
Length = 298
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 80/275 (29%), Positives = 135/275 (49%), Gaps = 28/275 (10%)
Query: 26 LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLL 80
+G+G FG VY G LLD G++I A+K L++ + G + +F E ++ H N++ LL
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 81 G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
G C +G L+V Y+ + L FI + + + F + + +G+ YL +
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 147
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYVMNG 197
+ +HRDL A N +LD++ K++DFG+AR E + N+ +M+ E +
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 207
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
+ KSDV+SFGVL+ E+++ + Y ++ Y Q G+ L L
Sbjct: 208 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ----GRRL------LQPE 255
Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
PD + V L C KA RP+ S++ S ++
Sbjct: 256 YCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 287
>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolotriazine Based Inhibitor
Length = 373
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 79/275 (28%), Positives = 136/275 (49%), Gaps = 28/275 (10%)
Query: 26 LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLL 80
+G+G FG VY G LLD G++I A+K L++ + G + +F E ++ H N++ LL
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 81 G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
G C +G L+V Y+ + L FI + + + F + + +G+ +L +
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL---ASK 211
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG--THGYMSPEYVMNG 197
+ +HRDL A N +LD++ K++DFG+AR E ++ N+ +M+ E +
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 271
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
+ KSDV+SFGVL+ E+++ + Y ++ Y Q G+ L L
Sbjct: 272 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ----GRRL------LQPE 319
Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
PD + V L C KA RP+ S++ S ++
Sbjct: 320 YCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 351
>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Nvp- Tae684
pdb|2XBA|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Pha-E429
Length = 315
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 68/206 (33%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 26 LGQGGFGPVYKGKL------LDGQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVR 78
LG G FG VY+G++ ++A+K L + S Q ++F EA +I+K H N+VR
Sbjct: 30 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLH 134
+G SLQ R ++ E + L F+ ++ S+ L ++ I G YL
Sbjct: 90 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 135 KYSRLRVIHRDLKASNILL---DDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
+ IHRD+ A N LL KI DFGMAR + +M P
Sbjct: 150 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 206
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS 217
E M GI + K+D +SFGVL+ EI S
Sbjct: 207 EAFMEGIFTSKTDTWSFGVLLWEIFS 232
>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1
Length = 317
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 79/275 (28%), Positives = 136/275 (49%), Gaps = 28/275 (10%)
Query: 26 LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLL 80
+G+G FG VY G LLD G++I A+K L++ + G + +F E ++ H N++ LL
Sbjct: 39 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 81 G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
G C +G L+V Y+ + L FI + + + F + + +G+ +L +
Sbjct: 99 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL---ASK 153
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG--THGYMSPEYVMNG 197
+ +HRDL A N +LD++ K++DFG+AR E ++ N+ +M+ E +
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQ 213
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
+ KSDV+SFGVL+ E+++ + Y ++ Y Q G+ L L
Sbjct: 214 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ----GRRL------LQPE 261
Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
PD + V L C KA RP+ S++ S ++
Sbjct: 262 YCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 293
>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor
Length = 292
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 80/275 (29%), Positives = 135/275 (49%), Gaps = 28/275 (10%)
Query: 26 LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLL 80
+G+G FG VY G LLD G++I A+K L++ + G + +F E ++ H N++ LL
Sbjct: 30 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 81 G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
G C +G L+V Y+ + L FI + + + F + + +G+ YL +
Sbjct: 90 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 144
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG--THGYMSPEYVMNG 197
+ +HRDL A N +LD++ K++DFG+AR E + N+ +M+ E +
Sbjct: 145 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 204
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
+ KSDV+SFGVL+ E+++ + Y ++ Y Q G+ L L
Sbjct: 205 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ----GRRL------LQPE 252
Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
PD + V L C KA RP+ S++ S ++
Sbjct: 253 YCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 284
>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The
Dually-Phosphorylated, Activated State
Length = 308
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 80/275 (29%), Positives = 135/275 (49%), Gaps = 28/275 (10%)
Query: 26 LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLL 80
+G+G FG VY G LLD G++I A+K L++ + G + +F E ++ H N++ LL
Sbjct: 38 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 81 G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
G C +G L+V Y+ + L FI + + + F + + +G+ YL +
Sbjct: 98 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 152
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG--THGYMSPEYVMNG 197
+ +HRDL A N +LD++ K++DFG+AR E + N+ +M+ E +
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 212
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
+ KSDV+SFGVL+ E+++ + Y ++ Y Q G+ L L
Sbjct: 213 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ----GRRL------LQPE 260
Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
PD + V L C KA RP+ S++ S ++
Sbjct: 261 YCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 292
>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain
Of C-Met
pdb|2WKM|A Chain A, X-Ray Structure Of Pha-00665752 Bound To The Kinase Domain
Of C-Met
pdb|3ZXZ|A Chain A, X-Ray Structure Of Pf-04217903 Bound To The Kinase Domain
Of C-Met
pdb|3ZZE|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
N'-
((3z)-4-Chloro-7-Methyl-2-Oxo-1,2-Dihydro-3h-Indol-3-
Ylidene)-2-(4-Hydroxyphenyl)propanohydrazide
pdb|4AOI|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( 3-((1h-
Pyrrolo(2,3-B)pyridin-3-Yl)methyl)-(1,2,4)triazolo(
4,3-B)(1,2,4) Triazin-6-Yl)benzonitrile
pdb|4AP7|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( (6-(4-
Fluorophenyl)-(1,2,4)triazolo(4,3-B)(1,2,
4)triazin-3-Yl)methyl) Phenol
Length = 306
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 80/275 (29%), Positives = 135/275 (49%), Gaps = 28/275 (10%)
Query: 26 LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLL 80
+G+G FG VY G LLD G++I A+K L++ + G + +F E ++ H N++ LL
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 81 G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
G C +G L+V Y+ + L FI + + + F + + +G+ YL +
Sbjct: 95 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 149
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG--THGYMSPEYVMNG 197
+ +HRDL A N +LD++ K++DFG+AR E + N+ +M+ E +
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 209
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
+ KSDV+SFGVL+ E+++ + Y ++ Y Q G+ L L
Sbjct: 210 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ----GRRL------LQPE 257
Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
PD + V L C KA RP+ S++ S ++
Sbjct: 258 YCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 289
>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
pdb|4GG7|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
Length = 319
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 80/275 (29%), Positives = 135/275 (49%), Gaps = 28/275 (10%)
Query: 26 LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLL 80
+G+G FG VY G LLD G++I A+K L++ + G + +F E ++ H N++ LL
Sbjct: 57 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 81 G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
G C +G L+V Y+ + L FI + + + F + + +G+ YL +
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 171
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYVMNG 197
+ +HRDL A N +LD++ K++DFG+AR E + N+ +M+ E +
Sbjct: 172 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 231
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
+ KSDV+SFGVL+ E+++ + Y ++ Y Q G+ L L
Sbjct: 232 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ----GRRL------LQPE 279
Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
PD + V L C KA RP+ S++ S ++
Sbjct: 280 YCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 311
>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In
Complex With Crizotinib
Length = 327
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 68/206 (33%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 26 LGQGGFGPVYKGKL------LDGQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVR 78
LG G FG VY+G++ ++A+K L + S Q ++F EA +I+K H N+VR
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLH 134
+G SLQ R ++ E + L F+ ++ S+ L ++ I G YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 135 KYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
+ IHRD+ A N LL KI DFGMAR + +M P
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS 217
E M GI + K+D +SFGVL+ EI S
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240
>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Piperidine-Carboxamide Inhibitor 2
Length = 327
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 68/206 (33%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 26 LGQGGFGPVYKGKL------LDGQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVR 78
LG G FG VY+G++ ++A+K L + S Q ++F EA +I+K H N+VR
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLH 134
+G SLQ R ++ E + L F+ ++ S+ L ++ I G YL
Sbjct: 99 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 135 KYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
+ IHRD+ A N LL KI DFGMAR + +M P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS 217
E M GI + K+D +SFGVL+ EI S
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 84/297 (28%), Positives = 140/297 (47%), Gaps = 31/297 (10%)
Query: 24 NRLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVR 78
+LG+G FG V + L D G+ +A+K+L S+ + + +F+ E +++ LQH N+V+
Sbjct: 20 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 79 LLGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
G G R L+ EYLP SL ++ KE +D K I +G+ YL
Sbjct: 80 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 134
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYV 194
R IHRDL NIL++++ KI DFG+ + ++ E + G + +PE +
Sbjct: 135 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESL 193
Query: 195 MNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL 254
S+ SDV+SFGV++ E+ + + + E + ++G Q + LI+
Sbjct: 194 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-FMRMIGNDKQ--GQMIVFHLIELLK 250
Query: 255 H-------ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTN--DTMALPTPR 302
+ + C PDE+ + C + RP+ D+A + D MA PR
Sbjct: 251 NNGRLPRPDGC-PDEI---YMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAGLVPR 303
>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In
Complex With Crizotinib (Pf-02341066)
Length = 327
Score = 90.5 bits (223), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 68/206 (33%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 26 LGQGGFGPVYKGKL------LDGQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVR 78
LG G FG VY+G++ ++A+K L + S Q ++F EA +I+K H N+VR
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLH 134
+G SLQ R ++ E + L F+ ++ S+ L ++ I G YL
Sbjct: 98 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 135 KYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
+ IHRD+ A N LL KI DFGMAR + +M P
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS 217
E M GI + K+D +SFGVL+ EI S
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240
>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine
Inhibitor 13
pdb|3U6H|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 26
pdb|3U6I|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 58a
pdb|4DEG|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridazine Inhibitor 2
pdb|4DEH|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 3
pdb|4DEI|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 24
Length = 309
Score = 90.5 bits (223), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 80/275 (29%), Positives = 135/275 (49%), Gaps = 28/275 (10%)
Query: 26 LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLL 80
+G+G FG VY G LLD G++I A+K L++ + G + +F E ++ H N++ LL
Sbjct: 37 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 81 G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
G C +G L+V Y+ + L FI + + + F + + +G+ YL +
Sbjct: 97 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 151
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYVMNG 197
+ +HRDL A N +LD++ K++DFG+AR E + N+ +M+ E +
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 211
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
+ KSDV+SFGVL+ E+++ + Y ++ Y Q G+ L L
Sbjct: 212 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ----GRRL------LQPE 259
Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
PD + V L C KA RP+ S++ S ++
Sbjct: 260 YCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 291
>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase
pdb|3RHK|A Chain A, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
pdb|3RHK|B Chain B, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
Length = 318
Score = 90.5 bits (223), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 80/275 (29%), Positives = 135/275 (49%), Gaps = 28/275 (10%)
Query: 26 LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLL 80
+G+G FG VY G LLD G++I A+K L++ + G + +F E ++ H N++ LL
Sbjct: 56 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 81 G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
G C +G L+V Y+ + L FI + + + F + + +G+ YL +
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 170
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG--THGYMSPEYVMNG 197
+ +HRDL A N +LD++ K++DFG+AR E + N+ +M+ E +
Sbjct: 171 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 230
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
+ KSDV+SFGVL+ E+++ + Y ++ Y Q G+ L L
Sbjct: 231 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ----GRRL------LQPE 278
Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
PD + V L C KA RP+ S++ S ++
Sbjct: 279 YCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 310
>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4DCE|B Chain B, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4FOD|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 36
Length = 333
Score = 90.5 bits (223), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 68/206 (33%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 26 LGQGGFGPVYKGKL------LDGQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVR 78
LG G FG VY+G++ ++A+K L + S Q ++F EA +I+K H N+VR
Sbjct: 45 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLH 134
+G SLQ R ++ E + L F+ ++ S+ L ++ I G YL
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 135 KYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
+ IHRD+ A N LL KI DFGMAR + +M P
Sbjct: 165 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 221
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS 217
E M GI + K+D +SFGVL+ EI S
Sbjct: 222 EAFMEGIFTSKTDTWSFGVLLWEIFS 247
>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma
Kinase In Complex With Ch5424802
Length = 344
Score = 90.5 bits (223), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 68/206 (33%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 26 LGQGGFGPVYKGKL------LDGQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVR 78
LG G FG VY+G++ ++A+K L + S Q ++F EA +I+K H N+VR
Sbjct: 55 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLH 134
+G SLQ R ++ E + L F+ ++ S+ L ++ I G YL
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 135 KYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
+ IHRD+ A N LL KI DFGMAR + +M P
Sbjct: 175 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 231
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS 217
E M GI + K+D +SFGVL+ EI S
Sbjct: 232 EAFMEGIFTSKTDTWSFGVLLWEIFS 257
>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 90.5 bits (223), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 68/206 (33%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 26 LGQGGFGPVYKGKL------LDGQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVR 78
LG G FG VY+G++ ++A+K L + S Q ++F EA +I+K H N+VR
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLH 134
+G SLQ R ++ E + L F+ ++ S+ L ++ I G YL
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 135 KYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
+ IHRD+ A N LL KI DFGMAR + +M P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS 217
E M GI + K+D +SFGVL+ EI S
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255
>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor.
pdb|2RFN|B Chain B, X-ray Structure Of C-met With Inhibitor.
pdb|2RFS|A Chain A, X-Ray Structure Of Su11274 Bound To C-Met
pdb|3CCN|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3CD8|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3EFJ|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFJ|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFK|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 50
pdb|3EFK|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 50
Length = 310
Score = 90.5 bits (223), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 80/275 (29%), Positives = 135/275 (49%), Gaps = 28/275 (10%)
Query: 26 LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLL 80
+G+G FG VY G LLD G++I A+K L++ + G + +F E ++ H N++ LL
Sbjct: 38 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 81 G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
G C +G L+V Y+ + L FI + + + F + + +G+ YL +
Sbjct: 98 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 152
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG--THGYMSPEYVMNG 197
+ +HRDL A N +LD++ K++DFG+AR E + N+ +M+ E +
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 212
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
+ KSDV+SFGVL+ E+++ + Y ++ Y Q G+ L L
Sbjct: 213 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ----GRRL------LQPE 260
Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
PD + V L C KA RP+ S++ S ++
Sbjct: 261 YCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 292
>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QQ7|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QI8|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|2QI8|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|3F3W|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3F3W|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3LOK|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
pdb|3LOK|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
Length = 286
Score = 90.5 bits (223), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 9/197 (4%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
+LGQG FG V+ G +AIK L K F EA+++ KL+H LV+L +
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 85 QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ +V EY+ L DF + K L + ++ I G+ Y+ R+ +H
Sbjct: 83 SEEPIYIVMEYMSKGCLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL+A+NIL+ + + K++DFG+AR NE A + +PE + G ++KS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKS 196
Query: 204 DVYSFGVLVLEIISSKK 220
DV+SFG+L+ E+ + +
Sbjct: 197 DVWSFGILLTELTTKGR 213
>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880
(Gsk1
Length = 302
Score = 90.5 bits (223), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 80/275 (29%), Positives = 135/275 (49%), Gaps = 28/275 (10%)
Query: 26 LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLL 80
+G+G FG VY G LLD G++I A+K L++ + G + +F E ++ H N++ LL
Sbjct: 36 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 81 G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
G C +G L+V Y+ + L FI + + + F + + +G+ YL +
Sbjct: 96 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 150
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG--THGYMSPEYVMNG 197
+ +HRDL A N +LD++ K++DFG+AR E + N+ +M+ E +
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 210
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHES 257
+ KSDV+SFGVL+ E+++ + Y ++ Y Q G+ L L
Sbjct: 211 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ----GRRL------LQPE 258
Query: 258 CSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
PD + V L C KA RP+ S++ S ++
Sbjct: 259 YCPDPLYE---VMLKCWHPKAEMRPSFSELVSRIS 290
>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWO|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWP|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2HWP|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2QLQ|A Chain A, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|2QLQ|B Chain B, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|3F3T|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3T|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3U|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3U|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3V|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3F3V|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3G5D|A Chain A, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3G5D|B Chain B, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3TZ7|A Chain A, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ7|B Chain B, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ8|A Chain A, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ8|B Chain B, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ9|A Chain A, Kinase Domain Of Csrc In Complex With Rl130
pdb|3TZ9|B Chain B, Kinase Domain Of Csrc In Complex With Rl130
Length = 286
Score = 90.1 bits (222), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 9/197 (4%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
+LGQG FG V+ G +AIK L K F EA+++ KL+H LV+L +
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 85 QKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ +V EY+ L DF + K L + ++ I G+ Y+ R+ +H
Sbjct: 83 SEEPIYIVTEYMSKGCLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RDL+A+NIL+ + + K++DFG+AR NE A + +PE + G ++KS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKS 196
Query: 204 DVYSFGVLVLEIISSKK 220
DV+SFG+L+ E+ + +
Sbjct: 197 DVWSFGILLTELTTKGR 213
>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 1
pdb|4FOC|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 2
Length = 353
Score = 90.1 bits (222), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 68/206 (33%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 26 LGQGGFGPVYKGKL------LDGQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVR 78
LG G FG VY+G++ ++A+K L + S Q ++F EA +I+K H N+VR
Sbjct: 65 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLH 134
+G SLQ R ++ E + L F+ ++ S+ L ++ I G YL
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 135 KYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
+ IHRD+ A N LL KI DFGMAR + +M P
Sbjct: 185 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 241
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS 217
E M GI + K+D +SFGVL+ EI S
Sbjct: 242 EAFMEGIFTSKTDTWSFGVLLWEIFS 267
>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka
pdb|4F0I|B Chain B, Crystal Structure Of Apo Trka
Length = 300
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 78/300 (26%), Positives = 127/300 (42%), Gaps = 50/300 (16%)
Query: 26 LGQGGFGPVYKGK---LLDGQE---IAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG+G FG V+ + LL Q+ +A+K L ++S +F+ EA+L+ LQH ++VR
Sbjct: 20 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKE------------LLDWKKRFNIIEGIV 127
G + L+V+EY+ + L+ F+ L + + +
Sbjct: 80 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
G++YL + L +HRDL N L+ + KI DFGM+R + R +
Sbjct: 140 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
+M PE ++ + +SDV+SFGV++ EI + Y Q W +
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFT------------------YGKQPWYQLSNT 238
Query: 248 ELIDTTLH-------ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPT 300
E ID +C P+ I G C Q + R ++ DV + L A P
Sbjct: 239 EAIDCITQGRELERPRACPPE--VYAIMRG--CWQREPQQRHSIKDVHARLQALAQAPPV 294
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 65/202 (32%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 25 RLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
+LG+G FG V + L D G+ +A+K+L S+ + + +F+ E +++ LQH N+V+
Sbjct: 23 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 82
Query: 80 LGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
G G R L+ EYLP SL ++ KE +D K I +G+ YL
Sbjct: 83 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 137
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYVM 195
R IHRDL NIL++++ KI DFG+ + ++ E + G + +PE +
Sbjct: 138 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLT 196
Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
S+ SDV+SFGV++ E+ +
Sbjct: 197 ESKFSVASDVWSFGVVLYELFT 218
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 65/202 (32%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 25 RLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
+LG+G FG V + L D G+ +A+K+L S+ + + +F+ E +++ LQH N+V+
Sbjct: 16 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 80 LGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
G G R L+ EYLP SL ++ KE +D K I +G+ YL
Sbjct: 76 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 130
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYVM 195
R IHRDL NIL++++ KI DFG+ + ++ E + G + +PE +
Sbjct: 131 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLT 189
Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
S+ SDV+SFGV++ E+ +
Sbjct: 190 ESKFSVASDVWSFGVVLYELFT 211
>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain
Length = 306
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 78/300 (26%), Positives = 127/300 (42%), Gaps = 50/300 (16%)
Query: 26 LGQGGFGPVYKGK---LLDGQE---IAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG+G FG V+ + LL Q+ +A+K L ++S +F+ EA+L+ LQH ++VR
Sbjct: 26 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKE------------LLDWKKRFNIIEGIV 127
G + L+V+EY+ + L+ F+ L + + +
Sbjct: 86 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
G++YL + L +HRDL N L+ + KI DFGM+R + R +
Sbjct: 146 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
+M PE ++ + +SDV+SFGV++ EI + Y Q W +
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFT------------------YGKQPWYQLSNT 244
Query: 248 ELIDTTLH-------ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPT 300
E ID +C P+ I G C Q + R ++ DV + L A P
Sbjct: 245 EAIDCITQGRELERPRACPPE--VYAIMRG--CWQREPQQRHSIKDVHARLQALAQAPPV 300
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 65/203 (32%), Positives = 106/203 (52%), Gaps = 15/203 (7%)
Query: 24 NRLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVR 78
+LG+G FG V + L D G+ +A+K+L S+ + + +F+ E +++ LQH N+V+
Sbjct: 14 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 79 LLGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
G G R L+ EYLP SL ++ KE +D K I +G+ YL
Sbjct: 74 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 128
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYV 194
R IHRDL NIL++++ KI DFG+ + ++ E + G + +PE +
Sbjct: 129 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESL 187
Query: 195 MNGIVSMKSDVYSFGVLVLEIIS 217
S+ SDV+SFGV++ E+ +
Sbjct: 188 TESKFSVASDVWSFGVVLYELFT 210
>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 367
Score = 89.7 bits (221), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 68/206 (33%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 26 LGQGGFGPVYKGKL------LDGQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVR 78
LG G FG VY+G++ ++A+K L + S Q ++F EA +I+K H N+VR
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLH 134
+G SLQ R ++ E + L F+ ++ S+ L ++ I G YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 135 KYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
+ IHRD+ A N LL KI DFGMAR + +M P
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS 217
E M GI + K+D +SFGVL+ EI S
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFS 281
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 89.7 bits (221), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 65/202 (32%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 25 RLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
+LG+G FG V + L D G+ +A+K+L S+ + + +F+ E +++ LQH N+V+
Sbjct: 20 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 80 LGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
G G R L+ EYLP SL ++ KE +D K I +G+ YL
Sbjct: 80 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 134
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYVM 195
R IHRDL NIL++++ KI DFG+ + ++ E + G + +PE +
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLT 193
Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
S+ SDV+SFGV++ E+ +
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 89.7 bits (221), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 65/203 (32%), Positives = 106/203 (52%), Gaps = 15/203 (7%)
Query: 24 NRLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVR 78
+LG+G FG V + L D G+ +A+K+L S+ + + +F+ E +++ LQH N+V+
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 79 LLGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
G G R L+ EYLP SL ++ KE +D K I +G+ YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 161
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYV 194
R IHRDL NIL++++ KI DFG+ + ++ E + G + +PE +
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESL 220
Query: 195 MNGIVSMKSDVYSFGVLVLEIIS 217
S+ SDV+SFGV++ E+ +
Sbjct: 221 TESKFSVASDVWSFGVVLYELFT 243
>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 89.7 bits (221), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 68/206 (33%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 26 LGQGGFGPVYKGKL------LDGQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVR 78
LG G FG VY+G++ ++A+K L + S Q ++F EA +I+K H N+VR
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLH 134
+G SLQ R ++ E + L F+ ++ S+ L ++ I G YL
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 135 KYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
+ IHRD+ A N LL KI DFGMAR + +M P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS 217
E M GI + K+D +SFGVL+ EI S
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 89.7 bits (221), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 65/202 (32%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 25 RLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
+LG+G FG V + L D G+ +A+K+L S+ + + +F+ E +++ LQH N+V+
Sbjct: 24 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 80 LGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
G G R L+ EYLP SL ++ KE +D K I +G+ YL
Sbjct: 84 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 138
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYVM 195
R IHRDL NIL++++ KI DFG+ + ++ E + G + +PE +
Sbjct: 139 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLT 197
Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
S+ SDV+SFGV++ E+ +
Sbjct: 198 ESKFSVASDVWSFGVVLYELFT 219
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 89.7 bits (221), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 65/202 (32%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 25 RLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
+LG+G FG V + L D G+ +A+K+L S+ + + +F+ E +++ LQH N+V+
Sbjct: 22 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 80 LGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
G G R L+ EYLP SL ++ KE +D K I +G+ YL
Sbjct: 82 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 136
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYVM 195
R IHRDL NIL++++ KI DFG+ + ++ E + G + +PE +
Sbjct: 137 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLT 195
Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
S+ SDV+SFGV++ E+ +
Sbjct: 196 ESKFSVASDVWSFGVVLYELFT 217
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 89.7 bits (221), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 65/202 (32%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 25 RLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
+LG+G FG V + L D G+ +A+K+L S+ + + +F+ E +++ LQH N+V+
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 80 LGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
G G R L+ EYLP SL ++ KE +D K I +G+ YL
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 131
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYVM 195
R IHRDL NIL++++ KI DFG+ + ++ E + G + +PE +
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLT 190
Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
S+ SDV+SFGV++ E+ +
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 89.7 bits (221), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 65/202 (32%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 25 RLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
+LG+G FG V + L D G+ +A+K+L S+ + + +F+ E +++ LQH N+V+
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 80 LGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
G G R L+ EYLP SL ++ KE +D K I +G+ YL
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 131
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYVM 195
R IHRDL NIL++++ KI DFG+ + ++ E + G + +PE +
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLT 190
Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
S+ SDV+SFGV++ E+ +
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212
>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
pdb|3LCS|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 344
Score = 89.7 bits (221), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 68/206 (33%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 26 LGQGGFGPVYKGKL------LDGQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVR 78
LG G FG VY+G++ ++A+K L + S Q ++F EA +I+K H N+VR
Sbjct: 56 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLH 134
+G SLQ R ++ E + L F+ ++ S+ L ++ I G YL
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 135 KYSRLRVIHRDLKASNILL---DDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
+ IHRD+ A N LL KI DFGMAR + +M P
Sbjct: 176 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 232
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS 217
E M GI + K+D +SFGVL+ EI S
Sbjct: 233 EAFMEGIFTSKTDTWSFGVLLWEIFS 258
>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|B Chain B, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|C Chain C, Human Trka In Complex With The Inhibitor Az-23
Length = 329
Score = 89.4 bits (220), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 78/300 (26%), Positives = 127/300 (42%), Gaps = 50/300 (16%)
Query: 26 LGQGGFGPVYKGK---LLDGQE---IAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG+G FG V+ + LL Q+ +A+K L ++S +F+ EA+L+ LQH ++VR
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKE------------LLDWKKRFNIIEGIV 127
G + L+V+EY+ + L+ F+ L + + +
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
G++YL + L +HRDL N L+ + KI DFGM+R + R +
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
+M PE ++ + +SDV+SFGV++ EI + Y Q W +
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFT------------------YGKQPWYQLSNT 267
Query: 248 ELIDTTLH-------ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALPT 300
E ID +C P+ I G C Q + R ++ DV + L A P
Sbjct: 268 EAIDCITQGRELERPRACPPE--VYAIMRG--CWQREPQQRHSIKDVHARLQALAQAPPV 323
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 89.4 bits (220), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 65/202 (32%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 25 RLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
+LG+G FG V + L D G+ +A+K+L S+ + + +F+ E +++ LQH N+V+
Sbjct: 35 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 80 LGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
G G R L+ EYLP SL ++ KE +D K I +G+ YL
Sbjct: 95 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 149
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYVM 195
R IHRDL NIL++++ KI DFG+ + ++ E + G + +PE +
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLT 208
Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
S+ SDV+SFGV++ E+ +
Sbjct: 209 ESKFSVASDVWSFGVVLYELFT 230
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 89.4 bits (220), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 65/202 (32%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 25 RLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
+LG+G FG V + L D G+ +A+K+L S+ + + +F+ E +++ LQH N+V+
Sbjct: 35 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 80 LGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
G G R L+ EYLP SL ++ KE +D K I +G+ YL
Sbjct: 95 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 149
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYVM 195
R IHRDL NIL++++ KI DFG+ + ++ E + G + +PE +
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLT 208
Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
S+ SDV+SFGV++ E+ +
Sbjct: 209 ESKFSVASDVWSFGVVLYELFT 230
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 89.0 bits (219), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 33/210 (15%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLG--- 81
R+G G FG VYKGK + I ++ + + F+NE ++ K +H N++ +G
Sbjct: 43 RIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT 102
Query: 82 -----CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
Q E +Y++L + F +F +L+D I QG+ YLH
Sbjct: 103 KDNLAIVTQWCEGSSLYKHLHVQETKFQMF-----QLID------IARQTAQGMDYLHAK 151
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMA----RTFGMNELEANTNRIVGTHGYMSPE 192
+ +IHRD+K++NI L + + KI DFG+A R G ++E T ++ +M+PE
Sbjct: 152 N---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVL----WMAPE 204
Query: 193 YVM---NGIVSMKSDVYSFGVLVLEIISSK 219
+ N S +SDVYS+G+++ E+++ +
Sbjct: 205 VIRMQDNNPFSFQSDVYSYGIVLYELMTGE 234
>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma
Kinase Catalytic Domain
pdb|4FNY|A Chain A, Crystal Structure Of The R1275q Anaplastic Lymphoma Kinase
Catalytic Domain In Complex With A Benzoxazole Inhibitor
Length = 327
Score = 88.6 bits (218), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 67/206 (32%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 26 LGQGGFGPVYKGKL------LDGQEIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVR 78
LG G FG VY+G++ ++A+K L + S Q ++F EA +I+K H N+VR
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLH 134
+G SLQ R ++ E + L F+ ++ S+ L ++ I G YL
Sbjct: 99 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 135 KYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
+ IHRD+ A N LL KI DFGMA+ + +M P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPP 215
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS 217
E M GI + K+D +SFGVL+ EI S
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 88.6 bits (218), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 64/202 (31%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 25 RLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
+LG+G FG V + L D G+ +A+K+L S+ + + +F+ E +++ LQH N+V+
Sbjct: 20 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 80 LGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
G G R L+ E+LP SL ++ KE +D K I +G+ YL
Sbjct: 80 KGVCYSAGRRNLKLIMEFLPYGSLREYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 134
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYVM 195
R IHRDL NIL++++ KI DFG+ + ++ E + G + +PE +
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLT 193
Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
S+ SDV+SFGV++ E+ +
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 88.6 bits (218), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 106/205 (51%), Gaps = 21/205 (10%)
Query: 25 RLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
+LG+G FG V + L D G+ +A+K+L S+ + + +F+ E +++ LQH N+V+
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 80 LGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
G G R L+ EYLP SL ++ KE +D K I +G+ YL
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 131
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE-----LEANTNRIVGTHGYMSPE 192
R IHRDL NIL++++ KI DFG+ + ++ E + I + +PE
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF----WYAPE 187
Query: 193 YVMNGIVSMKSDVYSFGVLVLEIIS 217
+ S+ SDV+SFGV++ E+ +
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFT 212
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 88.6 bits (218), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 64/202 (31%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 25 RLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
+LG+G FG V + L D G+ +A+K+L S+ + + +F+ E +++ LQH N+V+
Sbjct: 20 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 80 LGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
G G R L+ EYLP SL ++ + E +D K I +G+ YL
Sbjct: 80 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QAHAERIDHIKLLQYTSQICKGMEYL---G 134
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYVM 195
R IHRDL NIL++++ KI DFG+ + ++ E + G + +PE +
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLT 193
Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
S+ SDV+SFGV++ E+ +
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215
>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:s768a Triple Mutant
Length = 373
Score = 88.2 bits (217), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 77/284 (27%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVE-----FKNEAKLIAKLQH 73
N S +G G FG V G+L + I K+ G E F EA ++ + H
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74 TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
N++RL G + ++V EY+ N SLD F+ + + + ++ GI G+ YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL 163
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------ 187
S + +HRDL A NIL++ + K+SDFG+AR LE + T G
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLARV-----LEDDPEAAYTTRGGKIPIR 215
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
+ SPE + + SDV+S+G+++ E++S ER W++ N+ +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------ERPY------WEMSNQ-DVI 260
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
+ +D D + L C Q +RP + S+L
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 87.8 bits (216), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 62/197 (31%), Positives = 99/197 (50%), Gaps = 7/197 (3%)
Query: 23 GNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSSGQGI-VEFKNEAKLIAKLQHTNLVRLL 80
G ++G+G FG V+ G+L D +A+K ++ + +F EA+++ + H N+VRL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 81 GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
G QK +V E + + DF F ++ L K ++ G+ YL
Sbjct: 179 GVCTQKQPIYIVMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
IHRDL A N L+ ++ KISDFGM+R A+ + +PE + G S
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 201 MKSDVYSFGVLVLEIIS 217
+SDV+SFG+L+ E S
Sbjct: 294 SESDVWSFGILLWETFS 310
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 87.4 bits (215), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 62/197 (31%), Positives = 99/197 (50%), Gaps = 7/197 (3%)
Query: 23 GNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSSGQGI-VEFKNEAKLIAKLQHTNLVRLL 80
G ++G+G FG V+ G+L D +A+K ++ + +F EA+++ + H N+VRL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 81 GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
G QK +V E + + DF F ++ L K ++ G+ YL
Sbjct: 179 GVCTQKQPIYIVMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
IHRDL A N L+ ++ KISDFGM+R A+ + +PE + G S
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 201 MKSDVYSFGVLVLEIIS 217
+SDV+SFG+L+ E S
Sbjct: 294 SESDVWSFGILLWETFS 310
>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase
1)
Length = 294
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 65/217 (29%), Positives = 111/217 (51%), Gaps = 11/217 (5%)
Query: 20 FSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLS-KSSGQGIVEFKNEAKLIAKLQHTNLV 77
F+ +R+G+G FG VYKG +E+ AIK + + + I + + E ++++ +
Sbjct: 21 FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 78 RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
R G L+ + ++ EYL S D K L+ I+ I++GL YLH
Sbjct: 81 RYFGSYLKSTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSE- 135
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG 197
R IHRD+KA+N+LL +Q + K++DFG+A + + + N VGT +M+PE +
Sbjct: 136 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQ--LTDTQIKRNXFVGTPFWMAPEVIKQS 191
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
K+D++S G+ +E+ + N R L L+
Sbjct: 192 AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 228
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 87.0 bits (214), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 64/202 (31%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 25 RLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
+LG+G FG V + L D G+ +A+K+L S+ + + +F+ E +++ LQH N+V+
Sbjct: 18 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 80 LGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
G G R L+ EYLP SL ++ KE +D K I +G+ YL
Sbjct: 78 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 132
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYVM 195
R IHR+L NIL++++ KI DFG+ + ++ E + G + +PE +
Sbjct: 133 TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDK-EYYKVKEPGESPIFWYAPESLT 191
Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
S+ SDV+SFGV++ E+ +
Sbjct: 192 ESKFSVASDVWSFGVVLYELFT 213
>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnye[ptyr]iw
pdb|3FY2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnyefiw
Length = 371
Score = 87.0 bits (214), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVE-----FKNEAKLIAKLQH 73
N S +G G FG V G+L + I K+ G E F EA ++ + H
Sbjct: 44 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 103
Query: 74 TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
N++RL G + ++V EY+ N SLD F+ + + + ++ GI G+ YL
Sbjct: 104 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL 161
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------ 187
S + +HRDL A NIL++ + K+SDFG++R LE + T G
Sbjct: 162 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRV-----LEDDPEAAYTTRGGKIPIR 213
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
+ SPE + + SDV+S+G+++ E++S ER W++ N+ +
Sbjct: 214 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------ERPY------WEMSNQ-DVI 258
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
+ +D D + L C Q +RP + S+L
Sbjct: 259 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 302
>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742f Triple Mutant
Length = 373
Score = 87.0 bits (214), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVE-----FKNEAKLIAKLQH 73
N S +G G FG V G+L + I K+ G E F EA ++ + H
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74 TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
N++RL G + ++V EY+ N SLD F+ + + + ++ GI G+ YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL 163
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------ 187
S + +HRDL A NIL++ + K+SDFG++R LE + T G
Sbjct: 164 ---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRV-----LEDDPEAAYTTRGGKIPIR 215
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
+ SPE + + SDV+S+G+++ E++S ER W++ N+ +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------ERPY------WEMSNQ-DVI 260
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
+ +D D + L C Q +RP + S+L
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304
>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a)
Length = 306
Score = 87.0 bits (214), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 79/283 (27%), Positives = 136/283 (48%), Gaps = 48/283 (16%)
Query: 26 LGQGGFGPVYKGKL-LDGQE---IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLL 80
+G G FG V G+L + G+ +AIK L + + +F +EA ++ + H N++ L
Sbjct: 37 IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 81 GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE--GIVQGLLYLHKY-S 137
G + +++ EY+ N SLD F+ + RF +I+ G+++G+ KY S
Sbjct: 97 GVVTKCKPVMIITEYMENGSLDAFLRKNDG--------RFTVIQLVGMLRGIGSGMKYLS 148
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------YMSP 191
+ +HRDL A NIL++ + K+SDFGM+R LE + T G + +P
Sbjct: 149 DMSAVHRDLAARNILVNSNLVCKVSDFGMSRV-----LEDDPEAAYTTRGGKIPIRWTAP 203
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG--KALEL 249
E + + SDV+S+G+++ E++S ER W + N+ KA+E
Sbjct: 204 EAIAYRKFTSASDVWSYGIVMWEVMSY--------GERPY------WDMSNQDVIKAIE- 248
Query: 250 IDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPTMSDVASML 291
+ P + +H +L C Q + +DRP + +ML
Sbjct: 249 ---EGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 288
>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant
Length = 373
Score = 87.0 bits (214), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVE-----FKNEAKLIAKLQH 73
N S +G G FG V G+L + I K+ G E F EA ++ + H
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74 TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
N++RL G + ++V EY+ N SLD F+ + + + ++ GI G+ YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL 163
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------ 187
S + +HRDL A NIL++ + K+SDFG++R LE + T G
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRV-----LEDDPEAAYTTRGGKIPIR 215
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
+ SPE + + SDV+S+G+++ E++S ER W++ N+ +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------ERPY------WEMSNQ-DVI 260
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
+ +D D + L C Q +RP + S+L
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304
>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant
Length = 373
Score = 87.0 bits (214), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVE-----FKNEAKLIAKLQH 73
N S +G G FG V G+L + I K+ G E F EA ++ + H
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74 TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
N++RL G + ++V EY+ N SLD F+ + + + ++ GI G+ YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL 163
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------ 187
S + +HRDL A NIL++ + K+SDFG++R LE + T G
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRV-----LEDDPEAAYTTRGGKIPIR 215
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
+ SPE + + SDV+S+G+++ E++S ER W++ N+ +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------ERPY------WEMSNQ-DVI 260
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
+ +D D + L C Q +RP + S+L
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304
>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f
Double Mutant
Length = 373
Score = 87.0 bits (214), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVE-----FKNEAKLIAKLQH 73
N S +G G FG V G+L + I K+ G E F EA ++ + H
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74 TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
N++RL G + ++V EY+ N SLD F+ + + + ++ GI G+ YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL 163
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------ 187
S + +HRDL A NIL++ + K+SDFG++R LE + T G
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRV-----LEDDPEAAYTTRGGKIPIR 215
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
+ SPE + + SDV+S+G+++ E++S ER W++ N+ +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------ERPY------WEMSNQ-DVI 260
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
+ +D D + L C Q +RP + S+L
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304
>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound
Structure
Length = 344
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVE-----FKNEAKLIAKLQH 73
N S +G G FG V G+L + I K+ G E F EA ++ + H
Sbjct: 17 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 74 TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
N++RL G + ++V EY+ N SLD F+ + + + ++ GI G+ YL
Sbjct: 77 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL 134
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------ 187
S + +HRDL A NIL++ + K+SDFG++R LE + T G
Sbjct: 135 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRV-----LEDDPEAAYTTRGGKIPIR 186
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
+ SPE + + SDV+S+G+++ E++S ER W++ N+ +
Sbjct: 187 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------ERPY------WEMSNQ-DVI 231
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
+ +D D + L C Q +RP + S+L
Sbjct: 232 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275
>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane
Region
pdb|2QO2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Apo Structure
pdb|2QO9|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Phosphorylated, Amp-pnp Bound
Length = 373
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVE-----FKNEAKLIAKLQH 73
N S +G G FG V G+L + I K+ G E F EA ++ + H
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74 TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
N++RL G + ++V EY+ N SLD F+ + + + ++ GI G+ YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL 163
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------ 187
S + +HRDL A NIL++ + K+SDFG++R LE + T G
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRV-----LEDDPEAAYTTRGGKIPIR 215
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
+ SPE + + SDV+S+G+++ E++S ER W++ N+ +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------ERPY------WEMSNQ-DVI 260
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
+ +D D + L C Q +RP + S+L
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304
>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596:y602:s768g Triple Mutant
Length = 373
Score = 86.7 bits (213), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 76/284 (26%), Positives = 124/284 (43%), Gaps = 36/284 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVE-----FKNEAKLIAKLQH 73
N S +G G FG V G+L + I K+ G E F EA ++ + H
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74 TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
N++RL G + ++V EY+ N SLD F+ + + + ++ GI G+ YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL 163
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------ 187
S + +HRDL A NIL++ + K+SDFG+ R LE + T G
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRV-----LEDDPEAAYTTRGGKIPIR 215
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
+ SPE + + SDV+S+G+++ E++S ER W++ N+ +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------ERPY------WEMSNQ-DVI 260
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
+ +D D + L C Q +RP + S+L
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304
>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor
Awl-Ii- 38.3
pdb|4G2F|A Chain A, Human Epha3 Kinase Domain In Complex With Compound 7
pdb|4GK2|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 66
pdb|4GK3|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 87
pdb|4GK4|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 90
Length = 361
Score = 86.7 bits (213), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVE-----FKNEAKLIAKLQH 73
N S +G G FG V G+L + I K+ G E F EA ++ + H
Sbjct: 34 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 93
Query: 74 TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
N++RL G + ++V EY+ N SLD F+ + + + ++ GI G+ YL
Sbjct: 94 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL 151
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------ 187
S + +HRDL A NIL++ + K+SDFG++R LE + T G
Sbjct: 152 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRV-----LEDDPEAAYTTRGGKIPIR 203
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
+ SPE + + SDV+S+G+++ E++S ER W++ N+ +
Sbjct: 204 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------ERPY------WEMSNQ-DVI 248
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
+ +D D + L C Q +RP + S+L
Sbjct: 249 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 292
>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1,
Cgd3_920
pdb|3MWU|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Rm-1-95
pdb|3NCG|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Nm-Pp1
Length = 486
Score = 86.7 bits (213), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 89/293 (30%), Positives = 143/293 (48%), Gaps = 54/293 (18%)
Query: 26 LGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQG--IVEFKNEAKLIAKLQHTNLVRLLGC 82
LG+G FG V K K + QE A+K ++K+S + E +L+ KL H N+++L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL--- 86
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDS--SKKELLDW---KKRFN------IIEGIVQGLL 131
+E L + S F+I + EL D +KRF+ II+ + G+
Sbjct: 87 ----------FEILEDSS-SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQ---MNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
Y+HK++ ++HRDLK NILL+ + + KI DFG++ F N +GT Y
Sbjct: 136 YMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYY 189
Query: 189 MSPEYVMNGIVSMKSDVYSFGVLVLEIISSK-----KNNGCYDTERHLNLVGYAWQL--W 241
++PE V+ G K DV+S GV++ ++S KN YD + + YA+ L W
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDILKRVETGKYAFDLPQW 246
Query: 242 ----NEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASM 290
++ K L T H S T+C+ +Q +++ PT+SD+ S+
Sbjct: 247 RTISDDAKDLIRKMLTFHPSLRI-TATQCLEHP--WIQKYSSETPTISDLPSL 296
>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Vuf 12058
Length = 285
Score = 86.3 bits (212), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 79/283 (27%), Positives = 136/283 (48%), Gaps = 48/283 (16%)
Query: 26 LGQGGFGPVYKGKL-LDGQE---IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLL 80
+G G FG V G+L + G+ +AIK L + + +F +EA ++ + H N++ L
Sbjct: 16 IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 81 GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE--GIVQGLLYLHKY-S 137
G + +++ EY+ N SLD F+ + RF +I+ G+++G+ KY S
Sbjct: 76 GVVTKCKPVMIITEYMENGSLDAFLRKNDG--------RFTVIQLVGMLRGIGSGMKYLS 127
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------YMSP 191
+ +HRDL A NIL++ + K+SDFGM+R LE + T G + +P
Sbjct: 128 DMSYVHRDLAARNILVNSNLVCKVSDFGMSRV-----LEDDPEAAYTTRGGKIPIRWTAP 182
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG--KALEL 249
E + + SDV+S+G+++ E++S ER W + N+ KA+E
Sbjct: 183 EAIAYRKFTSASDVWSYGIVMWEVMSY--------GERPY------WDMSNQDVIKAIE- 227
Query: 250 IDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPTMSDVASML 291
+ P + +H +L C Q + +DRP + +ML
Sbjct: 228 ---EGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 267
>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain
pdb|2Y6O|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Dasatinib
Length = 291
Score = 85.9 bits (211), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 79/283 (27%), Positives = 136/283 (48%), Gaps = 48/283 (16%)
Query: 26 LGQGGFGPVYKGKL-LDGQE---IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLL 80
+G G FG V G+L + G+ +AIK L + + +F +EA ++ + H N++ L
Sbjct: 22 IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 81 GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE--GIVQGLLYLHKY-S 137
G + +++ EY+ N SLD F+ + RF +I+ G+++G+ KY S
Sbjct: 82 GVVTKCKPVMIITEYMENGSLDAFLRKNDG--------RFTVIQLVGMLRGIGSGMKYLS 133
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------YMSP 191
+ +HRDL A NIL++ + K+SDFGM+R LE + T G + +P
Sbjct: 134 DMSYVHRDLAARNILVNSNLVCKVSDFGMSRV-----LEDDPEAAYTTRGGKIPIRWTAP 188
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG--KALEL 249
E + + SDV+S+G+++ E++S ER W + N+ KA+E
Sbjct: 189 EAIAYRKFTSASDVWSYGIVMWEVMSY--------GERPY------WDMSNQDVIKAIE- 233
Query: 250 IDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPTMSDVASML 291
+ P + +H +L C Q + +DRP + +ML
Sbjct: 234 ---EGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 273
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 85.9 bits (211), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 61/209 (29%), Positives = 117/209 (55%), Gaps = 11/209 (5%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKL 71
+ +NF ++G+G +G VYK + L G+ +A+K++ + +G+ E L+ +L
Sbjct: 1 GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
H N+V+LL + + LV+E+L ++ L F+ D+S + + + ++QGL
Sbjct: 61 NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 118
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
+ H + RV+HRDLK N+L++ + K++DFG+AR FG+ + T+ +V T Y +P
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAP 173
Query: 192 EYVMN-GIVSMKSDVYSFGVLVLEIISSK 219
E ++ S D++S G + E+++ +
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202
>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain
pdb|4AT3|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Cpd5n
pdb|4AT4|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Ex429
pdb|4AT5|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Gw2580
Length = 299
Score = 85.9 bits (211), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 29/217 (13%)
Query: 26 LGQGGFGPVYKGKLL------DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG+G FG V+ + D +A+K L +S +F EA+L+ LQH ++V+
Sbjct: 21 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFI----------FDSSKKELLDWKKRFNIIEGIVQG 129
G ++ ++V+EY+ + L+ F+ + + L + +I + I G
Sbjct: 81 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG-- 187
++YL + +HRDL N L+ + + KI DFGM+R ++ + VG H
Sbjct: 141 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR-----DVYSTDYYRVGGHTML 192
Query: 188 ---YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKN 221
+M PE +M + +SDV+S GV++ EI + K
Sbjct: 193 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 229
>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex
pdb|1AD5|B Chain B, Src Family Kinase Hck-Amp-Pnp Complex
pdb|2HCK|A Chain A, Src Family Kinase Hck-Quercetin Complex
pdb|2HCK|B Chain B, Src Family Kinase Hck-Quercetin Complex
Length = 438
Score = 85.9 bits (211), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 71/271 (26%), Positives = 130/271 (47%), Gaps = 34/271 (12%)
Query: 24 NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
+LG G FG V+ ++A+K + K + F EA ++ LQH LV+L
Sbjct: 188 KKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV- 245
Query: 84 LQKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
+ K ++ E++ SL DF D K+ L K + I +G+ ++ + + I
Sbjct: 246 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YI 300
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
HRDL+A+NIL+ + KI+DFG+AR ++ + +PE + G ++K
Sbjct: 301 HRDLRAANILVSASLVCKIADFGLARVGAKFPIK-----------WTAPEAINFGSFTIK 349
Query: 203 SDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDE 262
SDV+SFG+L++EI++ + Y + ++ +ALE P+E
Sbjct: 350 SDVWSFGILLMEIVTYGRIP--YPGMSNPEVI----------RALERGYRMPRPENCPEE 397
Query: 263 VTRCIHVGLLCVQDKATDRPTMSDVASMLTN 293
+ ++ + C +++ +RPT + S+L +
Sbjct: 398 L---YNIMMRCWKNRPEERPTFEYIQSVLDD 425
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 85.9 bits (211), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 61/206 (29%), Positives = 116/206 (56%), Gaps = 11/206 (5%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 74
+NF ++G+G +G VYK + L G+ +A+K++ + +G+ E L+ +L H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 75 NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
N+V+LL + + LV+E+L ++ L F+ D+S + + + ++QGL + H
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
+ RV+HRDLK N+L++ + K++DFG+AR FG+ + T+ +V T Y +PE +
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 195 MN-GIVSMKSDVYSFGVLVLEIISSK 219
+ S D++S G + E+++ +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 85.9 bits (211), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 61/206 (29%), Positives = 116/206 (56%), Gaps = 11/206 (5%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 74
+NF ++G+G +G VYK + L G+ +A+K++ + +G+ E L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 75 NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
N+V+LL + + LV+E+L ++ L F+ D+S + + + ++QGL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
+ RV+HRDLK N+L++ + K++DFG+AR FG+ + T+ +V T Y +PE +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 174
Query: 195 MN-GIVSMKSDVYSFGVLVLEIISSK 219
+ S D++S G + E+++ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 85.9 bits (211), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 61/206 (29%), Positives = 116/206 (56%), Gaps = 11/206 (5%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 74
+NF ++G+G +G VYK + L G+ +A+K++ + +G+ E L+ +L H
Sbjct: 7 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 75 NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
N+V+LL + + LV+E+L ++ L F+ D+S + + + ++QGL + H
Sbjct: 67 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
+ RV+HRDLK N+L++ + K++DFG+AR FG+ + T+ +V T Y +PE +
Sbjct: 125 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 179
Query: 195 MN-GIVSMKSDVYSFGVLVLEIISSK 219
+ S D++S G + E+++ +
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMVTRR 205
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 85.9 bits (211), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 61/206 (29%), Positives = 116/206 (56%), Gaps = 11/206 (5%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 74
+NF ++G+G +G VYK + L G+ +A+K++ + +G+ E L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 75 NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
N+V+LL + + LV+E+L ++ L F+ D+S + + + ++QGL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
+ RV+HRDLK N+L++ + K++DFG+AR FG+ + T+ +V T Y +PE +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 174
Query: 195 MN-GIVSMKSDVYSFGVLVLEIISSK 219
+ S D++S G + E+++ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 85.5 bits (210), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 61/206 (29%), Positives = 116/206 (56%), Gaps = 11/206 (5%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 74
+NF ++G+G +G VYK + L G+ +A+K++ + +G+ E L+ +L H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 75 NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
N+V+LL + + LV+E+L ++ L F+ D+S + + + ++QGL + H
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
+ RV+HRDLK N+L++ + K++DFG+AR FG+ + T+ +V T Y +PE +
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 195 MN-GIVSMKSDVYSFGVLVLEIISSK 219
+ S D++S G + E+++ +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 85.5 bits (210), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 113/208 (54%), Gaps = 11/208 (5%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQ 72
+ +NF ++G+G +G VYK + L G+ +A+K++ + +G+ E L+ +L
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 73 HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
H N+V+LL + + LV+E+L DF D+S + + + ++QGL +
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFLHQDLKDFM--DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
H + RV+HRDLK N+L++ + K++DFG+AR FG+ + + +V T Y +PE
Sbjct: 119 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 173
Query: 193 YVMN-GIVSMKSDVYSFGVLVLEIISSK 219
++ S D++S G + E+++ +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 85.5 bits (210), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 61/206 (29%), Positives = 116/206 (56%), Gaps = 11/206 (5%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 74
+NF ++G+G +G VYK + L G+ +A+K++ + +G+ E L+ +L H
Sbjct: 10 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 75 NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
N+V+LL + + LV+E+L ++ L F+ D+S + + + ++QGL + H
Sbjct: 70 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
+ RV+HRDLK N+L++ + K++DFG+AR FG+ + T+ +V T Y +PE +
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 182
Query: 195 MN-GIVSMKSDVYSFGVLVLEIISSK 219
+ S D++S G + E+++ +
Sbjct: 183 LGCKYYSTAVDIWSLGCIFAEMVTRR 208
>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 85.5 bits (210), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 63/203 (31%), Positives = 106/203 (52%), Gaps = 21/203 (10%)
Query: 26 LGQGGFGPVYKGKL-LDGQE---IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLL 80
+G G G V G+L + GQ +AIK L + + +F +EA ++ + H N++RL
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 81 GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
G + ++V EY+ N SLD F+ + + + ++ G+ G+ YL S L
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI--MQLVGMLRGVGAGMRYL---SDLG 171
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------YMSPEYV 194
+HRDL A N+L+D + K+SDFG++R LE + + T G + +PE +
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRV-----LEDDPDAAXTTTGGKIPIRWTAPEAI 226
Query: 195 MNGIVSMKSDVYSFGVLVLEIIS 217
S SDV+SFGV++ E+++
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLA 249
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 85.5 bits (210), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 61/206 (29%), Positives = 116/206 (56%), Gaps = 11/206 (5%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 74
+NF ++G+G +G VYK + L G+ +A+K++ + +G+ E L+ +L H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 75 NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
N+V+LL + + LV+E+L ++ L F+ D+S + + + ++QGL + H
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
+ RV+HRDLK N+L++ + K++DFG+AR FG+ + T+ +V T Y +PE +
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 195 MN-GIVSMKSDVYSFGVLVLEIISSK 219
+ S D++S G + E+++ +
Sbjct: 176 LGXKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 85.5 bits (210), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 61/206 (29%), Positives = 116/206 (56%), Gaps = 11/206 (5%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 74
+NF ++G+G +G VYK + L G+ +A+K++ + +G+ E L+ +L H
Sbjct: 10 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 75 NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
N+V+LL + + LV+E+L ++ L F+ D+S + + + ++QGL + H
Sbjct: 70 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
+ RV+HRDLK N+L++ + K++DFG+AR FG+ + T+ +V T Y +PE +
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 182
Query: 195 MNG-IVSMKSDVYSFGVLVLEIISSK 219
+ S D++S G + E+++ +
Sbjct: 183 LGXKYYSTAVDIWSLGCIFAEMVTRR 208
>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 85.1 bits (209), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 63/203 (31%), Positives = 106/203 (52%), Gaps = 21/203 (10%)
Query: 26 LGQGGFGPVYKGKL-LDGQE---IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLL 80
+G G G V G+L + GQ +AIK L + + +F +EA ++ + H N++RL
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 81 GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
G + ++V EY+ N SLD F+ + + + ++ G+ G+ YL S L
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI--MQLVGMLRGVGAGMRYL---SDLG 171
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------YMSPEYV 194
+HRDL A N+L+D + K+SDFG++R LE + + T G + +PE +
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRV-----LEDDPDAAYTTTGGKIPIRWTAPEAI 226
Query: 195 MNGIVSMKSDVYSFGVLVLEIIS 217
S SDV+SFGV++ E+++
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLA 249
>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase
pdb|3COM|B Chain B, Crystal Structure Of Mst1 Kinase
Length = 314
Score = 85.1 bits (209), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 62/220 (28%), Positives = 113/220 (51%), Gaps = 11/220 (5%)
Query: 2 KRDLKIFDFQTIAAATDN-FSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIV 59
+R LK D ++ + F +LG+G +G VYK + GQ +AIK++ S +
Sbjct: 12 RRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQ 69
Query: 60 EFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKR 119
E E ++ + ++V+ G + + +V EY S+ I + + L +
Sbjct: 70 EIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEI 127
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
I++ ++GL YLH +R IHRD+KA NILL+ + + K++DFG+A + + A
Sbjct: 128 ATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQ--LTDXMAKR 182
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
N ++GT +M+PE + + +D++S G+ +E+ K
Sbjct: 183 NXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 85.1 bits (209), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 113/209 (54%), Gaps = 11/209 (5%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKL 71
+ +NF ++G+G +G VYK + L G+ +A+K++ + +G+ E L+ +L
Sbjct: 2 GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
H N+V+LL + + LV+E+L DF D+S + + + ++QGL
Sbjct: 62 NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFM--DASALTGIPLPLIKSYLFQLLQGLA 119
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
+ H + RV+HRDLK N+L++ + K++DFG+AR FG+ + + +V T Y +P
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAP 174
Query: 192 EYVMN-GIVSMKSDVYSFGVLVLEIISSK 219
E ++ S D++S G + E+++ +
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 85.1 bits (209), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 61/206 (29%), Positives = 116/206 (56%), Gaps = 11/206 (5%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 74
+NF ++G+G +G VYK + L G+ +A+K++ + +G+ E L+ +L H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 75 NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
N+V+LL + + LV+E+L ++ L F+ D+S + + + ++QGL + H
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
+ RV+HRDLK N+L++ + K++DFG+AR FG+ + T+ +V T Y +PE +
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 195 MN-GIVSMKSDVYSFGVLVLEIISSK 219
+ S D++S G + E+++ +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 85.1 bits (209), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 113/209 (54%), Gaps = 11/209 (5%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKL 71
+ +NF ++G+G +G VYK + L G+ +A+K++ + +G+ E L+ +L
Sbjct: 3 GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
H N+V+LL + + LV+E+L DF D+S + + + ++QGL
Sbjct: 63 NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFM--DASALTGIPLPLIKSYLFQLLQGLA 120
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
+ H + RV+HRDLK N+L++ + K++DFG+AR FG+ + + +V T Y +P
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAP 175
Query: 192 EYVMN-GIVSMKSDVYSFGVLVLEIISSK 219
E ++ S D++S G + E+++ +
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204
>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
pdb|3GGF|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
Length = 301
Score = 84.7 bits (208), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 64/226 (28%), Positives = 117/226 (51%), Gaps = 15/226 (6%)
Query: 13 IAAATDNFSPGNRLGQGGFGPVYKGKLLDG---QEIAIKRLS-KSSGQGIVEFKNEAKLI 68
IA + F+ R+G+G FG V+KG +D Q +AIK + + + I + + E ++
Sbjct: 18 IADPEELFTKLERIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVL 75
Query: 69 AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ 128
++ + + + G L+ + ++ EYL S D + D + +++ I++
Sbjct: 76 SQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILK 131
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
GL YLH + IHRD+KA+N+LL +Q + K++DFG+A +++ NT VGT +
Sbjct: 132 GLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFW 186
Query: 189 MSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
M+PE + K+D++S G+ +E+ + N R L L+
Sbjct: 187 MAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI 232
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 84.7 bits (208), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 116/206 (56%), Gaps = 11/206 (5%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 74
+NF ++G+G +G VYK + L G+ +A+K++ + +G+ E L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 75 NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
N+V+LL + + LV+E++ ++ L F+ D+S + + + ++QGL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEHV-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
+ RV+HRDLK N+L++ + K++DFG+AR FG+ + T+ +V T Y +PE +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 174
Query: 195 MN-GIVSMKSDVYSFGVLVLEIISSK 219
+ S D++S G + E+++ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200
>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain
pdb|3P08|B Chain B, Crystal Structure Of The Human Btk Kinase Domain
Length = 267
Score = 84.7 bits (208), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 59/192 (30%), Positives = 97/192 (50%), Gaps = 7/192 (3%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
LG G FG V GK ++AIK + K EF EAK++ L H LV+L G +
Sbjct: 16 LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 86 KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRD 145
+ ++ EY+ N L ++ + + ++ + + + + + YL + +HRD
Sbjct: 75 QRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES---KQFLHRD 129
Query: 146 LKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDV 205
L A N L++DQ K+SDFG++R +E ++ + PE +M S KSD+
Sbjct: 130 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-WSPPEVLMYSKFSSKSDI 188
Query: 206 YSFGVLVLEIIS 217
++FGVL+ EI S
Sbjct: 189 WAFGVLMWEIYS 200
>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
pdb|1M7N|B Chain B, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
Length = 322
Score = 84.7 bits (208), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 86/319 (26%), Positives = 148/319 (46%), Gaps = 38/319 (11%)
Query: 16 ATDNFSPGNRLGQGGFGPVY----KGKLLDGQE--IAIKRLSKS-SGQGIVEFKNEAKLI 68
A + + LGQG FG VY KG + D E +AIK ++++ S + +EF NEA ++
Sbjct: 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 69 AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLD--------WKKRF 120
+ ++VRLLG Q L++ E + L ++ S + E+ + K
Sbjct: 83 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMI 141
Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
+ I G+ YL+ + +HRDL A N ++ + KI DFGM R +
Sbjct: 142 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQ 239
+ + +MSPE + +G+ + SDV+SFGV++ EI + +++ E+ L V
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV----- 253
Query: 240 LWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP 299
EG L+ D +C PD + + +C Q RP+ ++ S + + P
Sbjct: 254 --MEGGLLDKPD-----NC-PDMLFELMR---MCWQYNPKMRPSFLEIISSIKEEME--P 300
Query: 300 TPRQPAFFINISSDYEEPE 318
R+ +F+ + + EPE
Sbjct: 301 GFREVSFYYSEENKLPEPE 319
>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Isopropyl-7-
(4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3-
Ylamino)-2h- Phthalazin-1-One
pdb|3PIY|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With R406
pdb|3PIZ|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
(5-Amino-1-O-
Tolyl-1h-Pyrazol-4-Yl)-[3-(1-Methanesulfonyl-Piperidin-
4-Yl)-Phenyl]- Methanone
pdb|3PJ1|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
3-(2,6-Dichloro-
Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-Phenylamino]-1-
Methyl-3,4- Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3PJ2|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-[4-(2-
Diethylamino-Ethoxy)-Phenylamino]-6-(4-Fluoro-Phenoxy)-
8-Methyl-8h- Pyrido[2,3-D]pyrimidin-7-One
pdb|3PJ3|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Methyl-5-[(E)-
(3-Phenyl-Acryloyl)amino]-N-(2-Phenyl-3h-Imidazo[4,
5-B]pyridin-6-Yl)- Benzamide
Length = 274
Score = 84.3 bits (207), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 60/195 (30%), Positives = 99/195 (50%), Gaps = 7/195 (3%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
LG G FG V GK ++AIK + + S EF EAK++ L H LV+L G +
Sbjct: 23 LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 86 KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRD 145
+ ++ EY+ N L ++ + + ++ + + + + + YL + +HRD
Sbjct: 82 QRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES---KQFLHRD 136
Query: 146 LKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDV 205
L A N L++DQ K+SDFG++R +E ++ + PE +M S KSD+
Sbjct: 137 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-WSPPEVLMYSKFSSKSDI 195
Query: 206 YSFGVLVLEIISSKK 220
++FGVL+ EI S K
Sbjct: 196 WAFGVLMWEIYSLGK 210
>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|1RQQ|B Chain B, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|2AUH|A Chain A, Crystal Structure Of The Grb14 Bps Region In Complex With
The Insulin Receptor Tyrosine Kinase
pdb|2B4S|B Chain B, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|2B4S|D Chain D, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|3BU3|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide
pdb|3BU5|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide And Atp
pdb|3BU6|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Phosphopeptide
Length = 306
Score = 84.3 bits (207), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 75/284 (26%), Positives = 135/284 (47%), Gaps = 34/284 (11%)
Query: 26 LGQGGFGPVYKGKLLD---GQ---EIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVR 78
LGQG FG VY+G D G+ +A+K +++S+ + +EF NEA ++ ++VR
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFIF-------DSSKKELLDWKKRFNIIEGIVQGLL 131
LLG + L+V E + + L ++ ++ + ++ + I G+
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
YL+ + +HRDL A N ++ KI DFGM R + + + +M+P
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELI 250
E + +G+ + SD++SFGV++ EI S +++ E+ L V +G L+
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-------MDGGYLDQP 254
Query: 251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND 294
D +C P+ VT + +C Q RPT ++ ++L +D
Sbjct: 255 D-----NC-PERVTDLMR---MCWQFNPNMRPTFLEIVNLLKDD 289
>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine
Kinase Bound To A Pyrrolopyrimidine-Containing Compound
Length = 283
Score = 84.3 bits (207), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 60/195 (30%), Positives = 99/195 (50%), Gaps = 7/195 (3%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
LG G FG V GK ++AIK + + S EF EAK++ L H LV+L G +
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 86 KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRD 145
+ ++ EY+ N L ++ + + ++ + + + + + YL + +HRD
Sbjct: 91 QRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES---KQFLHRD 145
Query: 146 LKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDV 205
L A N L++DQ K+SDFG++R +E ++ + PE +M S KSD+
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-WSPPEVLMYSKFSSKSDI 204
Query: 206 YSFGVLVLEIISSKK 220
++FGVL+ EI S K
Sbjct: 205 WAFGVLMWEIYSLGK 219
>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex
With Inhibitor Cgi1746
Length = 271
Score = 84.3 bits (207), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 60/195 (30%), Positives = 99/195 (50%), Gaps = 7/195 (3%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
LG G FG V GK ++AIK + + S EF EAK++ L H LV+L G +
Sbjct: 17 LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 86 KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRD 145
+ ++ EY+ N L ++ + + ++ + + + + + YL + +HRD
Sbjct: 76 QRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES---KQFLHRD 130
Query: 146 LKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDV 205
L A N L++DQ K+SDFG++R +E ++ + PE +M S KSD+
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-WSPPEVLMYSKFSSKSDI 189
Query: 206 YSFGVLVLEIISSKK 220
++FGVL+ EI S K
Sbjct: 190 WAFGVLMWEIYSLGK 204
>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain
pdb|1K2P|B Chain B, Crystal Structure Of Bruton's Tyrosine Kinase Domain
Length = 263
Score = 84.3 bits (207), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 59/192 (30%), Positives = 97/192 (50%), Gaps = 7/192 (3%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
LG G FG V GK ++AIK + K EF EAK++ L H LV+L G +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 86 KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRD 145
+ ++ EY+ N L ++ + + ++ + + + + + YL + +HRD
Sbjct: 71 QRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK---QFLHRD 125
Query: 146 LKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDV 205
L A N L++DQ K+SDFG++R +E ++ + PE +M S KSD+
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-WSPPEVLMYSKFSSKSDI 184
Query: 206 YSFGVLVLEIIS 217
++FGVL+ EI S
Sbjct: 185 WAFGVLMWEIYS 196
>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex
With A Staurosporine Analogue
Length = 290
Score = 84.3 bits (207), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 80/277 (28%), Positives = 133/277 (48%), Gaps = 16/277 (5%)
Query: 24 NRLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVR 78
++LG+G FG V + L D G +A+K+L S +F+ E +++ L +V+
Sbjct: 13 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 79 LLGCSLQKG--ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
G S G E LV EYLP+ L F+ + LD + I +G+ YL
Sbjct: 73 YRGVSYGPGRPELRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLG-- 128
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYV 194
SR R +HRDL A NIL++ + + KI+DFG+A+ +++ + R G + +PE +
Sbjct: 129 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK-DXXVVREPGQSPIFWYAPESL 186
Query: 195 MNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTL 254
+ I S +SDV+SFGV++ E+ + + C + L ++G + + LEL++
Sbjct: 187 SDNIFSRQSDVWSFGVVLYELF-TYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQ 245
Query: 255 HESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
P + LC DRP+ S + L
Sbjct: 246 RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 282
>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And
Inactive Conformations Suggests A Mechanism Of
Activation For Tec Family Kinases
Length = 283
Score = 84.3 bits (207), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 60/195 (30%), Positives = 102/195 (52%), Gaps = 7/195 (3%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
LG G FG V GK ++AIK + + S EF EAK++ L H LV+L G +
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 86 KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRD 145
+ ++ EY+ N L ++ + + ++ + + + + + YL + +HRD
Sbjct: 91 QRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK---QFLHRD 145
Query: 146 LKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDV 205
L A N L++DQ K+SDFG++R + +++ E ++ + PE +M S KSD+
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSR-YVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDI 204
Query: 206 YSFGVLVLEIISSKK 220
++FGVL+ EI S K
Sbjct: 205 WAFGVLMWEIYSLGK 219
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 84.3 bits (207), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 116/209 (55%), Gaps = 11/209 (5%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKL 71
+ +NF ++G+G +G VYK + L G+ +A+K++ + +G+ E L+ +L
Sbjct: 3 GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
H N+V+LL + + LV+E+L ++ L F+ D+S + + + ++QGL
Sbjct: 63 NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLA 120
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
+ H + RV+HRDLK N+L++ + K++DFG+AR FG+ + + +V T Y +P
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAP 175
Query: 192 EYVMN-GIVSMKSDVYSFGVLVLEIISSK 219
E ++ S D++S G + E+++ +
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204
>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With Peptide Substrate And Atp Analog
pdb|1GAG|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With A Bisubstrate Inhibitor
Length = 306
Score = 84.3 bits (207), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 75/284 (26%), Positives = 135/284 (47%), Gaps = 34/284 (11%)
Query: 26 LGQGGFGPVYKGKLLD---GQ---EIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVR 78
LGQG FG VY+G D G+ +A+K +++S+ + +EF NEA ++ ++VR
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFIF-------DSSKKELLDWKKRFNIIEGIVQGLL 131
LLG + L+V E + + L ++ ++ + ++ + I G+
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
YL+ + +HRDL A N ++ KI DFGM R + + + +M+P
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELI 250
E + +G+ + SD++SFGV++ EI S +++ E+ L V +G L+
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-------MDGGYLDQP 254
Query: 251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND 294
D +C P+ VT + +C Q RPT ++ ++L +D
Sbjct: 255 D-----NC-PERVTDLMR---MCWQFNPKMRPTFLEIVNLLKDD 289
>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase
Domain
Length = 317
Score = 84.3 bits (207), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 80/296 (27%), Positives = 133/296 (44%), Gaps = 46/296 (15%)
Query: 18 DNFSPGNRLGQGGFGPVYKGKLLD-GQE-----IAIKRLSKSSGQGIVE-FKNEAKLIAK 70
+N G LG G FG V + G+E +A+K L ++ E +E K+++
Sbjct: 38 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 71 L-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKEL-------LDWKKRFNI 122
L QH N+V LLG G L++ EY L F+ ++ +L L+ + +
Sbjct: 98 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 157
Query: 123 IEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI 182
+ QG+ +L + IHRD+ A N+LL + KI DFG+AR MN+ +N I
Sbjct: 158 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI-MND----SNYI 209
Query: 183 VGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKN--NGCYDTERHLNLVG 235
V + +M+PE + + + +++SDV+S+G+L+ EI S N G + LV
Sbjct: 210 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 269
Query: 236 YAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
+Q+ + +P + + C + T RPT + S L
Sbjct: 270 DGYQM-------------AQPAFAPKNIYSIMQA---CWALEPTHRPTFQQICSFL 309
>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2-
Yl]amino}phenyl)acetic Acid
Length = 303
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 75/284 (26%), Positives = 135/284 (47%), Gaps = 34/284 (11%)
Query: 26 LGQGGFGPVYKGKLLD---GQ---EIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVR 78
LGQG FG VY+G D G+ +A+K +++S+ + +EF NEA ++ ++VR
Sbjct: 22 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFIF-------DSSKKELLDWKKRFNIIEGIVQGLL 131
LLG + L+V E + + L ++ ++ + ++ + I G+
Sbjct: 82 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
YL+ + +HRDL A N ++ KI DFGM R + + + +M+P
Sbjct: 142 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELI 250
E + +G+ + SD++SFGV++ EI S +++ E+ L V +G L+
Sbjct: 199 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-------MDGGYLDQP 251
Query: 251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND 294
D +C P+ VT + +C Q RPT ++ ++L +D
Sbjct: 252 D-----NC-PERVTDLMR---MCWQFNPKMRPTFLEIVNLLKDD 286
>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWV|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWW|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWX|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWY|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWZ|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX0|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX1|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2X9F|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2XVD|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|4BB4|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
Length = 302
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 72/275 (26%), Positives = 128/275 (46%), Gaps = 30/275 (10%)
Query: 26 LGQGGFGPVYKGKL-LDGQE---IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLL 80
+G G FG V +G+L G++ +AIK L + + EF +EA ++ + +H N++RL
Sbjct: 24 IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 81 GCSLQKGERLLVYEYLPNKSLDFFI-FDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
G +++ E++ N +LD F+ + + ++ + ++ GI G+ YL + S
Sbjct: 84 GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI---QLVGMLRGIASGMRYLAEMS-- 138
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH---GYMSPEYVMN 196
+HRDL A NIL++ + K+SDFG++R N + +G + +PE +
Sbjct: 139 -YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAF 197
Query: 197 GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHE 256
+ SD +S+G+++ E++S ER W + N+ + I+
Sbjct: 198 RKFTSASDAWSYGIVMWEVMSF--------GERPY------WDMSNQ-DVINAIEQDYRL 242
Query: 257 SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
PD T + L C Q RP V S L
Sbjct: 243 PPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSAL 277
>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain
pdb|2IVU|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Zd6474
pdb|2X2K|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2L|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|B Chain B, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
Length = 314
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 89/318 (27%), Positives = 145/318 (45%), Gaps = 52/318 (16%)
Query: 5 LKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKL--LDGQE----IAIKRLSK-SSGQG 57
KI + N G LG+G FG V K L G+ +A+K L + +S
Sbjct: 10 FKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE 69
Query: 58 IVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK------- 110
+ + +E ++ ++ H ++++L G Q G LL+ EY SL F+ +S K
Sbjct: 70 LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLG 129
Query: 111 ------KELLDWKKRFNIIEG--------IVQGLLYLHKYSRLRVIHRDLKASNILLDDQ 156
LD + G I QG+ YL + ++++HRDL A NIL+ +
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEG 186
Query: 157 MNPKISDFGMARTFGMNELEANTNRIVG--THGYMSPEYVMNGIVSMKSDVYSFGVLVLE 214
KISDFG++R + E ++ R G +M+ E + + I + +SDV+SFGVL+ E
Sbjct: 187 RKMKISDFGLSRD--VYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244
Query: 215 IISSKKNN-GCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLC 273
I++ N ER NL+ G +E D +CS +E+ R + L C
Sbjct: 245 IVTLGGNPYPGIPPERLFNLL-------KTGHRMERPD-----NCS-EEMYRLM---LQC 288
Query: 274 VQDKATDRPTMSDVASML 291
+ + RP +D++ L
Sbjct: 289 WKQEPDKRPVFADISKDL 306
>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
pdb|3S95|B Chain B, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
Length = 310
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 20/208 (9%)
Query: 23 GNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
G LG+G FG K + G+ + +K L + + F E K++ L+H N+++ +G
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 82 CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
L K +RL + EY+ +L I S W +R + + I G+ YLH +
Sbjct: 75 V-LYKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHS---MN 128
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTF--------GMNELEANTNR----IVGTHGY 188
+IHRDL + N L+ + N ++DFG+AR G+ L+ + +VG +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 189 MSPEYVMNGIVSMKSDVYSFGVLVLEII 216
M+PE + K DV+SFG+++ EII
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEII 216
>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742a Triple Mutant
Length = 373
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 75/284 (26%), Positives = 124/284 (43%), Gaps = 36/284 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVE-----FKNEAKLIAKLQH 73
N S +G G FG V G+L + I K+ G E F EA ++ + H
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74 TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
N++RL G + ++V E + N SLD F+ + + + ++ GI G+ YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL 163
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------ 187
S + +HRDL A NIL++ + K+SDFG++R LE + T G
Sbjct: 164 ---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRV-----LEDDPEAAYTTRGGKIPIR 215
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
+ SPE + + SDV+S+G+++ E++S ER W++ N+ +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------ERPY------WEMSNQ-DVI 260
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
+ +D D + L C Q +RP + S+L
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 61/210 (29%), Positives = 115/210 (54%), Gaps = 13/210 (6%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKL 71
+ +NF ++G+G +G VYK + L G+ +A+K++ + +G+ E L+ +L
Sbjct: 3 GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIF-DSSKKELLDWKKRFNIIEGIVQGL 130
H N+V+LL + + LV+E+L S+D F D+S + + + ++QGL
Sbjct: 63 NHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMS 190
+ H + RV+HRDLK N+L++ + K++DFG+AR FG+ + + +V T Y +
Sbjct: 120 AFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRA 174
Query: 191 PEYVMN-GIVSMKSDVYSFGVLVLEIISSK 219
PE ++ S D++S G + E+++ +
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204
>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor
Kinase
Length = 299
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 65/217 (29%), Positives = 108/217 (49%), Gaps = 19/217 (8%)
Query: 16 ATDNFSPGNRLGQGGFGPVY----KGKLLDGQE--IAIKRLSKS-SGQGIVEFKNEAKLI 68
A + + LGQG FG VY KG + D E +AIK ++++ S + +EF NEA ++
Sbjct: 8 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 67
Query: 69 AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLD--------WKKRF 120
+ ++VRLLG Q L++ E + L ++ S + E+ + K
Sbjct: 68 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMI 126
Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
+ I G+ YL+ + +HRDL A N ++ + KI DFGM R +
Sbjct: 127 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGG 183
Query: 181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
+ + +MSPE + +G+ + SDV+SFGV++ EI +
Sbjct: 184 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220
>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r
In Complex With Dasatinib
Length = 265
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 60/195 (30%), Positives = 99/195 (50%), Gaps = 7/195 (3%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
LG G FG V GK ++AIK + + S EF EAK++ L H LV+L G +
Sbjct: 17 LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 86 KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRD 145
+ ++ EY+ N L ++ + + ++ + + + + + YL + +HRD
Sbjct: 76 QRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES---KQFLHRD 130
Query: 146 LKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDV 205
L A N L++DQ K+SDFG++R +E ++ + PE +M S KSD+
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVR-WSPPEVLMYSKFSSKSDI 189
Query: 206 YSFGVLVLEIISSKK 220
++FGVL+ EI S K
Sbjct: 190 WAFGVLMWEIYSLGK 204
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 61/210 (29%), Positives = 115/210 (54%), Gaps = 13/210 (6%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKL 71
+ +NF ++G+G +G VYK + L G+ +A+K++ + +G+ E L+ +L
Sbjct: 1 GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIF-DSSKKELLDWKKRFNIIEGIVQGL 130
H N+V+LL + + LV+E+L S+D F D+S + + + ++QGL
Sbjct: 61 NHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMS 190
+ H + RV+HRDLK N+L++ + K++DFG+AR FG+ + + +V T Y +
Sbjct: 118 AFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRA 172
Query: 191 PEYVMN-GIVSMKSDVYSFGVLVLEIISSK 219
PE ++ S D++S G + E+++ +
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202
>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation
pdb|2JIT|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation
Length = 327
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 114/215 (53%), Gaps = 22/215 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG G FG VYKG + E +AIK L ++ S + E +EA ++A + + ++ RL
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
LG L +L++ + +P L ++ + + LL+W + I +G+ YL
Sbjct: 83 LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 135
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
R++HRDL A N+L+ + KI+DFG+A+ G E E + +M+ E ++
Sbjct: 136 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
+ I + +SDV+S+GV V E+++ SK +G +E
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227
>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5)
Length = 295
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 77/280 (27%), Positives = 134/280 (47%), Gaps = 42/280 (15%)
Query: 26 LGQGGFGPVYKGKL-LDGQE---IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLL 80
+G G FG V G+L L G+ +AIK L + + +F EA ++ + H N++ L
Sbjct: 30 IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 81 GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
G + ++V EY+ N SLD F+ + + + + ++ GI G+ YL S +
Sbjct: 90 GVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTV--IQLVGMLRGISAGMKYL---SDMG 144
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------YMSPEYV 194
+HRDL A NIL++ + K+SDFG++R LE + T G + +PE +
Sbjct: 145 YVHRDLAARNILINSNLVCKVSDFGLSRV-----LEDDPEAAYTTRGGKIPIRWTAPEAI 199
Query: 195 MNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEG--KALELIDT 252
+ SDV+S+G+++ E++S ER W++ N+ KA+E
Sbjct: 200 AFRKFTSASDVWSYGIVMWEVVSY--------GERPY------WEMTNQDVIKAVE---- 241
Query: 253 TLHESCSPDEVTRCIHVGLL-CVQDKATDRPTMSDVASML 291
+ SP + ++ +L C Q + RP ++ +ML
Sbjct: 242 EGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNML 281
>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFD|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|C Chain C, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|D Chain D, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
Length = 324
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG G FG VYKG + E +AIK L ++ S + E +EA ++A + + ++ RL
Sbjct: 20 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 79
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
LG L +L+ + +P L ++ + + LL+W + I +G+ YL
Sbjct: 80 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAEGMNYLED 132
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
R++HRDL A N+L+ + KI+DFG+A+ G E E + +M+ E ++
Sbjct: 133 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 189
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
+ I + +SDV+S+GV V E+++ SK +G +E
Sbjct: 190 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 224
>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain
Of Csf-1r
Length = 329
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 80/296 (27%), Positives = 133/296 (44%), Gaps = 46/296 (15%)
Query: 18 DNFSPGNRLGQGGFGPVYKGKLLD-GQE-----IAIKRLSKSSGQGIVE-FKNEAKLIAK 70
+N G LG G FG V + G+E +A+K L ++ E +E K+++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 71 L-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKEL-------LDWKKRFNI 122
L QH N+V LLG G L++ EY L F+ ++ +L L+ + +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 165
Query: 123 IEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI 182
+ QG+ +L + IHRD+ A N+LL + KI DFG+AR MN+ +N I
Sbjct: 166 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI-MND----SNYI 217
Query: 183 VGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKN--NGCYDTERHLNLVG 235
V + +M+PE + + + +++SDV+S+G+L+ EI S N G + LV
Sbjct: 218 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 277
Query: 236 YAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
+Q+ + +P + + C + T RPT + S L
Sbjct: 278 DGYQM-------------AQPAFAPKNIYSIMQA---CWALEPTHRPTFQQICSFL 317
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 116/209 (55%), Gaps = 11/209 (5%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKL 71
+ +NF ++G+G +G VYK + L G+ +A+K++ + +G+ E L+ +L
Sbjct: 3 GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
H N+V+LL + + LV+E+L ++ L F+ D+S + + + ++QGL
Sbjct: 63 NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 120
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
+ H + RV+HRDLK N+L++ + K++DFG+AR FG+ + + +V T Y +P
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAP 175
Query: 192 EYVMN-GIVSMKSDVYSFGVLVLEIISSK 219
E ++ S D++S G + E+++ +
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 116/209 (55%), Gaps = 11/209 (5%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKL 71
+ +NF ++G+G +G VYK + L G+ +A+K++ + +G+ E L+ +L
Sbjct: 2 GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
H N+V+LL + + LV+E+L ++ L F+ D+S + + + ++QGL
Sbjct: 62 NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 119
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
+ H + RV+HRDLK N+L++ + K++DFG+AR FG+ + + +V T Y +P
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAP 174
Query: 192 EYVMN-GIVSMKSDVYSFGVLVLEIISSK 219
E ++ S D++S G + E+++ +
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203
>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor
pdb|2RGP|A Chain A, Structure Of Egfr In Complex With Hydrazone, A Potent Dual
Inhibitor
Length = 315
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG G FG VYKG + E +AIK L ++ S + E +EA ++A + + ++ RL
Sbjct: 17 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDSS----KKELLDWKKRFNIIEGIVQGLLYLHK 135
LG L +L+ + +P L ++ + + LL+W + I +G+ YL
Sbjct: 77 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 129
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
R++HRDL A N+L+ + KI+DFG+A+ G E E + +M+ E ++
Sbjct: 130 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
+ I + +SDV+S+GV V E+++ SK +G +E
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 221
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 115/206 (55%), Gaps = 11/206 (5%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 74
+NF ++G+G +G VYK + L G+ +A+ ++ + +G+ E L+ +L H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 75 NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
N+V+LL + + LV+E+L ++ L F+ D+S + + + ++QGL + H
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
+ RV+HRDLK N+L++ + K++DFG+AR FG+ + T+ +V T Y +PE +
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 195 MN-GIVSMKSDVYSFGVLVLEIISSK 219
+ S D++S G + E+++ +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 115/206 (55%), Gaps = 11/206 (5%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 74
+NF ++G+G +G VYK + L G+ +A+ ++ + +G+ E L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 75 NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
N+V+LL + + LV+E+L ++ L F+ D+S + + + ++QGL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
+ RV+HRDLK N+L++ + K++DFG+AR FG+ + T+ +V T Y +PE +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 174
Query: 195 MN-GIVSMKSDVYSFGVLVLEIISSK 219
+ S D++S G + E+++ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 116/208 (55%), Gaps = 11/208 (5%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQ 72
+ +NF ++G+G +G VYK + L G+ +A+K++ + +G+ E L+ +L
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 73 HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
H N+V+LL + + LV+E+L ++ L F+ D+S + + + ++QGL +
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
H + RV+HRDLK N+L++ + K++DFG+AR FG+ + + +V T Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 173
Query: 193 YVMN-GIVSMKSDVYSFGVLVLEIISSK 219
++ S D++S G + E+++ +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole
Inhibitor
Length = 291
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 72/275 (26%), Positives = 128/275 (46%), Gaps = 30/275 (10%)
Query: 26 LGQGGFGPVYKGKL-LDGQE---IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLL 80
+G G FG V +G+L G++ +AIK L + + EF +EA ++ + +H N++RL
Sbjct: 22 IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 81 GCSLQKGERLLVYEYLPNKSLDFFI-FDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
G +++ E++ N +LD F+ + + ++ + ++ GI G+ YL + S
Sbjct: 82 GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI---QLVGMLRGIASGMRYLAEMS-- 136
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH---GYMSPEYVMN 196
+HRDL A NIL++ + K+SDFG++R N + +G + +PE +
Sbjct: 137 -YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAF 195
Query: 197 GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHE 256
+ SD +S+G+++ E++S ER W + N+ + I+
Sbjct: 196 RKFTSASDAWSYGIVMWEVMSF--------GERPY------WDMSNQ-DVINAIEQDYRL 240
Query: 257 SCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
PD T + L C Q RP V S L
Sbjct: 241 PPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSAL 275
>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
pdb|3IKA|B Chain B, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
Length = 331
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 114/215 (53%), Gaps = 22/215 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG G FG VYKG + E +AIK L ++ S + E +EA ++A + + ++ RL
Sbjct: 27 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
LG L +L++ + +P L ++ + + LL+W + I +G+ YL
Sbjct: 87 LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 139
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
R++HRDL A N+L+ + KI+DFG+A+ G E E + +M+ E ++
Sbjct: 140 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 196
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
+ I + +SDV+S+GV V E+++ SK +G +E
Sbjct: 197 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 231
>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor
Receptor
pdb|1M17|A Chain A, Epidermal Growth Factor Receptor Tyrosine Kinase Domain
With 4-Anilinoquinazoline Inhibitor Erlotinib
Length = 333
Score = 83.6 bits (205), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG G FG VYKG + E +AIK L ++ S + E +EA ++A + + ++ RL
Sbjct: 29 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 88
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
LG L +L+ + +P L ++ + + LL+W + I +G+ YL
Sbjct: 89 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 141
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
R++HRDL A N+L+ + KI+DFG+A+ G E E + +M+ E ++
Sbjct: 142 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 198
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
+ I + +SDV+S+GV V E+++ SK +G +E
Sbjct: 199 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 233
>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
pdb|2IVS|B Chain B, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
Length = 314
Score = 83.6 bits (205), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 89/318 (27%), Positives = 145/318 (45%), Gaps = 52/318 (16%)
Query: 5 LKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKL--LDGQE----IAIKRLSK-SSGQG 57
KI + N G LG+G FG V K L G+ +A+K L + +S
Sbjct: 10 FKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE 69
Query: 58 IVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK------- 110
+ + +E ++ ++ H ++++L G Q G LL+ EY SL F+ +S K
Sbjct: 70 LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLG 129
Query: 111 ------KELLDWKKRFNIIEG--------IVQGLLYLHKYSRLRVIHRDLKASNILLDDQ 156
LD + G I QG+ YL + ++++HRDL A NIL+ +
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEG 186
Query: 157 MNPKISDFGMARTFGMNELEANTNRIVG--THGYMSPEYVMNGIVSMKSDVYSFGVLVLE 214
KISDFG++R + E ++ R G +M+ E + + I + +SDV+SFGVL+ E
Sbjct: 187 RKMKISDFGLSRD--VYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244
Query: 215 IISSKKNN-GCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLC 273
I++ N ER NL+ G +E D +CS +E+ R + L C
Sbjct: 245 IVTLGGNPYPGIPPERLFNLL-------KTGHRMERPD-----NCS-EEMYRLM---LQC 288
Query: 274 VQDKATDRPTMSDVASML 291
+ + RP +D++ L
Sbjct: 289 WKQEPDKRPVFADISKDL 306
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 83.6 bits (205), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 116/208 (55%), Gaps = 11/208 (5%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQ 72
+ +NF ++G+G +G VYK + L G+ +A+K++ + +G+ E L+ +L
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 73 HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
H N+V+LL + + LV+E+L ++ L F+ D+S + + + ++QGL +
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
H + RV+HRDLK N+L++ + K++DFG+AR FG+ + + +V T Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 173
Query: 193 YVMN-GIVSMKSDVYSFGVLVLEIISSK 219
++ S D++S G + E+++ +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 83.6 bits (205), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 116/208 (55%), Gaps = 11/208 (5%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQ 72
+ +NF ++G+G +G VYK + L G+ +A+K++ + +G+ E L+ +L
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 73 HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
H N+V+LL + + LV+E+L ++ L F+ D+S + + + ++QGL +
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
H + RV+HRDLK N+L++ + K++DFG+AR FG+ + + +V T Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 173
Query: 193 YVMN-GIVSMKSDVYSFGVLVLEIISSK 219
++ S D++S G + E+++ +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 83.6 bits (205), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 115/206 (55%), Gaps = 11/206 (5%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 74
+NF ++G+G +G VYK + L G+ +A+K++ + +G+ E L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 75 NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
N+V+LL + + LV+E+L ++ L F+ D+S + + + ++QGL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
+ RV+HRDLK N+L++ + K++DFG+AR FG+ + + +V T Y +PE +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEIL 174
Query: 195 MN-GIVSMKSDVYSFGVLVLEIISSK 219
+ S D++S G + E+++ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200
>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
pdb|2JIU|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
Length = 328
Score = 83.6 bits (205), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 114/215 (53%), Gaps = 22/215 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG G FG VYKG + E +AIK L ++ S + E +EA ++A + + ++ RL
Sbjct: 24 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
LG L +L++ + +P L ++ + + LL+W + I +G+ YL
Sbjct: 84 LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 136
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
R++HRDL A N+L+ + KI+DFG+A+ G E E + +M+ E ++
Sbjct: 137 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 193
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
+ I + +SDV+S+GV V E+++ SK +G +E
Sbjct: 194 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 228
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 83.6 bits (205), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 116/209 (55%), Gaps = 11/209 (5%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKL 71
+ +NF ++G+G +G VYK + L G+ +A+K++ + +G+ E L+ +L
Sbjct: 2 GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
H N+V+LL + + LV+E+L ++ L F+ D+S + + + ++QGL
Sbjct: 62 NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 119
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
+ H + RV+HRDLK N+L++ + K++DFG+AR FG+ + + +V T Y +P
Sbjct: 120 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAP 174
Query: 192 EYVMN-GIVSMKSDVYSFGVLVLEIISSK 219
E ++ S D++S G + E+++ +
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 83.6 bits (205), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 116/209 (55%), Gaps = 11/209 (5%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKL 71
+ +NF ++G+G +G VYK + L G+ +A+K++ + +G+ E L+ +L
Sbjct: 2 GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
H N+V+LL + + LV+E+L ++ L F+ D+S + + + ++QGL
Sbjct: 62 NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 119
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
+ H + RV+HRDLK N+L++ + K++DFG+AR FG+ + + +V T Y +P
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAP 174
Query: 192 EYVMN-GIVSMKSDVYSFGVLVLEIISSK 219
E ++ S D++S G + E+++ +
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 83.6 bits (205), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 116/209 (55%), Gaps = 11/209 (5%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKL 71
+ +NF ++G+G +G VYK + L G+ +A+K++ + +G+ E L+ +L
Sbjct: 1 GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
H N+V+LL + + LV+E+L ++ L F+ D+S + + + ++QGL
Sbjct: 61 NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 118
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
+ H + RV+HRDLK N+L++ + K++DFG+AR FG+ + + +V T Y +P
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAP 173
Query: 192 EYVMN-GIVSMKSDVYSFGVLVLEIISSK 219
E ++ S D++S G + E+++ +
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202
>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|3F5P|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|E Chain E, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|F Chain F, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|G Chain G, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|H Chain H, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|I Chain I, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|J Chain J, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|K Chain K, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|M Chain M, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|L Chain L, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|R Chain R, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|S Chain S, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|T Chain T, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
Length = 308
Score = 83.6 bits (205), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 65/217 (29%), Positives = 108/217 (49%), Gaps = 19/217 (8%)
Query: 16 ATDNFSPGNRLGQGGFGPVY----KGKLLDGQE--IAIKRLSKS-SGQGIVEFKNEAKLI 68
A + + LGQG FG VY KG + D E +AIK ++++ S + +EF NEA ++
Sbjct: 17 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 69 AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLD--------WKKRF 120
+ ++VRLLG Q L++ E + L ++ S + E+ + K
Sbjct: 77 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMI 135
Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
+ I G+ YL+ + +HRDL A N ++ + KI DFGM R +
Sbjct: 136 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGG 192
Query: 181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
+ + +MSPE + +G+ + SDV+SFGV++ EI +
Sbjct: 193 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 83.6 bits (205), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 116/209 (55%), Gaps = 11/209 (5%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKL 71
+ +NF ++G+G +G VYK + L G+ +A+K++ + +G+ E L+ +L
Sbjct: 1 GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
H N+V+LL + + LV+E+L ++ L F+ D+S + + + ++QGL
Sbjct: 61 NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 118
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
+ H + RV+HRDLK N+L++ + K++DFG+AR FG+ + + +V T Y +P
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAP 173
Query: 192 EYVMN-GIVSMKSDVYSFGVLVLEIISSK 219
E ++ S D++S G + E+++ +
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 83.6 bits (205), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 116/208 (55%), Gaps = 11/208 (5%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQ 72
+ +NF ++G+G +G VYK + L G+ +A+K++ + +G+ E L+ +L
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 73 HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
H N+V+LL + + LV+E+L ++ L F+ D+S + + + ++QGL +
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
H + RV+HRDLK N+L++ + K++DFG+AR FG+ + + +V T Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 173
Query: 193 YVMN-GIVSMKSDVYSFGVLVLEIISSK 219
++ S D++S G + E+++ +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
pdb|4G5P|B Chain B, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
Length = 330
Score = 83.6 bits (205), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 114/215 (53%), Gaps = 22/215 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG G FG VYKG + E +AIK L ++ S + E +EA ++A + + ++ RL
Sbjct: 26 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
LG L +L++ + +P L ++ + + LL+W + I +G+ YL
Sbjct: 86 LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 138
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
R++HRDL A N+L+ + KI+DFG+A+ G E E + +M+ E ++
Sbjct: 139 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
+ I + +SDV+S+GV V E+++ SK +G +E
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 230
>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 34-Jab
pdb|2ITW|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Afn941
pdb|2ITX|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Amp- Pnp
pdb|2ITY|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Iressa
pdb|2J6M|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Aee788
pdb|3POZ|A Chain A, Egfr Kinase Domain Complexed With Tak-285
Length = 327
Score = 83.6 bits (205), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG G FG VYKG + E +AIK L ++ S + E +EA ++A + + ++ RL
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
LG L +L+ + +P L ++ + + LL+W + I +G+ YL
Sbjct: 83 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 135
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
R++HRDL A N+L+ + KI+DFG+A+ G E E + +M+ E ++
Sbjct: 136 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
+ I + +SDV+S+GV V E+++ SK +G +E
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 83.6 bits (205), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 115/206 (55%), Gaps = 11/206 (5%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 74
+NF ++G+G +G VYK + L G+ +A+K++ + +G+ E L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 75 NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
N+V+LL + + LV+E+L ++ L F+ D+S + + + ++QGL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
+ RV+HRDLK N+L++ + K++DFG+AR FG+ + + +V T Y +PE +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEIL 174
Query: 195 MN-GIVSMKSDVYSFGVLVLEIISSK 219
+ S D++S G + E+++ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200
>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
pdb|4I24|B Chain B, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
Length = 329
Score = 83.6 bits (205), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 114/215 (53%), Gaps = 22/215 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG G FG VYKG + E +AIK L ++ S + E +EA ++A + + ++ RL
Sbjct: 25 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
LG L +L++ + +P L ++ + + LL+W + I +G+ YL
Sbjct: 85 LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 137
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
R++HRDL A N+L+ + KI+DFG+A+ G E E + +M+ E ++
Sbjct: 138 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
+ I + +SDV+S+GV V E+++ SK +G +E
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 229
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 83.6 bits (205), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 116/209 (55%), Gaps = 11/209 (5%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKL 71
+ +NF ++G+G +G VYK + L G+ +A+K++ + +G+ E L+ +L
Sbjct: 3 GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
H N+V+LL + + LV+E+L ++ L F+ D+S + + + ++QGL
Sbjct: 63 NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 120
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
+ H + RV+HRDLK N+L++ + K++DFG+AR FG+ + + +V T Y +P
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAP 175
Query: 192 EYVMN-GIVSMKSDVYSFGVLVLEIISSK 219
E ++ S D++S G + E+++ +
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 83.6 bits (205), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 116/209 (55%), Gaps = 11/209 (5%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKL 71
+ +NF ++G+G +G VYK + L G+ +A+K++ + +G+ E L+ +L
Sbjct: 4 GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
H N+V+LL + + LV+E+L ++ L F+ D+S + + + ++QGL
Sbjct: 64 NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 121
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
+ H + RV+HRDLK N+L++ + K++DFG+AR FG+ + + +V T Y +P
Sbjct: 122 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAP 176
Query: 192 EYVMN-GIVSMKSDVYSFGVLVLEIISSK 219
E ++ S D++S G + E+++ +
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 205
>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Amp-Pnp Bound
pdb|2QOQ|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Base, Amp-Pnp
Bound Structure
Length = 373
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 75/284 (26%), Positives = 124/284 (43%), Gaps = 36/284 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVE-----FKNEAKLIAKLQH 73
N S +G G FG V G+L + I K+ G E F EA ++ + H
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74 TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
N++RL G + ++V E + N SLD F+ + + + ++ GI G+ YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL 163
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------ 187
S + +HRDL A NIL++ + K+SDFG++R LE + T G
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRV-----LEDDPEAAYTTRGGKIPIR 215
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
+ SPE + + SDV+S+G+++ E++S ER W++ N+ +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------ERPY------WEMSNQ-DVI 260
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
+ +D D + L C Q +RP + S+L
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 115/206 (55%), Gaps = 11/206 (5%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHT 74
+NF ++G+G +G VYK + L G+ +A+K++ + +G+ E L+ +L H
Sbjct: 4 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 75 NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
N+V+LL + + LV+E+L ++ L F+ D+S + + + ++QGL + H
Sbjct: 64 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
+ RV+HRDLK N+L++ + K++DFG+AR FG+ + + +V T Y +PE +
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEIL 176
Query: 195 MN-GIVSMKSDVYSFGVLVLEIISSK 219
+ S D++S G + E+++ +
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRR 202
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 114/215 (53%), Gaps = 22/215 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG G FG VYKG + E +AIK L ++ S + E +EA ++A + + ++ RL
Sbjct: 24 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
LG L +L++ + +P L ++ + + LL+W + I +G+ YL
Sbjct: 84 LGICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 136
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
R++HRDL A N+L+ + KI+DFG+A+ G E E + +M+ E ++
Sbjct: 137 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 193
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
+ I + +SDV+S+GV V E+++ SK +G +E
Sbjct: 194 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 228
>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|B Chain B, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|C Chain C, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|D Chain D, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|E Chain E, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|F Chain F, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|G Chain G, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|H Chain H, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
Length = 327
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG G FG VYKG + E +AIK L ++ S + E +EA ++A + + ++ RL
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
LG L +L+ + +P L ++ + + LL+W + I +G+ YL
Sbjct: 83 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 135
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
R++HRDL A N+L+ + KI+DFG+A+ G E E + +M+ E ++
Sbjct: 136 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
+ I + +SDV+S+GV V E+++ SK +G +E
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227
>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992
Length = 330
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG G FG VYKG + E +AIK L ++ S + E +EA ++A + + ++ RL
Sbjct: 26 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
LG L +L+ + +P L ++ + + LL+W + I +G+ YL
Sbjct: 86 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 138
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
R++HRDL A N+L+ + KI+DFG+A+ G E E + +M+ E ++
Sbjct: 139 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
+ I + +SDV+S+GV V E+++ SK +G +E
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 230
>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor-
Gw572016
Length = 352
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG G FG VYKG + E +AIK L ++ S + E +EA ++A + + ++ RL
Sbjct: 48 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 107
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
LG L +L+ + +P L ++ + + LL+W + I +G+ YL
Sbjct: 108 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 160
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
R++HRDL A N+L+ + KI+DFG+A+ G E E + +M+ E ++
Sbjct: 161 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 217
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
+ I + +SDV+S+GV V E+++ SK +G +E
Sbjct: 218 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 252
>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure
Length = 344
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 75/284 (26%), Positives = 124/284 (43%), Gaps = 36/284 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVE-----FKNEAKLIAKLQH 73
N S +G G FG V G+L + I K+ G E F EA ++ + H
Sbjct: 17 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 74 TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
N++RL G + ++V E + N SLD F+ + + + ++ GI G+ YL
Sbjct: 77 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL 134
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------ 187
S + +HRDL A NIL++ + K+SDFG++R LE + T G
Sbjct: 135 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRV-----LEDDPEAAYTTRGGKIPIR 186
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
+ SPE + + SDV+S+G+++ E++S ER W++ N+ +
Sbjct: 187 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--------ERPY------WEMSNQ-DVI 231
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
+ +D D + L C Q +RP + S+L
Sbjct: 232 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275
>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase
Domain With Erlotinib
Length = 337
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG G FG VYKG + E +AIK L ++ S + E +EA ++A + + ++ RL
Sbjct: 33 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 92
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDSS----KKELLDWKKRFNIIEGIVQGLLYLHK 135
LG L +L+ + +P L ++ + + LL+W + I +G+ YL
Sbjct: 93 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 145
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
R++HRDL A N+L+ + KI+DFG+A+ G E E + +M+ E ++
Sbjct: 146 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 202
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
+ I + +SDV+S+GV V E+++ SK +G +E
Sbjct: 203 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 237
>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain
pdb|2GS6|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain In
Complex With An Atp Analog-Peptide Conjugate
pdb|2RF9|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RF9|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|3W2S|A Chain A, Egfr Kinase Domain With Compound4
Length = 330
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG G FG VYKG + E +AIK L ++ S + E +EA ++A + + ++ RL
Sbjct: 26 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
LG L +L+ + +P L ++ + + LL+W + I +G+ YL
Sbjct: 86 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 138
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
R++HRDL A N+L+ + KI+DFG+A+ G E E + +M+ E ++
Sbjct: 139 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
+ I + +SDV+S+GV V E+++ SK +G +E
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 230
>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In
Complex With Dacomitinib (soaked)
Length = 329
Score = 83.2 bits (204), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG G FG VYKG + E +AIK L ++ S + E +EA ++A + + ++ RL
Sbjct: 25 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
LG L +L+ + +P L ++ + + LL+W + I +G+ YL
Sbjct: 85 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 137
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
R++HRDL A N+L+ + KI+DFG+A+ G E E + +M+ E ++
Sbjct: 138 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
+ I + +SDV+S+GV V E+++ SK +G +E
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 229
>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-1,2,2-trimethyl-propyl)-amide
pdb|4HVG|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-2-hydroxy-1,2-dimethyl-propyl)- Amide
pdb|4HVH|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-2-hydroxy-1,2-dimethyl-propyl
pdb|4HVI|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-1-methyl-2-oxo-2-piperidin-1-yl- Ethyl)-amide
Length = 314
Score = 83.2 bits (204), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 77/280 (27%), Positives = 131/280 (46%), Gaps = 22/280 (7%)
Query: 24 NRLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVR 78
++LG+G FG V + L D G +A+K+L S +F+ E +++ L +V+
Sbjct: 16 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 75
Query: 79 LLGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
G S G + LV EYLP+ L F+ + LD + I +G+ YL
Sbjct: 76 YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--- 130
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE-----LEANTNRIVGTHGYMSP 191
R +HRDL A NIL++ + + KI+DFG+A+ +++ E + I + +P
Sbjct: 131 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----WYAP 186
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID 251
E + + I S +SDV+SFGV++ E+ + + C + L ++G + + LEL++
Sbjct: 187 ESLSDNIFSRQSDVWSFGVVLYELF-TYCDKSCSPSAEFLRMMGSERDVPALSRLLELLE 245
Query: 252 TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
P + LC DRP+ S + L
Sbjct: 246 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 285
>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 13-Jab
Length = 327
Score = 83.2 bits (204), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG G FG VYKG + E +AIK L ++ S + E +EA ++A + + ++ RL
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
LG L +L+ + +P L ++ + + LL+W + I +G+ YL
Sbjct: 83 LGICLTSTVQLIT-QLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 135
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
R++HRDL A N+L+ + KI+DFG+A+ G E E + +M+ E ++
Sbjct: 136 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
+ I + +SDV+S+GV V E+++ SK +G +E
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227
>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|2GS7|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|C Chain C, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|D Chain D, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
Length = 330
Score = 83.2 bits (204), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG G FG VYKG + E +AIK L ++ S + E +EA ++A + + ++ RL
Sbjct: 26 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
LG L +L+ + +P L ++ + + LL+W + I +G+ YL
Sbjct: 86 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 138
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
R++HRDL A N+L+ + KI+DFG+A+ G E E + +M+ E ++
Sbjct: 139 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
+ I + +SDV+S+GV V E+++ SK +G +E
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 230
>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXL|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 327
Score = 83.2 bits (204), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 77/280 (27%), Positives = 131/280 (46%), Gaps = 22/280 (7%)
Query: 24 NRLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVR 78
++LG+G FG V + L D G +A+K+L S +F+ E +++ L +V+
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 79 LLGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
G S G + LV EYLP+ L F+ + LD + I +G+ YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--- 143
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE-----LEANTNRIVGTHGYMSP 191
R +HRDL A NIL++ + + KI+DFG+A+ +++ E + I + +P
Sbjct: 144 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----WYAP 199
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID 251
E + + I S +SDV+SFGV++ E+ + + C + L ++G + + LEL++
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELF-TYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258
Query: 252 TTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
P + LC DRP+ S + L
Sbjct: 259 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298
>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In
Complex With Amppnp
Length = 334
Score = 83.2 bits (204), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG G FG VYKG + E +AIK L ++ S + E +EA ++A + + ++ RL
Sbjct: 30 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
LG L +L+ + +P L ++ + + LL+W + I +G+ YL
Sbjct: 90 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 142
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
R++HRDL A N+L+ + KI+DFG+A+ G E E + +M+ E ++
Sbjct: 143 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
+ I + +SDV+S+GV V E+++ SK +G +E
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 234
>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Human Insulin Receptor
Length = 306
Score = 83.2 bits (204), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 75/284 (26%), Positives = 135/284 (47%), Gaps = 34/284 (11%)
Query: 26 LGQGGFGPVYKGKLLD---GQ---EIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVR 78
LGQG FG VY+G D G+ +A+K +++S+ + +EF NEA ++ ++VR
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFIF-------DSSKKELLDWKKRFNIIEGIVQGLL 131
LLG + L+V E + + L ++ ++ + ++ + I G+
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
YL+ + +HRDL A N ++ KI DFGM R + + + +M+P
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELI 250
E + +G+ + SD++SFGV++ EI S +++ E+ L V +G L+
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-------MDGGYLDQP 254
Query: 251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND 294
D +C P+ VT + +C Q RPT ++ ++L +D
Sbjct: 255 D-----NC-PERVTDLMR---MCWQFNPKMRPTFLEIVNLLKDD 289
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 83.2 bits (204), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 75/283 (26%), Positives = 135/283 (47%), Gaps = 38/283 (13%)
Query: 25 RLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQG-------IVEFKNEAKLIAKLQHTNL 76
++G+GGFG V+KG+L+ D +AIK L +G EF+ E +++ L H N+
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 77 VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
V+L G L +V E++P L + D K + W + ++ I G+ Y+
Sbjct: 86 VKLYG--LMHNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 137 SRLRVIHRDLKASNILLD--DQMNP---KISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
+ ++HRDL++ NI L D+ P K++DFG+++ + + + ++G +M+P
Sbjct: 142 NP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAP 195
Query: 192 EYV--MNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL 249
E + + K+D YSF +++ I++ + G +D E + + + EG
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGE---GPFD-EYSYGKIKFINMIREEG----- 246
Query: 250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
+ T+ E C P R +V LC RP S + L+
Sbjct: 247 LRPTIPEDCPP----RLRNVIELCWSGDPKKRPHFSYIVKELS 285
>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
pdb|3G2F|B Chain B, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
Length = 336
Score = 83.2 bits (204), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 67/224 (29%), Positives = 109/224 (48%), Gaps = 32/224 (14%)
Query: 18 DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLV 77
DN +G+G +G VYKG L D + +A+K S ++ Q + KN + + ++H N+
Sbjct: 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYR-VPLMEHDNIA 70
Query: 78 RLLGCSLQ-----KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
R + + + E LLV EY PN SL ++ + DW + + +GL Y
Sbjct: 71 RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSCRLAHSVTRGLAY 126
Query: 133 LHK------YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL----EANTNRI 182
LH + + + HRDL + N+L+ + ISDFG++ N L E + I
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 183 --VGTHGYMSPEYVMNGIVSMKS--------DVYSFGVLVLEII 216
VGT YM+PE V+ G V+++ D+Y+ G++ EI
Sbjct: 187 SEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution.
pdb|1P4O|B Chain B, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution
Length = 322
Score = 83.2 bits (204), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 85/319 (26%), Positives = 147/319 (46%), Gaps = 38/319 (11%)
Query: 16 ATDNFSPGNRLGQGGFGPVY----KGKLLDGQE--IAIKRLSKS-SGQGIVEFKNEAKLI 68
A + + LGQG FG VY KG + D E +AIK ++++ S + +EF NEA ++
Sbjct: 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 69 AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLD--------WKKRF 120
+ ++VRLLG Q L++ E + L ++ S + + + K
Sbjct: 83 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPAMANNPVLAPPSLSKMI 141
Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
+ I G+ YL+ + +HRDL A N ++ + KI DFGM R +
Sbjct: 142 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQ 239
+ + +MSPE + +G+ + SDV+SFGV++ EI + +++ E+ L V
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV----- 253
Query: 240 LWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP 299
EG L+ D +C PD + + +C Q RP+ ++ S + + P
Sbjct: 254 --MEGGLLDKPD-----NC-PDMLFELMR---MCWQYNPKMRPSFLEIISSIKEEME--P 300
Query: 300 TPRQPAFFINISSDYEEPE 318
R+ +F+ + + EPE
Sbjct: 301 GFREVSFYYSEENKLPEPE 319
>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site
Inhibitor Showing High Selectivity Within The Janus
Kinase Family
Length = 315
Score = 83.2 bits (204), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 66/224 (29%), Positives = 113/224 (50%), Gaps = 22/224 (9%)
Query: 24 NRLGQGGFGPVYKGK---LLD--GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVR 78
++LG+G FG V + L D G +A+K+L S +F+ E +++ L +V+
Sbjct: 17 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 76
Query: 79 LLGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
G S G + LV EYLP+ L F+ + LD + I +G+ YL
Sbjct: 77 YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--- 131
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE-----LEANTNRIVGTHGYMSP 191
R +HRDL A NIL++ + + KI+DFG+A+ +++ E + I + +P
Sbjct: 132 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----WYAP 187
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVG 235
E + + I S +SDV+SFGV++ E+ + + C + L ++G
Sbjct: 188 ESLSDNIFSRQSDVWSFGVVLYELF-TYCDKSCSPSAEFLRMMG 230
>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Pp1
Length = 314
Score = 82.8 bits (203), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 90/318 (28%), Positives = 144/318 (45%), Gaps = 52/318 (16%)
Query: 5 LKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKL--LDGQE----IAIKRLSK-SSGQG 57
KI + N G LG+G FG V K L G+ +A+K L + +S
Sbjct: 10 FKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE 69
Query: 58 IVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK------- 110
+ + +E ++ ++ H ++++L G Q G LL+ EY SL F+ +S K
Sbjct: 70 LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLG 129
Query: 111 ------KELLDWKKRFNIIEG--------IVQGLLYLHKYSRLRVIHRDLKASNILLDDQ 156
LD + G I QG+ YL + S ++HRDL A NIL+ +
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEG 186
Query: 157 MNPKISDFGMARTFGMNELEANTNRIVG--THGYMSPEYVMNGIVSMKSDVYSFGVLVLE 214
KISDFG++R + E ++ R G +M+ E + + I + +SDV+SFGVL+ E
Sbjct: 187 RKMKISDFGLSRD--VYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244
Query: 215 IISSKKNN-GCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLC 273
I++ N ER NL+ G +E D +CS +E+ R + L C
Sbjct: 245 IVTLGGNPYPGIPPERLFNLL-------KTGHRMERPD-----NCS-EEMYRLM---LQC 288
Query: 274 VQDKATDRPTMSDVASML 291
+ + RP +D++ L
Sbjct: 289 WKQEPDKRPVFADISKDL 306
>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A19|C Chain C, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A1A|B Chain B, Pkr Kinase Domain-Eif2alpha Complex
Length = 284
Score = 82.8 bits (203), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 28/215 (13%)
Query: 19 NFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLV 77
+F +G GGFG V+K K +DG+ IKR+ ++ + + E K +AKL H N+V
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA----EREVKALAKLDHVNIV 67
Query: 78 RLLGC---------------SLQKGERLLV-YEYLPNKSLDFFIFDSSKKELLDWKKRFN 121
GC S K + L + E+ +L+ +I + + E LD
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALE 126
Query: 122 IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR 181
+ E I +G+ Y+H ++I+RDLK SNI L D KI DFG+ + + + R
Sbjct: 127 LFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRXR 180
Query: 182 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
GT YMSPE + + + D+Y+ G+++ E++
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215
>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With Bms-754807
[1-(4-((5-Cyclopropyl-
1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2,
4]triazin-2-Yl)-N-
(6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide]
Length = 315
Score = 82.8 bits (203), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 65/217 (29%), Positives = 108/217 (49%), Gaps = 19/217 (8%)
Query: 16 ATDNFSPGNRLGQGGFGPVY----KGKLLDGQE--IAIKRLSKS-SGQGIVEFKNEAKLI 68
A + + LGQG FG VY KG + D E +AIK ++++ S + +EF NEA ++
Sbjct: 16 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 69 AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLD--------WKKRF 120
+ ++VRLLG Q L++ E + L ++ S + E+ + K
Sbjct: 76 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMI 134
Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
+ I G+ YL+ + +HRDL A N ++ + KI DFGM R +
Sbjct: 135 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 191
Query: 181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
+ + +MSPE + +G+ + SDV+SFGV++ EI +
Sbjct: 192 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228
>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
pdb|3ETA|B Chain B, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
Length = 317
Score = 82.8 bits (203), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 75/284 (26%), Positives = 135/284 (47%), Gaps = 34/284 (11%)
Query: 26 LGQGGFGPVYKGKLLD---GQ---EIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVR 78
LGQG FG VY+G D G+ +A+K +++S+ + +EF NEA ++ ++VR
Sbjct: 24 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFIF-------DSSKKELLDWKKRFNIIEGIVQGLL 131
LLG + L+V E + + L ++ ++ + ++ + I G+
Sbjct: 84 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
YL+ + +HRDL A N ++ KI DFGM R + + + +M+P
Sbjct: 144 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELI 250
E + +G+ + SD++SFGV++ EI S +++ E+ L V +G L+
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-------MDGGYLDQP 253
Query: 251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND 294
D +C P+ VT + +C Q RPT ++ ++L +D
Sbjct: 254 D-----NC-PERVTDLMR---MCWQFNPKMRPTFLEIVNLLKDD 288
>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A
Benzimidazole Inhibitor
pdb|3NW5|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11b)
pdb|3NW6|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11a)
pdb|3NW7|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (34)
Length = 307
Score = 82.8 bits (203), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 65/217 (29%), Positives = 108/217 (49%), Gaps = 19/217 (8%)
Query: 16 ATDNFSPGNRLGQGGFGPVY----KGKLLDGQE--IAIKRLSKS-SGQGIVEFKNEAKLI 68
A + + LGQG FG VY KG + D E +AIK ++++ S + +EF NEA ++
Sbjct: 16 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 69 AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLD--------WKKRF 120
+ ++VRLLG Q L++ E + L ++ S + E+ + K
Sbjct: 76 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMI 134
Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
+ I G+ YL+ + +HRDL A N ++ + KI DFGM R +
Sbjct: 135 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 191
Query: 181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
+ + +MSPE + +G+ + SDV+SFGV++ EI +
Sbjct: 192 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228
>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex
With An Hydantoin Inhibitor
Length = 305
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 65/217 (29%), Positives = 108/217 (49%), Gaps = 19/217 (8%)
Query: 16 ATDNFSPGNRLGQGGFGPVY----KGKLLDGQE--IAIKRLSKS-SGQGIVEFKNEAKLI 68
A + + LGQG FG VY KG + D E +AIK ++++ S + +EF NEA ++
Sbjct: 14 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 73
Query: 69 AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLD--------WKKRF 120
+ ++VRLLG Q L++ E + L ++ S + E+ + K
Sbjct: 74 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMI 132
Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
+ I G+ YL+ + +HRDL A N ++ + KI DFGM R +
Sbjct: 133 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 189
Query: 181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
+ + +MSPE + +G+ + SDV+SFGV++ EI +
Sbjct: 190 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226
>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285
pdb|3W2P|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 2
pdb|3W2Q|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Hki-272
pdb|3W2R|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 4
Length = 331
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG G FG VYKG + E +AIK L ++ S + E +EA ++A + + ++ RL
Sbjct: 27 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDSS----KKELLDWKKRFNIIEGIVQGLLYLHK 135
LG L +L++ + +P L ++ + + LL+W + I +G+ YL
Sbjct: 87 LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 139
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
R++HRDL A N+L+ + KI+DFG A+ G E E + +M+ E ++
Sbjct: 140 R---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 196
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
+ I + +SDV+S+GV V E+++ SK +G +E
Sbjct: 197 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 231
>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain
pdb|1JQH|B Chain B, Igf-1 Receptor Kinase Domain
pdb|1JQH|C Chain C, Igf-1 Receptor Kinase Domain
Length = 308
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 65/217 (29%), Positives = 108/217 (49%), Gaps = 19/217 (8%)
Query: 16 ATDNFSPGNRLGQGGFGPVY----KGKLLDGQE--IAIKRLSKS-SGQGIVEFKNEAKLI 68
A + + LGQG FG VY KG + D E +AIK ++++ S + +EF NEA ++
Sbjct: 17 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 69 AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLD--------WKKRF 120
+ ++VRLLG Q L++ E + L ++ S + E+ + K
Sbjct: 77 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMI 135
Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
+ I G+ YL+ + +HRDL A N ++ + KI DFGM R +
Sbjct: 136 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 192
Query: 181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
+ + +MSPE + +G+ + SDV+SFGV++ EI +
Sbjct: 193 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229
>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|B Chain B, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|C Chain C, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|D Chain D, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
Length = 301
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 65/217 (29%), Positives = 108/217 (49%), Gaps = 19/217 (8%)
Query: 16 ATDNFSPGNRLGQGGFGPVY----KGKLLDGQE--IAIKRLSKS-SGQGIVEFKNEAKLI 68
A + + LGQG FG VY KG + D E +AIK ++++ S + +EF NEA ++
Sbjct: 10 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 69 AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLD--------WKKRF 120
+ ++VRLLG Q L++ E + L ++ S + E+ + K
Sbjct: 70 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMI 128
Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
+ I G+ YL+ + +HRDL A N ++ + KI DFGM R +
Sbjct: 129 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 185
Query: 181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
+ + +MSPE + +G+ + SDV+SFGV++ EI +
Sbjct: 186 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222
>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
pdb|4I21|B Chain B, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
Length = 329
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG G FG VYKG + E +AIK L ++ S + E +EA ++A + + ++ RL
Sbjct: 25 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
LG L +L++ + +P L ++ + + LL+W + I +G+ YL
Sbjct: 85 LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 137
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
R++HRDL A N+L+ + KI+DFG A+ G E E + +M+ E ++
Sbjct: 138 R---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
+ I + +SDV+S+GV V E+++ SK +G +E
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 229
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 60/198 (30%), Positives = 112/198 (56%), Gaps = 11/198 (5%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGC 82
++G+G +G VYK K G+ +A+KR+ + +GI E L+ +L H N+V L+
Sbjct: 28 KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
+ LV+E++ K L + D +K L D + + + + +++G+ + H++ R++
Sbjct: 88 IHSERCLTLVFEFM-EKDLKK-VLDENKTGLQDSQIKIYLYQ-LLRGVAHCHQH---RIL 141
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG-IVSM 201
HRDLK N+L++ K++DFG+AR FG+ + + T+ +V T Y +P+ +M S
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV-TLWYRAPDVLMGSKKYST 199
Query: 202 KSDVYSFGVLVLEIISSK 219
D++S G + E+I+ K
Sbjct: 200 SVDIWSIGCIFAEMITGK 217
>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of
The Insulin Receptor Tyrosine Kinase
Length = 306
Score = 82.4 bits (202), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 75/284 (26%), Positives = 134/284 (47%), Gaps = 34/284 (11%)
Query: 26 LGQGGFGPVYKGKLLD---GQ---EIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVR 78
LGQG FG VY+G D G+ +A+K +++S+ + +EF NEA ++ ++VR
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFIF-------DSSKKELLDWKKRFNIIEGIVQGLL 131
LLG + L+V E + + L ++ ++ + ++ + I G+
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
YL+ + +HRDL A N ++ KI DFGM R + + +M+P
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELI 250
E + +G+ + SD++SFGV++ EI S +++ E+ L V +G L+
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-------MDGGYLDQP 254
Query: 251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND 294
D +C P+ VT + +C Q RPT ++ ++L +D
Sbjct: 255 D-----NC-PERVTDLMR---MCWQFNPKMRPTFLEIVNLLKDD 289
>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The
Gefitinib/erlotinib Resistant Egfr Kinase Domain
L858r+t790m
pdb|4I22|A Chain A, Structure Of The Monomeric (v948r)gefitinib/erlotinib
Resistant Double Mutant (l858r+t790m) Egfr Kinase Domain
Co-crystallized With Gefitinib
Length = 329
Score = 82.4 bits (202), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG G FG VYKG + E +AIK L ++ S + E +EA ++A + + ++ RL
Sbjct: 25 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
LG L +L++ + +P L ++ + + LL+W + I +G+ YL
Sbjct: 85 LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 137
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
R++HRDL A N+L+ + KI+DFG A+ G E E + +M+ E ++
Sbjct: 138 R---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
+ I + +SDV+S+GV V E+++ SK +G +E
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 229
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 82.4 bits (202), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 60/198 (30%), Positives = 112/198 (56%), Gaps = 11/198 (5%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGC 82
++G+G +G VYK K G+ +A+KR+ + +GI E L+ +L H N+V L+
Sbjct: 28 KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
+ LV+E++ K L + D +K L D + + + + +++G+ + H++ R++
Sbjct: 88 IHSERCLTLVFEFM-EKDLKK-VLDENKTGLQDSQIKIYLYQ-LLRGVAHCHQH---RIL 141
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG-IVSM 201
HRDLK N+L++ K++DFG+AR FG+ + + T+ +V T Y +P+ +M S
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV-TLWYRAPDVLMGSKKYST 199
Query: 202 KSDVYSFGVLVLEIISSK 219
D++S G + E+I+ K
Sbjct: 200 SVDIWSIGCIFAEMITGK 217
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain
From D. Discoideum Bound To Appcp
Length = 287
Score = 82.4 bits (202), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 75/283 (26%), Positives = 134/283 (47%), Gaps = 38/283 (13%)
Query: 25 RLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQG-------IVEFKNEAKLIAKLQHTNL 76
++G+GGFG V+KG+L+ D +AIK L +G EF+ E +++ L H N+
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 77 VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
V+L G L +V E++P L + D K + W + ++ I G+ Y+
Sbjct: 86 VKLYG--LMHNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 137 SRLRVIHRDLKASNILLD--DQMNP---KISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
+ ++HRDL++ NI L D+ P K++DFG ++ + + + ++G +M+P
Sbjct: 142 NP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVSGLLGNFQWMAP 195
Query: 192 EYV--MNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL 249
E + + K+D YSF +++ I++ + G +D E + + + EG
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGE---GPFD-EYSYGKIKFINMIREEG----- 246
Query: 250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
+ T+ E C P R +V LC RP S + L+
Sbjct: 247 LRPTIPEDCPP----RLRNVIELCWSGDPKKRPHFSYIVKELS 285
>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|B Chain B, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|C Chain C, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|D Chain D, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|E Chain E, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|F Chain F, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|G Chain G, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|H Chain H, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORZ|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|B Chain B, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|C Chain C, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|D Chain D, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3OTU|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator Js30
Length = 316
Score = 82.0 bits (201), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 66/210 (31%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
++F G LG+G F V + L +E AIK L K + E ++++L H
Sbjct: 37 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 74 TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
V+L C Q E+L Y N L +I FD + RF E IV
Sbjct: 97 PFFVKLYFC-FQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 147
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
L YLH +IHRDLK NILL++ M+ +I+DFG A+ +A N VGT
Sbjct: 148 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 204
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y+SPE + SD+++ G ++ ++++
Sbjct: 205 YVSPELLTEKSACKSSDLWALGCIIYQLVA 234
>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Aee788
pdb|2ITU|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Afn941
pdb|2ITV|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Amp-pnp
pdb|2ITZ|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Iressa
Length = 327
Score = 82.0 bits (201), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 112/215 (52%), Gaps = 22/215 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG G FG VYKG + E +AIK L ++ S + E +EA ++A + + ++ RL
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
LG L +L+ + +P L ++ + + LL+W + I +G+ YL
Sbjct: 83 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 135
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
R++HRDL A N+L+ + KI+DFG A+ G E E + +M+ E ++
Sbjct: 136 R---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
+ I + +SDV+S+GV V E+++ SK +G +E
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227
>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic
Mutant L858r Egfr Kinase Domain
Length = 329
Score = 82.0 bits (201), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 112/215 (52%), Gaps = 22/215 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG G FG VYKG + E +AIK L ++ S + E +EA ++A + + ++ RL
Sbjct: 25 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
LG L +L+ + +P L ++ + + LL+W + I +G+ YL
Sbjct: 85 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 137
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
R++HRDL A N+L+ + KI+DFG A+ G E E + +M+ E ++
Sbjct: 138 R---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
+ I + +SDV+S+GV V E+++ SK +G +E
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 229
>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|B Chain B, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|C Chain C, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|D Chain D, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
Length = 336
Score = 82.0 bits (201), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 65/217 (29%), Positives = 108/217 (49%), Gaps = 19/217 (8%)
Query: 16 ATDNFSPGNRLGQGGFGPVY----KGKLLDGQE--IAIKRLSKS-SGQGIVEFKNEAKLI 68
A + + LGQG FG VY KG + D E +AIK ++++ S + +EF NEA ++
Sbjct: 45 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 104
Query: 69 AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLD--------WKKRF 120
+ ++VRLLG Q L++ E + L ++ S + E+ + K
Sbjct: 105 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMI 163
Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
+ I G+ YL+ + +HRDL A N ++ + KI DFGM R +
Sbjct: 164 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 220
Query: 181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
+ + +MSPE + +G+ + SDV+SFGV++ EI +
Sbjct: 221 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257
>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In
Complex With Amppnp
Length = 334
Score = 82.0 bits (201), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 112/215 (52%), Gaps = 22/215 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG G FG VYKG + E +AIK L ++ S + E +EA ++A + + ++ RL
Sbjct: 30 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
LG L +L+ + +P L ++ + + LL+W + I +G+ YL
Sbjct: 90 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 142
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
R++HRDL A N+L+ + KI+DFG A+ G E E + +M+ E ++
Sbjct: 143 R---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
+ I + +SDV+S+GV V E+++ SK +G +E
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 234
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 82.0 bits (201), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 116/209 (55%), Gaps = 11/209 (5%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKL 71
+ +NF ++G+G +G VYK + L G+ +A+K++ + +G+ E L+ +L
Sbjct: 3 GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
H N+V+LL + + LV+E++ ++ L F+ D+S + + + ++QGL
Sbjct: 63 NHPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 120
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
+ H + RV+HRDLK N+L++ + K++DFG+AR FG+ + + +V T Y +P
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAP 175
Query: 192 EYVMN-GIVSMKSDVYSFGVLVLEIISSK 219
E ++ S D++S G + E+++ +
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204
>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2OSC|A Chain A, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2P4I|A Chain A, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|2P4I|B Chain B, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|3L8P|A Chain A, Crystal Structure Of Cytoplasmic Kinase Domain Of Tie2
Complexed With Inhibitor Cep11207
Length = 317
Score = 82.0 bits (201), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 66/212 (31%), Positives = 108/212 (50%), Gaps = 28/212 (13%)
Query: 26 LGQGGFGPVYKGKLL-DG--QEIAIKRLSK-SSGQGIVEFKNEAKLIAKL-QHTNLVRLL 80
+G+G FG V K ++ DG + AIKR+ + +S +F E +++ KL H N++ LL
Sbjct: 23 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 81 GCSLQKGERLLVYEYLPNKSL-DF------------FIFDSSKKELLDWKKRFNIIEGIV 127
G +G L EY P+ +L DF F +S L ++ + +
Sbjct: 83 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 142
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
+G+ YL S+ + IHRDL A NIL+ + KI+DFG++R E + +G
Sbjct: 143 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG-----QEVYVKKTMGRLP 194
Query: 188 --YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
+M+ E + + + SDV+S+GVL+ EI+S
Sbjct: 195 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 81.6 bits (200), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 61/220 (27%), Positives = 103/220 (46%), Gaps = 32/220 (14%)
Query: 26 LGQGGFGPVYKGKLL------DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG+G FG V+ + D +A+K L + +F+ EA+L+ LQH ++V+
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFF----------IFDSSKKEL---LDWKKRFNIIEGI 126
G ++V+EY+ + L+ F + D ++ L + +I I
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 127 VQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH 186
G++YL + +HRDL N L+ + KI DFGM+R ++ + VG H
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-----DVYSTDYYRVGGH 194
Query: 187 G-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKN 221
+M PE +M + +SDV+SFGV++ EI + K
Sbjct: 195 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 234
>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A
Pyrimidinopyridone Inhibitor
Length = 333
Score = 81.6 bits (200), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 83/302 (27%), Positives = 130/302 (43%), Gaps = 54/302 (17%)
Query: 18 DNFSPGNRLGQGGFGPVYKGKLLD-GQE-----IAIKRLSKSSGQGIVE-FKNEAKLIAK 70
+N G LG G FG V + G+E +A+K L ++ E +E K+++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 71 L-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEG---- 125
L QH N+V LLG G L++ EY D F K +L+ F I
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYG--DLLNFLRRKSRVLETDPAFAIANSTLST 163
Query: 126 ---------IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE 176
+ QG+ +L + IHRD+ A N+LL + KI DFG+AR MN+
Sbjct: 164 RDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI-MND-- 217
Query: 177 ANTNRIVGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKN--NGCYDTER 229
+N IV + +M+PE + + + +++SDV+S+G+L+ EI S N G +
Sbjct: 218 --SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275
Query: 230 HLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS 289
LV +Q+ A + I + + C + T RPT + S
Sbjct: 276 FYKLVKDGYQMAQPAFAPKNIYSIMQA----------------CWALEPTHRPTFQQICS 319
Query: 290 ML 291
L
Sbjct: 320 FL 321
>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|B Chain B, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|C Chain C, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|D Chain D, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|E Chain E, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|F Chain F, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
Length = 294
Score = 81.6 bits (200), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 55/197 (27%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 24 NRLGQGGFGPVYKGK-LLDGQEIAIKRL---SKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
++LG GG VY + + ++AIK + + + + F+ E ++L H N+V +
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
+ + LV EY+ +L +I L N I+ G+ + H +
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHD---M 130
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
R++HRD+K NIL+D KI DFG+A+ L TN ++GT Y SPE
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEAT 189
Query: 200 SMKSDVYSFGVLVLEII 216
+D+YS G+++ E++
Sbjct: 190 DECTDIYSIGIVLYEML 206
>pdb|1FVR|A Chain A, Tie2 Kinase Domain
pdb|1FVR|B Chain B, Tie2 Kinase Domain
Length = 327
Score = 81.6 bits (200), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 66/212 (31%), Positives = 108/212 (50%), Gaps = 28/212 (13%)
Query: 26 LGQGGFGPVYKGKLL-DG--QEIAIKRLSK-SSGQGIVEFKNEAKLIAKL-QHTNLVRLL 80
+G+G FG V K ++ DG + AIKR+ + +S +F E +++ KL H N++ LL
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 81 GCSLQKGERLLVYEYLPNKSL-DF------------FIFDSSKKELLDWKKRFNIIEGIV 127
G +G L EY P+ +L DF F +S L ++ + +
Sbjct: 93 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
+G+ YL S+ + IHRDL A NIL+ + KI+DFG++R E + +G
Sbjct: 153 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG-----QEVYVKKTMGRLP 204
Query: 188 --YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
+M+ E + + + SDV+S+GVL+ EI+S
Sbjct: 205 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An
Arylamide Inhibitor
Length = 333
Score = 81.6 bits (200), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 83/302 (27%), Positives = 130/302 (43%), Gaps = 54/302 (17%)
Query: 18 DNFSPGNRLGQGGFGPVYKGKLLD-GQE-----IAIKRLSKSSGQGIVE-FKNEAKLIAK 70
+N G LG G FG V + G+E +A+K L ++ E +E K+++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 71 L-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEG---- 125
L QH N+V LLG G L++ EY D F K +L+ F I
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYG--DLLNFLRRKSRVLETDPAFAIANSTAST 163
Query: 126 ---------IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE 176
+ QG+ +L + IHRD+ A N+LL + KI DFG+AR MN+
Sbjct: 164 RDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI-MND-- 217
Query: 177 ANTNRIVGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKN--NGCYDTER 229
+N IV + +M+PE + + + +++SDV+S+G+L+ EI S N G +
Sbjct: 218 --SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275
Query: 230 HLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS 289
LV +Q+ A + I + + C + T RPT + S
Sbjct: 276 FYKLVKDGYQMAQPAFAPKNIYSIMQA----------------CWALEPTHRPTFQQICS 319
Query: 290 ML 291
L
Sbjct: 320 FL 321
>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
pdb|3EKN|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
Length = 307
Score = 81.6 bits (200), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 74/284 (26%), Positives = 135/284 (47%), Gaps = 34/284 (11%)
Query: 26 LGQGGFGPVYKGKLLD---GQ---EIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVR 78
LGQG FG VY+G D G+ +A+K +++S+ + +EF NEA ++ ++VR
Sbjct: 26 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFIF-------DSSKKELLDWKKRFNIIEGIVQGLL 131
LLG + L+V E + + L ++ ++ + ++ + I G+
Sbjct: 86 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
YL+ + +HR+L A N ++ KI DFGM R + + + +M+P
Sbjct: 146 YLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELI 250
E + +G+ + SD++SFGV++ EI S +++ E+ L V +G L+
Sbjct: 203 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-------MDGGYLDQP 255
Query: 251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND 294
D +C P+ VT + +C Q RPT ++ ++L +D
Sbjct: 256 D-----NC-PERVTDLMR---MCWQFNPNMRPTFLEIVNLLKDD 290
>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The
Insulin Receptor Tyrosine Kinase
Length = 306
Score = 81.6 bits (200), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 74/284 (26%), Positives = 135/284 (47%), Gaps = 34/284 (11%)
Query: 26 LGQGGFGPVYKGKLLD---GQ---EIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVR 78
LGQG FG VY+G D G+ +A+K +++S+ + +EF NEA ++ ++VR
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFIF-------DSSKKELLDWKKRFNIIEGIVQGLL 131
LLG + L+V E + + L ++ ++ + ++ + I G+
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
YL+ + +HR+L A N ++ KI DFGM R + + + +M+P
Sbjct: 145 YLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKALELI 250
E + +G+ + SD++SFGV++ EI S +++ E+ L V +G L+
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-------MDGGYLDQP 254
Query: 251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND 294
D +C P+ VT + +C Q RPT ++ ++L +D
Sbjct: 255 D-----NC-PERVTDLMR---MCWQFNPNMRPTFLEIVNLLKDD 289
>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN The Apo Form
pdb|3UG2|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Gefitinib
pdb|3VJN|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Amppnp
Length = 334
Score = 81.3 bits (199), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 65/215 (30%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
L G FG VYKG + E +AIK L ++ S + E +EA ++A + + ++ RL
Sbjct: 30 LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
LG L +L++ + +P L ++ + + LL+W + I +G+ YL
Sbjct: 90 LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 142
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
R++HRDL A N+L+ + KI+DFG+A+ G E E + +M+ E ++
Sbjct: 143 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
+ I + +SDV+S+GV V E+++ SK +G +E
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 234
>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And
Kinase Domains
Length = 361
Score = 81.3 bits (199), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 65/215 (30%), Positives = 112/215 (52%), Gaps = 22/215 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQE-----IAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG G FG VYKG + E +AI L + +S + E +EA ++A + + ++ RL
Sbjct: 57 LGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRL 116
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDSS----KKELLDWKKRFNIIEGIVQGLLYLHK 135
LG L +L+ + +P L ++ + + LL+W + I +G+ YL
Sbjct: 117 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 169
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
R++HRDL A N+L+ + KI+DFG+A+ G E E + +M+ E ++
Sbjct: 170 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 226
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
+ I + +SDV+S+GV V E+++ SK +G +E
Sbjct: 227 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 261
>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s)
Length = 334
Score = 81.3 bits (199), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 65/215 (30%), Positives = 112/215 (52%), Gaps = 22/215 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
L G FG VYKG + E +AIK L ++ S + E +EA ++A + + ++ RL
Sbjct: 30 LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
LG L +L+ + +P L ++ + + LL+W + I +G+ YL
Sbjct: 90 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 142
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
R++HRDL A N+L+ + KI+DFG+A+ G E E + +M+ E ++
Sbjct: 143 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
+ I + +SDV+S+GV V E+++ SK +G +E
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 234
>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1
Receptor Kinase In Complex With Pqip
Length = 301
Score = 81.3 bits (199), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 19/217 (8%)
Query: 16 ATDNFSPGNRLGQGGFGPVY----KGKLLDGQE--IAIKRLSKS-SGQGIVEFKNEAKLI 68
A + + LGQG FG VY KG + D E +AIK ++++ S + +EF NEA ++
Sbjct: 10 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 69 AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLD--------WKKRF 120
+ ++VRLLG Q L++ E + L ++ S + E+ + K
Sbjct: 70 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMI 128
Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
+ I G+ YL+ + +HRDL A N + + KI DFGM R +
Sbjct: 129 QMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGG 185
Query: 181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
+ + +MSPE + +G+ + SDV+SFGV++ EI +
Sbjct: 186 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222
>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Amp-Pnp
pdb|2ITO|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Iressa
pdb|2ITP|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Aee788
pdb|2ITQ|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Afn941
Length = 327
Score = 80.9 bits (198), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 65/215 (30%), Positives = 112/215 (52%), Gaps = 22/215 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQE-----IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRL 79
L G FG VYKG + E +AIK L ++ S + E +EA ++A + + ++ RL
Sbjct: 23 LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDSS----KKELLDWKKRFNIIEGIVQGLLYLHK 135
LG L +L+ + +P L ++ + + LL+W + I +G+ YL
Sbjct: 83 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLED 135
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
R++HRDL A N+L+ + KI+DFG+A+ G E E + +M+ E ++
Sbjct: 136 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 196 NGIVSMKSDVYSFGVLVLEIIS--SKKNNGCYDTE 228
+ I + +SDV+S+GV V E+++ SK +G +E
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 80.9 bits (198), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 58/195 (29%), Positives = 104/195 (53%), Gaps = 7/195 (3%)
Query: 24 NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
++LG G +G VY G +A+K L + + + + EF EA ++ +++H NLV+LLG
Sbjct: 38 HKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 96
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
+ +V EY+P +L ++ + +++E+ + + I + YL K + I
Sbjct: 97 CTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQ-ISSAMEYLEKKN---FI 152
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
HRDL A N L+ + K++DFG++R + A+ + +PE + S+K
Sbjct: 153 HRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNTFSIK 211
Query: 203 SDVYSFGVLVLEIIS 217
SDV++FGVL+ EI +
Sbjct: 212 SDVWAFGVLLWEIAT 226
>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|B Chain B, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|C Chain C, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|D Chain D, Igf-1rk In Complex With Ligand Msc1609119a-1
Length = 304
Score = 80.9 bits (198), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 64/217 (29%), Positives = 107/217 (49%), Gaps = 19/217 (8%)
Query: 16 ATDNFSPGNRLGQGGFGPVY----KGKLLDGQE--IAIKRLSKS-SGQGIVEFKNEAKLI 68
A + + LGQG FG VY KG + D E +AIK ++++ S + +EF NEA ++
Sbjct: 13 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 72
Query: 69 AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLD--------WKKRF 120
+ ++VRLLG Q L++ E + L ++ S + + + K
Sbjct: 73 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPAMANNPVLAPPSLSKMI 131
Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
+ I G+ YL+ + +HRDL A N ++ + KI DFGM R +
Sbjct: 132 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 188
Query: 181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
+ + +MSPE + +G+ + SDV+SFGV++ EI +
Sbjct: 189 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225
>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain
pdb|3UIU|B Chain B, Crystal Structure Of Apo-Pkr Kinase Domain
Length = 306
Score = 80.9 bits (198), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 65/228 (28%), Positives = 105/228 (46%), Gaps = 41/228 (17%)
Query: 19 NFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLV 77
+F +G GGFG V+K K +DG+ I+R+ ++ + + E K +AKL H N+V
Sbjct: 13 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKA----EREVKALAKLDHVNIV 68
Query: 78 RLLGC----------------------------SLQKGERLLV-YEYLPNKSLDFFIFDS 108
GC S K + L + E+ +L+ +I +
Sbjct: 69 HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EK 127
Query: 109 SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR 168
+ E LD + E I +G+ Y+H ++IHRDLK SNI L D KI DFG+
Sbjct: 128 RRGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVT 184
Query: 169 TFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
+ + R GT YMSPE + + + D+Y+ G+++ E++
Sbjct: 185 SLKND---GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound
To Appcp From D. Discoideum
Length = 287
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 74/283 (26%), Positives = 134/283 (47%), Gaps = 38/283 (13%)
Query: 25 RLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQG-------IVEFKNEAKLIAKLQHTNL 76
++G+GGFG V+KG+L+ D +AIK L +G EF+ E +++ L H N+
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 77 VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
V+L G L +V E++P L + D K + W + ++ I G+ Y+
Sbjct: 86 VKLYG--LMHNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 137 SRLRVIHRDLKASNILLD--DQMNP---KISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
+ ++HRDL++ NI L D+ P K++DF +++ + + + ++G +M+P
Sbjct: 142 NP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVSGLLGNFQWMAP 195
Query: 192 EYV--MNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL 249
E + + K+D YSF +++ I++ + G +D E + + + EG
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGE---GPFD-EYSYGKIKFINMIREEG----- 246
Query: 250 IDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLT 292
+ T+ E C P R +V LC RP S + L+
Sbjct: 247 LRPTIPEDCPP----RLRNVIELCWSGDPKKRPHFSYIVKELS 285
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 62/197 (31%), Positives = 96/197 (48%), Gaps = 13/197 (6%)
Query: 24 NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
LG G FG V GK ++A+K + + S EF EA+ + KL H LV+ G
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
++ +V EY+ N L ++ K L+ + + + +G+ +L + + IH
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKG--LEPSQLLEMCYDVCEGMAFLESH---QFIH 127
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH---GYMSPEYVMNGIVS 200
RDL A N L+D + K+SDFGM R L+ VGT + +PE S
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYV----LDDQYVSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 201 MKSDVYSFGVLVLEIIS 217
KSDV++FG+L+ E+ S
Sbjct: 184 SKSDVWAFGILMWEVFS 200
>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human
Pdk1 Complex 2
Length = 311
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
++F G LG+G F V + L +E AIK L K + E ++++L H
Sbjct: 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 74 TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
V+L + Q E+L Y N L +I FD + RF E IV
Sbjct: 92 PFFVKLY-FTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCT-------RFYTAE-IV 142
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
L YLH +IHRDLK NILL++ M+ +I+DFG A+ +A N VGT
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 199
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y+SPE + S SD+++ G ++ ++++
Sbjct: 200 YVSPELLTEKSASKSSDLWALGCIIYQLVA 229
>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium
Parvum Calcium Dependent Protein Kinase In Complex With
3- Mb-Pp1
Length = 287
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 73/232 (31%), Positives = 113/232 (48%), Gaps = 35/232 (15%)
Query: 26 LGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQG--IVEFKNEAKLIAKLQHTNLVRLLGC 82
LG+G FG V K K + QE A+K ++K+S + E +L+ KL H N+++L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN------IIEGIVQGLLYLHKY 136
+V E L FD K +KRF+ II+ + G+ Y+HK+
Sbjct: 90 LEDSSSFYIVGELYTGGEL----FDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 137 SRLRVIHRDLKASNILLDDQ---MNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
+ ++HRDLK NILL+ + + KI DFG++ F N +GT Y++PE
Sbjct: 141 N---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPE- 193
Query: 194 VMNGIVSMKSDVYSFGVLVLEIISSK-----KNNGCYDTERHLNLVGYAWQL 240
V+ G K DV+S GV++ ++S KN YD + + YA+ L
Sbjct: 194 VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDILKRVETGKYAFDL 243
>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
pdb|3MA6|B Chain B, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
Length = 298
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 72/231 (31%), Positives = 117/231 (50%), Gaps = 34/231 (14%)
Query: 7 IFDFQTIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN-- 63
+F + A +D + LG+G FG V K + GQE A+K +SK + + ++
Sbjct: 21 MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 80
Query: 64 -EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN- 121
E +L+ +L H N+++L KG LV E L FD E++ +KRF+
Sbjct: 81 REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FD----EIIS-RKRFSE 131
Query: 122 -----IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQ---MNPKISDFGMARTFGMN 173
II ++ G+ Y+HK +++HRDLK N+LL+ + N +I DFG++ F
Sbjct: 132 VDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--- 185
Query: 174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGC 224
E +GT Y++PE V++G K DV+S GV++ ++S GC
Sbjct: 186 EASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLS-----GC 230
>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Novel Bosutinib Isoform 1, Previously Thought
To Be Bosutinib
Length = 293
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 54/196 (27%), Positives = 104/196 (53%), Gaps = 13/196 (6%)
Query: 26 LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
LG G FG VYK K + G A K + S + + ++ E +++A H +V+LLG
Sbjct: 19 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 85 QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHR 144
G+ ++ E+ P ++D + + + L + + +++ L +LH R+IHR
Sbjct: 79 HDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLHSK---RIIHR 133
Query: 145 DLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM-----NGIV 199
DLKA N+L+ + + +++DFG++ + L+ + +GT +M+PE VM +
Sbjct: 134 DLKAGNVLMTLEGDIRLADFGVSAK-NLKTLQ-KRDSFIGTPYWMAPEVVMCETMKDTPY 191
Query: 200 SMKSDVYSFGVLVLEI 215
K+D++S G+ ++E+
Sbjct: 192 DYKADIWSLGITLIEM 207
>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1)
pdb|3I7B|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Nm-Pp1
pdb|3N51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor
Rm-1-95
pdb|3SX9|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-132
pdb|3SXF|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-89
pdb|3T3U|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-130
pdb|3T3V|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-87
pdb|3UPX|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1300
pdb|3UPZ|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumpless Bki Analog Uw1243
pdb|3V51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Rm-1-176
pdb|3V5P|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1288
pdb|3V5T|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1299
Length = 484
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 72/231 (31%), Positives = 117/231 (50%), Gaps = 34/231 (14%)
Query: 7 IFDFQTIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN-- 63
+F + A +D + LG+G FG V K + GQE A+K +SK + + ++
Sbjct: 15 MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 74
Query: 64 -EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN- 121
E +L+ +L H N+++L KG LV E L FD E++ +KRF+
Sbjct: 75 REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FD----EIIS-RKRFSE 125
Query: 122 -----IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQ---MNPKISDFGMARTFGMN 173
II ++ G+ Y+HK +++HRDLK N+LL+ + N +I DFG++ F
Sbjct: 126 VDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--- 179
Query: 174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGC 224
E +GT Y++PE V++G K DV+S GV++ ++S GC
Sbjct: 180 EASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLS-----GC 224
>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Su11274
pdb|4AOT|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4AOT|B Chain B, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4EQU|A Chain A, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
pdb|4EQU|B Chain B, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
Length = 302
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 54/196 (27%), Positives = 104/196 (53%), Gaps = 13/196 (6%)
Query: 26 LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
LG G FG VYK K + G A K + S + + ++ E +++A H +V+LLG
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 85 QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHR 144
G+ ++ E+ P ++D + + + L + + +++ L +LH R+IHR
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLHSK---RIIHR 141
Query: 145 DLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM-----NGIV 199
DLKA N+L+ + + +++DFG++ + L+ + +GT +M+PE VM +
Sbjct: 142 DLKAGNVLMTLEGDIRLADFGVSAK-NLKTLQ-KRDSFIGTPYWMAPEVVMCETMKDTPY 199
Query: 200 SMKSDVYSFGVLVLEI 215
K+D++S G+ ++E+
Sbjct: 200 DYKADIWSLGITLIEM 215
>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent
Protein Kinase Cgd3_920 From Cryptosporidium Parvum
Length = 286
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 73/232 (31%), Positives = 113/232 (48%), Gaps = 35/232 (15%)
Query: 26 LGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQG--IVEFKNEAKLIAKLQHTNLVRLLGC 82
LG+G FG V K K + QE A+K ++K+S + E +L+ KL H N+++L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN------IIEGIVQGLLYLHKY 136
+V E L FD K +KRF+ II+ + G+ Y+HK+
Sbjct: 90 LEDSSSFYIVGELYTGGEL----FDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 137 SRLRVIHRDLKASNILLDDQ---MNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
+ ++HRDLK NILL+ + + KI DFG++ F N +GT Y++PE
Sbjct: 141 N---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPE- 193
Query: 194 VMNGIVSMKSDVYSFGVLVLEIISSK-----KNNGCYDTERHLNLVGYAWQL 240
V+ G K DV+S GV++ ++S KN YD + + YA+ L
Sbjct: 194 VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDILKRVETGKYAFDL 243
>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A
Thiazolopyrimidine Inhibitor
Length = 324
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 65/212 (30%), Positives = 108/212 (50%), Gaps = 28/212 (13%)
Query: 26 LGQGGFGPVYKGKLL-DG--QEIAIKRLSK-SSGQGIVEFKNEAKLIAKL-QHTNLVRLL 80
+G+G FG V K ++ DG + AIKR+ + +S +F E +++ KL H N++ LL
Sbjct: 30 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 81 GCSLQKGERLLVYEYLPNKSL-DF------------FIFDSSKKELLDWKKRFNIIEGIV 127
G +G L EY P+ +L DF F +S L ++ + +
Sbjct: 90 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 149
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
+G+ YL S+ + IHR+L A NIL+ + KI+DFG++R E + +G
Sbjct: 150 RGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSRG-----QEVYVKKTMGRLP 201
Query: 188 --YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
+M+ E + + + SDV+S+GVL+ EI+S
Sbjct: 202 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233
>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights
Into Receptor Autoregulation
Length = 343
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 58/221 (26%), Positives = 106/221 (47%), Gaps = 33/221 (14%)
Query: 26 LGQGGFGPVYKGK---LLDGQE---IAIKRLSKSSGQGI-VEFKNEAKLIAKLQHTNLVR 78
+G+G FG V++ + LL + +A+K L + + + +F+ EA L+A+ + N+V+
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFI---------------------FDSSKKELLDWK 117
LLG L++EY+ L+ F+ S L
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 118 KRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART-FGMNELE 176
++ I + G+ YL S + +HRDL N L+ + M KI+DFG++R + + +
Sbjct: 175 EQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
A+ N + +M PE + + +SDV+++GV++ EI S
Sbjct: 232 ADGNDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
pdb|1JPA|B Chain B, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
Length = 312
Score = 79.7 bits (195), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 56/200 (28%), Positives = 105/200 (52%), Gaps = 13/200 (6%)
Query: 26 LGQGGFGPVYKGKL-LDGQE---IAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNLVRLL 80
+G G FG V G L L G+ +AIK L S + + +F +EA ++ + H N++ L
Sbjct: 41 IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 81 GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
G + +++ E++ N SLD F+ + + + + ++ GI G+ YL + +
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYL---ADMN 155
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH---GYMSPEYVMNG 197
+HRDL A NIL++ + K+SDFG++R + + +G + +PE +
Sbjct: 156 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 215
Query: 198 IVSMKSDVYSFGVLVLEIIS 217
+ SDV+S+G+++ E++S
Sbjct: 216 KFTSASDVWSYGIVMWEVMS 235
>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone
Inhibitor
pdb|2I0Y|A Chain A, Cfms Tyrosine Kinase (Fgf Kid) In Complex With An
Arylamide Inhibitor
pdb|3DPK|A Chain A, Cfms Tyrosine Kinase In Complex With A Pyridopyrimidinone
Inhibitor
pdb|3KRJ|A Chain A, Cfms Tyrosine Kinase In Complex With
4-Cyano-1h-Imidazole-2-Carboxylic Acid
(2-Cyclohex-1-Enyl-4-Piperidin-4-Yl-Phenyl)-Amide
pdb|3KRL|A Chain A, Cfms Tyrosine Kinase In Complex With
5-Cyano-Furan-2-Carboxylic Acid
[4-(4-Methyl-Piperazin-1-Yl)-2-Piperidin-1-Yl-Phenyl]-
Amide
Length = 335
Score = 79.7 bits (195), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 82/302 (27%), Positives = 133/302 (44%), Gaps = 52/302 (17%)
Query: 18 DNFSPGNRLGQGGFGPVYKGKLLD-GQE-----IAIKRLSKSSGQGIVE-FKNEAKLIAK 70
+N G LG G FG V + G+E +A+K L ++ E +E K+++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 71 L-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSSK--KELLDW 116
L QH N+V LLG G L++ EY L F+ ++ S +E L
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 117 KKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE 176
+ + + QG+ +L + IHRD+ A N+LL + KI DFG+AR MN+
Sbjct: 166 RDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI-MND-- 219
Query: 177 ANTNRIVGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKN--NGCYDTER 229
+N IV + +M+PE + + + +++SDV+S+G+L+ EI S N G +
Sbjct: 220 --SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 277
Query: 230 HLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVAS 289
LV +Q+ A + I + + C + T RPT + S
Sbjct: 278 FYKLVKDGYQMAQPAFAPKNIYSIMQA----------------CWALEPTHRPTFQQICS 321
Query: 290 ML 291
L
Sbjct: 322 FL 323
>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From
Toxoplasma Gondii, Tgme49.101440
Length = 507
Score = 79.7 bits (195), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 72/231 (31%), Positives = 117/231 (50%), Gaps = 34/231 (14%)
Query: 7 IFDFQTIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN-- 63
+F + A +D + LG+G FG V K + GQE A+K +SK + + ++
Sbjct: 38 MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 97
Query: 64 -EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN- 121
E +L+ +L H N+++L KG LV E L FD E++ +KRF+
Sbjct: 98 REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FD----EIIS-RKRFSE 148
Query: 122 -----IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQ---MNPKISDFGMARTFGMN 173
II ++ G+ Y+HK +++HRDLK N+LL+ + N +I DFG++ F
Sbjct: 149 VDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--- 202
Query: 174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGC 224
E +GT Y++PE V++G K DV+S GV++ ++S GC
Sbjct: 203 EASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLS-----GC 247
>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3PP0|B Chain B, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3RCD|A Chain A, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|B Chain B, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|C Chain C, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|D Chain D, Her2 Kinase Domain Complexed With Tak-285
Length = 338
Score = 79.7 bits (195), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 63/202 (31%), Positives = 109/202 (53%), Gaps = 20/202 (9%)
Query: 26 LGQGGFGPVYKGKLL-DGQ----EIAIKRLSK-SSGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG G FG VYKG + DG+ +AIK L + +S + E +EA ++A + + RL
Sbjct: 25 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLHK 135
LG L +L V + +P L + ++ ++LL+W + I +G+ YL
Sbjct: 85 LGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQ------IAKGMSYLED 137
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
+R++HRDL A N+L+ + KI+DFG+AR ++E E + + +M+ E ++
Sbjct: 138 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 194
Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
+ +SDV+S+GV V E+++
Sbjct: 195 RRRFTHQSDVWSYGVTVWELMT 216
>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii,
Tgme49_101440, In Presence Of Calcium
Length = 508
Score = 79.3 bits (194), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 72/231 (31%), Positives = 117/231 (50%), Gaps = 34/231 (14%)
Query: 7 IFDFQTIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN-- 63
+F + A +D + LG+G FG V K + GQE A+K +SK + + ++
Sbjct: 39 MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 98
Query: 64 -EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN- 121
E +L+ +L H N+++L KG LV E L FD E++ +KRF+
Sbjct: 99 REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FD----EIIS-RKRFSE 149
Query: 122 -----IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQ---MNPKISDFGMARTFGMN 173
II ++ G+ Y+HK +++HRDLK N+LL+ + N +I DFG++ F
Sbjct: 150 VDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--- 203
Query: 174 ELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGC 224
E +GT Y++PE V++G K DV+S GV++ ++S GC
Sbjct: 204 EASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLS-----GC 248
>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-3
Length = 286
Score = 79.3 bits (194), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
++F G LG+G F V + L +E AIK L K + E ++++L H
Sbjct: 9 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 74 TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
V+L + Q E+L Y N L +I FD + RF E IV
Sbjct: 69 PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 119
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
L YLH +IHRDLK NILL++ M+ +I+DFG A+ +A N VGT
Sbjct: 120 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 176
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y+SPE + SD+++ G ++ ++++
Sbjct: 177 YVSPELLTEKSACKSSDLWALGCIIYQLVA 206
>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1
Catalytic Domain
pdb|1UVR|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-8
Length = 289
Score = 79.3 bits (194), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
++F G LG+G F V + L +E AIK L K + E ++++L H
Sbjct: 10 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 74 TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
V+L + Q E+L Y N L +I FD + RF E IV
Sbjct: 70 PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 120
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
L YLH +IHRDLK NILL++ M+ +I+DFG A+ +A N VGT
Sbjct: 121 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 177
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y+SPE + SD+++ G ++ ++++
Sbjct: 178 YVSPELLTEKSACKSSDLWALGCIIYQLVA 207
>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3-
Phosphoinositide Dependent Kinase (Pdk1)
Length = 311
Score = 79.3 bits (194), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
++F G LG+G F V + L +E AIK L K + E ++++L H
Sbjct: 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 74 TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
V+L + Q E+L Y N L +I FD + RF E IV
Sbjct: 92 PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 142
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
L YLH +IHRDLK NILL++ M+ +I+DFG A+ +A N VGT
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y+SPE + SD+++ G ++ ++++
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVA 229
>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|C Chain C, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|D Chain D, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome
Length = 324
Score = 79.3 bits (194), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 63/225 (28%), Positives = 107/225 (47%), Gaps = 30/225 (13%)
Query: 18 DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRLSKSSGQ----GIVEFKNEA 65
D + G LG+G FG V K K + +A+K L + + +V
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 66 KLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSSK--KE 112
K+I K H N++ LLG Q G ++ EY +L ++ +D ++ +E
Sbjct: 95 KMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 113 LLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM 172
+ +K + + +G+ YL + + IHRDL A N+L+ + KI+DFG+AR
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
+ NT +M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 210 IDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Ly333531
pdb|1UU7|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-2
pdb|1UU8|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-1
pdb|1OKY|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Staurosporine
pdb|1OKZ|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Ucn-01
Length = 310
Score = 79.3 bits (194), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
++F G LG+G F V + L +E AIK L K + E ++++L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 74 TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
V+L + Q E+L Y N L +I FD + RF E IV
Sbjct: 90 PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 140
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
L YLH +IHRDLK NILL++ M+ +I+DFG A+ +A N VGT
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y+SPE + SD+++ G ++ ++++
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVA 227
>pdb|1Z5M|A Chain A, Crystal Structure Of
N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl)
Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2-
Dimethylpropanediamide Complexed With Human Pdk1
pdb|2PE0|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
5-Hydroxy-3-[1-(1h-Pyrrol-2-Yl)-Eth-(Z)-Ylidene]-1,
3-Dihydro- Indol-2-One Complex
pdb|2PE1|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
{2-Oxo-3-[1-(1h-Pyrrol-2-Yl)-Eth-(Z)-Ylidene]-2,
3-Dihydro-1h- Indol-5-Yl}-Urea {bx-517} Complex
pdb|2PE2|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
3-{5-[2-Oxo-5-Ureido-1,
2-Dihydro-Indol-(3z)-Ylidenemethyl]-1h-
Pyrrol-3-Yl}-N-(2-Piperidin-1-Yl-Ethyl)-Benzamide
Complex
Length = 286
Score = 79.3 bits (194), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
++F G LG+G F V + L +E AIK L K + E ++++L H
Sbjct: 7 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 74 TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
V+L + Q E+L Y N L +I FD + RF E IV
Sbjct: 67 PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 117
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
L YLH +IHRDLK NILL++ M+ +I+DFG A+ +A N VGT
Sbjct: 118 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 174
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y+SPE + SD+++ G ++ ++++
Sbjct: 175 YVSPELLTEKSACKSSDLWALGCIIYQLVA 204
>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 309
Score = 79.3 bits (194), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
++F G LG+G F V + L +E AIK L K + E ++++L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 74 TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
V+L + Q E+L Y N L +I FD + RF E IV
Sbjct: 90 PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 140
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
L YLH +IHRDLK NILL++ M+ +I+DFG A+ +A N VGT
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y+SPE + SD+++ G ++ ++++
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVA 227
>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PK9|C Chain C, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PMI|A Chain A, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
pdb|2PMI|C Chain C, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
Length = 317
Score = 79.3 bits (194), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 67/228 (29%), Positives = 116/228 (50%), Gaps = 16/228 (7%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQ 72
+++ F +LG G + VYKG G +A+K + S +G E L+ +L+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 73 HTNLVRLLGCSLQKGERLLVYEYLPN---KSLDFFIFDSSKKEL-LDWKKRFNIIEGIVQ 128
H N+VRL + + LV+E++ N K +D ++ + L L+ K F ++Q
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW--QLLQ 119
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT-NRIVGTHG 187
GL + H+ +++HRDLK N+L++ + K+ DFG+AR FG + NT + V T
Sbjct: 120 GLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG---IPVNTFSSEVVTLW 173
Query: 188 YMSPEYVMNG-IVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
Y +P+ +M S D++S G ++ E+I+ K + E L L+
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI 221
>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain
Length = 310
Score = 79.3 bits (194), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
++F G LG+G F V + L +E AIK L K + E ++++L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 74 TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
V+L + Q E+L Y N L +I FD + RF E IV
Sbjct: 90 PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 140
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
L YLH +IHRDLK NILL++ M+ +I+DFG A+ +A N VGT
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQ 197
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y+SPE + SD+++ G ++ ++++
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVA 227
>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8
pdb|3NUU|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment11
pdb|3NUY|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment17
Length = 286
Score = 79.3 bits (194), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
++F G LG+G F V + L +E AIK L K + E ++++L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 74 TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
V+L + Q E+L Y N L +I FD + RF E IV
Sbjct: 68 PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 118
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
L YLH +IHRDLK NILL++ M+ +I+DFG A+ +A N VGT
Sbjct: 119 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 175
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y+SPE + SD+++ G ++ ++++
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVA 205
>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead
Compound
Length = 292
Score = 79.3 bits (194), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
++F G LG+G F V + L +E AIK L K + E ++++L H
Sbjct: 14 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 74 TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
V+L + Q E+L Y N L +I FD + RF E IV
Sbjct: 74 PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 124
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
L YLH +IHRDLK NILL++ M+ +I+DFG A+ +A N VGT
Sbjct: 125 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 181
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y+SPE + SD+++ G ++ ++++
Sbjct: 182 YVSPELLTEKSACKSSDLWALGCIIYQLVA 211
>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent
Kinase- 1 (Pdk-1)catalytic Domain Bound To A
Dibenzonaphthyridine Inhibitor
pdb|3ION|A Chain A, Pdk1 In Complex With Compound 8h
Length = 312
Score = 79.3 bits (194), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
++F G LG+G F V + L +E AIK L K + E ++++L H
Sbjct: 33 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 74 TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
V+L + Q E+L Y N L +I FD + RF E IV
Sbjct: 93 PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 143
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
L YLH +IHRDLK NILL++ M+ +I+DFG A+ +A N VGT
Sbjct: 144 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 200
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y+SPE + SD+++ G ++ ++++
Sbjct: 201 YVSPELLTEKSACKSSDLWALGCIIYQLVA 230
>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6
pdb|3NAY|B Chain B, Pdk1 In Complex With Inhibitor Mp6
Length = 311
Score = 79.3 bits (194), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
++F G LG+G F V + L +E AIK L K + E ++++L H
Sbjct: 29 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 74 TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
V+L + Q E+L Y N L +I FD + RF E IV
Sbjct: 89 PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 139
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
L YLH +IHRDLK NILL++ M+ +I+DFG A+ +A N VGT
Sbjct: 140 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 196
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y+SPE + SD+++ G ++ ++++
Sbjct: 197 YVSPELLTEKSACKSSDLWALGCIIYQLVA 226
>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i
pdb|3QCQ|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-(3-
Amino-1h-Indazol-6-Yl)-N4-Ethyl-2,4-Pyrimidinediamine
pdb|3QCS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-[2-
Amino-6-(4-Morpholinyl)-4-Pyrimidinyl]-1h-Indazol-3-
Amine
pdb|3QCX|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-{2-
Amino-6-[(3r)-3-Methyl-4-Morpholinyl]-4-Pyrimidinyl}-1h-
Indazol-3- Amine
pdb|3QCY|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 4-[2-
Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-Pyrimidinyl]-N-
Phenyl-2- Morpholinecarboxamide
pdb|3QD0|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With (2r,5s)-
1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-Pyrimidinyl]-6-
Methyl-N- Phenyl-3-Piperidinecarboxamide
pdb|3QD3|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 1,1- Dimethylethyl
{(3r,6s)-1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-
Pyrimidinyl]-6-Methyl-3-Piperidinyl}carbamate
pdb|3QD4|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 1,1-
Dimethylethyl{(3r,
5r)-1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-
Pyrimidinyl]-5-Methyl-3-Piperidinyl}carbamate
Length = 312
Score = 79.3 bits (194), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
++F G LG+G F V + L +E AIK L K + E ++++L H
Sbjct: 33 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 74 TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
V+L + Q E+L Y N L +I FD + RF E IV
Sbjct: 93 PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 143
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
L YLH +IHRDLK NILL++ M+ +I+DFG A+ +A N VGT
Sbjct: 144 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 200
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y+SPE + SD+++ G ++ ++++
Sbjct: 201 YVSPELLTEKSACKSSDLWALGCIIYQLVA 230
>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through
Fragment-Based Lead Discovery
pdb|3RWQ|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3-
Phosphoinositide Dependent Kinase (Pdk1)
Length = 311
Score = 79.0 bits (193), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
++F G LG+G F V + L +E AIK L K + E ++++L H
Sbjct: 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 74 TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
V+L + Q E+L Y N L +I FD + RF E IV
Sbjct: 92 PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 142
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
L YLH +IHRDLK NILL++ M+ +I+DFG A+ +A N VGT
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y+SPE + SD+++ G ++ ++++
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVA 229
>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7
Length = 311
Score = 79.0 bits (193), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
++F G LG+G F V + L +E AIK L K + E ++++L H
Sbjct: 29 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 74 TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
V+L + Q E+L Y N L +I FD + RF E IV
Sbjct: 89 PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 139
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
L YLH +IHRDLK NILL++ M+ +I+DFG A+ +A N VGT
Sbjct: 140 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 196
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y+SPE + SD+++ G ++ ++++
Sbjct: 197 YVSPELLTEKSACKSSDLWALGCIIYQLVA 226
>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain
In Complex With Atp
pdb|3HRF|A Chain A, Crystal Structure Of Human Pdk1 Kinase Domain In Complex
With An Allosteric Activator Bound To The Pif-Pocket
pdb|3RCJ|A Chain A, Rapid Preparation Of Triazolyl Substituted Nh-Heterocyclic
Kinase Inhibitors Via One-Pot Sonogashira Coupling
Tms-Deprotection Cuaac Sequence
pdb|4A06|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Activator Ps114 Bound To The Pif-Pocket
pdb|4AW1|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Compound Ps210 Bound To The Pif-Pocket
Length = 311
Score = 79.0 bits (193), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
++F G LG+G F V + L +E AIK L K + E ++++L H
Sbjct: 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 74 TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
V+L + Q E+L Y N L +I FD + RF E IV
Sbjct: 92 PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 142
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
L YLH +IHRDLK NILL++ M+ +I+DFG A+ +A N VGT
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y+SPE + SD+++ G ++ ++++
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVA 229
>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Activator Ps171 Bound To The Pif-Pocket
pdb|4AW0|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Compound Ps182 Bound To The Pif-Pocket
Length = 311
Score = 79.0 bits (193), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
++F G LG+G F V + L +E AIK L K + E ++++L H
Sbjct: 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 74 TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
V+L + Q E+L Y N L +I FD + RF E IV
Sbjct: 92 PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 142
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
L YLH +IHRDLK NILL++ M+ +I+DFG A+ +A N VGT
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y+SPE + SD+++ G ++ ++++
Sbjct: 200 YVSPELLTEKSAXKSSDLWALGCIIYQLVA 229
>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In
Complex With Compound 9
Length = 311
Score = 79.0 bits (193), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
++F G LG+G F V + L +E AIK L K + E ++++L H
Sbjct: 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 74 TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
V+L + Q E+L Y N L +I FD + RF E IV
Sbjct: 92 PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 142
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
L YLH +IHRDLK NILL++ M+ +I+DFG A+ +A N VGT
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y+SPE + SD+++ G ++ ++++
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVA 229
>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase
Domain Of Csf-1r
Length = 324
Score = 79.0 bits (193), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 80/309 (25%), Positives = 130/309 (42%), Gaps = 59/309 (19%)
Query: 18 DNFSPGNRLGQGGFGPVYKGKLLD-GQE-----IAIKRLSKSSGQGIVE-FKNEAKLIAK 70
+N G LG G FG V + G+E +A+K L ++ E +E K+++
Sbjct: 31 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 71 L-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI--------------------FDSS 109
L QH N+V LLG G L++ EY L F+ D
Sbjct: 91 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKE 150
Query: 110 KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART 169
L+ + + + QG+ +L + IHRD+ A N+LL + KI DFG+AR
Sbjct: 151 DGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 207
Query: 170 FGMNELEANTNRIVGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKN--N 222
MN+ +N IV + +M+PE + + + +++SDV+S+G+L+ EI S N
Sbjct: 208 I-MND----SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 262
Query: 223 GCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRP 282
G + LV +Q+ + +P + + C + T RP
Sbjct: 263 GILVNSKFYKLVKDGYQM-------------AQPAFAPKNIYSIMQA---CWALEPTHRP 306
Query: 283 TMSDVASML 291
T + S L
Sbjct: 307 TFQQICSFL 315
>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx
pdb|3QC4|B Chain B, Pdk1 In Complex With Dfg-Out Inhibitor Xxx
Length = 314
Score = 79.0 bits (193), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
++F G LG+G F V + L +E AIK L K + E ++++L H
Sbjct: 35 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 74 TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
V+L + Q E+L Y N L +I FD + RF E IV
Sbjct: 95 PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 145
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
L YLH +IHRDLK NILL++ M+ +I+DFG A+ +A N VGT
Sbjct: 146 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 202
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y+SPE + SD+++ G ++ ++++
Sbjct: 203 YVSPELLTEKSACKSSDLWALGCIIYQLVA 232
>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7
pdb|2WQN|A Chain A, Structure Of Adp-Bound Human Nek7
Length = 310
Score = 78.6 bits (192), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 10/204 (4%)
Query: 19 NFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLS---KSSGQGIVEFKNEAKLIAKLQHT 74
NF ++G+G F VY+ LLDG +A+K++ + + E L+ +L H
Sbjct: 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 75 NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK-KELLDWKKRFNIIEGIVQGLLYL 133
N+++ ++ E +V E L I K K L+ + + + L ++
Sbjct: 93 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
H SR RV+HRD+K +N+ + K+ D G+ R F A++ +VGT YMSPE
Sbjct: 153 H--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 207
Query: 194 VMNGIVSMKSDVYSFGVLVLEIIS 217
+ + KSD++S G L+ E+ +
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAA 231
>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1F3M|D Chain D, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1YHW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With One Point
Mutations (K299r)
Length = 297
Score = 78.6 bits (192), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 57/196 (29%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 25 RLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
++GQG G VY + GQE+AI++++ NE ++ + ++ N+V L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
L E +V EYL SL + ++ +D + + +Q L +LH +VIH
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RD+K+ NILL + K++DFG + + +T +VGT +M+PE V K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKV 197
Query: 204 DVYSFGVLVLEIISSK 219
D++S G++ +E+I +
Sbjct: 198 DIWSLGIMAIEMIEGE 213
>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 309
Score = 78.6 bits (192), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 18 DNFSPGNRLGQGGFGP-VYKGKLLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQH 73
++F G LG+G F V +L +E AIK L K + E ++++L H
Sbjct: 30 EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 74 TNLVRLLGCSLQKGERLLV-YEYLPNKSLDFFI-----FDSSKKELLDWKKRFNIIEGIV 127
V+L + Q E+L Y N L +I FD + RF E IV
Sbjct: 90 PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IV 140
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
L YLH +IHRDLK NILL++ M+ +I+DFG A+ +A N VGT
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y+SPE + SD+++ G ++ ++++
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVA 227
>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea
Inhibitor
Length = 316
Score = 78.6 bits (192), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 80/309 (25%), Positives = 137/309 (44%), Gaps = 42/309 (13%)
Query: 8 FDFQTIAAATDNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQG-IVE 60
+D D + G LG+G FG V + K + +A+K L + +
Sbjct: 18 YDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 77
Query: 61 FKNEAKLIAKL-QHTNLVRLLG-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWK- 117
+E K++ + H N+V LLG C+ G +++ E+ +L ++ S + E + +K
Sbjct: 78 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKT 136
Query: 118 -----KRFNIIEGIV-------QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG 165
K F +E ++ +G+ +L + + IHRDL A NILL ++ KI DFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFG 193
Query: 166 MARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCY 225
+AR + +M+PE + + + +++SDV+SFGVL+ EI S
Sbjct: 194 LARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------- 245
Query: 226 DTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPTM 284
L Y +E L + T +PD T ++ +L C + + RPT
Sbjct: 246 -----LGASPYPGVKIDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTF 298
Query: 285 SDVASMLTN 293
S++ L N
Sbjct: 299 SELVEHLGN 307
>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.28 A Resolution
pdb|4G34|A Chain A, Crystal Structure Of Gsk6924 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.70 A Resolution
Length = 299
Score = 78.6 bits (192), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 68/224 (30%), Positives = 104/224 (46%), Gaps = 31/224 (13%)
Query: 19 NFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL 76
+F P LG+GGFG V++ K +D AIKR+ + + E E K +AKL+H +
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 77 VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDW---------KKR---FNIIE 124
VR L+K + P L + K+ L DW ++R +I
Sbjct: 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNIL--LDDQMNPKISDFGMARTFGMNELE------ 176
I + + +LH ++HRDLK SNI +DD + K+ DFG+ +E E
Sbjct: 126 QIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVV--KVGDFGLVTAMDQDEEEQTVLTP 180
Query: 177 ----ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
A VGT YMSPE + S K D++S G+++ E++
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7)
pdb|3DKO|A Chain A, Complex Between The Kinase Domain Of Human Ephrin Type-A
Receptor 7 (Epha7) And Inhibitor Alw-Ii-49-7
Length = 318
Score = 78.6 bits (192), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 58/203 (28%), Positives = 105/203 (51%), Gaps = 21/203 (10%)
Query: 26 LGQGGFGPVYKGKL-LDGQE---IAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLVRLL 80
+G G FG V G+L L G+ +AIK L + + +F EA ++ + H N+V L
Sbjct: 51 IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 81 GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
G + ++V E++ N +LD F+ + + + ++ GI G+ YL + +
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTV--IQLVGMLRGIAAGMRYL---ADMG 165
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG------YMSPEYV 194
+HRDL A NIL++ + K+SDFG++R +E + + T G + +PE +
Sbjct: 166 YVHRDLAARNILVNSNLVCKVSDFGLSRV-----IEDDPEAVYTTTGGKIPVRWTAPEAI 220
Query: 195 MNGIVSMKSDVYSFGVLVLEIIS 217
+ SDV+S+G+++ E++S
Sbjct: 221 QYRKFTSASDVWSYGIVMWEVMS 243
>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662
Length = 279
Score = 78.6 bits (192), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 26 LGQGGFGPVYK------GKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
+G G +G K GK+L +E+ ++++ Q +V +E L+ +L+H N+VR
Sbjct: 14 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV---SEVNLLRELKHPNIVRY 70
Query: 80 LGCSLQKGERLL--VYEYLPNKSLDFFIFDSSK-KELLDWKKRFNIIEGIVQGLLYLHKY 136
+ + L V EY L I +K ++ LD + ++ + L H+
Sbjct: 71 YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 137 SR--LRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
S V+HRDLK +N+ LD + N K+ DFG+AR +N E VGT YMSPE +
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDEDFAKEFVGTPYYMSPEQM 188
Query: 195 MNGIVSMKSDVYSFGVLVLEIIS 217
+ KSD++S G L+ E+ +
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCA 211
>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point
Mutations (K299r, T423e)
pdb|2HY8|1 Chain 1, Pak1 Complex With St2001
Length = 297
Score = 78.2 bits (191), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 56/196 (28%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 25 RLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
++GQG G VY + GQE+AI++++ NE ++ + ++ N+V L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
L E +V EYL SL + ++ +D + + +Q L +LH +VIH
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RD+K+ NILL + K++DFG + ++ + +VGT +M+PE V K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKV 197
Query: 204 DVYSFGVLVLEIISSK 219
D++S G++ +E+I +
Sbjct: 198 DIWSLGIMAIEMIEGE 213
>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 78.2 bits (191), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 79/305 (25%), Positives = 130/305 (42%), Gaps = 37/305 (12%)
Query: 8 FDFQTIAAATDNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQG-IVE 60
+D D + G LG+G FG V + K + +A+K L + +
Sbjct: 17 YDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA 76
Query: 61 FKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLVY----------EYLPNKSLDFFIFDSS 109
+E K++ + H N+V LLG + G L+V YL +K +F +
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDL 136
Query: 110 KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART 169
K+ L + + +G+ +L + + IHRDL A NILL ++ KI DFG+AR
Sbjct: 137 YKDFLTLEHLICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARD 193
Query: 170 FGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTER 229
+ +M+PE + + + +++SDV+SFGVL+ EI S
Sbjct: 194 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------------ 241
Query: 230 HLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPTMSDVA 288
L Y +E L + T +PD T ++ +L C + + RPT S++
Sbjct: 242 -LGASPYPGVKIDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELV 298
Query: 289 SMLTN 293
L N
Sbjct: 299 EHLGN 303
>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 78.2 bits (191), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 79/305 (25%), Positives = 130/305 (42%), Gaps = 37/305 (12%)
Query: 8 FDFQTIAAATDNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQG-IVE 60
+D D + G LG+G FG V + K + +A+K L + +
Sbjct: 17 YDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA 76
Query: 61 FKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLVY----------EYLPNKSLDFFIFDSS 109
+E K++ + H N+V LLG + G L+V YL +K +F +
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDL 136
Query: 110 KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMART 169
K+ L + + +G+ +L + + IHRDL A NILL ++ KI DFG+AR
Sbjct: 137 YKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARD 193
Query: 170 FGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTER 229
+ +M+PE + + + +++SDV+SFGVL+ EI S
Sbjct: 194 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------------ 241
Query: 230 HLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPTMSDVA 288
L Y +E L + T +PD T ++ +L C + + RPT S++
Sbjct: 242 -LGASPYPGVKIDEEFXRRLKEGT--RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 298
Query: 289 SMLTN 293
L N
Sbjct: 299 EHLGN 303
>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3Q4T|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3SOC|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|3SOC|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|4ASX|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
pdb|4ASX|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
Length = 322
Score = 78.2 bits (191), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 112/211 (53%), Gaps = 30/211 (14%)
Query: 27 GQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKL--IAKLQHTNLVRLLGCSL 84
+G FG V+K +LL+ + +A+K Q ++NE ++ + ++H N+++ +G
Sbjct: 33 ARGRFGCVWKAQLLN-EYVAVKIFPIQDKQS---WQNEYEVYSLPGMKHENILQFIGAE- 87
Query: 85 QKGERL-----LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK---- 135
++G + L+ + SL F+ K ++ W + +I E + +GL YLH+
Sbjct: 88 KRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHEDIPG 143
Query: 136 ---YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
+ + HRD+K+ N+LL + + I+DFG+A F + +T+ VGT YM+PE
Sbjct: 144 LKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE 203
Query: 193 YVMNGIVS------MKSDVYSFGVLVLEIIS 217
V+ G ++ ++ D+Y+ G+++ E+ S
Sbjct: 204 -VLEGAINFQRDAFLRIDMYAMGLVLWELAS 233
>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120
Length = 316
Score = 77.8 bits (190), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 80/308 (25%), Positives = 136/308 (44%), Gaps = 41/308 (13%)
Query: 8 FDFQTIAAATDNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQG-IVE 60
+D D G LG+G FG V + K + +A+K L + +
Sbjct: 19 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA 78
Query: 61 FKNEAKLIAKL-QHTNLVRLLG-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWK- 117
+E K++ + H N+V LLG C+ G +++ E+ +L ++ S + E + +K
Sbjct: 79 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKP 137
Query: 118 ----KRFNIIEGIV-------QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGM 166
K F +E ++ +G+ +L + + IHRDL A NILL ++ KI DFG+
Sbjct: 138 EDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGL 194
Query: 167 ARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYD 226
AR + +M+PE + + + +++SDV+SFGVL+ EI S
Sbjct: 195 ARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--------- 245
Query: 227 TERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPTMS 285
L Y +E L + T +PD T ++ +L C + + RPT S
Sbjct: 246 ----LGASPYPGVKIDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFS 299
Query: 286 DVASMLTN 293
++ L N
Sbjct: 300 ELVEHLGN 307
>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk
Length = 476
Score = 77.8 bits (190), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 55/199 (27%), Positives = 103/199 (51%), Gaps = 14/199 (7%)
Query: 23 GNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSSGQG---IVEFKNEAKLIAKLQHTNLVR 78
G+ LG G FG V GK L G ++A+K L++ + + + + E + + +H ++++
Sbjct: 21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSR 138
L + +V EY+ L +I + + LD K+ + + I+ G+ Y H++
Sbjct: 81 LYQVISTPSDIFMVMEYVSGGELFDYICKNGR---LDEKESRRLFQQILSGVDYCHRHM- 136
Query: 139 LRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGI 198
V+HRDLK N+LLD MN KI+DFG++ E + G+ Y +PE + +
Sbjct: 137 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXS---CGSPNYAAPEVISGRL 191
Query: 199 VS-MKSDVYSFGVLVLEII 216
+ + D++S GV++ ++
Sbjct: 192 YAGPEVDIWSSGVILYALL 210
>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol
Length = 315
Score = 77.8 bits (190), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 58/196 (29%), Positives = 94/196 (47%), Gaps = 11/196 (5%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
+G+G FG V K K +++AIK++ S + F E + ++++ H N+V+L G L
Sbjct: 17 VGRGAFGVVCKAKW-RAKDVAIKQIESESERK--AFIVELRQLSRVNHPNIVKLYGACLN 73
Query: 86 KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRD 145
LV EY SL + + + QG+ YLH +IHRD
Sbjct: 74 P--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 131
Query: 146 LKASNILL-DDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSD 204
LK N+LL KI DFG A +++ + G+ +M+PE S K D
Sbjct: 132 LKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 186
Query: 205 VYSFGVLVLEIISSKK 220
V+S+G+++ E+I+ +K
Sbjct: 187 VFSWGIILWEVITRRK 202
>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain
pdb|3Q53|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain In Complex
With Atp
Length = 306
Score = 77.8 bits (190), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 57/215 (26%), Positives = 105/215 (48%), Gaps = 10/215 (4%)
Query: 6 KIFDFQTIAAATDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNE 64
K+ ++ ++ ++GQG G VY + GQE+AI++++ NE
Sbjct: 9 KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE 68
Query: 65 AKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE 124
++ + ++ N+V L L E +V EYL SL + ++ +D + +
Sbjct: 69 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCR 124
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
+Q L +LH +VIHRD+K+ NILL + K++DFG + ++ + +VG
Sbjct: 125 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSXMVG 179
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
T +M+PE V K D++S G++ +E+I +
Sbjct: 180 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214
>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2
pdb|3NYV|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Non-Specific Inhibitor
Whi-P180
Length = 484
Score = 77.8 bits (190), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 71/227 (31%), Positives = 113/227 (49%), Gaps = 34/227 (14%)
Query: 11 QTIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKN---EAK 66
+ A +D + LG+G FG V K + GQE A+K +SK + + ++ E +
Sbjct: 19 HSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQ 78
Query: 67 LIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN----- 121
L+ +L H N+ +L KG LV E L FD E++ +KRF+
Sbjct: 79 LLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGEL----FD----EIIS-RKRFSEVDAA 129
Query: 122 -IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQ---MNPKISDFGMARTFGMNELEA 177
II ++ G+ Y HK +++HRDLK N+LL+ + N +I DFG++ F E
Sbjct: 130 RIIRQVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASK 183
Query: 178 NTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGC 224
+GT Y++PE V++G K DV+S GV++ ++S GC
Sbjct: 184 KXKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLS-----GC 224
>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Lambda-Fl172
pdb|3FY0|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Dw1
pdb|4DAW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With The Ruthenium
Phthalimide Complex
Length = 297
Score = 77.8 bits (190), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 56/196 (28%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 25 RLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
++GQG G VY + GQE+AI++++ NE ++ + ++ N+V L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
L E +V EYL SL + ++ +D + + +Q L +LH +VIH
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RD+K+ NILL + K++DFG + ++ + +VGT +M+PE V K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKV 197
Query: 204 DVYSFGVLVLEIISSK 219
D++S G++ +E+I +
Sbjct: 198 DIWSLGIMAIEMIEGE 213
>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound
pdb|2WQO|A Chain A, Structure Of Nek2 Bound To The Aminopyridine Cct241950
pdb|2XK3|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 35
pdb|2XK4|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 17
pdb|2XK6|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 36
pdb|2XK7|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 23
pdb|2XK8|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 15
pdb|2XKC|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 14
pdb|2XKD|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 12
pdb|2XKF|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 2
pdb|2XKE|A Chain A, Structure Of Nek2 Bound To Aminipyrazine Compound 5
pdb|2XNM|A Chain A, Structure Of Nek2 Bound To Cct
pdb|2XNN|A Chain A, Structure Of Nek2 Bound To Cct242430
pdb|2XNO|A Chain A, Structure Of Nek2 Bound To Cct243779
pdb|2XNP|A Chain A, Structure Of Nek2 Bound To Cct244858
pdb|4AFE|A Chain A, Nek2 Bound To Hybrid Compound 21
Length = 279
Score = 77.8 bits (190), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 26 LGQGGFGPVYK------GKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
+G G +G K GK+L +E+ ++++ Q +V +E L+ +L+H N+VR
Sbjct: 14 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV---SEVNLLRELKHPNIVRY 70
Query: 80 LGCSLQKGERLL--VYEYLPNKSLDFFIFDSSK-KELLDWKKRFNIIEGIVQGLLYLHKY 136
+ + L V EY L I +K ++ LD + ++ + L H+
Sbjct: 71 YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 137 SR--LRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
S V+HRDLK +N+ LD + N K+ DFG+AR + A T VGT YMSPE +
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQM 188
Query: 195 MNGIVSMKSDVYSFGVLVLEIIS 217
+ KSD++S G L+ E+ +
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCA 211
>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With
Its Activating Protein Tab1
pdb|2YIY|A Chain A, Crystal Structure Of Compound 8 Bound To Tak1-Tab
Length = 307
Score = 77.8 bits (190), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 58/196 (29%), Positives = 94/196 (47%), Gaps = 11/196 (5%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
+G+G FG V K K +++AIK++ S + F E + ++++ H N+V+L G L
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIKQIESESERK--AFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 86 KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRD 145
LV EY SL + + + QG+ YLH +IHRD
Sbjct: 73 P--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 146 LKASNILL-DDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSD 204
LK N+LL KI DFG A +++ + G+ +M+PE S K D
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 185
Query: 205 VYSFGVLVLEIISSKK 220
V+S+G+++ E+I+ +K
Sbjct: 186 VFSWGIILWEVITRRK 201
>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3EYH|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 290
Score = 77.8 bits (190), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 59/202 (29%), Positives = 105/202 (51%), Gaps = 16/202 (7%)
Query: 26 LGQGGFGPVYKGKL-----LDGQEIAIKRLS-KSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG+G FG V + G+++A+K L +S G I + K E +++ L H N+V+
Sbjct: 17 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 80 LG-CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
G C+ G + L+ E+LP+ SL ++ + K ++ K++ I +G+ YL
Sbjct: 77 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK--INLKQQLKYAVQICKGMDYL---G 131
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE--LEANTNRIVGTHGYMSPEYVM 195
+ +HRDL A N+L++ + KI DFG+ + ++ +R Y +PE +M
Sbjct: 132 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLM 190
Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
+ SDV+SFGV + E+++
Sbjct: 191 QSKFYIASDVWSFGVTLHELLT 212
>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|E Chain E, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|D Chain D, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4N|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E4N|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E5W|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4E5W|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4EHZ|A Chain A, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|B Chain B, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|C Chain C, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|D Chain D, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EI4|A Chain A, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4EI4|B Chain B, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4FK6|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
pdb|4FK6|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
Length = 302
Score = 77.8 bits (190), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 59/202 (29%), Positives = 105/202 (51%), Gaps = 16/202 (7%)
Query: 26 LGQGGFGPVYKGKLLD-----GQEIAIKRLS-KSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG+G FG V + G+++A+K L +S G I + K E +++ L H N+V+
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 80 LG-CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
G C+ G + L+ E+LP+ SL ++ + K ++ K++ I +G+ YL
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK--INLKQQLKYAVQICKGMDYL---G 143
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE--LEANTNRIVGTHGYMSPEYVM 195
+ +HRDL A N+L++ + KI DFG+ + ++ +R Y +PE +M
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLM 202
Query: 196 NGIVSMKSDVYSFGVLVLEIIS 217
+ SDV+SFGV + E+++
Sbjct: 203 QSKFYIASDVWSFGVTLHELLT 224
>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|2P2I|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|3EFL|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
pdb|3EFL|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
Length = 314
Score = 77.8 bits (190), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 80/310 (25%), Positives = 136/310 (43%), Gaps = 43/310 (13%)
Query: 8 FDFQTIAAATDNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQG-IVE 60
+D D G LG+G FG V + K + +A+K L + +
Sbjct: 8 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 61 FKNEAKLIAKL-QHTNLVRLLG-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWK- 117
+E K++ + H N+V LLG C+ G +++ E+ +L ++ S + E + +K
Sbjct: 68 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKV 126
Query: 118 ------KRFNIIEGIV-------QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDF 164
K F +E ++ +G+ +L + + IHRDL A NILL ++ KI DF
Sbjct: 127 APEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDF 183
Query: 165 GMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGC 224
G+AR + +M+PE + + + +++SDV+SFGVL+ EI S
Sbjct: 184 GLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------- 236
Query: 225 YDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPT 283
L Y +E L + T +PD T ++ +L C + + RPT
Sbjct: 237 ------LGASPYPGVKIDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPT 288
Query: 284 MSDVASMLTN 293
S++ L N
Sbjct: 289 FSELVEHLGN 298
>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel
4-amino-furo[2,3-d]pyrimidine
Length = 316
Score = 77.8 bits (190), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 80/310 (25%), Positives = 136/310 (43%), Gaps = 43/310 (13%)
Query: 8 FDFQTIAAATDNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQG-IVE 60
+D D G LG+G FG V + K + +A+K L + +
Sbjct: 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 61 FKNEAKLIAKL-QHTNLVRLLG-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWK- 117
+E K++ + H N+V LLG C+ G +++ E+ +L ++ S + E + +K
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKV 135
Query: 118 ------KRFNIIEGIV-------QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDF 164
K F +E ++ +G+ +L + + IHRDL A NILL ++ KI DF
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDF 192
Query: 165 GMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGC 224
G+AR + +M+PE + + + +++SDV+SFGVL+ EI S
Sbjct: 193 GLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------- 245
Query: 225 YDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPT 283
L Y +E L + T +PD T ++ +L C + + RPT
Sbjct: 246 ------LGASPYPGVKIDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPT 297
Query: 284 MSDVASMLTN 293
S++ L N
Sbjct: 298 FSELVEHLGN 307
>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679
pdb|3UNZ|B Chain B, Aurora A In Complex With Rpm1679
pdb|3UO4|A Chain A, Aurora A In Complex With Rpm1680
pdb|3UO5|A Chain A, Aurora A In Complex With Yl1-038-31
pdb|3UO6|A Chain A, Aurora A In Complex With Yl5-083
pdb|3UO6|B Chain B, Aurora A In Complex With Yl5-083
pdb|3UOD|A Chain A, Aurora A In Complex With Rpm1693
pdb|3UOH|A Chain A, Aurora A In Complex With Rpm1722
pdb|3UOH|B Chain B, Aurora A In Complex With Rpm1722
pdb|3UOJ|A Chain A, Aurora A In Complex With Rpm1715
pdb|3UOJ|B Chain B, Aurora A In Complex With Rpm1715
pdb|3UOK|A Chain A, Aurora A In Complex With Yl5-81-1
pdb|3UOK|B Chain B, Aurora A In Complex With Yl5-81-1
pdb|3UOL|A Chain A, Aurora A In Complex With So2-162
pdb|3UOL|B Chain B, Aurora A In Complex With So2-162
pdb|3UP2|A Chain A, Aurora A In Complex With Rpm1686
pdb|3UP7|A Chain A, Aurora A In Complex With Yl1-038-09
pdb|4DEA|A Chain A, Aurora A In Complex With Yl1-038-18
pdb|4DEB|A Chain A, Aurora A In Complex With Rk2-17-01
pdb|4DED|A Chain A, Aurora A In Complex With Yl1-038-21
pdb|4DEE|A Chain A, Aurora A In Complex With Adp
Length = 279
Score = 77.4 bits (189), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 71/257 (27%), Positives = 119/257 (46%), Gaps = 17/257 (6%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
A ++F G LG+G FG VY + + I A+K L K+ + G+ + + E ++ + L
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
+H N++RL G L+ EY P L + K D ++ I + L
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
Y H RVIHRD+K N+LL KI+DFG + ++ + + + GT Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDTLCGTLDYLPP 176
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
E + + K D++S GVL E + K + N +T + ++ V + + + A +
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 249 LIDTTLHESCSPDEVTR 265
LI L + S + R
Sbjct: 237 LISRLLKHNPSQRPMLR 253
>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains
Trapped In Trans-Phosphorylation Reaction
Length = 334
Score = 77.4 bits (189), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 62/225 (27%), Positives = 106/225 (47%), Gaps = 30/225 (13%)
Query: 18 DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRLSKSSGQ----GIVEFKNEA 65
D + G LG+G FG V K K + +A+K L + + +V
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 66 KLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSSK--KE 112
K+I K H N++ LLG Q G ++ EY +L ++ +D ++ +E
Sbjct: 95 KMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 113 LLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM 172
+ +K + + +G+ YL + + IHRDL A N+L+ + KI+DFG+AR
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
+ T +M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 210 IDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
pdb|3DAE|B Chain B, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
Length = 283
Score = 77.4 bits (189), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 56/206 (27%), Positives = 104/206 (50%), Gaps = 19/206 (9%)
Query: 14 AAATDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIK-----RLSKSSGQGIVEFKNEAKL 67
A N+ LG+G FG V GQ++A+K L+KS QG +E E
Sbjct: 10 GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISY 67
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
+ L+H ++++L K E ++V EY N+ D+ + +++ + ++ + I+
Sbjct: 68 LRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQII 123
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
+ Y H++ +++HRDLK N+LLD+ +N KI+DFG++ + G+
Sbjct: 124 SAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS---CGSPN 177
Query: 188 YMSPEYVMNGIVS-MKSDVYSFGVLV 212
Y +PE + + + + DV+S GV++
Sbjct: 178 YAAPEVISGKLYAGPEVDVWSCGVIL 203
>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridinyl-Triazine Inhibitor
pdb|2QU5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzimidazole Inhibitor
pdb|2QU6|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|2QU6|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|3B8Q|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8Q|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|2RL5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A 2,3-Dihydro-1,4-Benzoxazine Inhibitor
pdb|3BE2|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzamide Inhibitor
pdb|3CP9|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CP9|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPB|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPB|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPC|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPC|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3DTW|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
pdb|3DTW|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
Length = 314
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 79/300 (26%), Positives = 134/300 (44%), Gaps = 43/300 (14%)
Query: 18 DNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQG-IVEFKNEAKLIAK 70
D G LG+G FG V + K + +A+K L + + +E K++
Sbjct: 18 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 71 L-QHTNLVRLLG-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWK-------KRFN 121
+ H N+V LLG C+ G +++ E+ +L ++ S + E + +K K F
Sbjct: 78 IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFL 136
Query: 122 IIEGIV-------QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
+E ++ +G+ +L + + IHRDL A NILL ++ KI DFG+AR +
Sbjct: 137 TLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 193
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
+M+PE + + + +++SDV+SFGVL+ EI S L
Sbjct: 194 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------------LGAS 240
Query: 235 GYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPTMSDVASMLTN 293
Y +E L + T +PD T ++ +L C + + RPT S++ L N
Sbjct: 241 PYPGVKIDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 298
>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf
Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp
Analog And Substrate Peptide
Length = 334
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 62/225 (27%), Positives = 106/225 (47%), Gaps = 30/225 (13%)
Query: 18 DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRLSKSSGQ----GIVEFKNEA 65
D + G LG+G FG V K K + +A+K L + + +V
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 66 KLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSSK--KE 112
K+I K H N++ LLG Q G ++ EY +L ++ +D ++ +E
Sbjct: 95 KMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEE 152
Query: 113 LLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM 172
+ +K + + +G+ YL + + IHRDL A N+L+ + KI+DFG+AR
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
+ T +M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 210 IDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24)
Length = 304
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 57/200 (28%), Positives = 105/200 (52%), Gaps = 15/200 (7%)
Query: 20 FSPGNRLGQGGFGPVYKGKLLDGQE---IAIKRLS-KSSGQGIVEFKNEAKLIAKLQHTN 75
F+ ++G+G FG V+KG +D + +AIK + + + I + + E ++++
Sbjct: 9 FTKLEKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 76 LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
+ + G L+ + ++ EYL S D + LD + I+ I++GL YLH
Sbjct: 67 VTKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHS 122
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
+ IHRD+KA+N+LL + K++DFG+A +++ NT VGT +M+PE +
Sbjct: 123 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIK 177
Query: 196 NGIVSMKSDVYSFGVLVLEI 215
K+D++S G+ +E+
Sbjct: 178 QSAYDSKADIWSLGITAIEL 197
>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300
Length = 280
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 17/257 (6%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
A ++F G LG+G FG VY + + I A+K L K+ + G+ + + E ++ + L
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
+H N++RL G L+ EY P L + K D ++ I + L
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
Y H RVIHRD+K N+LL KI+DFG + ++ + + GT Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTELCGTLDYLPP 175
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
E + + K D++S GVL E + K + N +T + ++ V + + + A +
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 249 LIDTTLHESCSPDEVTR 265
LI L + S + R
Sbjct: 236 LISRLLKHNPSQRPMLR 252
>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
pdb|2PZP|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 59/223 (26%), Positives = 110/223 (49%), Gaps = 26/223 (11%)
Query: 18 DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRLSK-SSGQGIVEFKNEAKLI 68
D + G LG+G FG V K K + +A+K L ++ + + + +E +++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 69 AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSSK--KELL 114
+ +H N++ LLG Q G ++ EY +L ++ +D ++ +E +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
+K + + +G+ YL + + IHRDL A N+L+ + KI+DFG+AR +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of
The Saccharomyces Cerevisiae Ampk Homolog Snf1
Length = 271
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 19/205 (9%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIK-----RLSKSSGQGIVEFKNEAKLI 68
A N+ LG+G FG V GQ++A+K L+KS QG +E E +
Sbjct: 1 AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYL 58
Query: 69 AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ 128
L+H ++++L K E ++V EY N+ D+ + E +RF + I+
Sbjct: 59 RLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSE--QEARRF--FQQIIS 114
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
+ Y H++ +++HRDLK N+LLD+ +N KI+DFG++ + G+ Y
Sbjct: 115 AVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS---CGSPNY 168
Query: 189 MSPEYVMNGIVS-MKSDVYSFGVLV 212
+PE + + + + DV+S GV++
Sbjct: 169 AAPEVISGKLYAGPEVDVWSCGVIL 193
>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
pdb|3HYH|B Chain B, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
Length = 275
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 56/206 (27%), Positives = 104/206 (50%), Gaps = 19/206 (9%)
Query: 14 AAATDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIK-----RLSKSSGQGIVEFKNEAKL 67
A N+ LG+G FG V GQ++A+K L+KS QG +E E
Sbjct: 9 GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISY 66
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
+ L+H ++++L K E ++V EY N+ D+ + +++ + ++ + I+
Sbjct: 67 LRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQII 122
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
+ Y H++ +++HRDLK N+LLD+ +N KI+DFG++ + G+
Sbjct: 123 SAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS---CGSPN 176
Query: 188 YMSPEYVMNGIVS-MKSDVYSFGVLV 212
Y +PE + + + + DV+S GV++
Sbjct: 177 YAAPEVISGKLYAGPEVDVWSCGVIL 202
>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome.
pdb|2PWL|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 62/225 (27%), Positives = 106/225 (47%), Gaps = 30/225 (13%)
Query: 18 DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRLSKSSGQ----GIVEFKNEA 65
D + G LG+G FG V K K + +A+K L + + +V
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 66 KLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSSK--KE 112
K+I K H N++ LLG Q G ++ EY +L ++ +D ++ +E
Sbjct: 95 KMIGK--HKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 113 LLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM 172
+ +K + + +G+ YL + + IHRDL A N+L+ + KI+DFG+AR
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
+ T +M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta
pdb|3ZHP|D Chain D, Human Mst3 (stk24) In Complex With Mo25beta
Length = 294
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 57/200 (28%), Positives = 105/200 (52%), Gaps = 15/200 (7%)
Query: 20 FSPGNRLGQGGFGPVYKGKLLDGQE---IAIKRLS-KSSGQGIVEFKNEAKLIAKLQHTN 75
F+ ++G+G FG V+KG +D + +AIK + + + I + + E ++++
Sbjct: 29 FTKLEKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 86
Query: 76 LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
+ + G L+ + ++ EYL S D + LD + I+ I++GL YLH
Sbjct: 87 VTKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHS 142
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
+ IHRD+KA+N+LL + K++DFG+A +++ NT VGT +M+PE +
Sbjct: 143 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIK 197
Query: 196 NGIVSMKSDVYSFGVLVLEI 215
K+D++S G+ +E+
Sbjct: 198 QSAYDSKADIWSLGITAIEL 217
>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
pdb|3COH|B Chain B, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
Length = 268
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 71/259 (27%), Positives = 120/259 (46%), Gaps = 17/259 (6%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
A ++F G LG+G FG VY + + + I A+K L K+ + G+ + + E ++ + L
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
+H N++RL G L+ EY P L + K D ++ I + L
Sbjct: 66 RHPNILRLYGYFHDSTRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
Y H +VIHRD+K N+LL KI+DFG + ++ + + GT Y+ P
Sbjct: 123 YCHSK---KVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 175
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
E + + K D++S GVL E + K + N DT + ++ V + + + A +
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTEGARD 235
Query: 249 LIDTTLHESCSPDEVTRCI 267
LI L + S + R +
Sbjct: 236 LISRLLKHNPSQRPMLREV 254
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 56/195 (28%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24 NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
++LG G FG VY+G +A+K L + + + + EF EA ++ +++H NLV+LLG
Sbjct: 17 HKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
++ ++ E++ +L ++ + +++E+ + + I + YL K + I
Sbjct: 76 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKKN---FI 131
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
HRDL A N L+ + K++DFG++R + A+ + +PE + S+K
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK-WTAPESLAYNKFSIK 190
Query: 203 SDVYSFGVLVLEIIS 217
SDV++FGVL+ EI +
Sbjct: 191 SDVWAFGVLLWEIAT 205
>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast
Snf1
Length = 274
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 56/206 (27%), Positives = 104/206 (50%), Gaps = 19/206 (9%)
Query: 14 AAATDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIK-----RLSKSSGQGIVEFKNEAKL 67
A N+ LG+G FG V GQ++A+K L+KS QG +E E
Sbjct: 4 GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISY 61
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
+ L+H ++++L K E ++V EY N+ D+ + +++ + ++ + I+
Sbjct: 62 LRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQII 117
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
+ Y H++ +++HRDLK N+LLD+ +N KI+DFG++ + G+
Sbjct: 118 SAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS---CGSPN 171
Query: 188 YMSPEYVMNGIVS-MKSDVYSFGVLV 212
Y +PE + + + + DV+S GV++
Sbjct: 172 YAAPEVISGKLYAGPEVDVWSCGVIL 197
>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|B Chain B, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|C Chain C, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|D Chain D, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|E Chain E, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|F Chain F, Aurora-2 T287d T288d Complexed With Pha-680632
Length = 306
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 71/259 (27%), Positives = 120/259 (46%), Gaps = 17/259 (6%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
A ++F G LG+G FG VY + + I A+K L K+ + G+ + + E ++ + L
Sbjct: 32 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
+H N++RL G L+ EY P L + K D ++ I + L
Sbjct: 92 RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
Y H RVIHRD+K N+LL KI+DFG + ++ + + + GT Y+ P
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGTLDYLPP 201
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
E + + K D++S GVL E + K + N +T + ++ V + + + A +
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 261
Query: 249 LIDTTLHESCSPDEVTRCI 267
LI L + S + R +
Sbjct: 262 LISRLLKHNPSQRPMLREV 280
>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr)
Kinase Domain
Length = 316
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 80/310 (25%), Positives = 136/310 (43%), Gaps = 43/310 (13%)
Query: 8 FDFQTIAAATDNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQG-IVE 60
+D D G LG+G FG V + K + +A+K L + +
Sbjct: 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 61 FKNEAKLIAKL-QHTNLVRLLG-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWK- 117
+E K++ + H N+V LLG C+ G +++ E+ +L ++ S + E + +K
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKV 135
Query: 118 ------KRFNIIEGIV-------QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDF 164
K F +E ++ +G+ +L + + IHRDL A NILL ++ KI DF
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDF 192
Query: 165 GMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGC 224
G+AR + +M+PE + + + +++SDV+SFGVL+ EI S
Sbjct: 193 GLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------- 245
Query: 225 YDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPT 283
L Y +E L + T +PD T ++ +L C + + RPT
Sbjct: 246 ------LGASPYPGVKIDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPT 297
Query: 284 MSDVASMLTN 293
S++ L N
Sbjct: 298 FSELVEHLGN 307
>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A
Gsk3beta Inhibitor
Length = 287
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 17/257 (6%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
A ++F G LG+G FG VY + + I A+K L K+ + G+ + + E ++ + L
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
+H N++RL G L+ EY P L + K D ++ I + L
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
Y H RVIHRD+K N+LL KI+DFG + ++ + + GT Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 175
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
E + + K D++S GVL E + K + N +T + ++ V + + + A +
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 249 LIDTTLHESCSPDEVTR 265
LI L + S + R
Sbjct: 236 LISRLLKHNPSQRPMLR 252
>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156.
pdb|2X4F|B Chain B, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156
Length = 373
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 76/248 (30%), Positives = 120/248 (48%), Gaps = 22/248 (8%)
Query: 8 FDFQTIAA---ATDNF---SPGNRLGQGGFGPVYK-GKLLDGQEIAIKRLSKSSGQGIVE 60
FD + + A A ++F S LG G FG V+K + G ++A K + + E
Sbjct: 73 FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE 132
Query: 61 FKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKR 119
KNE ++ +L H NL++L K + +LV EY+ L D I +S LD
Sbjct: 133 VKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELD---T 189
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILL--DDQMNPKISDFGMARTFGMNE-LE 176
++ I +G+ ++H ++ ++H DLK NIL D KI DFG+AR + E L+
Sbjct: 190 ILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK 246
Query: 177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISS-KKNNGCYDTERHLNLVG 235
N GT +++PE V VS +D++S GV+ ++S G D E N++
Sbjct: 247 VN----FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA 302
Query: 236 YAWQLWNE 243
W L +E
Sbjct: 303 CRWDLEDE 310
>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor
pdb|2X6E|A Chain A, Aurora-A Bound To An Inhibitor
Length = 285
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 17/257 (6%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
A ++F G LG+G FG VY + + I A+K L K+ + G+ + + E ++ + L
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
+H N++RL G L+ EY P L + K D ++ I + L
Sbjct: 71 RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
Y H RVIHRD+K N+LL KI+DFG + ++ + + GT Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
E + + K D++S GVL E + K + N +T + ++ V + + + A +
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 240
Query: 249 LIDTTLHESCSPDEVTR 265
LI L + S + R
Sbjct: 241 LISRLLKHNPSQRPMLR 257
>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZ5|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 59/223 (26%), Positives = 110/223 (49%), Gaps = 26/223 (11%)
Query: 18 DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRLSK-SSGQGIVEFKNEAKLI 68
D + G LG+G FG V K K + +A+K L ++ + + + +E +++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 69 AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSSK--KELL 114
+ +H N++ LLG Q G ++ EY +L ++ +D ++ +E +
Sbjct: 95 KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
+K + + +G+ YL + + IHRDL A N+L+ + KI+DFG+AR +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358
pdb|2J50|B Chain B, Structure Of Aurora-2 In Complex With Pha-739358
Length = 280
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 17/257 (6%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
A ++F G LG+G FG VY + + I A+K L K+ + G+ + + E ++ + L
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
+H N++RL G L+ EY P L + K D ++ I + L
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
Y H RVIHRD+K N+LL KI+DFG + ++ + + GT Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 175
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
E + + K D++S GVL E + K + N +T + ++ V + + + A +
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 249 LIDTTLHESCSPDEVTR 265
LI L + S + R
Sbjct: 236 LISRLLKHNPSQRPMLR 252
>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine
Inhibitor
Length = 283
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 17/257 (6%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
A ++F G LG+G FG VY + + I A+K L K+ + G+ + + E ++ + L
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
+H N++RL G L+ EY P L + K D ++ I + L
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
Y H RVIHRD+K N+LL KI+DFG + ++ + + GT Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
E + + K D++S GVL E + K + N +T + ++ V + + + A +
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 238
Query: 249 LIDTTLHESCSPDEVTR 265
LI L + S + R
Sbjct: 239 LISRLLKHNPSQRPMLR 255
>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 269
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 62/197 (31%), Positives = 107/197 (54%), Gaps = 21/197 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
+G+G FG V G G ++A+K + + ++ Q F EA ++ +L+H+NLV+LLG +
Sbjct: 20 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 75
Query: 85 Q-KGERLLVYEYLPNKSLDFFIFDSSKKELL-DWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
+ KG +V EY+ SL ++ + L D +F++ + + + YL + +
Sbjct: 76 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYLEGNN---FV 130
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH--GYMSPEYVMNGIVS 200
HRDL A N+L+ + K+SDFG+ + EA++ + G + +PE + S
Sbjct: 131 HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREAAFS 183
Query: 201 MKSDVYSFGVLVLEIIS 217
KSDV+SFG+L+ EI S
Sbjct: 184 TKSDVWSFGILLWEIYS 200
>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1E|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1F|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 71/259 (27%), Positives = 119/259 (45%), Gaps = 17/259 (6%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
A ++F G LG+G FG VY + + I A+K L K+ + G+ + + E ++ + L
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
+H N++RL G L+ EY P L + K D ++ I + L
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
Y H RVIHRD+K N+LL KI+DFG + ++ + + GT Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
E + + K D++S GVL E + K + N +T + ++ V + + + A +
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 238
Query: 249 LIDTTLHESCSPDEVTRCI 267
LI L + S + R +
Sbjct: 239 LISRLLKHNPSQRPMLREV 257
>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O50|B Chain B, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O51|A Chain A, Crystal Structure Of Anthranilamide 10 Bound To Auroraa
pdb|3EFW|A Chain A, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
pdb|3EFW|B Chain B, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
Length = 267
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 17/257 (6%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
A ++F G LG+G FG VY + + I A+K L K+ + G+ + + E ++ + L
Sbjct: 5 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
+H N++RL G L+ EY P L + K D ++ I + L
Sbjct: 65 RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 121
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
Y H RVIHRD+K N+LL KI+DFG + ++ + + GT Y+ P
Sbjct: 122 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 174
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
E + + K D++S GVL E + K + N +T + ++ V + + + A +
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 234
Query: 249 LIDTTLHESCSPDEVTR 265
LI L + S + R
Sbjct: 235 LISRLLKHNPSQRPMLR 251
>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And
Tpx2
Length = 268
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 17/257 (6%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
A ++F G LG+G FG VY + + I A+K L K+ + G+ + + E ++ + L
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
+H N++RL G L+ EY P L + K D ++ I + L
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
Y H RVIHRD+K N+LL KI+DFG + ++ + + GT Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTXLCGTLDYLPP 175
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
E + + K D++S GVL E + K + N +T + ++ V + + + A +
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 249 LIDTTLHESCSPDEVTR 265
LI L + S + R
Sbjct: 236 LISRLLKHNPSQRPMLR 252
>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2
With A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 318
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 81/312 (25%), Positives = 134/312 (42%), Gaps = 47/312 (15%)
Query: 8 FDFQTIAAATDNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQG-IVE 60
+D D G LG+G FG V + K + +A+K L + +
Sbjct: 19 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 78
Query: 61 FKNEAKLIAKL-QHTNLVRLLGCSLQKGERLLVY----------EYLPNKSLDFFIFDSS 109
+E K++ + H N+V LLG + G L+V YL +K +F + +
Sbjct: 79 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEA 138
Query: 110 KKELLDWKKRFNIIEGIV-------QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKIS 162
++L K F +E ++ +G+ +L + + IHRDL A NILL ++ KI
Sbjct: 139 PEDLY---KDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKIC 192
Query: 163 DFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNN 222
DFG+AR + +M+PE + + + +++SDV+SFGVL+ EI S
Sbjct: 193 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----- 247
Query: 223 GCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDR 281
L Y +E L + T +PD T ++ +L C + + R
Sbjct: 248 --------LGASPYPGVKIDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQR 297
Query: 282 PTMSDVASMLTN 293
PT S++ L N
Sbjct: 298 PTFSELVEHLGN 309
>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|3R22|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|4DHF|A Chain A, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
pdb|4DHF|B Chain B, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
Length = 271
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 71/259 (27%), Positives = 120/259 (46%), Gaps = 17/259 (6%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
A ++F G LG+G FG VY + + I A+K L K+ + G+ + + E ++ + L
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
+H N++RL G L+ EY P L + K D ++ I + L
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
Y H RVIHRD+K N+LL KI+DFG + ++ + + + GT Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGTLDYLPP 178
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
E + + K D++S GVL E + K + N +T + ++ V + + + A +
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 238
Query: 249 LIDTTLHESCSPDEVTRCI 267
LI L + S + R +
Sbjct: 239 LISRLLKHNPSQRPMLREV 257
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24 NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
++LG G +G VY+G +A+K L + + + + EF EA ++ +++H NLV+LLG
Sbjct: 24 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
++ ++ E++ +L ++ + +++E ++ + I + YL K + I
Sbjct: 83 CTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 138
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
HRDL A N L+ + K++DFG++R + A+ + +PE + S+K
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 197
Query: 203 SDVYSFGVLVLEIIS 217
SDV++FGVL+ EI +
Sbjct: 198 SDVWAFGVLLWEIAT 212
>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyrazolone Inhibitor
Length = 314
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 80/310 (25%), Positives = 136/310 (43%), Gaps = 43/310 (13%)
Query: 8 FDFQTIAAATDNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQG-IVE 60
+D D G LG+G FG V + K + +A+K L + +
Sbjct: 8 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 61 FKNEAKLIAKL-QHTNLVRLLG-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWK- 117
+E K++ + H N+V LLG C+ G +++ E+ +L ++ S + E + +K
Sbjct: 68 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL-RSKRNEFVPYKV 126
Query: 118 ------KRFNIIEGIV-------QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDF 164
K F +E ++ +G+ +L + + IHRDL A NILL ++ KI DF
Sbjct: 127 APEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDF 183
Query: 165 GMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGC 224
G+AR + +M+PE + + + +++SDV+SFGVL+ EI S
Sbjct: 184 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------- 236
Query: 225 YDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPT 283
L Y +E L + T +PD T ++ +L C + + RPT
Sbjct: 237 ------LGASPYPGVKIDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPT 288
Query: 284 MSDVASMLTN 293
S++ L N
Sbjct: 289 FSELVEHLGN 298
>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine-
Threonine Kinase
Length = 297
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
A ++F G LG+G FG VY + + I A+K L K+ + G+ + + E ++ + L
Sbjct: 23 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
+H N++RL G L+ EY P L + K D ++ I + L
Sbjct: 83 RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 139
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
Y H RVIHRD+K N+LL KI+DFG + ++ + + GT Y+ P
Sbjct: 140 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 192
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK 219
E + + K D++S GVL E + K
Sbjct: 193 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 220
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24 NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
++LG G +G VY+G +A+K L + + + + EF EA ++ +++H NLV+LLG
Sbjct: 24 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
++ ++ E++ +L ++ + +++E ++ + I + YL K + I
Sbjct: 83 CTREPPFYIIIEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 138
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
HRDL A N L+ + K++DFG++R + A+ + +PE + S+K
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 197
Query: 203 SDVYSFGVLVLEIIS 217
SDV++FGVL+ EI +
Sbjct: 198 SDVWAFGVLLWEIAT 212
>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A
Inhibitors: Structure Basis For Potency And Specificity
pdb|3K5U|A Chain A, Identification, Sar Studies And X-Ray Cocrystal Analysis
Of A Novel Furano-Pyrimidine Aurora Kinase A Inhibitor
pdb|3M11|A Chain A, Crystal Structure Of Aurora A Kinase Complexed With
Inhibitor
Length = 279
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 17/257 (6%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
A ++F G LG+G FG VY + + I A+K L K+ + G+ + + E ++ + L
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
+H N++RL G L+ EY P L + K D ++ I + L
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
Y H RVIHRD+K N+LL KI+DFG + ++ + + GT Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 176
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
E + + K D++S GVL E + K + N +T + ++ V + + + A +
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 249 LIDTTLHESCSPDEVTR 265
LI L + S + R
Sbjct: 237 LISRLLKHNPSQRPMLR 253
>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand
pdb|2W5B|A Chain A, Human Nek2 Kinase Atpgammas-bound
pdb|2W5H|A Chain A, Human Nek2 Kinase Apo
Length = 279
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 26 LGQGGFGPVYK------GKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
+G G +G K GK+L +E+ ++++ Q +V +E L+ +L+H N+VR
Sbjct: 14 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV---SEVNLLRELKHPNIVRY 70
Query: 80 LGCSLQKGERLL--VYEYLPNKSLDFFIFDSSK-KELLDWKKRFNIIEGIVQGLLYLHKY 136
+ + L V EY L I +K ++ LD + ++ + L H+
Sbjct: 71 YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 137 SR--LRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
S V+HRDLK +N+ LD + N K+ DFG+AR +N + VGT YMSPE +
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPYYMSPEQM 188
Query: 195 MNGIVSMKSDVYSFGVLVLEIIS 217
+ KSD++S G L+ E+ +
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCA 211
>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With
Adpnp
Length = 275
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 17/257 (6%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
A ++F G LG+G FG VY + + I A+K L K+ + G+ + + E ++ + L
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
+H N++RL G L+ EY P L + K D ++ I + L
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
Y H RVIHRD+K N+LL KI+DFG + ++ + + GT Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 175
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
E + + K D++S GVL E + K + N +T + ++ V + + + A +
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 249 LIDTTLHESCSPDEVTR 265
LI L + S + R
Sbjct: 236 LISRLLKHNPSQRPMLR 252
>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain
pdb|3Q4Z|B Chain B, Structure Of Unphosphorylated Pak1 Kinase Domain
Length = 306
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 56/196 (28%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 25 RLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
++GQG G VY + GQE+AI++++ NE ++ + ++ N+V L
Sbjct: 28 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
L E +V EYL SL + ++ +D + + +Q L +LH +VIH
Sbjct: 88 LVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSN---QVIH 140
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
R++K+ NILL + K++DFG + + +T +VGT +M+PE V K
Sbjct: 141 RNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKV 198
Query: 204 DVYSFGVLVLEIISSK 219
D++S G++ +E+I +
Sbjct: 199 DIWSLGIMAIEMIEGE 214
>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form)
Length = 285
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 71/257 (27%), Positives = 119/257 (46%), Gaps = 17/257 (6%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
A ++F G LG+G FG VY + + I A+K L K+ + G+ + + E ++ + L
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
+H N++RL G L+ EY P + + SK D ++ I + L
Sbjct: 71 RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK---FDEQRTATYITELANALS 127
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
Y H RVIHRD+K N+LL KI+DFG + ++ + + GT Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
E + + K D++S GVL E + K + N +T + ++ V + + + A +
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 240
Query: 249 LIDTTLHESCSPDEVTR 265
LI L + S + R
Sbjct: 241 LISRLLKHNPSQRPMLR 257
>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
pdb|2CLQ|B Chain B, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
Length = 295
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 15/205 (7%)
Query: 23 GNR--LGQGGFGPVYKGKLLDGQ-EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
G+R LG+G +G VY G+ L Q IAIK + + + E L L+H N+V+
Sbjct: 25 GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQY 84
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNI-IEGIVQGLLYLHKYSR 138
LG + G + E +P SL + S L D ++ + I++GL YLH
Sbjct: 85 LGSFSENGFIKIFMEQVPGGSLS-ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-- 141
Query: 139 LRVIHRDLKASNILLDDQMNP-KISDFGMA-RTFGMNELEANTNRIVGTHGYMSPEYVMN 196
+++HRD+K N+L++ KISDFG + R G+N T GT YM+PE +
Sbjct: 142 -QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC---TETFTGTLQYMAPEIIDK 197
Query: 197 GI--VSMKSDVYSFGVLVLEIISSK 219
G +D++S G ++E+ + K
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGK 222
>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
pdb|2C6E|B Chain B, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
Length = 283
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 17/257 (6%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
A ++F G LG+G FG VY + + I A+K L K+ + G+ + + E ++ + L
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
+H N++RL G L+ EY P L + K D ++ I + L
Sbjct: 71 RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
Y H RVIHRD+K N+LL KI+DFG + ++ + + GT Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 180
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
E + + K D++S GVL E + K + N +T + ++ V + + + A +
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 240
Query: 249 LIDTTLHESCSPDEVTR 265
LI L + S + R
Sbjct: 241 LISRLLKHNPSQRPMLR 257
>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287,
Thr288 And Bound To Tpx2 1-43
pdb|1OL7|A Chain A, Structure Of Human Aurora-A 122-403 Phosphorylated On
Thr287, Thr288
Length = 282
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 17/257 (6%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
A ++F G LG+G FG VY + + I A+K L K+ + G+ + + E ++ + L
Sbjct: 8 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
+H N++RL G L+ EY P L + K D ++ I + L
Sbjct: 68 RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
Y H RVIHRD+K N+LL KI+DFG + ++ + + GT Y+ P
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 177
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
E + + K D++S GVL E + K + N +T + ++ V + + + A +
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 237
Query: 249 LIDTTLHESCSPDEVTR 265
LI L + S + R
Sbjct: 238 LISRLLKHNPSQRPMLR 254
>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase
pdb|2NP8|A Chain A, Structural Basis For The Inhibition Of Aurora A Kinase By
A Novel Class Of High Affinity Disubstituted Pyrimidine
Inhibitors
pdb|2X81|A Chain A, Structure Of Aurora A In Complex With Mln8054
pdb|3MYG|A Chain A, Aurora A Kinase Complexed With Sch 1473759
pdb|3VAP|A Chain A, Synthesis And Sar Studies Of Imidazo-[1,2-A]-Pyrazine
Aurora Kinase Inhibitors With Improved Off Target Kinase
Selectivity
Length = 272
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 71/259 (27%), Positives = 119/259 (45%), Gaps = 17/259 (6%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
A ++F G LG+G FG VY + + I A+K L K+ + G+ + + E ++ + L
Sbjct: 10 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
+H N++RL G L+ EY P L + K D ++ I + L
Sbjct: 70 RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 126
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
Y H RVIHRD+K N+LL KI+DFG + ++ + + GT Y+ P
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 179
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
E + + K D++S GVL E + K + N +T + ++ V + + + A +
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 239
Query: 249 LIDTTLHESCSPDEVTRCI 267
LI L + S + R +
Sbjct: 240 LISRLLKHNPSQRPMLREV 258
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 67/269 (24%), Positives = 131/269 (48%), Gaps = 30/269 (11%)
Query: 24 NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
++LG G +G VY+G +A+K L + + + + EF EA ++ +++H NLV+LLG
Sbjct: 17 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
++ ++ E++ +L ++ + +++E+ + + I + YL K + I
Sbjct: 76 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKKN---FI 131
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
HRDL A N L+ + K++DFG++R + A+ + +PE + S+K
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIK-WTAPESLAYNKFSIK 190
Query: 203 SDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH----ESC 258
SDV++FGVL+ EI + Y + + + + EL++ E C
Sbjct: 191 SDVWAFGVLLWEIAT-------YGMSPYPGI--------DPSQVYELLEKDYRMERPEGC 235
Query: 259 SPDEVTRCIHVGLLCVQDKATDRPTMSDV 287
P++V + C Q +DRP+ +++
Sbjct: 236 -PEKVYELMRA---CWQWNPSDRPSFAEI 260
>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|B Chain B, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|C Chain C, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|D Chain D, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
Length = 286
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 55/200 (27%), Positives = 104/200 (52%), Gaps = 13/200 (6%)
Query: 26 LGQGGFGPVYKGKL-LDGQE---IAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNLVRLL 80
+G G FG V G L L G+ +AIK L S + + +F +EA ++ + H N++ L
Sbjct: 15 IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 81 GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
G + +++ E++ N SLD F+ + + + + ++ GI G+ YL + +
Sbjct: 75 GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYL---ADMN 129
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH---GYMSPEYVMNG 197
+HR L A NIL++ + K+SDFG++R + + +G + +PE +
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 189
Query: 198 IVSMKSDVYSFGVLVLEIIS 217
+ SDV+S+G+++ E++S
Sbjct: 190 KFTSASDVWSYGIVMWEVMS 209
>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626
pdb|2J4Z|B Chain B, Structure Of Aurora-2 In Complex With Pha-680626
Length = 306
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 71/259 (27%), Positives = 119/259 (45%), Gaps = 17/259 (6%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
A ++F G LG+G FG VY + + I A+K L K+ + G+ + + E ++ + L
Sbjct: 32 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
+H N++RL G L+ EY P L + K D ++ I + L
Sbjct: 92 RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
Y H RVIHRD+K N+LL KI+DFG + ++ + + GT Y+ P
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 201
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
E + + K D++S GVL E + K + N +T + ++ V + + + A +
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 261
Query: 249 LIDTTLHESCSPDEVTRCI 267
LI L + S + R +
Sbjct: 262 LISRLLKHNPSQRPMLREV 280
>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy)
Quinolin-4-Yloxy)benzofuran-3-Carboxamide)
pdb|4AG8|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Axitinib (Ag-013736)
(N-Methyl-2-(3-((E)-2-Pyridin-2-
Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-Benzamide)
Length = 316
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 80/310 (25%), Positives = 136/310 (43%), Gaps = 43/310 (13%)
Query: 8 FDFQTIAAATDNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQG-IVE 60
+D D G LG+G FG V + K + +A+K L + +
Sbjct: 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 61 FKNEAKLIAKL-QHTNLVRLLG-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWK- 117
+E K++ + H N+V LLG C+ G +++ E+ +L ++ S + E + +K
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKV 135
Query: 118 ------KRFNIIEGIV-------QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDF 164
K F +E ++ +G+ +L + + IHRDL A NILL ++ KI DF
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDF 192
Query: 165 GMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGC 224
G+AR + +M+PE + + + +++SDV+SFGVL+ EI S
Sbjct: 193 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------- 245
Query: 225 YDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPT 283
L Y +E L + T +PD T ++ +L C + + RPT
Sbjct: 246 ------LGASPYPGVKIDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPT 297
Query: 284 MSDVASMLTN 293
S++ L N
Sbjct: 298 FSELVEHLGN 307
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24 NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
++LG G +G VY+G +A+K L + + + + EF EA ++ +++H NLV+LLG
Sbjct: 24 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
++ ++ E++ +L ++ + +++E ++ + I + YL K + I
Sbjct: 83 CTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 138
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
HRDL A N L+ + K++DFG++R + A+ + +PE + S+K
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK-WTAPESLAYNKFSIK 197
Query: 203 SDVYSFGVLVLEIIS 217
SDV++FGVL+ EI +
Sbjct: 198 SDVWAFGVLLWEIAT 212
>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridyl-Pyrimidine Benzimidazole Inhibitor
Length = 314
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 79/300 (26%), Positives = 134/300 (44%), Gaps = 43/300 (14%)
Query: 18 DNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQG-IVEFKNEAKLIAK 70
D G LG+G FG V + K + +A+K L + + +E K++
Sbjct: 18 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 71 L-QHTNLVRLLG-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWK-------KRFN 121
+ H N+V LLG C+ G +++ E+ +L ++ S + E + +K K F
Sbjct: 78 IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFL 136
Query: 122 IIEGIV-------QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
+E ++ +G+ +L + + IHRDL A NILL ++ KI DFG+AR +
Sbjct: 137 TLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 193
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
+M+PE + + + +++SDV+SFGVL+ EI S L
Sbjct: 194 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------------LGAS 240
Query: 235 GYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPTMSDVASMLTN 293
Y +E L + T +PD T ++ +L C + + RPT S++ L N
Sbjct: 241 PYPGVKIDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 298
>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 290
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 81/290 (27%), Positives = 130/290 (44%), Gaps = 47/290 (16%)
Query: 26 LGQGGFG--------PVYKGKLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL 76
LG+G FG P G G+ +A+K L + G + ++ E +++ L H ++
Sbjct: 16 LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 77 VRLLGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
V+ GC +GE+ LV EY+P SL D + + + + I +G+ YLH
Sbjct: 73 VKYKGCCEDQGEKSVQLVMEYVPLGSLR----DYLPRHCVGLAQLLLFAQQICEGMAYLH 128
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG-----YM 189
IHR L A N+LLD+ KI DFG+A+ E + V G +
Sbjct: 129 A---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVP----EGHEYYRVREDGDSPVFWY 181
Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL 249
+PE + SDV+SFGV + E+++ +N T + L+G+ +G+ L
Sbjct: 182 APECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHT-KFTELIGH-----TQGQMTVL 235
Query: 250 IDTTLHESCS----PDEVTRC----IHVGLLCVQDKATDRPTMSDVASML 291
T L E PD RC H+ C + +A+ RPT ++ +L
Sbjct: 236 RLTELLERGERLPRPD---RCPCEIYHLMKNCWETEASFRPTFQNLVPIL 282
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24 NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
++LG G +G VY+G +A+K L + + + + EF EA ++ +++H NLV+LLG
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
++ ++ E++ +L ++ + +++E ++ + I + YL K + I
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 133
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
HRDL A N L+ + K++DFG++R + A+ + +PE + S+K
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 192
Query: 203 SDVYSFGVLVLEIIS 217
SDV++FGVL+ EI +
Sbjct: 193 SDVWAFGVLLWEIAT 207
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24 NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
++LG G +G VY+G +A+K L + + + + EF EA ++ +++H NLV+LLG
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
++ ++ E++ +L ++ + +++E ++ + I + YL K + I
Sbjct: 82 CTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 137
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
HRDL A N L+ + K++DFG++R + A+ + +PE + S+K
Sbjct: 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 196
Query: 203 SDVYSFGVLVLEIIS 217
SDV++FGVL+ EI +
Sbjct: 197 SDVWAFGVLLWEIAT 211
>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Axitinib (Ag-013736)
(N-Methyl-2-(
3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-
Benzamide)
pdb|4AGD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sunitinib (Su11248) (N-2-
Diethylaminoethyl)-5-((Z)-(5-Fluoro-2-Oxo-1h-Indol-3-
Ylidene)methyl)-2,4-Dimethyl-1h-Pyrrole-3-Carboxamide)
pdb|4ASD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sorafenib (Bay 43-9006)
pdb|4ASE|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Tivozanib (Av-951)
Length = 353
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 80/310 (25%), Positives = 136/310 (43%), Gaps = 43/310 (13%)
Query: 8 FDFQTIAAATDNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQG-IVE 60
+D D G LG+G FG V + K + +A+K L + +
Sbjct: 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 113
Query: 61 FKNEAKLIAKL-QHTNLVRLLG-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWK- 117
+E K++ + H N+V LLG C+ G +++ E+ +L ++ S + E + +K
Sbjct: 114 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKV 172
Query: 118 ------KRFNIIEGIV-------QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDF 164
K F +E ++ +G+ +L + + IHRDL A NILL ++ KI DF
Sbjct: 173 APEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDF 229
Query: 165 GMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGC 224
G+AR + +M+PE + + + +++SDV+SFGVL+ EI S
Sbjct: 230 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------- 282
Query: 225 YDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPT 283
L Y +E L + T +PD T ++ +L C + + RPT
Sbjct: 283 ------LGASPYPGVKIDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPT 334
Query: 284 MSDVASMLTN 293
S++ L N
Sbjct: 335 FSELVEHLGN 344
>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
pdb|2PSQ|B Chain B, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
Length = 370
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 59/223 (26%), Positives = 110/223 (49%), Gaps = 26/223 (11%)
Query: 18 DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRLSK-SSGQGIVEFKNEAKLI 68
D + G LG+G FG V K K + +A+K L ++ + + + +E +++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 69 AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSSK--KELL 114
+ +H N++ LLG Q G ++ EY +L ++ +D ++ +E +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
+K + + +G+ YL + + IHRDL A N+L+ + KI+DFG+AR +
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And
Compound 10
Length = 268
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 71/259 (27%), Positives = 119/259 (45%), Gaps = 17/259 (6%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
A ++F G LG+G FG VY + + I A+K L K+ + G+ + + E ++ + L
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
+H N++RL G L+ EY P L + K D ++ I + L
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
Y H RVIHRD+K N+LL KI+DFG + ++ + + GT Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 175
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
E + + K D++S GVL E + K + N +T + ++ V + + + A +
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 249 LIDTTLHESCSPDEVTRCI 267
LI L + S + R +
Sbjct: 236 LISRLLKHNPSQRPMLREV 254
>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1G|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 71/259 (27%), Positives = 119/259 (45%), Gaps = 17/259 (6%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
A ++F G LG+G FG VY + + I A+K L K+ + G+ + + E ++ + L
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
+H N++RL G L+ EY P L + K D ++ I + L
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
Y H RVIHRD+K N+LL KI+DFG + ++ + + GT Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 178
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
E + + K D++S GVL E + K + N +T + ++ V + + + A +
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 238
Query: 249 LIDTTLHESCSPDEVTRCI 267
LI L + S + R +
Sbjct: 239 LISRLLKHNPSQRPMLREV 257
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24 NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
++LG G +G VY+G +A+K L + + + + EF EA ++ +++H NLV+LLG
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
++ ++ E++ +L ++ + +++E ++ + I + YL K + I
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 133
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
HRDL A N L+ + K++DFG++R + A+ + +PE + S+K
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 192
Query: 203 SDVYSFGVLVLEIIS 217
SDV++FGVL+ EI +
Sbjct: 193 SDVWAFGVLLWEIAT 207
>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6
Length = 302
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 81/287 (28%), Positives = 129/287 (44%), Gaps = 41/287 (14%)
Query: 26 LGQGGFG--------PVYKGKLLDGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL 76
LG+G FG P G G+ +A+K L G Q +K E ++ L H ++
Sbjct: 22 LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 77 VRLLGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
++ GC +GE+ LV EY+P SL D + + + + I +G+ YLH
Sbjct: 79 IKYKGCCEDQGEKSLQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEGMAYLH 134
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG-----YM 189
IHR+L A N+LLD+ KI DFG+A+ E + V G +
Sbjct: 135 A---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVP----EGHEYYRVREDGDSPVFWY 187
Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL 249
+PE + SDV+SFGV + E+++ ++ T + L L+G A +G+ L
Sbjct: 188 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPT-KFLELIGIA-----QGQMTVL 241
Query: 250 IDTTLHESCS----PDEV-TRCIHVGLLCVQDKATDRPTMSDVASML 291
T L E PD+ H+ C + +A+ RPT ++ +L
Sbjct: 242 RLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPIL 288
>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With
Quinoline-Thiadiazole- Thiophene Inhibitor
Length = 302
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 81/287 (28%), Positives = 129/287 (44%), Gaps = 41/287 (14%)
Query: 26 LGQGGFG--------PVYKGKLLDGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL 76
LG+G FG P G G+ +A+K L G Q +K E ++ L H ++
Sbjct: 22 LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 77 VRLLGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
++ GC +GE+ LV EY+P SL D + + + + I +G+ YLH
Sbjct: 79 IKYKGCCEDQGEKSLQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEGMAYLH 134
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG-----YM 189
IHR+L A N+LLD+ KI DFG+A+ E + V G +
Sbjct: 135 S---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVP----EGHEYYRVREDGDSPVFWY 187
Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL 249
+PE + SDV+SFGV + E+++ ++ T + L L+G A +G+ L
Sbjct: 188 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPT-KFLELIGIA-----QGQMTVL 241
Query: 250 IDTTLHESCS----PDEV-TRCIHVGLLCVQDKATDRPTMSDVASML 291
T L E PD+ H+ C + +A+ RPT ++ +L
Sbjct: 242 RLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPIL 288
>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|B Chain B, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|C Chain C, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H10|A Chain A, Aurora A Inhibitor Complex
pdb|3H10|B Chain B, Aurora A Inhibitor Complex
pdb|3H10|D Chain D, Aurora A Inhibitor Complex
pdb|3P9J|A Chain A, Aurora A Kinase Domain With Phthalazinone Pyrazole
Inhibitor
Length = 268
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 17/257 (6%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
A ++F G LG+G FG VY + + I A+K L K+ + G+ + + E ++ + L
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
+H N++RL G L+ EY P L + K D ++ I + L
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
Y H RVIHRD+K N+LL KI+DFG + ++ + + GT Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 175
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
E + + K D++S GVL E + K + N +T + ++ V + + + A +
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 249 LIDTTLHESCSPDEVTR 265
LI L + S + R
Sbjct: 236 LISRLLKHNPSQRPMLR 252
>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 291
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 81/290 (27%), Positives = 130/290 (44%), Gaps = 47/290 (16%)
Query: 26 LGQGGFG--------PVYKGKLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL 76
LG+G FG P G G+ +A+K L + G + ++ E +++ L H ++
Sbjct: 17 LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 77 VRLLGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
V+ GC +GE+ LV EY+P SL D + + + + I +G+ YLH
Sbjct: 74 VKYKGCCEDQGEKSVQLVMEYVPLGSLR----DYLPRHCVGLAQLLLFAQQICEGMAYLH 129
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG-----YM 189
IHR L A N+LLD+ KI DFG+A+ E + V G +
Sbjct: 130 A---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVP----EGHEYYRVREDGDSPVFWY 182
Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL 249
+PE + SDV+SFGV + E+++ +N T + L+G+ +G+ L
Sbjct: 183 APECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHT-KFTELIGH-----TQGQMTVL 236
Query: 250 IDTTLHESCS----PDEVTRC----IHVGLLCVQDKATDRPTMSDVASML 291
T L E PD RC H+ C + +A+ RPT ++ +L
Sbjct: 237 RLTELLERGERLPRPD---RCPCEIYHLMKNCWETEASFRPTFQNLVPIL 283
>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure
pdb|2WTV|B Chain B, Aurora-A Inhibitor Structure
pdb|2WTV|C Chain C, Aurora-A Inhibitor Structure
pdb|2WTV|D Chain D, Aurora-A Inhibitor Structure
Length = 285
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 71/259 (27%), Positives = 120/259 (46%), Gaps = 17/259 (6%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
A ++F G LG+G FG VY + + I A+K L K+ + G+ + + E ++ + L
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
+H N++RL G L+ EY P + + SK D ++ I + L
Sbjct: 71 RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK---FDEQRTATYITELANALS 127
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
Y H RVIHRD+K N+LL KI+DFG + ++ + + GT Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLXGTLDYLPP 180
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
E + + K D++S GVL E + K + N +T + ++ V + + + A +
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 240
Query: 249 LIDTTLHESCSPDEVTRCI 267
LI L + S + R +
Sbjct: 241 LISRLLKHNPSQRPMLREV 259
>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5
pdb|1OB3|B Chain B, Structure Of P. Falciparum Pfpk5
pdb|1V0P|A Chain A, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
pdb|1V0P|B Chain B, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
Length = 288
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 37/209 (17%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGC 82
++G+G +G VYK + G+ A+K++ + +GI E ++ +L+H+N+V+L
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEG-------------IVQG 129
K +LV+E+L D K+LLD + EG ++ G
Sbjct: 69 IHTKKRLVLVFEHL----------DQDLKKLLD------VCEGGLESVTAKSFLLQLLNG 112
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
+ Y H RV+HRDLK N+L++ + KI+DFG+AR FG+ + T+ IV T Y
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIV-TLWYR 167
Query: 190 SPEYVMNG-IVSMKSDVYSFGVLVLEIIS 217
+P+ +M S D++S G + E+++
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVN 196
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24 NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
++LG G +G VY+G +A+K L + + + + EF EA ++ +++H NLV+LLG
Sbjct: 24 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
++ ++ E++ +L ++ + +++E ++ + I + YL K + I
Sbjct: 83 CTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 138
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
HRDL A N L+ + K++DFG++R + A+ + +PE + S+K
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 197
Query: 203 SDVYSFGVLVLEIIS 217
SDV++FGVL+ EI +
Sbjct: 198 SDVWAFGVLLWEIAT 212
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24 NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
++LG G +G VY+G +A+K L + + + + EF EA ++ +++H NLV+LLG
Sbjct: 21 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
++ ++ E++ +L ++ + +++E ++ + I + YL K + I
Sbjct: 80 CTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 135
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
HRDL A N L+ + K++DFG++R + A+ + +PE + S+K
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 194
Query: 203 SDVYSFGVLVLEIIS 217
SDV++FGVL+ EI +
Sbjct: 195 SDVWAFGVLLWEIAT 209
>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain
pdb|1OEC|A Chain A, Fgfr2 Kinase Domain
Length = 316
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 59/223 (26%), Positives = 110/223 (49%), Gaps = 26/223 (11%)
Query: 18 DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRLSK-SSGQGIVEFKNEAKLI 68
D + G LG+G FG V K K + +A+K L ++ + + + +E +++
Sbjct: 27 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 69 AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSSK--KELL 114
+ +H N++ LLG Q G ++ EY +L ++ +D ++ +E +
Sbjct: 87 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
+K + + +G+ YL + + IHRDL A N+L+ + KI+DFG+AR +
Sbjct: 147 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 203
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 204 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246
>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors
Length = 283
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 17/257 (6%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
A ++F G LG+G FG VY + + I A+K L K+ + G+ + + E ++ + L
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
+H N++RL G L+ EY P L + K D ++ I + L
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
Y H RVIHRD+K N+LL KI+DFG + ++ + + GT Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 178
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
E + + K D++S GVL E + K + N +T + ++ V + + + A +
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 238
Query: 249 LIDTTLHESCSPDEVTR 265
LI L + S + R
Sbjct: 239 LISRLLKHNPSQRPMLR 255
>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24) In Complex With Staurosporine
Length = 304
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 56/200 (28%), Positives = 104/200 (52%), Gaps = 15/200 (7%)
Query: 20 FSPGNRLGQGGFGPVYKGKLLDGQE---IAIKRLS-KSSGQGIVEFKNEAKLIAKLQHTN 75
F+ ++G+G FG V+KG +D + +AIK + + + I + + E ++++
Sbjct: 9 FTKLEKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 76 LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
+ + G L+ + ++ EYL S D + LD + I+ I++GL YLH
Sbjct: 67 VTKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHS 122
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
+ IHRD+KA+N+LL + K++DFG+A + + + N VGT +M+PE +
Sbjct: 123 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQ--LTDTQIKRNXFVGTPFWMAPEVIK 177
Query: 196 NGIVSMKSDVYSFGVLVLEI 215
K+D++S G+ +E+
Sbjct: 178 QSAYDSKADIWSLGITAIEL 197
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 67/269 (24%), Positives = 130/269 (48%), Gaps = 30/269 (11%)
Query: 24 NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
++LG G +G VY+G +A+K L + + + + EF EA ++ +++H NLV+LLG
Sbjct: 17 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
++ ++ E++ +L ++ + +++E+ + I + YL K + I
Sbjct: 76 CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLEKKN---FI 131
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
HRDL A N L+ + K++DFG++R + A+ + +PE + S+K
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK-WTAPESLAYNKFSIK 190
Query: 203 SDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLH----ESC 258
SDV++FGVL+ EI + Y + + + + EL++ E C
Sbjct: 191 SDVWAFGVLLWEIAT-------YGMSPYPGI--------DPSQVYELLEKDYRMERPEGC 235
Query: 259 SPDEVTRCIHVGLLCVQDKATDRPTMSDV 287
P++V + C Q +DRP+ +++
Sbjct: 236 -PEKVYELMRA---CWQWNPSDRPSFAEI 260
>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
pdb|3VW6|B Chain B, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
Length = 269
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 15/205 (7%)
Query: 23 GNR--LGQGGFGPVYKGKLLDGQ-EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
G+R LG+G +G VY G+ L Q IAIK + + + E L L+H N+V+
Sbjct: 11 GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQY 70
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNI-IEGIVQGLLYLHKYSR 138
LG + G + E +P SL + S L D ++ + I++GL YLH
Sbjct: 71 LGSFSENGFIKIFMEQVPGGSLS-ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-- 127
Query: 139 LRVIHRDLKASNILLDDQMNP-KISDFGMA-RTFGMNELEANTNRIVGTHGYMSPEYVMN 196
+++HRD+K N+L++ KISDFG + R G+N T GT YM+PE +
Sbjct: 128 -QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC---TETFTGTLQYMAPEIIDK 183
Query: 197 GI--VSMKSDVYSFGVLVLEIISSK 219
G +D++S G ++E+ + K
Sbjct: 184 GPRGYGKAADIWSLGCTIIEMATGK 208
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24 NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
++LG G +G VY+G +A+K L + + + + EF EA ++ +++H NLV+LLG
Sbjct: 24 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
++ ++ E++ +L ++ + +++E+ + + I + YL K + I
Sbjct: 83 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKKN---FI 138
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
HRDL A N L+ + K++DFG++R + A+ + +PE + S+K
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 197
Query: 203 SDVYSFGVLVLEIIS 217
SDV++FGVL+ EI +
Sbjct: 198 SDVWAFGVLLWEIAT 212
>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant
Length = 334
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 24/213 (11%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
D + G LG G F V K + L + KR +KSS +G+ + + E ++ +
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 71 LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
+QH N++ L K + +L+ E + L F+ ++KE L ++ ++ I+ G+
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 127
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPK----ISDFGMART--FGMNELEANTNRIVG 184
YLH L++ H DLK NI+L D+ PK I DFG+A FG NE + I G
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFK----NIFG 179
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +++PE V + +++D++S GV+ ++S
Sbjct: 180 TPAFVAPEIVNYEPLGLEADMWSIGVITYILLS 212
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24 NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
++LG G +G VY+G +A+K L + + + + EF EA ++ +++H NLV+LLG
Sbjct: 20 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
++ ++ E++ +L ++ + +++E ++ + I + YL K + I
Sbjct: 79 CTREPPFYIIIEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 134
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
HRDL A N L+ + K++DFG++R + A+ + +PE + S+K
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK-WTAPESLAYNKFSIK 193
Query: 203 SDVYSFGVLVLEIIS 217
SDV++FGVL+ EI +
Sbjct: 194 SDVWAFGVLLWEIAT 208
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24 NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
++LG G +G VY+G +A+K L + + + + EF EA ++ +++H NLV+LLG
Sbjct: 21 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
++ ++ E++ +L ++ + +++E ++ + I + YL K + I
Sbjct: 80 CTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 135
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
HRDL A N L+ + K++DFG++R + A+ + +PE + S+K
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 194
Query: 203 SDVYSFGVLVLEIIS 217
SDV++FGVL+ EI +
Sbjct: 195 SDVWAFGVLLWEIAT 209
>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZR|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 58/223 (26%), Positives = 110/223 (49%), Gaps = 26/223 (11%)
Query: 18 DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRLSK-SSGQGIVEFKNEAKLI 68
D + G LG+G FG V K K + +A+K L ++ + + + +E +++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 69 AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSSK--KELL 114
+ +H N++ LLG Q G ++ EY +L ++ +D ++ +E +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
+K + + +G+ YL + + IHRDL A N+L+ + +I+DFG+AR +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNID 211
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24 NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
++LG G +G VY+G +A+K L + + + + EF EA ++ +++H NLV+LLG
Sbjct: 32 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 90
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
++ ++ E++ +L ++ + +++E ++ + I + YL K + I
Sbjct: 91 CTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 146
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
HRDL A N L+ + K++DFG++R + A+ + +PE + S+K
Sbjct: 147 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 205
Query: 203 SDVYSFGVLVLEIIS 217
SDV++FGVL+ EI +
Sbjct: 206 SDVWAFGVLLWEIAT 220
>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant
Length = 262
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 17/257 (6%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
A ++F G LG+G FG VY + + I A+K L K+ + G+ + + E ++ + L
Sbjct: 3 ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
+H N++RL G L+ EY P L + K D ++ I + L
Sbjct: 63 RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 119
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
Y H RVIHRD+K N+LL KI+DFG + ++ + + GT Y+ P
Sbjct: 120 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 172
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
E + + K D++S GVL E + K + N +T + ++ V + + + A +
Sbjct: 173 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 232
Query: 249 LIDTTLHESCSPDEVTR 265
LI L + S + R
Sbjct: 233 LISRLLKHNPSQRPMLR 249
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24 NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
++LG G +G VY+G +A+K L + + + + EF EA ++ +++H NLV+LLG
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
++ ++ E++ +L ++ + +++E+ + + I + YL K + I
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKKN---FI 133
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
HRDL A N L+ + K++DFG++R + A+ + +PE + S+K
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 192
Query: 203 SDVYSFGVLVLEIIS 217
SDV++FGVL+ EI +
Sbjct: 193 SDVWAFGVLLWEIAT 207
>pdb|3B2T|A Chain A, Structure Of Phosphotransferase
pdb|3B2T|B Chain B, Structure Of Phosphotransferase
Length = 311
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 59/223 (26%), Positives = 110/223 (49%), Gaps = 26/223 (11%)
Query: 18 DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRLSK-SSGQGIVEFKNEAKLI 68
D + G LG+G FG V K K + +A+K L ++ + + + +E +++
Sbjct: 22 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 69 AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSSK--KELL 114
+ +H N++ LLG Q G ++ EY +L ++ +D ++ +E +
Sbjct: 82 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
+K + + +G+ YL + + IHRDL A N+L+ + KI+DFG+AR +
Sbjct: 142 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNID 198
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 199 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241
>pdb|3A7F|A Chain A, Human Mst3 Kinase
pdb|3A7G|A Chain A, Human Mst3 Kinase
pdb|3A7G|B Chain B, Human Mst3 Kinase
pdb|3A7H|A Chain A, Human Mst3 Kinase In Complex With Atp
pdb|3A7H|B Chain B, Human Mst3 Kinase In Complex With Atp
pdb|3A7I|A Chain A, Human Mst3 Kinase In Complex With Adenine
pdb|3A7J|A Chain A, Human Mst3 Kinase In Complex With Mnadp
Length = 303
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 56/200 (28%), Positives = 104/200 (52%), Gaps = 15/200 (7%)
Query: 20 FSPGNRLGQGGFGPVYKGKLLDGQE---IAIKRLS-KSSGQGIVEFKNEAKLIAKLQHTN 75
F+ ++G+G FG V+KG +D + +AIK + + + I + + E ++++
Sbjct: 24 FTKLEKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 76 LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
+ + G L+ + ++ EYL S D + LD + I+ I++GL YLH
Sbjct: 82 VTKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHS 137
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
+ IHRD+KA+N+LL + K++DFG+A + + + N VGT +M+PE +
Sbjct: 138 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQ--LTDTQIKRNXFVGTPFWMAPEVIK 192
Query: 196 NGIVSMKSDVYSFGVLVLEI 215
K+D++S G+ +E+
Sbjct: 193 QSAYDSKADIWSLGITAIEL 212
>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 63/223 (28%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 18 DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRL-SKSSGQGIVEFKNEAKLI 68
D G LG+G FG V K K ++A+K L S ++ + + + +E +++
Sbjct: 28 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 69 AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSS--KKELL 114
+ +H N++ LLG Q G ++ EY +L ++ F+ S +E L
Sbjct: 88 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQL 147
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
K + + +G+ YL + + IHRDL A N+L+ + KI+DFG+AR +
Sbjct: 148 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +M+PE + + I + +SDV+SFGVL+ EI +
Sbjct: 205 XXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24 NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
++LG G +G VY+G +A+K L + + + + EF EA ++ +++H NLV+LLG
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
++ ++ E++ +L ++ + +++E+ + + I + YL K + I
Sbjct: 78 CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKKN---FI 133
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
HRDL A N L+ + K++DFG++R + A+ + +PE + S+K
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 192
Query: 203 SDVYSFGVLVLEIIS 217
SDV++FGVL+ EI +
Sbjct: 193 SDVWAFGVLLWEIAT 207
>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYD|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp.
pdb|1ZYD|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp
Length = 303
Score = 75.9 bits (185), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 68/236 (28%), Positives = 111/236 (47%), Gaps = 45/236 (19%)
Query: 9 DFQTIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKL 67
DF+ IA LGQG FG V K + LD + AIK++ + + + + +E L
Sbjct: 7 DFEEIAV----------LGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVML 55
Query: 68 IAKLQHTNLVRLLGCSLQ-------------KGERLLVYEYLPNKSLDFFIFDSSKKELL 114
+A L H +VR L+ K + EY N++L I + +
Sbjct: 56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQR 115
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA----RTF 170
D + + + I++ L Y+H +IHRDLK NI +D+ N KI DFG+A R+
Sbjct: 116 D--EYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 171 GMNELEA--------NTNRIVGTHGYMSPEYVMNGI--VSMKSDVYSFGVLVLEII 216
+ +L++ N +GT Y++ E V++G + K D+YS G++ E+I
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMI 225
>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
pdb|3RI1|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
Length = 313
Score = 75.9 bits (185), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 59/223 (26%), Positives = 110/223 (49%), Gaps = 26/223 (11%)
Query: 18 DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRLSK-SSGQGIVEFKNEAKLI 68
D + G LG+G FG V K K + +A+K L ++ + + + +E +++
Sbjct: 24 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 69 AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSSK--KELL 114
+ +H N++ LLG Q G ++ EY +L ++ +D ++ +E +
Sbjct: 84 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
+K + + +G+ YL + + IHRDL A N+L+ + KI+DFG+AR +
Sbjct: 144 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 200
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 201 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 75.9 bits (185), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24 NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
++LG G +G VY+G +A+K L + + + + EF EA ++ +++H NLV+LLG
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
++ ++ E++ +L ++ + +++E+ + + I + YL K + I
Sbjct: 78 CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKKN---FI 133
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
HRDL A N L+ + K++DFG++R + A+ + +PE + S+K
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 192
Query: 203 SDVYSFGVLVLEIIS 217
SDV++FGVL+ EI +
Sbjct: 193 SDVWAFGVLLWEIAT 207
>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp
Length = 285
Score = 75.9 bits (185), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
A ++F G LG+G FG VY + + I A+K L K+ + G+ + + E ++ + L
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
+H N++RL G L+ EY P L + K D ++ I + L
Sbjct: 71 RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
Y H RVIHRD+K N+LL KI+DFG + ++ + + GT Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK 219
E + K D++S GVL E + K
Sbjct: 181 EXIEGRXHDEKVDLWSLGVLCYEFLVGK 208
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 75.9 bits (185), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24 NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
++LG G +G VY+G +A+K L + + + + EF EA ++ +++H NLV+LLG
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
++ ++ E++ +L ++ + +++E+ + + I + YL K + I
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKKN---FI 133
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
HRDL A N L+ + K++DFG++R + A+ + +PE + S+K
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 192
Query: 203 SDVYSFGVLVLEIIS 217
SDV++FGVL+ EI +
Sbjct: 193 SDVWAFGVLLWEIAT 207
>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
pdb|1V0O|B Chain B, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
Length = 288
Score = 75.9 bits (185), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 61/209 (29%), Positives = 107/209 (51%), Gaps = 37/209 (17%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGC 82
++G+G +G VYK + G+ A+K++ + +GI E ++ +L+H+N+V+L
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEG-------------IVQG 129
K +LV+E+L D K+LLD + EG ++ G
Sbjct: 69 IHTKKRLVLVFEHL----------DQDLKKLLD------VCEGGLESVTAKSFLLQLLNG 112
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
+ Y H RV+HRDLK N+L++ + KI+DFG+AR FG+ + T+ +V T Y
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEVV-TLWYR 167
Query: 190 SPEYVMNG-IVSMKSDVYSFGVLVLEIIS 217
+P+ +M S D++S G + E+++
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVN 196
>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|B Chain B, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|C Chain C, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|D Chain D, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|E Chain E, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|F Chain F, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
Length = 450
Score = 75.9 bits (185), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 62/197 (31%), Positives = 107/197 (54%), Gaps = 21/197 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
+G+G FG V G G ++A+K + + ++ Q F EA ++ +L+H+NLV+LLG +
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 256
Query: 85 Q-KGERLLVYEYLPNKSLDFFIFDSSKKELL-DWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
+ KG +V EY+ SL ++ + L D +F++ + + + YL + +
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYLEGNN---FV 311
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH--GYMSPEYVMNGIVS 200
HRDL A N+L+ + K+SDFG+ + EA++ + G + +PE + S
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFS 364
Query: 201 MKSDVYSFGVLVLEIIS 217
KSDV+SFG+L+ EI S
Sbjct: 365 TKSDVWSFGILLWEIYS 381
>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5
pdb|1V0B|B Chain B, Crystal Structure Of The T198a Mutant Of Pfpk5
Length = 288
Score = 75.9 bits (185), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 61/209 (29%), Positives = 107/209 (51%), Gaps = 37/209 (17%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGC 82
++G+G +G VYK + G+ A+K++ + +GI E ++ +L+H+N+V+L
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEG-------------IVQG 129
K +LV+E+L D K+LLD + EG ++ G
Sbjct: 69 IHTKKRLVLVFEHL----------DQDLKKLLD------VCEGGLESVTAKSFLLQLLNG 112
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
+ Y H RV+HRDLK N+L++ + KI+DFG+AR FG+ + T+ +V T Y
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEVV-TLWYR 167
Query: 190 SPEYVMNG-IVSMKSDVYSFGVLVLEIIS 217
+P+ +M S D++S G + E+++
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVN 196
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 75.5 bits (184), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 55/195 (28%), Positives = 104/195 (53%), Gaps = 7/195 (3%)
Query: 24 NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
++LG G +G VY+G +A+K L + + + + EF EA ++ +++H NLV+LLG
Sbjct: 20 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
++ ++ E++ +L ++ + +++E ++ + I + YL K + I
Sbjct: 79 CTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 134
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
HRDL A N L+ + K++DFG++R + A + +PE + S+K
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK-WTAPESLAYNKFSIK 193
Query: 203 SDVYSFGVLVLEIIS 217
SDV++FGVL+ EI +
Sbjct: 194 SDVWAFGVLLWEIAT 208
>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A
Diaminopyrimidine
Length = 281
Score = 75.5 bits (184), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 71/259 (27%), Positives = 118/259 (45%), Gaps = 17/259 (6%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
A ++F G LG+G FG VY + + I A+K L K+ + G+ + + E ++ + L
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
+H N++RL G L+ EY P L + K D ++ I + L
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
Y H RVIHRD+K N+LL KI+DFG + + + + GT Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSCHAPSSRRTTLSGTLDYLPP 176
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
E + + K D++S GVL E + K + N +T + ++ V + + + A +
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 249 LIDTTLHESCSPDEVTRCI 267
LI L + S + R +
Sbjct: 237 LISRLLKHNPSQRPMLREV 255
>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|C Chain C, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 263
Score = 75.5 bits (184), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 62/197 (31%), Positives = 107/197 (54%), Gaps = 21/197 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
+G+G FG V G G ++A+K + + ++ Q F EA ++ +L+H+NLV+LLG +
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 69
Query: 85 Q-KGERLLVYEYLPNKSLDFFIFDSSKKELL-DWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
+ KG +V EY+ SL ++ + L D +F++ + + + YL + +
Sbjct: 70 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYLEGNN---FV 124
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH--GYMSPEYVMNGIVS 200
HRDL A N+L+ + K+SDFG+ + EA++ + G + +PE + S
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFS 177
Query: 201 MKSDVYSFGVLVLEIIS 217
KSDV+SFG+L+ EI S
Sbjct: 178 TKSDVWSFGILLWEIYS 194
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 75.5 bits (184), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 55/195 (28%), Positives = 104/195 (53%), Gaps = 7/195 (3%)
Query: 24 NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
++LG G +G VY+G +A+K L + + + + EF EA ++ +++H NLV+LLG
Sbjct: 21 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
++ ++ E++ +L ++ + +++E ++ + I + YL K + I
Sbjct: 80 CTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 135
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
HRDL A N L+ + K++DFG++R + A + +PE + S+K
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK-WTAPESLAYNKFSIK 194
Query: 203 SDVYSFGVLVLEIIS 217
SDV++FGVL+ EI +
Sbjct: 195 SDVWAFGVLLWEIAT 209
>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain
pdb|4BBM|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
pdb|4BBM|B Chain B, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
Length = 331
Score = 75.5 bits (184), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 65/197 (32%), Positives = 101/197 (51%), Gaps = 16/197 (8%)
Query: 26 LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVE--FKNEAKLIAKLQHTNLVRLLGC 82
+G+G +G V K + D G+ +AIK+ +S +V+ E KL+ +L+H NLV LL
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 83 SLQKGERLLVYEYLPNKSLD-FFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
+K LV+E++ + LD +F + + K F II GI G + H +
Sbjct: 93 CKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGI--GFCHSHN-----I 145
Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGM-NELEANTNRIVGTHGYMSPEYVMNGIVS 200
IHRD+K NIL+ K+ DFG ART E+ + V T Y +PE ++ +
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE---VATRWYRAPELLVGDVKY 202
Query: 201 MKS-DVYSFGVLVLEII 216
K+ DV++ G LV E+
Sbjct: 203 GKAVDVWAIGCLVTEMF 219
>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 75.5 bits (184), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 58/215 (26%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQ-GI-VEFKNEAKLIAKLQ 72
AT + P +G G +G VYK + G +A+K + +G+ G+ + E L+ +L+
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 73 ---HTNLVRLLG-CSLQKGER----LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE 124
H N+VRL+ C+ + +R LV+E++ ++ L ++ D + L + +++
Sbjct: 62 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
++GL +LH ++HRDLK NIL+ K++DFG+AR + + + +V
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALDPVVV 173
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
T Y +PE ++ + D++S G + E+ K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208
>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With
Bound Inhibitor Fragment
Length = 293
Score = 75.1 bits (183), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 24/213 (11%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
D + G LG G F V K + L + KR +KSS +G+ + + E ++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 71 LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
+QH N++ L K + +L+ E + L F+ ++KE L ++ ++ I+ G+
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 126
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPK----ISDFGMART--FGMNELEANTNRIVG 184
YLH L++ H DLK NI+L D+ PK I DFG+A FG NE + I G
Sbjct: 127 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFK----NIFG 178
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +++PE V + +++D++S GV+ ++S
Sbjct: 179 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 211
>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In
Complex With Inhibitor Staurosporine
Length = 278
Score = 75.1 bits (183), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 62/197 (31%), Positives = 107/197 (54%), Gaps = 21/197 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRL-SKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
+G+G FG V G G ++A+K + + ++ Q F EA ++ +L+H+NLV+LLG +
Sbjct: 29 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 84
Query: 85 Q-KGERLLVYEYLPNKSLDFFIFDSSKKELL-DWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
+ KG +V EY+ SL ++ + L D +F++ + + + YL + +
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYLEGNN---FV 139
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH--GYMSPEYVMNGIVS 200
HRDL A N+L+ + K+SDFG+ + EA++ + G + +PE + S
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFS 192
Query: 201 MKSDVYSFGVLVLEIIS 217
KSDV+SFG+L+ EI S
Sbjct: 193 TKSDVWSFGILLWEIYS 209
>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex
Length = 334
Score = 75.1 bits (183), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 24/213 (11%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
D + G LG G F V K + L + KR +KSS +G+ + + E ++ +
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 71 LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
+QH N++ L K + +L+ E + L F+ ++KE L ++ ++ I+ G+
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 127
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPK----ISDFGMART--FGMNELEANTNRIVG 184
YLH L++ H DLK NI+L D+ PK I DFG+A FG NE + I G
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFK----NIFG 179
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +++PE V + +++D++S GV+ ++S
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212
>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase
In Complex With Amppnp And Mg2+
Length = 295
Score = 75.1 bits (183), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 24/213 (11%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
D + G LG G F V K + L + KR +KSS +G+ + + E ++ +
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 71 LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
+QH N++ L K + +L+ E + L F+ ++KE L ++ ++ I+ G+
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 127
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPK----ISDFGMART--FGMNELEANTNRIVG 184
YLH L++ H DLK NI+L D+ PK I DFG+A FG NE + I G
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFK----NIFG 179
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +++PE V + +++D++S GV+ ++S
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212
>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution.
pdb|2JED|B Chain B, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution
Length = 352
Score = 75.1 bits (183), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 19/212 (8%)
Query: 13 IAAATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAK- 70
I ++F LG+G FG V+ + Q AIK L K +++ E ++ K
Sbjct: 13 IKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--LMDDDVECTMVEKR 70
Query: 71 -----LQHTNLVRLLGCSLQKGERLL-VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE 124
+H L + C+ Q E L V EYL L + I K +L + F E
Sbjct: 71 VLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS--RATFYAAE 127
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
I+ GL +LH +++RDLK NILLD + KI+DFGM + + +A TN G
Sbjct: 128 -IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--DAKTNEFCG 181
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
T Y++PE ++ + D +SFGVL+ E++
Sbjct: 182 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEML 213
>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine
Inhibitor
Length = 272
Score = 75.1 bits (183), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 70/259 (27%), Positives = 119/259 (45%), Gaps = 17/259 (6%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
A ++F G LG+G FG VY + + I A+K L K+ + G+ + + E ++ + L
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
+H N++RL G L+ EY P L + K D ++ I + L
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
Y H RVIHRD+K N+LL KI++FG + ++ + + GT Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
E + + K D++S GVL E + K + N +T + ++ V + + + A +
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 238
Query: 249 LIDTTLHESCSPDEVTRCI 267
LI L + S + R +
Sbjct: 239 LISRLLKHNPSQRPMLREV 257
>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain With
Amppnp
pdb|3DGK|A Chain A, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain
Length = 295
Score = 75.1 bits (183), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 24/213 (11%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
D + G LG G F V K + L + KR +KSS +G+ + + E ++ +
Sbjct: 11 DYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 71 LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
+QH N++ L K + +L+ E + L F+ ++KE L ++ ++ I+ G+
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 127
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPK----ISDFGMART--FGMNELEANTNRIVG 184
YLH L++ H DLK NI+L D+ PK I DFG+A FG NE + I G
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFK----NIFG 179
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +++PE V + +++D++S GV+ ++S
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212
>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a
Length = 282
Score = 75.1 bits (183), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 70/257 (27%), Positives = 118/257 (45%), Gaps = 17/257 (6%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKL 71
A ++F G LG+G FG VY + + I A+K L K+ + G+ + + E ++ + L
Sbjct: 8 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
+H N++RL G L+ EY P L + K D ++ I + L
Sbjct: 68 RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
Y H RVIHRD+K N+LL KI++FG + ++ + + GT Y+ P
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPP 177
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSK---KNNGCYDTERHLNLVGYAWQLWNEGKALE 248
E + + K D++S GVL E + K + N +T + ++ V + + + A +
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 237
Query: 249 LIDTTLHESCSPDEVTR 265
LI L + S + R
Sbjct: 238 LISRLLKHNPSQRPMLR 254
>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mn.
pdb|1JKL|A Chain A, 1.6a X-Ray Structure Of Binary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue
pdb|1JKS|A Chain A, 1.5a X-Ray Structure Of Apo Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|A Chain A, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|B Chain B, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKK|A Chain A, 2.4a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mg.
pdb|3F5G|A Chain A, Crystal Structure Of Death Associated Protein Kinase In
Complex With Adp And Mg2+
pdb|3EH9|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Adp
pdb|3EHA|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Amppnp
Length = 294
Score = 75.1 bits (183), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 24/213 (11%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
D + G LG G F V K + L + KR +KSS +G+ + + E ++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 71 LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
+QH N++ L K + +L+ E + L F+ ++KE L ++ ++ I+ G+
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 126
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPK----ISDFGMART--FGMNELEANTNRIVG 184
YLH L++ H DLK NI+L D+ PK I DFG+A FG NE + I G
Sbjct: 127 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFK----NIFG 178
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +++PE V + +++D++S GV+ ++S
Sbjct: 179 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 211
>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXP|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 318
Score = 75.1 bits (183), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 81/287 (28%), Positives = 127/287 (44%), Gaps = 41/287 (14%)
Query: 26 LGQGGFG--------PVYKGKLLDGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNL 76
LG+G FG P G G+ +A+K L +G Q +K E ++ L H ++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 77 VRLLGCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
++ GC G LV EY+P SL D + + + + I +G+ YLH
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG-----YM 189
IHRDL A N+LLD+ KI DFG+A+ E + V G +
Sbjct: 152 AQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP----EGHEXYRVREDGDSPVFWY 204
Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALEL 249
+PE + SDV+SFGV + E+++ ++ T + L L+G A +G+ L
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPT-KFLELIGIA-----QGQMTVL 258
Query: 250 IDTTLHESCS----PDEV-TRCIHVGLLCVQDKATDRPTMSDVASML 291
T L E PD+ H+ C + +A+ RPT ++ +L
Sbjct: 259 RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305
>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
pdb|3F69|B Chain B, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
Length = 311
Score = 75.1 bits (183), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 15/212 (7%)
Query: 17 TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQG---IVEFKNEAKLIAKLQ 72
+D + G LG GG V+ + L D +++A+K L + + F+ EA+ A L
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 73 HTNLVRLLGCSLQKGER----LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ 128
H +V + + +V EY+ +L + + K+ +I Q
Sbjct: 71 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG-MNELEANTNRIVGTHG 187
L + H+ +IHRD+K +NIL+ K+ DFG+AR T ++GT
Sbjct: 128 ALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQ 184
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
Y+SPE V +SDVYS G ++ E+++ +
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor
Discovered Through Site-Directed Dynamic Tethering
Length = 272
Score = 75.1 bits (183), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 18 DNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKLQH 73
++F G LG+G FG VY + + I A+K L K+ + G+ + + E ++ + L+H
Sbjct: 12 EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 74 TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
N++RL G L+ EY P L + K D ++ I + L Y
Sbjct: 72 PNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYC 128
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
H RVIHRD+K N+LL KI+DFG + ++ + + + GT Y+ PE
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRDTLCGTLDYLPPEM 181
Query: 194 VMNGIVSMKSDVYSFGVLVLEII 216
+ + K D++S GVL E +
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFL 204
>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W9Z|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 75.1 bits (183), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 59/215 (27%), Positives = 109/215 (50%), Gaps = 19/215 (8%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQ-GI-VEFKNEAKLIAKLQ 72
AT + P +G G +G VYK + G +A+K + +G+ G+ + E L+ +L+
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 73 ---HTNLVRLLG-CSLQKGER----LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE 124
H N+VRL+ C+ + +R LV+E++ ++ L ++ D + L + +++
Sbjct: 62 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
++GL +LH ++HRDLK NIL+ K++DFG+AR + A +V
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAP---VVV 173
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
T Y +PE ++ + D++S G + E+ K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208
>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302
Length = 302
Score = 75.1 bits (183), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 24/213 (11%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
D + G LG G F V K + L + KR +KSS +G+ + + E ++ +
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 71 LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
+QH N++ L K + +L+ E + L F+ ++KE L ++ ++ I+ G+
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 127
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPK----ISDFGMART--FGMNELEANTNRIVG 184
YLH L++ H DLK NI+L D+ PK I DFG+A FG NE + I G
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFK----NIFG 179
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +++PE V + +++D++S GV+ ++S
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212
>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In
Complex With A Ruthenium Octasporine Ligand (Osv)
pdb|2Y4P|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|3ZXT|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
Length = 285
Score = 75.1 bits (183), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 24/213 (11%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
D + G LG G F V K + L + KR +KSS +G+ + + E ++ +
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 71 LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
+QH N++ L K + +L+ E + L F+ ++KE L ++ ++ I+ G+
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 127
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPK----ISDFGMART--FGMNELEANTNRIVG 184
YLH L++ H DLK NI+L D+ PK I DFG+A FG NE + I G
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFK----NIFG 179
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +++PE V + +++D++S GV+ ++S
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212
>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312
pdb|2XZS|B Chain B, Death Associated Protein Kinase 1 Residues 1-312
Length = 312
Score = 75.1 bits (183), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 24/213 (11%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
D + G LG G F V K + L + KR +KSS +G+ + + E ++ +
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 71 LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
+QH N++ L K + +L+ E + L F+ ++KE L ++ ++ I+ G+
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 127
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPK----ISDFGMART--FGMNELEANTNRIVG 184
YLH L++ H DLK NI+L D+ PK I DFG+A FG NE + I G
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFK----NIFG 179
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +++PE V + +++D++S GV+ ++S
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212
>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
pdb|3C4F|B Chain B, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
Length = 302
Score = 74.7 bits (182), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 62/223 (27%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 18 DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRL-SKSSGQGIVEFKNEAKLI 68
D G LG+G FG V K K ++A+K L S ++ + + + +E +++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 69 AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSS--KKELL 114
+ +H N++ LLG Q G ++ EY +L ++ ++ S +E L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 132
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
K + + +G+ YL + + IHRDL A N+L+ + KI+DFG+AR +
Sbjct: 133 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +M+PE + + I + +SDV+SFGVL+ EI +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232
>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277
Length = 277
Score = 74.7 bits (182), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 24/213 (11%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
D + G LG G F V K + L + KR +KSS +G+ + + E ++ +
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 71 LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
+QH N++ L K + +L+ E + L F+ ++KE L ++ ++ I+ G+
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 127
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPK----ISDFGMART--FGMNELEANTNRIVG 184
YLH L++ H DLK NI+L D+ PK I DFG+A FG NE + I G
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFK----NIFG 179
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +++PE V + +++D++S GV+ ++S
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212
>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
pdb|2Q0B|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 74.7 bits (182), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 58/223 (26%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 18 DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRLSK-SSGQGIVEFKNEAKLI 68
D + G LG+G FG V K K + +A+K L ++ + + + +E +++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 69 AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSSK--KELL 114
+ +H N++ LLG Q G ++ Y +L ++ +D ++ +E +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
+K + + +G+ YL + + IHRDL A N+L+ + KI+DFG+AR +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|B Chain B, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|C Chain C, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|D Chain D, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|E Chain E, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
Length = 326
Score = 74.7 bits (182), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 62/229 (27%), Positives = 105/229 (45%), Gaps = 26/229 (11%)
Query: 3 RDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFK 62
R L D + F +G G +G VYKG+ + ++A ++ +G E K
Sbjct: 9 RSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK 68
Query: 63 NEAKLIAKL-QHTNLVRLLGCSLQKG------ERLLVYEYLPNKSLDFFIFDSSKKELLD 115
E ++ K H N+ G ++K + LV E+ S+ I ++K L
Sbjct: 69 QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLK 127
Query: 116 WKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA----RTFG 171
+ I I++GL +LH++ +VIHRD+K N+LL + K+ DFG++ RT G
Sbjct: 128 EEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 184
Query: 172 MNELEANTNRIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEI 215
N +GT +M+PE + + KSD++S G+ +E+
Sbjct: 185 ------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227
>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly,
Lys240->arg, Met302- >leu) In Complex With
1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]-
Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea
pdb|3DJ5|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 290.
pdb|3DJ6|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 823.
pdb|3DJ7|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 130.
pdb|3D15|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
1-(3-Chloro-Phenyl)-3-
{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)-
Ethyl]-Thiazol-2- Yl}-Urea [sns-314]
pdb|3D2I|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With 1-{5-[2-(1-Methyl-1h-
Pyrazolo[4,
3-D]pyrimidin-7-Ylamino)-Ethyl]-Thiazol-2-Yl}-3-
(3-Trifluoromethyl-Phenyl)-Urea
pdb|3D2K|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
[7-(2-{2-[3-(3-Chloro-
Phenyl)-Ureido]-Thiazol-5-Yl}-Ethylamino)-Pyrazolo[4,3-
D]pyrimidin-1-Yl]-Acetic Acid
Length = 272
Score = 74.7 bits (182), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 14/203 (6%)
Query: 18 DNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQ--GIV-EFKNEAKLIAKLQH 73
++F G LG+G FG VY + + I A+K L K+ + G+ + + E ++ + L+H
Sbjct: 12 EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 74 TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
N++RL G L+ EY P L + K D ++ I + L Y
Sbjct: 72 PNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYC 128
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
H RVIHRD+K N+LL KI+DFG + ++ + + GT Y+ PE
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 181
Query: 194 VMNGIVSMKSDVYSFGVLVLEII 216
+ + K D++S GVL E +
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFL 204
>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVX|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVY|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
Length = 278
Score = 74.7 bits (182), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 24/213 (11%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
D + G LG G F V K + L + KR +KSS +G+ + + E ++ +
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 71 LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
+QH N++ L K + +L+ E + L F+ ++KE L ++ ++ I+ G+
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 127
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPK----ISDFGMART--FGMNELEANTNRIVG 184
YLH L++ H DLK NI+L D+ PK I DFG+A FG NE + I G
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFK----NIFG 179
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +++PE V + +++D++S GV+ ++S
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212
>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|B Chain B, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|C Chain C, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|D Chain D, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
Length = 341
Score = 74.7 bits (182), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 91/329 (27%), Positives = 139/329 (42%), Gaps = 53/329 (16%)
Query: 25 RLGQGGFGPVYKGKL--LDGQ--EIAIKRLSK---SSGQGIVEFKNEAKLIAKLQHTNLV 77
+LG G FG V +G+ G+ +A+K L S + + +F E + L H NL+
Sbjct: 19 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 78 RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
RL G L ++ V E P SL + LL R+ + + +G+ YL
Sbjct: 79 RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK- 134
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH-----GYMSPE 192
R IHRDL A N+LL + KI DFG+ R N + + ++ H + +PE
Sbjct: 135 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN----DDHYVMQEHRKVPFAWCAPE 188
Query: 193 YVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDT 252
+ S SD + FGV + E+ + Y E + L N + L ID
Sbjct: 189 SLKTRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGL--------NGSQILHKIDK 233
Query: 253 TLHESCSPDEVTRCIH-VGLLCVQDKATDRPTMSDVASMLTNDTMALPTPRQPAFFINIS 311
P++ + I+ V + C K DRPT + L A PT +
Sbjct: 234 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE---AQPTD------MRAL 284
Query: 312 SDYEEPEVTEIKLEVCSVNDVTISRMEAR 340
D+EEP+ I++ NDV I+ +E R
Sbjct: 285 QDFEEPDKLHIQM-----NDV-ITVIEGR 307
>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
pdb|3RHX|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
Length = 306
Score = 74.7 bits (182), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 62/223 (27%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 18 DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRL-SKSSGQGIVEFKNEAKLI 68
D G LG+G FG V K K ++A+K L S ++ + + + +E +++
Sbjct: 17 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 76
Query: 69 AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSS--KKELL 114
+ +H N++ LLG Q G ++ EY +L ++ ++ S +E L
Sbjct: 77 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 136
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
K + + +G+ YL + + IHRDL A N+L+ + KI+DFG+AR +
Sbjct: 137 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 193
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +M+PE + + I + +SDV+SFGVL+ EI +
Sbjct: 194 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236
>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|C Chain C, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|D Chain D, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|E Chain E, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|F Chain F, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|G Chain G, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|H Chain H, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
Length = 328
Score = 74.7 bits (182), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 25/219 (11%)
Query: 12 TIAAATD------NFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS--SGQGIVEFK 62
+I +ATD N+ +G+G F V + +L G+E+A+K + K+ + + +
Sbjct: 3 SITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLF 62
Query: 63 NEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPN-KSLDFFIFDSSKKELLDWKKRFN 121
E +++ L H N+V+L + LV EY + D+ + KE + + +F
Sbjct: 63 REVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKFR 121
Query: 122 IIEGIVQGLLYLH-KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM-NELEANT 179
I VQ Y H KY ++HRDLKA N+LLD MN KI+DFG + F + N+L+
Sbjct: 122 QIVSAVQ---YCHQKY----IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT-- 172
Query: 180 NRIVGTHGYMSPE-YVMNGIVSMKSDVYSFGVLVLEIIS 217
G+ Y +PE + + DV+S GV++ ++S
Sbjct: 173 --FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 209
>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGK|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1AGW|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|1AGW|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|2FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
pdb|2FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
Length = 310
Score = 74.7 bits (182), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 62/223 (27%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 18 DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRL-SKSSGQGIVEFKNEAKLI 68
D G LG+G FG V K K ++A+K L S ++ + + + +E +++
Sbjct: 21 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 80
Query: 69 AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSS--KKELL 114
+ +H N++ LLG Q G ++ EY +L ++ ++ S +E L
Sbjct: 81 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 140
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
K + + +G+ YL + + IHRDL A N+L+ + KI+DFG+AR +
Sbjct: 141 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 197
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +M+PE + + I + +SDV+SFGVL+ EI +
Sbjct: 198 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240
>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|B Chain B, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|C Chain C, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 74.7 bits (182), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 62/223 (27%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 18 DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRL-SKSSGQGIVEFKNEAKLI 68
D G LG+G FG V K K ++A+K L S ++ + + + +E +++
Sbjct: 28 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 69 AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSS--KKELL 114
+ +H N++ LLG Q G ++ EY +L ++ ++ S +E L
Sbjct: 88 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 147
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
K + + +G+ YL + + IHRDL A N+L+ + KI+DFG+AR +
Sbjct: 148 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +M+PE + + I + +SDV+SFGVL+ EI +
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp
pdb|3GU5|A Chain A, Crystal Structure Of Dapkq23v-Amppnp-Mg2+
pdb|3GU6|A Chain A, Crystal Structure Of Dapkq23v-Adp
pdb|3GU7|A Chain A, Crystal Structure Of Dapkq23v-Adp-Mg2+
Length = 295
Score = 74.7 bits (182), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 24/213 (11%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
D + G LG G F V K + L + KR +KSS +G+ + + E ++ +
Sbjct: 11 DYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 71 LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
+QH N++ L K + +L+ E + L F+ ++KE L ++ ++ I+ G+
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 127
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPK----ISDFGMART--FGMNELEANTNRIVG 184
YLH L++ H DLK NI+L D+ PK I DFG+A FG NE + I G
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFK----NIFG 179
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +++PE V + +++D++S GV+ ++S
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212
>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|B Chain B, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|C Chain C, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|D Chain D, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
Length = 317
Score = 74.3 bits (181), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 62/223 (27%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 18 DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRL-SKSSGQGIVEFKNEAKLI 68
D G LG+G FG V K K ++A+K L S ++ + + + +E +++
Sbjct: 28 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 69 AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSS--KKELL 114
+ +H N++ LLG Q G ++ EY +L ++ ++ S +E L
Sbjct: 88 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQL 147
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
K + + +G+ YL + + IHRDL A N+L+ + KI+DFG+AR +
Sbjct: 148 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +M+PE + + I + +SDV+SFGVL+ EI +
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304
Length = 326
Score = 74.3 bits (181), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 24/213 (11%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
D + G LG G F V K + L + KR +KSS +G+ + + E ++ +
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 71 LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
+QH N++ L K + +L+ E + L F+ ++KE L ++ ++ I+ G+
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 127
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPK----ISDFGMART--FGMNELEANTNRIVG 184
YLH L++ H DLK NI+L D+ PK I DFG+A FG NE + I G
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFK----NIFG 179
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +++PE V + +++D++S GV+ ++S
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212
>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY4|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY5|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp.
pdb|1ZY5|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp
Length = 303
Score = 74.3 bits (181), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 68/236 (28%), Positives = 110/236 (46%), Gaps = 45/236 (19%)
Query: 9 DFQTIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKL 67
DF+ IA LGQG FG V K + LD + AIK++ + + + + +E L
Sbjct: 7 DFEEIAV----------LGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVML 55
Query: 68 IAKLQHTNLVRLLGCSLQ-------------KGERLLVYEYLPNKSLDFFIFDSSKKELL 114
+A L H +VR L+ K + EY N +L I + +
Sbjct: 56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR 115
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA----RTF 170
D + + + I++ L Y+H +IHRDLK NI +D+ N KI DFG+A R+
Sbjct: 116 D--EYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 171 GMNELEA--------NTNRIVGTHGYMSPEYVMNGI--VSMKSDVYSFGVLVLEII 216
+ +L++ N +GT Y++ E V++G + K D+YS G++ E+I
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMI 225
>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb
Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP
Length = 311
Score = 74.3 bits (181), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 15/212 (7%)
Query: 17 TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQG---IVEFKNEAKLIAKLQ 72
+D + G LG GG V+ + L D +++A+K L + + F+ EA+ A L
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 73 HTNLVRLLGCSLQKGER----LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ 128
H +V + + +V EY+ +L + + K+ +I Q
Sbjct: 71 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG-MNELEANTNRIVGTHG 187
L + H+ +IHRD+K +NI++ K+ DFG+AR T ++GT
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
Y+SPE V +SDVYS G ++ E+++ +
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3JS2|B Chain B, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3KY2|A Chain A, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
pdb|3KY2|B Chain B, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
Length = 317
Score = 74.3 bits (181), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 62/223 (27%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 18 DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRL-SKSSGQGIVEFKNEAKLI 68
D G LG+G FG V K K ++A+K L S ++ + + + +E +++
Sbjct: 28 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 69 AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSS--KKELL 114
+ +H N++ LLG Q G ++ EY +L ++ ++ S +E L
Sbjct: 88 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 147
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
K + + +G+ YL + + IHRDL A N+L+ + KI+DFG+AR +
Sbjct: 148 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +M+PE + + I + +SDV+SFGVL+ EI +
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F63|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F64|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F64|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F65|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
pdb|4F65|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
Length = 309
Score = 74.3 bits (181), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 62/223 (27%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 18 DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRL-SKSSGQGIVEFKNEAKLI 68
D G LG+G FG V K K ++A+K L S ++ + + + +E +++
Sbjct: 20 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 79
Query: 69 AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSS--KKELL 114
+ +H N++ LLG Q G ++ EY +L ++ ++ S +E L
Sbjct: 80 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 139
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
K + + +G+ YL + + IHRDL A N+L+ + KI+DFG+AR +
Sbjct: 140 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 196
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +M+PE + + I + +SDV+SFGVL+ EI +
Sbjct: 197 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239
>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|B Chain B, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|C Chain C, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|D Chain D, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORK|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 2)
pdb|3ORL|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 3)
pdb|3ORO|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 4)
pdb|3ORP|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 5)
pdb|3ORT|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 6)
Length = 311
Score = 74.3 bits (181), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 15/212 (7%)
Query: 17 TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQG---IVEFKNEAKLIAKLQ 72
+D + G LG GG V+ + L D +++A+K L + + F+ EA+ A L
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 73 HTNLVRLLGCSLQKGER----LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ 128
H +V + + +V EY+ +L + + K+ +I Q
Sbjct: 71 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG-MNELEANTNRIVGTHG 187
L + H+ +IHRD+K +NI++ K+ DFG+AR T ++GT
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
Y+SPE V +SDVYS G ++ E+++ +
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI8|C Chain C, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI7|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structure Of The Cdk6-P16ink4a Tumor Suppressor
Complex
pdb|1BLX|A Chain A, P19ink4dCDK6 COMPLEX
pdb|1G3N|A Chain A, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
pdb|1G3N|E Chain E, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
Length = 326
Score = 74.3 bits (181), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 55/206 (26%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 26 LGQGGFGPVYKGKLLD--GQEIAIKRLSKSSGQ---GIVEFKNEAKL--IAKLQHTNLVR 78
+G+G +G V+K + L G+ +A+KR+ +G+ + + A L + +H N+VR
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 79 LLG-CSLQKGER----LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
L C++ + +R LV+E++ ++ L ++ D + + + +++ +++GL +L
Sbjct: 79 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
H + RV+HRDLK NIL+ K++DFG+AR + + +V T Y +PE
Sbjct: 137 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVTLWYRAPEV 190
Query: 194 VMNGIVSMKSDVYSFGVLVLEIISSK 219
++ + D++S G + E+ K
Sbjct: 191 LLQSSYATPVDLWSVGCIFAEMFRRK 216
>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine
pdb|3GUB|A Chain A, Crystal Structure Of Dapkl93g Complexed With N6-(2-
Phenylethyl)adenosine
Length = 295
Score = 74.3 bits (181), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 24/213 (11%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
D + G LG G F V K + L + KR +KSS +G+ + + E ++ +
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 71 LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
+QH N++ L K + +L+ E + L F+ ++KE L ++ ++ I+ G+
Sbjct: 71 IQHPNVITLHEVYENKTDVILIGELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 127
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPK----ISDFGMART--FGMNELEANTNRIVG 184
YLH L++ H DLK NI+L D+ PK I DFG+A FG NE + I G
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFK----NIFG 179
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +++PE V + +++D++S GV+ ++S
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212
>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
pdb|3FE3|B Chain B, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
Length = 328
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 61/217 (28%), Positives = 103/217 (47%), Gaps = 21/217 (9%)
Query: 12 TIAAATD------NFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS--SGQGIVEFK 62
+IA+ D N+ +G+G F V + +L G+E+AIK + K+ + + +
Sbjct: 3 SIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF 62
Query: 63 NEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPN-KSLDFFIFDSSKKELLDWKKRFN 121
E +++ L H N+V+L + L+ EY + D+ + KE K+ +
Sbjct: 63 REVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKE----KEARS 118
Query: 122 IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR 181
IV + Y H+ R++HRDLKA N+LLD MN KI+DFG + F + +
Sbjct: 119 KFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GKLDA 172
Query: 182 IVGTHGYMSPEYVMNGIV-SMKSDVYSFGVLVLEIIS 217
G Y +PE + DV+S GV++ ++S
Sbjct: 173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 209
>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With
Staurosporine At 2a Resolution
Length = 345
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 19/212 (8%)
Query: 13 IAAATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAK- 70
I ++F LG+G FG V+ + Q AIK L K +++ E ++ K
Sbjct: 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--LMDDDVECTMVEKR 69
Query: 71 -----LQHTNLVRLLGCSLQKGERLL-VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE 124
+H L + C+ Q E L V EYL L + I K +L + F E
Sbjct: 70 VLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS--RATFYAAE 126
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
I+ GL +LH +++RDLK NILLD + KI+DFGM + + +A TN G
Sbjct: 127 -IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--DAKTNXFCG 180
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
T Y++PE ++ + D +SFGVL+ E++
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEML 212
>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
pdb|2PY3|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 61/225 (27%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 18 DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRLSKSSGQ----GIVEFKNEA 65
D + G LG+G FG V K K + +A+K L + + +V
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 66 KLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSSK--KE 112
K+I K H N++ LLG Q G ++ Y +L ++ +D ++ +E
Sbjct: 95 KMIGK--HKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 113 LLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM 172
+ +K + + +G+ YL + + IHRDL A N+L+ + KI+DFG+AR
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 173 NELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
+ T +M+PE + + + + +SDV+SFGVL+ EI +
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|E Chain E, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|F Chain F, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
Length = 303
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 67/236 (28%), Positives = 109/236 (46%), Gaps = 45/236 (19%)
Query: 9 DFQTIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKL 67
DF+ IA LGQG FG V K + LD + AIK++ + + + + +E L
Sbjct: 7 DFEEIAV----------LGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXL 55
Query: 68 IAKLQHTNLVRLLGCSLQ-------------KGERLLVYEYLPNKSLDFFIFDSSKKELL 114
+A L H +VR L+ K + EY N++L I + +
Sbjct: 56 LASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQR 115
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA----RTF 170
D + + + I++ L Y+H +IHR+LK NI +D+ N KI DFG+A R+
Sbjct: 116 D--EYWRLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 171 GMNELEA--------NTNRIVGTHGYMSPEYVMNGI--VSMKSDVYSFGVLVLEII 216
+ +L++ N +GT Y++ E V++G + K D YS G++ E I
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAXYVATE-VLDGTGHYNEKIDXYSLGIIFFEXI 225
>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
pdb|2QNJ|B Chain B, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
Length = 328
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 15/204 (7%)
Query: 19 NFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTN 75
N+ +G+G F V + +L G+E+AIK + K+ + + + E +++ L H N
Sbjct: 13 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 76 LVRLLGCSLQKGERLLVYEYLPN-KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
+V+L + L+ EY + D+ + KE K+ + IV + Y H
Sbjct: 73 IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKE----KEARSKFRQIVSAVQYCH 128
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
+ R++HRDLKA N+LLD MN KI+DFG + F + + G+ Y +PE
Sbjct: 129 QK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GKLDTFCGSPPYAAPELF 182
Query: 195 MNGIV-SMKSDVYSFGVLVLEIIS 217
+ DV+S GV++ ++S
Sbjct: 183 QGKKYDGPEVDVWSLGVILYTLVS 206
>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680
Length = 292
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 9 DFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSS--GQGIV-EFKNE 64
D T D+F G LG+G FG VY + I A+K L KS +G+ + + E
Sbjct: 14 DILTRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRRE 73
Query: 65 AKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE 124
++ A L H N++RL + L+ EY P L + K D ++ I+E
Sbjct: 74 IEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGEL---YKELQKSCTFDEQRTATIME 130
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
+ L+Y H +VIHRD+K N+LL + KI+DFG + ++ + G
Sbjct: 131 ELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFG----WSVHAPSLRRKTMCG 183
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
T Y+ PE + + + K D++ GVL E++
Sbjct: 184 TLDYLPPEMIEGRMHNEKVDLWCIGVLCYELL 215
>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral
Cyclin
pdb|1XO2|B Chain B, Crystal Structure Of A Human Cyclin-Dependent Kinase 6
Complex With A Flavonol Inhibitor, Fisetin
pdb|2EUF|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclin In Complex With The
Inhibitor Pd0332991
pdb|2F2C|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclinwith The Inhibitor
Aminopurvalanol
Length = 308
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 55/206 (26%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 26 LGQGGFGPVYKGKLLD--GQEIAIKRLSKSSGQ---GIVEFKNEAKL--IAKLQHTNLVR 78
+G+G +G V+K + L G+ +A+KR+ +G+ + + A L + +H N+VR
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 79 LLG-CSLQKGER----LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
L C++ + +R LV+E++ ++ L ++ D + + + +++ +++GL +L
Sbjct: 79 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
H + RV+HRDLK NIL+ K++DFG+AR + + +V T Y +PE
Sbjct: 137 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVTLWYRAPEV 190
Query: 194 VMNGIVSMKSDVYSFGVLVLEIISSK 219
++ + D++S G + E+ K
Sbjct: 191 LLQSSYATPVDLWSVGCIFAEMFRRK 216
>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|3NUX|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|4AUA|A Chain A, Liganded X-ray Crystal Structure Of Cyclin Dependent
Kinase 6 (cdk6)
pdb|4EZ5|A Chain A, Cdk6 (monomeric) In Complex With Inhibitor
Length = 307
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 55/206 (26%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 26 LGQGGFGPVYKGKLLD--GQEIAIKRLSKSSGQ---GIVEFKNEAKL--IAKLQHTNLVR 78
+G+G +G V+K + L G+ +A+KR+ +G+ + + A L + +H N+VR
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 79 LLG-CSLQKGER----LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
L C++ + +R LV+E++ ++ L ++ D + + + +++ +++GL +L
Sbjct: 79 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
H + RV+HRDLK NIL+ K++DFG+AR + + +V T Y +PE
Sbjct: 137 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVTLWYRAPEV 190
Query: 194 VMNGIVSMKSDVYSFGVLVLEIISSK 219
++ + D++S G + E+ K
Sbjct: 191 LLQSSYATPVDLWSVGCIFAEMFRRK 216
>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N-
Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2
Length = 325
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 62/198 (31%), Positives = 107/198 (54%), Gaps = 14/198 (7%)
Query: 26 LGQGGFGPVYKGKLLDG----QEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRL 79
LGQG FG V+ K + G Q A+K L K++ + V K E ++ ++ H +V+L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
+G+ L+ ++L + D F S + + +F + E + L +LH L
Sbjct: 92 HYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LALALDHLHS---L 145
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
+I+RDLK NILLD++ + K++DFG+++ +E +A + GT YM+PE V
Sbjct: 146 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRGH 203
Query: 200 SMKSDVYSFGVLVLEIIS 217
+ +D +SFGVL+ E+++
Sbjct: 204 TQSADWWSFGVLMFEMLT 221
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 54/195 (27%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24 NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
++LG G +G VY+G +A+K L + + + + EF EA ++ +++H NLV+LLG
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
++ ++ E++ +L ++ + +++E+ + + I + YL K + I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKKN---FI 340
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
HR+L A N L+ + K++DFG++R + A+ + +PE + S+K
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 399
Query: 203 SDVYSFGVLVLEIIS 217
SDV++FGVL+ EI +
Sbjct: 400 SDVWAFGVLLWEIAT 414
>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/215 (26%), Positives = 109/215 (50%), Gaps = 19/215 (8%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQ-GI-VEFKNEAKLIAKLQ 72
AT + P +G G +G VYK + G +A+K + +G+ G+ + E L+ +L+
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 73 ---HTNLVRLLG-CSLQKGER----LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE 124
H N+VRL+ C+ + +R LV+E++ ++ L ++ D + L + +++
Sbjct: 62 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
++GL +LH ++HRDLK NIL+ K++DFG+AR + + +V
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALFPVVV 173
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
T Y +PE ++ + D++S G + E+ K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208
>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
pdb|3TT0|B Chain B, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
Length = 382
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 62/223 (27%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 18 DNFSPGNRLGQGGFGPVY--------KGKLLDGQEIAIKRL-SKSSGQGIVEFKNEAKLI 68
D G LG+G FG V K K ++A+K L S ++ + + + +E +++
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 69 AKL-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFI-----------FDSS--KKELL 114
+ +H N++ LLG Q G ++ EY +L ++ ++ S +E L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
K + + +G+ YL + + IHRDL A N+L+ + KI+DFG+AR +
Sbjct: 189 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 175 LEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +M+PE + + I + +SDV+SFGVL+ EI +
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk-1 Bound To Amp-Pcp
pdb|2Z7R|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Staurosporine
pdb|2Z7S|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Purvalnol A
Length = 321
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 62/198 (31%), Positives = 107/198 (54%), Gaps = 14/198 (7%)
Query: 26 LGQGGFGPVYKGKLL----DGQEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRL 79
LGQG FG V+ + + G A+K L K++ + V K E ++A + H +V+L
Sbjct: 36 LGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKL 95
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
+G+ L+ ++L + D F S + + +F + E + GL +LH L
Sbjct: 96 HYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LALGLDHLHS---L 149
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
+I+RDLK NILLD++ + K++DFG+++ +E +A + GT YM+PE V
Sbjct: 150 GIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--FCGTVEYMAPEVVNRQGH 207
Query: 200 SMKSDVYSFGVLVLEIIS 217
S +D +S+GVL+ E+++
Sbjct: 208 SHSADWWSYGVLMFEMLT 225
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 54/195 (27%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24 NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
++LG G +G VY+G +A+K L + + + + EF EA ++ +++H NLV+LLG
Sbjct: 223 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 281
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
++ ++ E++ +L ++ + +++E ++ + I + YL K + I
Sbjct: 282 CTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 337
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
HR+L A N L+ + K++DFG++R + A+ + +PE + S+K
Sbjct: 338 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 396
Query: 203 SDVYSFGVLVLEIIS 217
SDV++FGVL+ EI +
Sbjct: 397 SDVWAFGVLLWEIAT 411
>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYN|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYO|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
pdb|3NYO|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
Length = 576
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 65/200 (32%), Positives = 99/200 (49%), Gaps = 15/200 (7%)
Query: 26 LGQGGFGPVYK------GKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG+GGFG V GK+ +++ KR+ K G+ + NE +++ K+ +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 249
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
K LV + L F I+ + + + F E I GL LH R
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLH---RE 305
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
R+++RDLK NILLDD + +ISD G+A + E + R VGT GYM+PE V N
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGR-VGTVGYMAPEVVKNERY 362
Query: 200 SMKSDVYSFGVLVLEIISSK 219
+ D ++ G L+ E+I+ +
Sbjct: 363 TFSPDWWALGCLLYEMIAGQ 382
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 54/195 (27%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 24 NRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
++LG G +G VY+G +A+K L + + + + EF EA ++ +++H NLV+LLG
Sbjct: 265 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 323
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
++ ++ E++ +L ++ + +++E ++ + I + YL K + I
Sbjct: 324 CTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 379
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMK 202
HR+L A N L+ + K++DFG++R + A+ + +PE + S+K
Sbjct: 380 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 438
Query: 203 SDVYSFGVLVLEIIS 217
SDV++FGVL+ EI +
Sbjct: 439 SDVWAFGVLLWEIAT 453
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 60/198 (30%), Positives = 107/198 (54%), Gaps = 15/198 (7%)
Query: 26 LGQGGFGPVYKGKLLD-GQEIAIKRLS----KSSGQGIVEFK-NEAKLIAKLQHTNLVRL 79
LG+G F VYK + + Q +AIK++ + GI E KL+ +L H N++ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
L K LV++++ L+ I D+S K + ++ +QGL YLH++
Sbjct: 78 LDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLM--TLQGLEYLHQHW-- 132
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG-I 198
++HRDLK +N+LLD+ K++DFG+A++FG A +++V T Y +PE + +
Sbjct: 133 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYXHQVV-TRWYRAPELLFGARM 189
Query: 199 VSMKSDVYSFGVLVLEII 216
+ D+++ G ++ E++
Sbjct: 190 YGVGVDMWAVGCILAELL 207
>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human
5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant
(T172d)
pdb|3AQV|A Chain A, Human Amp-Activated Protein Kinase Alpha 2 Subunit Kinase
Domain (T172d) Complexed With Compound C
Length = 276
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 54/203 (26%), Positives = 105/203 (51%), Gaps = 14/203 (6%)
Query: 19 NFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHT 74
++ G+ LG G FG V G+ L G ++A+K L++ S + + K E + + +H
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 75 NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
++++L + +V EY+ L +I + E ++ ++ F + I+ + Y H
Sbjct: 72 HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF---QQILSAVDYCH 128
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
++ V+HRDLK N+LLD MN KI+DFG++ E ++ G+ Y +PE +
Sbjct: 129 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS---CGSPNYAAPEVI 182
Query: 195 MNGIVS-MKSDVYSFGVLVLEII 216
+ + + D++S GV++ ++
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALL 205
>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
pdb|2ACX|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
Length = 576
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 65/200 (32%), Positives = 99/200 (49%), Gaps = 15/200 (7%)
Query: 26 LGQGGFGPVYK------GKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
LG+GGFG V GK+ +++ KR+ K G+ + NE +++ K+ +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 249
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
K LV + L F I+ + + + F E I GL LH R
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLH---RE 305
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
R+++RDLK NILLDD + +ISD G+A + E + R VGT GYM+PE V N
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGR-VGTVGYMAPEVVKNERY 362
Query: 200 SMKSDVYSFGVLVLEIISSK 219
+ D ++ G L+ E+I+ +
Sbjct: 363 TFSPDWWALGCLLYEMIAGQ 382
>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6
Length = 321
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 52/193 (26%), Positives = 95/193 (49%), Gaps = 10/193 (5%)
Query: 25 RLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
++G+G G V + G+++A+K + Q NE ++ QH N+V +
Sbjct: 52 KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
L E ++ E+L +L D + L+ ++ + E ++Q L YLH VIH
Sbjct: 112 LVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIH 164
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKS 203
RD+K+ +ILL K+SDFG + +VGT +M+PE + + + +
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKXLVGTPYWMAPEVISRSLYATEV 222
Query: 204 DVYSFGVLVLEII 216
D++S G++V+E++
Sbjct: 223 DIWSLGIMVIEMV 235
>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
pdb|1ZMW|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
Length = 327
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 101/199 (50%), Gaps = 19/199 (9%)
Query: 26 LGQGGFGPVYKGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
+G+G F V + +L G+E+A+K + K+ + + + E +++ L H N+V+L
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 83 SLQKGERLLVYEYLPN-KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
+ LV EY + D+ + KE + + +F I VQ Y H+ +
Sbjct: 82 IETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKFRQIVSAVQ---YCHQKF---I 134
Query: 142 IHRDLKASNILLDDQMNPKISDFGMAR--TFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
+HRDLKA N+LLD MN KI+DFG + TFG N+L+A G Y +PE
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDA----FCGAPPYAAPELFQGKKY 189
Query: 200 -SMKSDVYSFGVLVLEIIS 217
+ DV+S GV++ ++S
Sbjct: 190 DGPEVDVWSLGVILYTLVS 208
>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin
pdb|4GUE|A Chain A, Structure Of N-terminal Kinase Domain Of Rsk2 With
Flavonoid Glycoside Quercitrin
Length = 305
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 62/198 (31%), Positives = 107/198 (54%), Gaps = 14/198 (7%)
Query: 26 LGQGGFGPVYKGKLLDG----QEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRL 79
LGQG FG V+ K + G Q A+K L K++ + V K E ++ ++ H +V+L
Sbjct: 33 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 92
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
+G+ L+ ++L + D F S + + +F + E + L +LH L
Sbjct: 93 HYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LALALDHLHS---L 146
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
+I+RDLK NILLD++ + K++DFG+++ +E +A + GT YM+PE V
Sbjct: 147 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRGH 204
Query: 200 SMKSDVYSFGVLVLEIIS 217
+ +D +SFGVL+ E+++
Sbjct: 205 TQSADWWSFGVLMFEMLT 222
>pdb|3KK9|A Chain A, Camkii Substrate Complex B
Length = 282
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 17 TDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLS--KSSGQGIVEFKNEAKLIAKLQH 73
+DN+ LG+G F V + G E A K ++ K S + + + EA++ KLQH
Sbjct: 4 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 74 TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
N+VRL ++ LV++ + L D +E + I+ I++ + Y
Sbjct: 64 PNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAYC 120
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANTNRIVGTHGYMS 190
H ++HR+LK N+LL + K++DFG+A +N+ EA + GT GY+S
Sbjct: 121 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-WHGFAGTPGYLS 174
Query: 191 PEYVMNGIVSMKSDVYSFGVLV 212
PE + S D+++ GV++
Sbjct: 175 PEVLKKDPYSKPVDIWACGVIL 196
>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex
With Flavonoid Glycoside Sl0101
Length = 304
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 62/198 (31%), Positives = 107/198 (54%), Gaps = 14/198 (7%)
Query: 26 LGQGGFGPVYKGKLLDG----QEIAIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRL 79
LGQG FG V+ K + G Q A+K L K++ + V K E ++ ++ H +V+L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
+G+ L+ ++L + D F S + + +F + E + L +LH L
Sbjct: 92 HYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LALALDHLHS---L 145
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
+I+RDLK NILLD++ + K++DFG+++ +E +A + GT YM+PE V
Sbjct: 146 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRGH 203
Query: 200 SMKSDVYSFGVLVLEIIS 217
+ +D +SFGVL+ E+++
Sbjct: 204 TQSADWWSFGVLMFEMLT 221
>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated
Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2
Chain)
Length = 276
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 53/203 (26%), Positives = 104/203 (51%), Gaps = 14/203 (6%)
Query: 19 NFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQG---IVEFKNEAKLIAKLQHT 74
++ G+ LG G FG V G+ L G ++A+K L++ + + + K E + + +H
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 75 NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
++++L + +V EY+ L +I + E ++ ++ F + I+ + Y H
Sbjct: 72 HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF---QQILSAVDYCH 128
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
++ V+HRDLK N+LLD MN KI+DFG++ E + G+ Y +PE +
Sbjct: 129 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPEVI 182
Query: 195 MNGIVS-MKSDVYSFGVLVLEII 216
+ + + D++S GV++ ++
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALL 205
>pdb|3KK8|A Chain A, Camkii Substrate Complex A
Length = 284
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 17 TDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLS--KSSGQGIVEFKNEAKLIAKLQH 73
+DN+ LG+G F V + G E A K ++ K S + + + EA++ KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 74 TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
N+VRL ++ LV++ + L D +E + I+ I++ + Y
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANTNRIVGTHGYMS 190
H ++HR+LK N+LL + K++DFG+A +N+ EA + GT GY+S
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-WHGFAGTPGYLS 175
Query: 191 PEYVMNGIVSMKSDVYSFGVLV 212
PE + S D+++ GV++
Sbjct: 176 PEVLKKDPYSKPVDIWACGVIL 197
>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase
Domain From Human
Length = 314
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 55/211 (26%), Positives = 109/211 (51%), Gaps = 23/211 (10%)
Query: 27 GQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAK--LQHTNLVRLLGCSL 84
+G FG V+K +L++ +A+K Q +++E ++ + ++H NL++ +
Sbjct: 24 ARGRFGCVWKAQLMN-DFVAVKIFPLQDKQS---WQSEREIFSTPGMKHENLLQFIAAE- 78
Query: 85 QKGERLLVYEYLPNKSLD-FFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK-------- 135
++G L V +L D + D K ++ W + ++ E + +GL YLH+
Sbjct: 79 KRGSNLEVELWLITAFHDKGSLTDYLKGNIITWNELCHVAETMSRGLSYLHEDVPWCRGE 138
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
+ + HRD K+ N+LL + ++DFG+A F + +T+ VGT YM+PE V+
Sbjct: 139 GHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPE-VL 197
Query: 196 NGIVS------MKSDVYSFGVLVLEIISSKK 220
G ++ ++ D+Y+ G+++ E++S K
Sbjct: 198 EGAINFQRDAFLRIDMYAMGLVLWELVSRCK 228
>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420
Length = 504
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 27/205 (13%)
Query: 25 RLGQGGFGPVYKGKLLDGQ-EIAIKRLSKSS---------GQGIVEFK----NEAKLIAK 70
+LG G +G V K +G E AIK + KS + I +F NE L+
Sbjct: 43 KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 71 LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
L H N+++L K LV E+ L I + K + D NI++ I+ G+
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA---NIMKQILSGI 159
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQ---MNPKISDFGMARTFGMNELEANTNRIVGTHG 187
YLHK++ ++HRD+K NILL+++ +N KI DFG++ F + +GT
Sbjct: 160 CYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK---DYKLRDRLGTAY 213
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLV 212
Y++PE V+ + K DV+S GV++
Sbjct: 214 YIAPE-VLKKKYNEKCDVWSCGVIM 237
>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex
pdb|3KL8|C Chain C, Camkiintide Inhibitor Complex
pdb|3KL8|E Chain E, Camkiintide Inhibitor Complex
pdb|3KL8|G Chain G, Camkiintide Inhibitor Complex
pdb|3KL8|I Chain I, Camkiintide Inhibitor Complex
Length = 269
Score = 72.4 bits (176), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 17 TDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLS--KSSGQGIVEFKNEAKLIAKLQH 73
+DN+ LG+G F V + G E A K ++ K S + + + EA++ KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 74 TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
N+VRL ++ LV++ + L D +E + I+ I++ + Y
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANTNRIVGTHGYMS 190
H ++HR+LK N+LL + K++DFG+A +N+ EA + GT GY+S
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-WHGFAGTPGYLS 175
Query: 191 PEYVMNGIVSMKSDVYSFGVLV 212
PE + S D+++ GV++
Sbjct: 176 PEVLKKDPYSKPVDIWACGVIL 197
>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp
Length = 298
Score = 72.4 bits (176), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 67/234 (28%), Positives = 109/234 (46%), Gaps = 30/234 (12%)
Query: 3 RDLKIFDFQTIAAATDNFSPGNR--------LGQGGFGPVYKGKLLDGQE----IAIKRL 50
RDL D +A D P R +G+G FG VY G+ +D + AIK L
Sbjct: 1 RDL---DSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL 57
Query: 51 SK-SSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ-KGERLLVYEYLPNKSLDFFIFDS 108
S+ + Q + F E L+ L H N++ L+G L +G ++ Y+ + L FI
Sbjct: 58 SRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP 117
Query: 109 SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR 168
+ + F + + +G+ YL + + +HRDL A N +LD+ K++DFG+AR
Sbjct: 118 QRNPTVKDLISFGL--QVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172
Query: 169 TFGMNELEANTNRIVGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
E + H + + E + + KSDV+SFGVL+ E+++
Sbjct: 173 DILDREYYSVQQH---RHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha
pdb|3OHT|B Chain B, Crystal Structure Of Salmo Salar P38alpha
Length = 389
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 112/219 (51%), Gaps = 23/219 (10%)
Query: 11 QTIAAATDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAK 66
+TI + + + +G G +G V + G +IA+K+LS+ Q I+ K E +
Sbjct: 44 KTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRP-FQSIIHAKRTYRELR 102
Query: 67 LIAKLQHTNLVRLL-----GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN 121
L+ ++H N++ LL SL++ + + +L L+ + ++L D +F
Sbjct: 103 LLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF- 158
Query: 122 IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR 181
+I I++GL Y+H +IHRDLK SN+ +++ KI DFG+AR +
Sbjct: 159 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 210
Query: 182 IVGTHGYMSPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
V T Y +PE ++N + +M D++S G ++ E+++ +
Sbjct: 211 YVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249
>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta
(I4122)
Length = 677
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 25/208 (12%)
Query: 25 RLGQGGFGPVYKGKLLD-GQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLV--RLL 80
RLG GGFG V + D G+++AIK+ + S + + E +++ KL H N+V R +
Sbjct: 22 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 81
Query: 81 GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL--------Y 132
LQK L LP ++++ +K L ++ + EG ++ LL Y
Sbjct: 82 PDGLQK----LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRY 137
Query: 133 LHKYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
LH+ R+IHRDLK NI+L ++ KI D G A+ EL VGT Y+
Sbjct: 138 LHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQYL 191
Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
+PE + ++ D +SFG L E I+
Sbjct: 192 APELLEQKKYTVTVDYWSFGTLAFECIT 219
>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|B Chain B, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|C Chain C, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|D Chain D, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
Length = 290
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 73/257 (28%), Positives = 124/257 (48%), Gaps = 24/257 (9%)
Query: 43 QEIAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKS- 100
+++AIKR++ Q + E E + +++ H N+V + K E LV + L S
Sbjct: 36 EKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSV 95
Query: 101 LDFFIFDSSKKE----LLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQ 156
LD +K E +LD I+ +++GL YLHK + IHRD+KA NILL +
Sbjct: 96 LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGED 152
Query: 157 MNPKISDFGMARTFGM-NELEANTNR--IVGTHGYMSPEYVMNGI--VSMKSDVYSFGVL 211
+ +I+DFG++ ++ N R VGT +M+PE VM + K+D++SFG+
Sbjct: 153 GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE-VMEQVRGYDFKADIWSFGIT 211
Query: 212 VLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGL 271
+E+ + Y + L L L N+ +LE T + + + + +
Sbjct: 212 AIELATGAAPYHKYPPMKVLMLT-----LQNDPPSLE---TGVQDKEMLKKYGKSFRKMI 263
Query: 272 -LCVQDKATDRPTMSDV 287
LC+Q RPT +++
Sbjct: 264 SLCLQKDPEKRPTAAEL 280
>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|B Chain B, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|C Chain C, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|D Chain D, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|E Chain E, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|F Chain F, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|G Chain G, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|H Chain H, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
Length = 676
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 25/208 (12%)
Query: 25 RLGQGGFGPVYKGKLLD-GQEIAIKRLSKS-SGQGIVEFKNEAKLIAKLQHTNLV--RLL 80
RLG GGFG V + D G+++AIK+ + S + + E +++ KL H N+V R +
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 81 GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL--------Y 132
LQK L LP ++++ +K L ++ + EG ++ LL Y
Sbjct: 81 PDGLQK----LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRY 136
Query: 133 LHKYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
LH+ R+IHRDLK NI+L ++ KI D G A+ EL VGT Y+
Sbjct: 137 LHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQYL 190
Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
+PE + ++ D +SFG L E I+
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECIT 218
>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|B Chain B, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|C Chain C, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|D Chain D, Structure Of The Osr1 Kinase, A Hypertension Drug Target
Length = 303
Score = 72.0 bits (175), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 78/283 (27%), Positives = 131/283 (46%), Gaps = 25/283 (8%)
Query: 18 DNFSPGNRLGQGGFGPVYKGKLLDGQE-IAIKRLSKSSGQ-GIVEFKNEAKLIAKLQHTN 75
D++ +G G V +E +AIKR++ Q + E E + +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 76 LVRLLGCSLQKGERLLVYEYLPNKS-LDFFIFDSSKKE----LLDWKKRFNIIEGIVQGL 130
+V + K E LV + L S LD +K E +LD I+ +++GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM-NELEANTNR--IVGTHG 187
YLHK + IHRD+KA NILL + + +I+DFG++ ++ N R VGT
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 188 YMSPEYVMNGI--VSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGK 245
+M+PE VM + K+D++SFG+ +E+ + Y + L L L N+
Sbjct: 192 WMAPE-VMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT-----LQNDPP 245
Query: 246 ALELIDTTLHESCSPDEVTRCIHVGL-LCVQDKATDRPTMSDV 287
+LE T + + + + + LC+Q RPT +++
Sbjct: 246 SLE---TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAEL 285
>pdb|1RJB|A Chain A, Crystal Structure Of Flt3
Length = 344
Score = 71.6 bits (174), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 66/235 (28%), Positives = 110/235 (46%), Gaps = 45/235 (19%)
Query: 18 DNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAK 70
+N G LG G FG V K ++A+K L + + E +E K++ +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 71 L-QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKE-------------LLDW 116
L H N+V LLG G L++EY D + SK+E L+
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYG--DLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 117 KKRFNIIE---------GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA 167
++ N++ + +G+ +L S +HRDL A N+L+ KI DFG+A
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLA 219
Query: 168 RTFGMNELEANTNRIVGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
R ++ +++N +V + +M+PE + GI ++KSDV+S+G+L+ EI S
Sbjct: 220 R-----DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4APC|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4B9D|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor.
pdb|4B9D|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor
Length = 350
Score = 71.6 bits (174), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 55/199 (27%), Positives = 101/199 (50%), Gaps = 9/199 (4%)
Query: 24 NRLGQGGFGPVYKGKLL-DGQEIAIKRL--SKSSGQGIVEFKNEAKLIAKLQHTNLVRLL 80
++G+G FG K DG++ IK + S+ S + E + E ++A ++H N+V+
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 81 GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
+ G +V +Y + D F +++K +L + + I++ VQ L L +
Sbjct: 90 ESFEENGSLYIVMDYC--EGGDLFKRINAQKGVLFQEDQ--ILDWFVQICLALKHVHDRK 145
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
++HRD+K+ NI L ++ DFG+AR +N +GT Y+SPE N +
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGTPYYLSPEICENKPYN 203
Query: 201 MKSDVYSFGVLVLEIISSK 219
KSD+++ G ++ E+ + K
Sbjct: 204 NKSDIWALGCVLYELCTLK 222
>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
pdb|2R0I|B Chain B, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
Length = 327
Score = 71.6 bits (174), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 61/199 (30%), Positives = 101/199 (50%), Gaps = 19/199 (9%)
Query: 26 LGQGGFGPVYKGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
+G+G F V + +L G+E+A+K + K+ + + + E +++ L H N+V+L
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 83 SLQKGERLLVYEYLPN-KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
+ LV EY + D+ + KE + + +F I VQ Y H+ +
Sbjct: 82 IETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKFRQIVSAVQ---YCHQKF---I 134
Query: 142 IHRDLKASNILLDDQMNPKISDFGMAR--TFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
+HRDLKA N+LLD MN KI+DFG + TFG N+L+ G+ Y +PE
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDT----FCGSPPYAAPELFQGKKY 189
Query: 200 -SMKSDVYSFGVLVLEIIS 217
+ DV+S GV++ ++S
Sbjct: 190 DGPEVDVWSLGVILYTLVS 208
>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
pdb|1ZMU|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
Length = 327
Score = 71.6 bits (174), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 61/199 (30%), Positives = 101/199 (50%), Gaps = 19/199 (9%)
Query: 26 LGQGGFGPVYKGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
+G+G F V + +L G+E+A+K + K+ + + + E +++ L H N+V+L
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 83 SLQKGERLLVYEYLPN-KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
+ LV EY + D+ + KE + + +F I VQ Y H+ +
Sbjct: 82 IETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKFRQIVSAVQ---YCHQKF---I 134
Query: 142 IHRDLKASNILLDDQMNPKISDFGMAR--TFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
+HRDLKA N+LLD MN KI+DFG + TFG N+L+ G+ Y +PE
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDT----FCGSPPYAAPELFQGKKY 189
Query: 200 -SMKSDVYSFGVLVLEIIS 217
+ DV+S GV++ ++S
Sbjct: 190 DGPEVDVWSLGVILYTLVS 208
>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
pdb|2BDW|B Chain B, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
Length = 362
Score = 71.6 bits (174), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 17 TDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLS--KSSGQGIVEFKNEAKLIAKLQH 73
+DN+ LG+G F V + G E A K ++ K S + + + EA++ KLQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 74 TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
N+VRL ++ LV++ + L D +E + I+ I++ + Y
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAYC 144
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANTNRIVGTHGYMS 190
H ++HR+LK N+LL + K++DFG+A +N+ EA + GT GY+S
Sbjct: 145 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-WHGFAGTPGYLS 198
Query: 191 PEYVMNGIVSMKSDVYSFGVLV 212
PE + S D+++ GV++
Sbjct: 199 PEVLKKDPYSKPVDIWACGVIL 220
>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant
Length = 311
Score = 71.2 bits (173), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 15/212 (7%)
Query: 17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQG---IVEFKNEAKLIAKLQ 72
+D + G LG GG V+ + L +++A+K L + + F+ EA+ A L
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 73 HTNLVRLLGCSLQKGER----LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ 128
H +V + + +V EY+ +L + + K+ +I Q
Sbjct: 71 HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG-MNELEANTNRIVGTHG 187
L + H+ +IHRD+K +NI++ K+ DFG+AR T ++GT
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
Y+SPE V +SDVYS G ++ E+++ +
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A
Pyrrolo-Pyridine Inhibitor
Length = 273
Score = 71.2 bits (173), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 57/201 (28%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
LG+G +G V + + +A+K + E K E + A L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
+ + L EY L FD + ++ D ++ F+ ++ G++YLH +
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 124
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
+ HRD+K N+LLD++ N KISDFG+A F N E N++ GT Y++PE +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
+ DV+S G+++ +++ +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGE 205
>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
pdb|3SAY|B Chain B, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
Length = 430
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26 LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
+G G FG VY+ KL D G+ +AIK++ + FKN E +++ KL H N+VRL
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 84 LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
GE+ LV +Y+P S K+ L + + + L Y+H +
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 176
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
+ HRD+K N+LLD D K+ DFG A+ E N + I + Y +PE +
Sbjct: 177 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSXICSRY-YRAPELIFG 230
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
S DV+S G ++ E++
Sbjct: 231 ATDYTSSIDVWSAGCVLAELL 251
>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
pdb|1ZMV|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
Length = 327
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 19/199 (9%)
Query: 26 LGQGGFGPVYKGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
+G+G F V + +L G+E+A++ + K+ + + + E +++ L H N+V+L
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 83 SLQKGERLLVYEYLPN-KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
+ LV EY + D+ + KE + + +F I VQ Y H+ +
Sbjct: 82 IETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKFRQIVSAVQ---YCHQKF---I 134
Query: 142 IHRDLKASNILLDDQMNPKISDFGMAR--TFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
+HRDLKA N+LLD MN KI+DFG + TFG N+L+ G+ Y +PE
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDT----FCGSPPYAAPELFQGKKY 189
Query: 200 -SMKSDVYSFGVLVLEIIS 217
+ DV+S GV++ ++S
Sbjct: 190 DGPEVDVWSLGVILYTLVS 208
>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|B Chain B, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|C Chain C, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|D Chain D, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
Length = 319
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 19/206 (9%)
Query: 19 NFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTN 75
N+ +G+G F V + +L G+E+A+K + K+ + + + E +++ L H N
Sbjct: 8 NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 76 LVRLLGCSLQKGERLLVYEYLPN-KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
+V+L + LV EY + D+ + KE + + +F I VQ Y H
Sbjct: 68 IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEK-EARAKFRQIVSAVQ---YCH 123
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR--TFGMNELEANTNRIVGTHGYMSPE 192
+ ++HRDLKA N+LLD MN KI+DFG + TFG N+L+ G+ Y +PE
Sbjct: 124 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDT----FCGSPPYAAPE 175
Query: 193 YVMNGIV-SMKSDVYSFGVLVLEIIS 217
+ DV+S GV++ ++S
Sbjct: 176 LFQGKKYDGPEVDVWSLGVILYTLVS 201
>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5-
Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide
Length = 325
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 30/223 (13%)
Query: 3 RDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAI-KRLSKSSGQGIVEF 61
RDL DF I LG G FG VYK + + +A K + S + + ++
Sbjct: 31 RDLNPEDFWEIIG---------ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY 81
Query: 62 KNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN 121
E ++A H N+V+LL + ++ E+ ++D + + + L +
Sbjct: 82 MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQV 139
Query: 122 IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA----RTFGMNELEA 177
+ + + L YLH ++IHRDLKA NIL + K++DFG++ RT
Sbjct: 140 VCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI------Q 190
Query: 178 NTNRIVGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEI 215
+ +GT +M+PE VM + K+DV+S G+ ++E+
Sbjct: 191 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233
>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
pdb|2VZ6|B Chain B, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
Length = 313
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 57/196 (29%), Positives = 99/196 (50%), Gaps = 20/196 (10%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLS--KSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
LG+G F V + K+L GQE A K ++ K S + + + EA++ L+H N+VRL
Sbjct: 30 LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
++G L+++ + L D +E + I+ I++ +L+ H+ + V+
Sbjct: 90 ISEEGHHYLIFDLVTGGEL---FEDIVAREYYSEADASHCIQQILEAVLHCHQ---MGVV 143
Query: 143 HRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANTNR---IVGTHGYMSPEYVMN 196
HRDLK N+LL ++ K++DFG+A E+E GT GY+SPE +
Sbjct: 144 HRDLKPENLLLASKLKGAAVKLADFGLA-----IEVEGEQQAWFGFAGTPGYLSPEVLRK 198
Query: 197 GIVSMKSDVYSFGVLV 212
D+++ GV++
Sbjct: 199 DPYGKPVDLWACGVIL 214
>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
pdb|1GNG|B Chain B, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
Length = 378
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26 LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
+G G FG VY+ KL D G+ +AIK++ + FKN E +++ KL H N+VRL
Sbjct: 47 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 101
Query: 84 LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
GE+ LV +Y+P S K+ L + + + L Y+H +
Sbjct: 102 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 161
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
+ HRD+K N+LLD D K+ DFG A+ E N + I + Y +PE +
Sbjct: 162 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSXICSRY-YRAPELIFG 215
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
S DV+S G ++ E++
Sbjct: 216 ATDYTSSIDVWSAGCVLAELL 236
>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|1Q5K|B Chain B, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|3I4B|A Chain A, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3I4B|B Chain B, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3L1S|A Chain A, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
pdb|3L1S|B Chain B, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
Length = 414
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26 LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
+G G FG VY+ KL D G+ +AIK++ + FKN E +++ KL H N+VRL
Sbjct: 56 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 110
Query: 84 LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
GE+ LV +Y+P S K+ L + + + L Y+H +
Sbjct: 111 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 170
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
+ HRD+K N+LLD D K+ DFG A+ E N + I + Y +PE +
Sbjct: 171 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRY-YRAPELIFG 224
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
S DV+S G ++ E++
Sbjct: 225 ATDYTSSIDVWSAGCVLAELL 245
>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Imidazopyridine Inhibitor
Length = 382
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26 LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
+G G FG VY+ KL D G+ +AIK++ + FKN E +++ KL H N+VRL
Sbjct: 40 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 94
Query: 84 LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
GE+ LV +Y+P S K+ L + + + L Y+H +
Sbjct: 95 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 154
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
+ HRD+K N+LLD D K+ DFG A+ E N + I + Y +PE +
Sbjct: 155 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSXICSRY-YRAPELIFG 208
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
S DV+S G ++ E++
Sbjct: 209 ATDYTSSIDVWSAGCVLAELL 229
>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex
pdb|3F88|B Chain B, Glycogen Synthase Kinase 3beta Inhibitor Complex
Length = 349
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26 LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
+G G FG VY+ KL D G+ +AIK++ + FKN E +++ KL H N+VRL
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 84 LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
GE+ LV +Y+P S K+ L + + + L Y+H +
Sbjct: 83 YSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
+ HRD+K N+LLD D K+ DFG A+ E N + I + Y +PE +
Sbjct: 143 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSXICSRY-YRAPELIFG 196
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
S DV+S G ++ E++
Sbjct: 197 ATDYTSSIDVWSAGCVLAELL 217
>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
pdb|2OW3|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
Length = 352
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26 LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
+G G FG VY+ KL D G+ +AIK++ + FKN E +++ KL H N+VRL
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 84 LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
GE+ LV +Y+P S K+ L + + + L Y+H +
Sbjct: 83 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
+ HRD+K N+LLD D K+ DFG A+ E N + I + Y +PE +
Sbjct: 143 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSXICSRY-YRAPELIFG 196
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
S DV+S G ++ E++
Sbjct: 197 ATDYTSSIDVWSAGCVLAELL 217
>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
pdb|4AFJ|B Chain B, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
Length = 367
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26 LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
+G G FG VY+ KL D G+ +AIK++ + FKN E +++ KL H N+VRL
Sbjct: 36 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 90
Query: 84 LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
GE+ LV +Y+P S K+ L + + + L Y+H +
Sbjct: 91 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 150
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
+ HRD+K N+LLD D K+ DFG A+ E N + I + Y +PE +
Sbjct: 151 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSXICSRY-YRAPELIFG 204
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
S DV+S G ++ E++
Sbjct: 205 ATDYTSSIDVWSAGCVLAELL 225
>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With
6-Bromoindirubin-3'-Oxime
Length = 350
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26 LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
+G G FG VY+ KL D G+ +AIK++ + FKN E +++ KL H N+VRL
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNIVRLRYFF 82
Query: 84 LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
GE+ LV +Y+P S K+ L + + + L Y+H +
Sbjct: 83 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
+ HRD+K N+LLD D K+ DFG A+ E N + I + Y +PE +
Sbjct: 143 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRY-YRAPELIFG 196
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
S DV+S G ++ E++
Sbjct: 197 ATDYTSSIDVWSAGCVLAELL 217
>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta.
pdb|1H8F|B Chain B, Glycogen Synthase Kinase 3 Beta
Length = 352
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26 LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
+G G FG VY+ KL D G+ +AIK++ + FKN E +++ KL H N+VRL
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNIVRLRYFF 82
Query: 84 LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
GE+ LV +Y+P S K+ L + + + L Y+H +
Sbjct: 83 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
+ HRD+K N+LLD D K+ DFG A+ E N + I + Y +PE +
Sbjct: 143 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRY-YRAPELIFG 196
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
S DV+S G ++ E++
Sbjct: 197 ATDYTSSIDVWSAGCVLAELL 217
>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex
Length = 353
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26 LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
+G G FG VY+ KL D G+ +AIK++ + FKN E +++ KL H N+VRL
Sbjct: 32 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 86
Query: 84 LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
GE+ LV +Y+P S K+ L + + + L Y+H +
Sbjct: 87 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 146
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
+ HRD+K N+LLD D K+ DFG A+ E N + I + Y +PE +
Sbjct: 147 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSXICSRY-YRAPELIFG 200
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
S DV+S G ++ E++
Sbjct: 201 ATDYTSSIDVWSAGCVLAELL 221
>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
pdb|3F7Z|B Chain B, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
Length = 350
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26 LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
+G G FG VY+ KL D G+ +AIK++ + FKN E +++ KL H N+VRL
Sbjct: 29 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 83
Query: 84 LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
GE+ LV +Y+P S K+ L + + + L Y+H +
Sbjct: 84 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 143
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
+ HRD+K N+LLD D K+ DFG A+ E N + I + Y +PE +
Sbjct: 144 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSXICSRY-YRAPELIFG 197
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
S DV+S G ++ E++
Sbjct: 198 ATDYTSSIDVWSAGCVLAELL 218
>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1I09|B Chain B, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1J1B|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1B|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1C|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|1J1C|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|2JLD|A Chain A, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|2JLD|B Chain B, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|3M1S|A Chain A, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3M1S|B Chain B, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3PUP|A Chain A, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
pdb|3PUP|B Chain B, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
Length = 420
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26 LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
+G G FG VY+ KL D G+ +AIK++ + FKN E +++ KL H N+VRL
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 84 LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
GE+ LV +Y+P S K+ L + + + L Y+H +
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 176
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
+ HRD+K N+LLD D K+ DFG A+ E N + I + Y +PE +
Sbjct: 177 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRY-YRAPELIFG 230
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
S DV+S G ++ E++
Sbjct: 231 ATDYTSSIDVWSAGCVLAELL 251
>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
pdb|1R0E|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
Length = 391
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26 LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
+G G FG VY+ KL D G+ +AIK++ + FKN E +++ KL H N+VRL
Sbjct: 33 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 87
Query: 84 LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
GE+ LV +Y+P S K+ L + + + L Y+H +
Sbjct: 88 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 147
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
+ HRD+K N+LLD D K+ DFG A+ E N + I + Y +PE +
Sbjct: 148 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRY-YRAPELIFG 201
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
S DV+S G ++ E++
Sbjct: 202 ATDYTSSIDVWSAGCVLAELL 222
>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb.
pdb|1MRU|B Chain B, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb
Length = 311
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 15/212 (7%)
Query: 17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQG---IVEFKNEAKLIAKLQ 72
+D + G LG GG V+ + L +++A+K L + + F+ EA+ A L
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 73 HTNLVRLLGCSLQKGER----LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ 128
H +V + + +V EY+ +L + + K+ +I Q
Sbjct: 71 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG-MNELEANTNRIVGTHG 187
L + H+ +IHRD+K +NI++ K+ DFG+AR T ++GT
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
Y+SPE V +SDVYS G ++ E+++ +
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine
Length = 353
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS---SGQGIVEFKNEAKLIAKL 71
DNF LG+G FG V ++ + G A+K L K + E ++++
Sbjct: 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 72 QHTNLVRLLGCSLQKGERLL-VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
++ + L C Q +RL V E++ L F I S + + + + RF E I+ L
Sbjct: 81 RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD--EARARFYAAE-IISAL 137
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMS 190
++LH +I+RDLK N+LLD + + K++DFGM + N + T GT Y++
Sbjct: 138 MFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV--TTATFCGTPDYIA 192
Query: 191 PEYVMNGIVSMKSDVYSFGVLVLEII 216
PE + + D ++ GVL+ E++
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEML 218
>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Benzoimidazol Inhibitor
Length = 372
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26 LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
+G G FG VY+ KL D G+ +AIK++ + FKN E +++ KL H N+VRL
Sbjct: 41 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 95
Query: 84 LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
GE+ LV +Y+P S K+ L + + + L Y+H +
Sbjct: 96 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 155
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
+ HRD+K N+LLD D K+ DFG A+ E N + I + Y +PE +
Sbjct: 156 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRY-YRAPELIFG 209
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
S DV+S G ++ E++
Sbjct: 210 ATDYTSSIDVWSAGCVLAELL 230
>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide
Length = 350
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26 LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
+G G FG VY+ KL D G+ +AIK++ + FKN E +++ KL H N+VRL
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNIVRLRYFF 82
Query: 84 LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
GE+ LV +Y+P S K+ L + + + L Y+H +
Sbjct: 83 YSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
+ HRD+K N+LLD D K+ DFG A+ E N + I + Y +PE +
Sbjct: 143 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSXICSRY-YRAPELIFG 196
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
S DV+S G ++ E++
Sbjct: 197 ATDYTSSIDVWSAGCVLAELL 217
>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Inhibitor 7d
Length = 350
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26 LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
+G G FG VY+ KL D G+ +AIK++ + FKN E +++ KL H N+VRL
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 84 LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
GE+ LV +Y+P S K+ L + + + L Y+H +
Sbjct: 83 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
+ HRD+K N+LLD D K+ DFG A+ E N + I + Y +PE +
Sbjct: 143 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSXICSRY-YRAPELIFG 196
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
S DV+S G ++ E++
Sbjct: 197 ATDYTSSIDVWSAGCVLAELL 217
>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|B Chain B, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|C Chain C, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|D Chain D, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|E Chain E, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|F Chain F, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
Length = 327
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 19/199 (9%)
Query: 26 LGQGGFGPVYKGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
+G+G F V + +L G+E+A++ + K+ + + + E +++ L H N+V+L
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 83 SLQKGERLLVYEYLPN-KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
+ LV EY + D+ + KE + + +F I VQ Y H+ +
Sbjct: 82 IETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKFRQIVSAVQ---YCHQKF---I 134
Query: 142 IHRDLKASNILLDDQMNPKISDFGMAR--TFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
+HRDLKA N+LLD MN KI+DFG + TFG N+L + G+ Y +PE
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKL----DEFCGSPPYAAPELFQGKKY 189
Query: 200 -SMKSDVYSFGVLVLEIIS 217
+ DV+S GV++ ++S
Sbjct: 190 DGPEVDVWSLGVILYTLVS 208
>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp
pdb|1PYX|B Chain B, Gsk-3 Beta Complexed With Amp-Pnp
pdb|3DU8|A Chain A, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
pdb|3DU8|B Chain B, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
Length = 422
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26 LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
+G G FG VY+ KL D G+ +AIK++ + FKN E +++ KL H N+VRL
Sbjct: 64 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 118
Query: 84 LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
GE+ LV +Y+P S K+ L + + + L Y+H +
Sbjct: 119 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 178
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
+ HRD+K N+LLD D K+ DFG A+ E N + I + Y +PE +
Sbjct: 179 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRY-YRAPELIFG 232
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
S DV+S G ++ E++
Sbjct: 233 ATDYTSSIDVWSAGCVLAELL 253
>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRK|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRM|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
pdb|3ZRM|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
Length = 371
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26 LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
+G G FG VY+ KL D G+ +AIK++ + FKN E +++ KL H N+VRL
Sbjct: 40 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 94
Query: 84 LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
GE+ LV +Y+P S K+ L + + + L Y+H +
Sbjct: 95 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 154
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
+ HRD+K N+LLD D K+ DFG A+ E N + I + Y +PE +
Sbjct: 155 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSXICSRY-YRAPELIFG 208
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
S DV+S G ++ E++
Sbjct: 209 ATDYTSSIDVWSAGCVLAELL 229
>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded
Form)
Length = 325
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 34/225 (15%)
Query: 3 RDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAI-KRLSKSSGQGIVEF 61
RDL DF I LG G FG VYK + + +A K + S + + ++
Sbjct: 31 RDLNPEDFWEIIG---------ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY 81
Query: 62 KNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN 121
E ++A H N+V+LL + ++ E+ ++D + + + L +
Sbjct: 82 MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQV 139
Query: 122 IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR 181
+ + + L YLH ++IHRDLKA NIL + K++DFG++ NT
Sbjct: 140 VCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAK--------NTRX 188
Query: 182 I------VGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEI 215
I +GT +M+PE VM + K+DV+S G+ ++E+
Sbjct: 189 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233
>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
pdb|3LMG|B Chain B, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
Length = 344
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 22/203 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQE-----IAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVRL 79
LG G FG V+KG + E + IK + SG Q + I L H ++VRL
Sbjct: 39 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 80 LGCSLQKGERL-LVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLH 134
LG L G L LV +YLP SL + + LL+W + I +G+ YL
Sbjct: 99 LG--LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGMYYLE 150
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
++ ++HR+L A N+LL +++DFG+A ++ + + +M+ E +
Sbjct: 151 EHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI 207
Query: 195 MNGIVSMKSDVYSFGVLVLEIIS 217
G + +SDV+S+GV V E+++
Sbjct: 208 HFGKYTHQSDVWSYGVTVWELMT 230
>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (
Diphosphorylated Form) Bound To 5- Amino-3-((4-(
Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide
Length = 325
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 34/225 (15%)
Query: 3 RDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAI-KRLSKSSGQGIVEF 61
RDL DF I LG G FG VYK + + +A K + S + + ++
Sbjct: 31 RDLNPEDFWEIIG---------ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY 81
Query: 62 KNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN 121
E ++A H N+V+LL + ++ E+ ++D + + + L +
Sbjct: 82 MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQV 139
Query: 122 IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR 181
+ + + L YLH ++IHRDLKA NIL + K++DFG++ NT
Sbjct: 140 VCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAK--------NTRX 188
Query: 182 I------VGTHGYMSPEYVM-----NGIVSMKSDVYSFGVLVLEI 215
I +GT +M+PE VM + K+DV+S G+ ++E+
Sbjct: 189 IQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233
>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACC|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACD|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACD|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACG|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACG|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACH|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACH|B Chain B, Gsk3b In Complex With Inhibitor
Length = 465
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26 LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
+G G FG VY+ KL D G+ +AIK++ + FKN E +++ KL H N+VRL
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 161
Query: 84 LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
GE+ LV +Y+P S K+ L + + + L Y+H +
Sbjct: 162 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 221
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
+ HRD+K N+LLD D K+ DFG A+ E N + I + Y +PE +
Sbjct: 222 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRY-YRAPELIFG 275
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
S DV+S G ++ E++
Sbjct: 276 ATDYTSSIDVWSAGCVLAELL 296
>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
pdb|1YRP|B Chain B, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
Length = 278
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 64/214 (29%), Positives = 110/214 (51%), Gaps = 26/214 (12%)
Query: 18 DNFSPGNRLGQGGFGPVYK------GKLLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIA 69
D++ G LG G F V K GK + I +RLS SS +G+ E + E ++
Sbjct: 12 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLS-SSRRGVSREEIEREVNILR 70
Query: 70 KLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
+++H N++ L K + +L+ E + L F+ ++KE L + ++ I+ G
Sbjct: 71 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDG 127
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQ--MNPKIS--DFGMARTFGMNELEANTN--RIV 183
+ YLH R+ H DLK NI+L D+ NP+I DFG+A +++EA I
Sbjct: 128 VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA-----HKIEAGNEFKNIF 179
Query: 184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
GT +++PE V + +++D++S GV+ ++S
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213
>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium
Tuberculosis
pdb|2FUM|A Chain A, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|B Chain B, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|C Chain C, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|D Chain D, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
Length = 299
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 15/212 (7%)
Query: 17 TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQG---IVEFKNEAKLIAKLQ 72
+D + G LG GG V+ + L +++A+K L + + F+ EA+ A L
Sbjct: 28 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 73 HTNLVRLLGCSLQKGER----LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ 128
H +V + + +V EY+ +L + + K+ +I Q
Sbjct: 88 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 144
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG-MNELEANTNRIVGTHG 187
L + H+ +IHRD+K +NI++ K+ DFG+AR T ++GT
Sbjct: 145 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 201
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
Y+SPE V +SDVYS G ++ E+++ +
Sbjct: 202 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 233
>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3D|B Chain B, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3W|A Chain A, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q3W|B Chain B, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q41|A Chain A, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q41|B Chain B, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q4L|A Chain A, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|1Q4L|B Chain B, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|3Q3B|A Chain A, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
pdb|3Q3B|B Chain B, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
Length = 424
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26 LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
+G G FG VY+ KL D G+ +AIK++ + FKN E +++ KL H N+VRL
Sbjct: 66 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 120
Query: 84 LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
GE+ LV +Y+P S K+ L + + + L Y+H +
Sbjct: 121 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 180
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
+ HRD+K N+LLD D K+ DFG A+ E N + I + Y +PE +
Sbjct: 181 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRY-YRAPELIFG 234
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
S DV+S G ++ E++
Sbjct: 235 ATDYTSSIDVWSAGCVLAELL 255
>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution
Length = 543
Score = 70.1 bits (170), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 18/203 (8%)
Query: 26 LGQGGFGPVYK------GKLLDGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVR 78
LG+GGFG V+ GKL +++ KRL K G QG + E K++AK+ +V
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM---VEKKILAKVHSRFIVS 249
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFIF--DSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
L K + LV + + + I+ D + + F + IV GL +LH+
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGLEHLHQR 308
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
+ +I+RDLK N+LLDD N +ISD G+A + + T GT G+M+PE ++
Sbjct: 309 N---IIYRDLKPENVLLDDDGNVRISDLGLAVE--LKAGQTKTKGYAGTPGFMAPELLLG 363
Query: 197 GIVSMKSDVYSFGVLVLEIISSK 219
D ++ GV + E+I+++
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAAR 386
>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|3SD0|B Chain B, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|4B7T|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Leucettine L4
Length = 350
Score = 70.1 bits (170), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 26 LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCS 83
+G G FG VY+ KL D G+ +AIK++ + FKN E +++ KL H N+VRL
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 84 LQKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
GE+ LV +Y+P S K+ L + + + L Y+H +
Sbjct: 83 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 138 RLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
+ HRD+K N+LLD D K+ DFG A+ E N + I + Y +PE +
Sbjct: 143 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRY-YRAPELIFG 196
Query: 197 GIVSMKS-DVYSFGVLVLEII 216
S DV+S G ++ E++
Sbjct: 197 ATDYTSSIDVWSAGCVLAELL 217
>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|B Chain B, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|C Chain C, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|D Chain D, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
Length = 543
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 18/203 (8%)
Query: 26 LGQGGFGPVYK------GKLLDGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVR 78
LG+GGFG V+ GKL +++ KRL K G QG + E K++AK+ +V
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM---VEKKILAKVHSRFIVS 249
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFIF--DSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
L K + LV + + + I+ D + + F + IV GL +LH+
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGLEHLHQR 308
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
+ +I+RDLK N+LLDD N +ISD G+A + + T GT G+M+PE ++
Sbjct: 309 N---IIYRDLKPENVLLDDDGNVRISDLGLAVE--LKAGQTKTKGYAGTPGFMAPELLLG 363
Query: 197 GIVSMKSDVYSFGVLVLEIISSK 219
D ++ GV + E+I+++
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAAR 386
>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With A Beta-Carboline Ligand
pdb|3BQR|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With An Imidazo-Pyridazine Ligand
Length = 283
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 64/214 (29%), Positives = 110/214 (51%), Gaps = 26/214 (12%)
Query: 18 DNFSPGNRLGQGGFGPVYK------GKLLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIA 69
D++ G LG G F V K GK + I +RLS SS +G+ E + E ++
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLS-SSRRGVSREEIEREVNILR 63
Query: 70 KLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
+++H N++ L K + +L+ E + L F+ ++KE L + ++ I+ G
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDG 120
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQ--MNPKIS--DFGMARTFGMNELEANT--NRIV 183
+ YLH R+ H DLK NI+L D+ NP+I DFG+A +++EA I
Sbjct: 121 VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA-----HKIEAGNEFKNIF 172
Query: 184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
GT +++PE V + +++D++S GV+ ++S
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 206
>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4X|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4Y|A Chain A, Crystal Structure Of Apo Form Of G Protein Coupled
Receptor Kinase 1 At 7.51a
pdb|3C4Y|B Chain B, Crystal Structure Of Apo Form Of G Protein Coupled
Receptor Kinase 1 At 7.51a
pdb|3C4Z|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 1.84a
pdb|3C50|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C50|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C51|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
pdb|3C51|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
Length = 543
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 18/203 (8%)
Query: 26 LGQGGFGPVYK------GKLLDGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVR 78
LG+GGFG V+ GKL +++ KRL K G QG + E K++AK+ +V
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM---VEKKILAKVHSRFIVS 249
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFIF--DSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
L K + LV + + + I+ D + + F + IV GL +LH+
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGLEHLHQR 308
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
+ +I+RDLK N+LLDD N +ISD G+A + + T GT G+M+PE ++
Sbjct: 309 N---IIYRDLKPENVLLDDDGNVRISDLGLAVE--LKAGQTKTKGYAGTPGFMAPELLLG 363
Query: 197 GIVSMKSDVYSFGVLVLEIISSK 219
D ++ GV + E+I+++
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAAR 386
>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
pdb|3KEX|B Chain B, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
Length = 325
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 22/203 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQE-----IAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVRL 79
LG G FG V+KG + E + IK + SG Q + I L H ++VRL
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 80 LGCSLQKGERL-LVYEYLPNKSLDFFIFDS----SKKELLDWKKRFNIIEGIVQGLLYLH 134
LG L G L LV +YLP SL + + LL+W + I +G+ YL
Sbjct: 81 LG--LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGMYYLE 132
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
++ ++HR+L A N+LL +++DFG+A ++ + + +M+ E +
Sbjct: 133 EHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI 189
Query: 195 MNGIVSMKSDVYSFGVLVLEIIS 217
G + +SDV+S+GV V E+++
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMT 212
>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3
pdb|3G33|C Chain C, Crystal Structure Of Cdk4CYCLIN D3
Length = 308
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 107/218 (49%), Gaps = 22/218 (10%)
Query: 16 ATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGI-----VEFKNEAKLIA 69
AT + P +G G +G VYK + G +A+K + +G G + E L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 70 KLQ---HTNLVRLLG-CSLQKGER----LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFN 121
+L+ H N+VRL+ C+ + +R LV+E++ ++ L ++ D + L + +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124
Query: 122 IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR 181
++ ++GL +LH ++HRDLK NIL+ K++DFG+AR + +
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALTP 178
Query: 182 IVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
+V T Y +PE ++ + D++S G + E+ K
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
pdb|3C4W|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
Length = 543
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 18/203 (8%)
Query: 26 LGQGGFGPVYK------GKLLDGQEIAIKRLSKSSG-QGIVEFKNEAKLIAKLQHTNLVR 78
LG+GGFG V+ GKL +++ KRL K G QG + E K++AK+ +V
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM---VEKKILAKVHSRFIVS 249
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFIF--DSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
L K + LV + + + I+ D + + F + IV GL +LH+
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGLEHLHQR 308
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
+ +I+RDLK N+LLDD N +ISD G+A + + T GT G+M+PE ++
Sbjct: 309 N---IIYRDLKPENVLLDDDGNVRISDLGLAVE--LKAGQTKTKGYAGTPGFMAPELLLG 363
Query: 197 GIVSMKSDVYSFGVLVLEIISSK 219
D ++ GV + E+I+++
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAAR 386
>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex
pdb|1PKG|B Chain B, Structure Of A C-kit Kinase Product Complex
Length = 329
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 36/228 (15%)
Query: 18 DNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAK 70
+ S G LG G FG V + K +A+K L S+ E +E K+++
Sbjct: 39 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 98
Query: 71 L-QHTNLVRLLGCSLQKGERLLVYEYLPNKSL--------DFFIFDSSKKELLDWKKRF- 120
L H N+V LLG G L++ EY L D FI + +++ +
Sbjct: 99 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 158
Query: 121 ------NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
+ + +G+ +L + IHRDL A NILL KI DFG+AR +
Sbjct: 159 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----D 210
Query: 175 LEANTNRIVGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
++ ++N +V + +M+PE + N + + +SDV+S+G+ + E+ S
Sbjct: 211 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258
>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|C Chain C, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|D Chain D, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
Length = 295
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 20/205 (9%)
Query: 17 TDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLS--KSSGQGIVEFKNEAKLIAKLQH 73
TD + +G+G F V + KL G E A K ++ K S + + + EA++ L+H
Sbjct: 3 TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 74 TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
+N+VRL ++G LV++ + L D +E + I+ I++ +L+
Sbjct: 63 SNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILEAVLHC 119
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANTNR---IVGTHG 187
H+ + V+HRDLK N+LL + K++DFG+A E++ + GT G
Sbjct: 120 HQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLA-----IEVQGDQQAWFGFAGTPG 171
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLV 212
Y+SPE + D+++ GV++
Sbjct: 172 YLSPEVLRKEAYGKPVDIWACGVIL 196
>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits
pdb|3V5W|A Chain A, Human G Protein-Coupled Receptor Kinase 2 In Complex With
Soluble Gbetagamma Subunits And Paroxetine
Length = 689
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 64/213 (30%), Positives = 107/213 (50%), Gaps = 20/213 (9%)
Query: 13 IAAATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEAKLI 68
I ++FS +G+GGFG VY + D G+ A+K L K QG NE +++
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIM 242
Query: 69 AKLQHTNLVRLLGC---SLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE 124
L T + C + ++L + + + L + + S + RF E
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAE 300
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
I+ GL ++H +R V++RDLK +NILLD+ + +ISD G+A F + A+ VG
Sbjct: 301 -IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VG 352
Query: 185 THGYMSPEYVMNGIV-SMKSDVYSFGVLVLEII 216
THGYM+PE + G+ +D +S G ++ +++
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled
Receptor Kinase 2 And Heterotrimeric G Protein Beta 1
And Gamma 2 Subunits
pdb|1YM7|A Chain A, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|B Chain B, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|C Chain C, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|D Chain D, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|2BCJ|A Chain A, Crystal Structure Of G Protein-coupled Receptor Kinase 2
In Complex With Galpha-q And Gbetagamma Subunits
pdb|3UZS|A Chain A, Structure Of The C13.28 Rna Aptamer Bound To The G
Protein-Coupled Receptor Kinase 2-Heterotrimeric G
Protein Beta 1 And Gamma 2 Subunit Complex
pdb|3UZT|A Chain A, Structure Of The C13.18 Rna Aptamer In Complex With G
Protein-Coupled Receptor Kinase 2
Length = 689
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 64/213 (30%), Positives = 107/213 (50%), Gaps = 20/213 (9%)
Query: 13 IAAATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEAKLI 68
I ++FS +G+GGFG VY + D G+ A+K L K QG NE +++
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIM 242
Query: 69 AKLQHTNLVRLLGC---SLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE 124
L T + C + ++L + + + L + + S + RF E
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAE 300
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
I+ GL ++H +R V++RDLK +NILLD+ + +ISD G+A F + A+ VG
Sbjct: 301 -IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VG 352
Query: 185 THGYMSPEYVMNGIV-SMKSDVYSFGVLVLEII 216
THGYM+PE + G+ +D +S G ++ +++
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits
pdb|3PVU|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd101)
pdb|3PVW|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd103a)
Length = 695
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 64/213 (30%), Positives = 107/213 (50%), Gaps = 20/213 (9%)
Query: 13 IAAATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEAKLI 68
I ++FS +G+GGFG VY + D G+ A+K L K QG NE +++
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIM 242
Query: 69 AKLQHTNLVRLLGC---SLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE 124
L T + C + ++L + + + L + + S + RF E
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAE 300
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
I+ GL ++H +R V++RDLK +NILLD+ + +ISD G+A F + A+ VG
Sbjct: 301 -IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VG 352
Query: 185 THGYMSPEYVMNGIV-SMKSDVYSFGVLVLEII 216
THGYM+PE + G+ +D +S G ++ +++
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Soak)
pdb|3KRX|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Co-Crystal)
Length = 688
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 64/213 (30%), Positives = 107/213 (50%), Gaps = 20/213 (9%)
Query: 13 IAAATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSS---GQGIVEFKNEAKLI 68
I ++FS +G+GGFG VY + D G+ A+K L K QG NE +++
Sbjct: 183 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIM 241
Query: 69 AKLQHTNLVRLLGC---SLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE 124
L T + C + ++L + + + L + + S + RF E
Sbjct: 242 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAE 299
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
I+ GL ++H +R V++RDLK +NILLD+ + +ISD G+A F + A+ VG
Sbjct: 300 -IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VG 351
Query: 185 THGYMSPEYVMNGIV-SMKSDVYSFGVLVLEII 216
THGYM+PE + G+ +D +S G ++ +++
Sbjct: 352 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 384
>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex
With Staurosporine
Length = 287
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 60/198 (30%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 26 LGQGGFGPVYKG--KLLDGQ-EIAIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLLG 81
LG G FG V +G ++ Q ++AIK L + + + E EA+++ +L + +VRL+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 82 CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
Q +LV E L F+ K+E + ++ + G+ YL + +
Sbjct: 78 VC-QAEALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEKN---F 131
Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH--GYMSPEYVMNGIV 199
+HRDL A N+LL ++ KISDFG+++ G ++ T R G + +PE +
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINFRKF 190
Query: 200 SMKSDVYSFGVLVLEIIS 217
S +SDV+S+GV + E +S
Sbjct: 191 SSRSDVWSYGVTMWEALS 208
>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C-kit Tyrosine Kinase
Length = 313
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 36/228 (15%)
Query: 18 DNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAK 70
+ S G LG G FG V + K +A+K L S+ E +E K+++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 71 L-QHTNLVRLLGCSLQKGERLLVYEYLPNKSL--------DFFIFDSSKKELLDWKKRF- 120
L H N+V LLG G L++ EY L D FI + +++ +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 121 ------NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
+ + +G+ +L + IHRDL A NILL KI DFG+AR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----D 194
Query: 175 LEANTNRIVGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
++ ++N +V + +M+PE + N + + +SDV+S+G+ + E+ S
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
LG+G +G V + + +A+K + E K E + L H N+V+ G
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
+ + L EY L FD + ++ D ++ F+ ++ G++YLH +
Sbjct: 74 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 123
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
+ HRD+K N+LLD++ N KISDFG+A F N E N++ GT Y++PE +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
+ DV+S G+++ +++ +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGE 204
>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1)
Catalytic Domain
Length = 317
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 64/233 (27%), Positives = 102/233 (43%), Gaps = 26/233 (11%)
Query: 23 GNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVR 78
G LG+GGF Y+ +D +E+ A K + KS + E + L + ++V
Sbjct: 47 GRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVG 106
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSR 138
G +V E +SL +K + + + R+ + +QG+ YLH
Sbjct: 107 FHGFFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARY-FMRQTIQGVQYLHNN-- 161
Query: 139 LRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGI 198
RVIHRDLK N+ L+D M+ KI DFG+A + T + GT Y++PE +
Sbjct: 162 -RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT--LCGTPNYIAPEVLCKKG 218
Query: 199 VSMKSDVYSFGVLVLEIISSKK--NNGC------------YDTERHLNLVGYA 237
S + D++S G ++ ++ K C Y RH+N V A
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASA 271
>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
pdb|1Y8G|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
Length = 327
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 17/198 (8%)
Query: 26 LGQGGFGPVYKGK-LLDGQEIAIKRLSKS--SGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
+G+G F V + +L G+E+A+K + K+ + + + E ++ L H N+V+L
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 83 SLQKGERLLVYEYLPN-KSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
+ LV EY + D+ + KE + + +F I VQ Y H+ +
Sbjct: 82 IETEKTLYLVXEYASGGEVFDYLVAHGRXKEK-EARAKFRQIVSAVQ---YCHQKF---I 134
Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGM-NELEANTNRIVGTHGYMSPE-YVMNGIV 199
+HRDLKA N+LLD N KI+DFG + F N+L+A G Y +PE +
Sbjct: 135 VHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA----FCGAPPYAAPELFQGKKYD 190
Query: 200 SMKSDVYSFGVLVLEIIS 217
+ DV+S GV++ ++S
Sbjct: 191 GPEVDVWSLGVILYTLVS 208
>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib
Length = 336
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 36/228 (15%)
Query: 18 DNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAK 70
+ S G LG G FG V + K +A+K L S+ E +E K+++
Sbjct: 46 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 71 L-QHTNLVRLLGCSLQKGERLLVYEYLPNKSL--------DFFIFDSSKKELLDWKKRF- 120
L H N+V LLG G L++ EY L D FI + +++ +
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 121 ------NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
+ + +G+ +L + IHRDL A NILL KI DFG+AR +
Sbjct: 166 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----D 217
Query: 175 LEANTNRIVGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
++ ++N +V + +M+PE + N + + +SDV+S+G+ + E+ S
Sbjct: 218 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265
>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C- Kit Tyrosine Kinase
Length = 331
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 36/228 (15%)
Query: 18 DNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAK 70
+ S G LG G FG V + K +A+K L S+ E +E K+++
Sbjct: 41 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 100
Query: 71 L-QHTNLVRLLGCSLQKGERLLVYEYLPNKSL--------DFFIFDSSKKELLDWKKRF- 120
L H N+V LLG G L++ EY L D FI + +++ +
Sbjct: 101 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 160
Query: 121 ------NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
+ + +G+ +L + IHRDL A NILL KI DFG+AR +
Sbjct: 161 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----D 212
Query: 175 LEANTNRIVGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
++ ++N +V + +M+PE + N + + +SDV+S+G+ + E+ S
Sbjct: 213 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260
>pdb|3SOA|A Chain A, Full-Length Human Camkii
Length = 444
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 12 TIAAATDNFSPGNRLGQGGFGPVYKG-KLLDGQEIA--IKRLSKSSGQGIVEFKNEAKLI 68
T T+ + LG+G F V + K+L GQE A I K S + + + EA++
Sbjct: 5 TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARIC 64
Query: 69 AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ 128
L+H N+VRL ++G L+++ + L D +E + I+ I++
Sbjct: 65 RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL---FEDIVAREYYSEADASHCIQQILE 121
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANTNR---I 182
+L+ H+ + V+HR+LK N+LL ++ K++DFG+A E+E
Sbjct: 122 AVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLA-----IEVEGEQQAWFGF 173
Query: 183 VGTHGYMSPEYVMNGIVSMKSDVYSFGVLV 212
GT GY+SPE + D+++ GV++
Sbjct: 174 AGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|2P0C|B Chain B, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|3BRB|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BRB|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BPR|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|C Chain C, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|D Chain D, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3TCP|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
pdb|3TCP|B Chain B, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
Length = 313
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 56/209 (26%), Positives = 102/209 (48%), Gaps = 17/209 (8%)
Query: 23 GNRLGQGGFGPVYKGKLL--DGQ--EIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTNL 76
G LG+G FG V +G L DG ++A+K +L SS + I EF +EA + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 77 VRLLGCSLQKGER-----LLVYEYLPNKSLDFFIFDS---SKKELLDWKKRFNIIEGIVQ 128
+RLLG ++ + +++ ++ L ++ S + + + + + I
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
G+ YL S +HRDL A N +L D M ++DFG+++ + +
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 189 MSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
++ E + + + + KSDV++FGV + EI +
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIAT 244
>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994
pdb|2YWP|A Chain A, Crystal Structure Of Chk1 With A Urea Inhibitor
pdb|2E9N|A Chain A, Structure Of H-chk1 Complexed With A767085
pdb|2E9O|A Chain A, Structure Of H-Chk1 Complexed With Aa582939
pdb|2E9P|A Chain A, Structure Of H-Chk1 Complexed With A771129
pdb|2E9U|A Chain A, Structure Of H-Chk1 Complexed With A780125
Length = 269
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
LG+G +G V + + +A+K + E K E + L H N+V+ G
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
+ + L EY L FD + ++ D ++ F+ ++ G++YLH +
Sbjct: 74 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 123
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
+ HRD+K N+LLD++ N KISDFG+A F N E N++ GT Y++PE +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
+ DV+S G+++ +++ +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGE 204
>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 76/273 (27%), Positives = 116/273 (42%), Gaps = 38/273 (13%)
Query: 24 NRLGQGGFGPVYKGKL--LDGQ--EIAIKRLSK---SSGQGIVEFKNEAKLIAKLQHTNL 76
+LG G FG V +G+ G+ +A+K L S + + +F E + L H NL
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 77 VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
+RL G L ++ V E P SL + LL R+ + + +G+ YL
Sbjct: 84 IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 140
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH-----GYMSP 191
R IHRDL A N+LL + KI DFG+ R N + + ++ H + +P
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN----DDHXVMQEHRKVPFAWCAP 193
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID 251
E + S SD + FGV + E+ + Y E + L N + L ID
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGL--------NGSQILHKID 238
Query: 252 TTLHESCSPDEVTRCIH-VGLLCVQDKATDRPT 283
P++ + I+ V + C K DRPT
Sbjct: 239 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 271
>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017
pdb|2E9V|B Chain B, Structure Of H-Chk1 Complexed With A859017
Length = 268
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
LG+G +G V + + +A+K + E K E + L H N+V+ G
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
+ + L EY L FD + ++ D ++ F+ ++ G++YLH +
Sbjct: 74 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 123
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
+ HRD+K N+LLD++ N KISDFG+A F N E N++ GT Y++PE +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
+ DV+S G+++ +++ +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGE 204
>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor
pdb|4EWH|A Chain A, Co-Crystal Structure Of Ack1 With Inhibitor
Length = 275
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 76/273 (27%), Positives = 116/273 (42%), Gaps = 38/273 (13%)
Query: 24 NRLGQGGFGPVYKGKL--LDGQ--EIAIKRLSK---SSGQGIVEFKNEAKLIAKLQHTNL 76
+LG G FG V +G+ G+ +A+K L S + + +F E + L H NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 77 VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
+RL G L ++ V E P SL + LL R+ + + +G+ YL
Sbjct: 74 IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH-----GYMSP 191
R IHRDL A N+LL + KI DFG+ R N + + ++ H + +P
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN----DDHXVMQEHRKVPFAWCAP 183
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID 251
E + S SD + FGV + E+ + Y E + L N + L ID
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGL--------NGSQILHKID 228
Query: 252 TTLHESCSPDEVTRCIH-VGLLCVQDKATDRPT 283
P++ + I+ V + C K DRPT
Sbjct: 229 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 261
>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor
Length = 269
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
LG+G +G V + + +A+K + E K E + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
+ + L EY L FD + ++ D ++ F+ ++ G++YLH +
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 124
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
+ HRD+K N+LLD++ N KISDFG+A F N E N++ GT Y++PE +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
+ DV+S G+++ +++ +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGE 205
>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
LG+G +G V + + +A+K + E K E + L H N+V+ G
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
+ + L EY L FD + ++ D ++ F+ ++ G++YLH +
Sbjct: 74 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 123
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
+ HRD+K N+LLD++ N KISDFG+A F N E N++ GT Y++PE +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
+ DV+S G+++ +++ +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGE 204
>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
pdb|3G0F|B Chain B, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
Length = 336
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 36/228 (15%)
Query: 18 DNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAK 70
+ S G LG G FG V + K +A+K L S+ E +E K+++
Sbjct: 46 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 71 L-QHTNLVRLLGCSLQKGERLLVYEYLPNKSL--------DFFIFDSSKKELLDWKKRF- 120
L H N+V LLG G L++ EY L D FI + +++ +
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 121 ------NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
+ + +G+ +L + IHRDL A NILL KI DFG+AR
Sbjct: 166 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----H 217
Query: 175 LEANTNRIVGTHG-----YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
++ ++N +V + +M+PE + N + + +SDV+S+G+ + E+ S
Sbjct: 218 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265
>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
pdb|2YDJ|B Chain B, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
LG+G +G V + + +A+K + E K E + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
+ + L EY L FD + ++ D ++ F+ ++ G++YLH +
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 124
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
+ HRD+K N+LLD++ N KISDFG+A F N E N++ GT Y++PE +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 184
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
+ DV+S G+++ +++ +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGE 205
>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1
Length = 278
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
LG+G +G V + + +A+K + E K E + L H N+V+ G
Sbjct: 13 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
+ + L EY L FD + ++ D ++ F+ ++ G++YLH +
Sbjct: 73 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 122
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
+ HRD+K N+LLD++ N KISDFG+A F N E N++ GT Y++PE +
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
+ DV+S G+++ +++ +
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGE 203
>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1
pdb|4FSQ|A Chain A, Crystal Structure Of The Chk1
pdb|4FSR|A Chain A, Crystal Structure Of The Chk1
pdb|4FT0|A Chain A, Crystal Structure Of The Chk1
pdb|4FT5|A Chain A, Crystal Structure Of The Chk1
pdb|4FT7|A Chain A, Crystal Structure Of The Chk1
pdb|4FT9|A Chain A, Crystal Structure Of The Chk1
pdb|4FTI|A Chain A, Crystal Structure Of The Chk1
pdb|4FTJ|A Chain A, Crystal Structure Of The Chk1
pdb|4FTK|A Chain A, Crystal Structure Of The Chk1
pdb|4FTL|A Chain A, Crystal Structure Of The Chk1
pdb|4FTM|A Chain A, Crystal Structure Of The Chk1
pdb|4FTO|A Chain A, Crystal Structure Of The Chk1
pdb|4FTR|A Chain A, Crystal Structure Of The Chk1
pdb|4FTT|A Chain A, Crystal Structure Of The Chk1
pdb|4FTU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
LG+G +G V + + +A+K + E K E + L H N+V+ G
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
+ + L EY L FD + ++ D ++ F+ ++ G++YLH +
Sbjct: 74 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 123
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
+ HRD+K N+LLD++ N KISDFG+A F N E N++ GT Y++PE +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
+ DV+S G+++ +++ +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGE 204
>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain
pdb|4HZR|B Chain B, Crystal Structure Of Ack1 Kinase Domain
Length = 277
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 76/273 (27%), Positives = 116/273 (42%), Gaps = 38/273 (13%)
Query: 24 NRLGQGGFGPVYKGKL--LDGQ--EIAIKRLSK---SSGQGIVEFKNEAKLIAKLQHTNL 76
+LG G FG V +G+ G+ +A+K L S + + +F E + L H NL
Sbjct: 18 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 77 VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
+RL G L ++ V E P SL + LL R+ + + +G+ YL
Sbjct: 78 IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 134
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH-----GYMSP 191
R IHRDL A N+LL + KI DFG+ R N + + ++ H + +P
Sbjct: 135 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN----DDHYVMQEHRKVPFAWCAP 187
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID 251
E + S SD + FGV + E+ + Y E + L N + L ID
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGL--------NGSQILHKID 232
Query: 252 TTLHESCSPDEVTRCIH-VGLLCVQDKATDRPT 283
P++ + I+ V + C K DRPT
Sbjct: 233 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 265
>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U46|B Chain B, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U4D|A Chain A, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U4D|B Chain B, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U54|B Chain B, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 76/273 (27%), Positives = 116/273 (42%), Gaps = 38/273 (13%)
Query: 24 NRLGQGGFGPVYKGKL--LDGQ--EIAIKRLSK---SSGQGIVEFKNEAKLIAKLQHTNL 76
+LG G FG V +G+ G+ +A+K L S + + +F E + L H NL
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 77 VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
+RL G L ++ V E P SL + LL R+ + + +G+ YL
Sbjct: 84 IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 140
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH-----GYMSP 191
R IHRDL A N+LL + KI DFG+ R N + + ++ H + +P
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN----DDHYVMQEHRKVPFAWCAP 193
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID 251
E + S SD + FGV + E+ + Y E + L N + L ID
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGL--------NGSQILHKID 238
Query: 252 TTLHESCSPDEVTRCIH-VGLLCVQDKATDRPT 283
P++ + I+ V + C K DRPT
Sbjct: 239 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 271
>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain.
pdb|3DB8|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 041
pdb|3DBC|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 257
pdb|3DBD|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 094
Length = 317
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 65/236 (27%), Positives = 105/236 (44%), Gaps = 32/236 (13%)
Query: 23 GNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVR 78
G LG+GGF Y+ +D +E+ A K + KS + E + L + ++V
Sbjct: 47 GRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVG 106
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSR 138
G +V E +SL +K + + + R+ + +QG+ YLH
Sbjct: 107 FHGFFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARY-FMRQTIQGVQYLHNN-- 161
Query: 139 LRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR---IVGTHGYMSPEYVM 195
RVIHRDLK N+ L+D M+ KI DFG+A ++E + R + GT Y++PE +
Sbjct: 162 -RVIHRDLKLGNLFLNDDMDVKIGDFGLA-----TKIEFDGERKKDLCGTPNYIAPEVLC 215
Query: 196 NGIVSMKSDVYSFGVLVLEIISSKK--NNGC------------YDTERHLNLVGYA 237
S + D++S G ++ ++ K C Y RH+N V A
Sbjct: 216 KKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASA 271
>pdb|2BFX|A Chain A, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2BFX|B Chain B, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2VGP|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGP|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGO|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|2VGO|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|3ZTX|A Chain A, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen.
pdb|3ZTX|B Chain B, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen
Length = 284
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 60/222 (27%), Positives = 103/222 (46%), Gaps = 15/222 (6%)
Query: 18 DNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSS--GQGIV-EFKNEAKLIAKLQH 73
D+F G LG+G FG VY + + I A+K L KS +G+ + + E ++ + L+H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 74 TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
N++R+ + L+ E+ P L + K D ++ +E + L Y
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGEL---YKELQKHGRFDEQRSATFMEELADALHYC 130
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
H+ +VIHRD+K N+L+ + KI+DFG + ++ + GT Y+ PE
Sbjct: 131 HER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPPEM 183
Query: 194 VMNGIVSMKSDVYSFGVLVLE-IISSKKNNGCYDTERHLNLV 234
+ K D++ GVL E ++ + TE H +V
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV 225
>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YER|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YEX|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YDK|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
LG+G +G V + + +A+K + E K E + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
+ + L EY L FD + ++ D ++ F+ ++ G++YLH +
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 124
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
+ HRD+K N+LLD++ N KISDFG+A F N E N++ GT Y++PE +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
+ DV+S G+++ +++ +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGE 205
>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
pdb|3JVS|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
Length = 271
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
LG+G +G V + + +A+K + E K E + L H N+V+ G
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
+ + L EY L FD + ++ D ++ F+ ++ G++YLH +
Sbjct: 74 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 123
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
+ HRD+K N+LLD++ N KISDFG+A F N E N++ GT Y++PE +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
+ DV+S G+++ +++ +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGE 204
>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
pdb|2J90|B Chain B, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
Length = 304
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 65/221 (29%), Positives = 114/221 (51%), Gaps = 26/221 (11%)
Query: 10 FQTIAAATDNFSPGNRLGQGGFGPVYKGKLL-DGQEIAIKRLSK----SSGQGIV--EFK 62
FQ++ D++ G LG G F V K + G+E A K + K SS +G+ E +
Sbjct: 20 FQSMVE--DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIE 77
Query: 63 NEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNI 122
E ++ +++H N++ L K + +L+ E + L F+ ++KE L +
Sbjct: 78 REVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQF 134
Query: 123 IEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQM--NPKIS--DFGMARTFGMNELEAN 178
++ I+ G+ YLH R+ H DLK NI+L D+ NP+I DFG+A +++EA
Sbjct: 135 LKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA-----HKIEAG 186
Query: 179 T--NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
I GT +++PE V + +++D++S GV+ ++S
Sbjct: 187 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 227
>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1
(Plk1) Catalytic Domain In Complex With Adp
Length = 317
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 65/236 (27%), Positives = 105/236 (44%), Gaps = 32/236 (13%)
Query: 23 GNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVR 78
G LG+GGF Y+ +D +E+ A K + KS + E + L + ++V
Sbjct: 47 GRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVG 106
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSR 138
G +V E +SL +K + + + R+ + +QG+ YLH
Sbjct: 107 FHGFFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARY-FMRQTIQGVQYLHNN-- 161
Query: 139 LRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR---IVGTHGYMSPEYVM 195
RVIHRDLK N+ L+D M+ KI DFG+A ++E + R + GT Y++PE +
Sbjct: 162 -RVIHRDLKLGNLFLNDDMDVKIGDFGLA-----TKIEFDGERKKXLCGTPNYIAPEVLC 215
Query: 196 NGIVSMKSDVYSFGVLVLEIISSKK--NNGC------------YDTERHLNLVGYA 237
S + D++S G ++ ++ K C Y RH+N V A
Sbjct: 216 KKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASA 271
>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439
pdb|2VRX|B Chain B, Structure Of Aurora B Kinase In Complex With Zm447439
Length = 285
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 60/222 (27%), Positives = 103/222 (46%), Gaps = 15/222 (6%)
Query: 18 DNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSS--GQGIV-EFKNEAKLIAKLQH 73
D+F G LG+G FG VY + + I A+K L KS +G+ + + E ++ + L+H
Sbjct: 15 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 74 TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
N++R+ + L+ E+ P L + K D ++ +E + L Y
Sbjct: 75 PNILRMYNYFHDRKRIYLMLEFAPRGEL---YKELQKHGRFDEQRSATFMEELADALHYC 131
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
H+ +VIHRD+K N+L+ + KI+DFG + ++ + GT Y+ PE
Sbjct: 132 HER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPPEM 184
Query: 194 VMNGIVSMKSDVYSFGVLVLE-IISSKKNNGCYDTERHLNLV 234
+ K D++ GVL E ++ + TE H +V
Sbjct: 185 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV 226
>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95
pdb|3EQP|A Chain A, Crystal Structure Of Ack1 With Compound T95
pdb|3EQR|A Chain A, Crystal Structure Of Ack1 With Compound T74
pdb|3EQR|B Chain B, Crystal Structure Of Ack1 With Compound T74
Length = 276
Score = 68.9 bits (167), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 76/273 (27%), Positives = 116/273 (42%), Gaps = 38/273 (13%)
Query: 24 NRLGQGGFGPVYKGKL--LDGQ--EIAIKRLSK---SSGQGIVEFKNEAKLIAKLQHTNL 76
+LG G FG V +G+ G+ +A+K L S + + +F E + L H NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 77 VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
+RL G L ++ V E P SL + LL R+ + + +G+ YL
Sbjct: 74 IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH-----GYMSP 191
R IHRDL A N+LL + KI DFG+ R N + + ++ H + +P
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN----DDHYVMQEHRKVPFAWCAP 183
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID 251
E + S SD + FGV + E+ + Y E + L N + L ID
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGL--------NGSQILHKID 228
Query: 252 TTLHESCSPDEVTRCIH-VGLLCVQDKATDRPT 283
P++ + I+ V + C K DRPT
Sbjct: 229 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 261
>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human
Chk1 Kinase Domain
pdb|3OT8|A Chain A, X-Ray Crystal Structure Of Compound 17r Bound To Human
Chk1 Kinase Domain
pdb|3PA3|A Chain A, X-Ray Crystal Structure Of Compound 70 Bound To Human Chk1
Kinase Domain
pdb|3PA4|A Chain A, X-Ray Crystal Structure Of Compound 2a Bound To Human Chk1
Kinase Domain
pdb|3PA5|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
pdb|3U9N|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
Length = 273
Score = 68.9 bits (167), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
LG+G +G V + + +A+K + E K E + L H N+V+ G
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
+ + L EY L FD + ++ D ++ F+ ++ G++YLH +
Sbjct: 74 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 123
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
+ HRD+K N+LLD++ N KISDFG+A F N E N++ GT Y++PE +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
+ DV+S G+++ +++ +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGE 204
>pdb|4FST|A Chain A, Crystal Structure Of The Chk1
Length = 269
Score = 68.9 bits (167), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
LG+G +G V + + +A+K + E K E + L H N+V+ G
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
+ + L EY L FD + ++ D ++ F+ ++ G++YLH +
Sbjct: 74 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 123
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
+ HRD+K N+LLD++ N KISDFG+A F N E N++ GT Y++PE +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
+ DV+S G+++ +++ +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGE 204
>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor
Cis-3-[8-amino-1-(4-
Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol
Length = 273
Score = 68.9 bits (167), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 76/273 (27%), Positives = 116/273 (42%), Gaps = 38/273 (13%)
Query: 24 NRLGQGGFGPVYKGKL--LDGQ--EIAIKRLSK---SSGQGIVEFKNEAKLIAKLQHTNL 76
+LG G FG V +G+ G+ +A+K L S + + +F E + L H NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 77 VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
+RL G L ++ V E P SL + LL R+ + + +G+ YL
Sbjct: 74 IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTH-----GYMSP 191
R IHRDL A N+LL + KI DFG+ R N + + ++ H + +P
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN----DDHYVMQEHRKVPFAWCAP 183
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELID 251
E + S SD + FGV + E+ + Y E + L N + L ID
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGL--------NGSQILHKID 228
Query: 252 TTLHESCSPDEVTRCIH-VGLLCVQDKATDRPT 283
P++ + I+ V + C K DRPT
Sbjct: 229 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 261
>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 902
pdb|3D5X|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Wortmannin.
pdb|3DBE|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 557
pdb|3DBF|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 562
Length = 301
Score = 68.9 bits (167), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 65/236 (27%), Positives = 105/236 (44%), Gaps = 32/236 (13%)
Query: 23 GNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVR 78
G LG+GGF Y+ +D +E+ A K + KS + E + L + ++V
Sbjct: 31 GRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVG 90
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSR 138
G +V E +SL +K + + + R+ + +QG+ YLH
Sbjct: 91 FHGFFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARY-FMRQTIQGVQYLHNN-- 145
Query: 139 LRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR---IVGTHGYMSPEYVM 195
RVIHRDLK N+ L+D M+ KI DFG+A ++E + R + GT Y++PE +
Sbjct: 146 -RVIHRDLKLGNLFLNDDMDVKIGDFGLA-----TKIEFDGERKKDLCGTPNYIAPEVLC 199
Query: 196 NGIVSMKSDVYSFGVLVLEIISSKK--NNGC------------YDTERHLNLVGYA 237
S + D++S G ++ ++ K C Y RH+N V A
Sbjct: 200 KKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASA 255
>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRB|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRG|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRH|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRM|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRN|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRO|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2C3J|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3K|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3L|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2CGU|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGV|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGW|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGX|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|3NLB|A Chain A, Novel Kinase Profile Highlights The Temporal Basis Of
Context Dependent Checkpoint Pathways To Cell Death
Length = 297
Score = 68.9 bits (167), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
LG+G +G V + + +A+K + E K E + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
+ + L EY L FD + ++ D ++ F+ ++ G++YLH +
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 124
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
+ HRD+K N+LLD++ N KISDFG+A F N E N++ GT Y++PE +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
+ DV+S G+++ +++ +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGE 205
>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint
Kinase Chk1
pdb|1NVQ|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1UCN-01
pdb|1NVR|A Chain A, The Complex Structure Of Checkpoint Kinase
Chk1STAUROSPORINE
pdb|1NVS|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1SB218078
pdb|2WMQ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMR|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMS|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMT|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMU|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMV|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMX|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMW|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEY|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XF0|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEZ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2X8D|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2X8I|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YM3|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM4|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM5|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM6|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM7|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM8|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YDI|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 289
Score = 68.9 bits (167), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
LG+G +G V + + +A+K + E K E + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
+ + L EY L FD + ++ D ++ F+ ++ G++YLH +
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 124
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
+ HRD+K N+LLD++ N KISDFG+A F N E N++ GT Y++PE +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
+ DV+S G+++ +++ +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGE 205
>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine
Analog
pdb|2GDO|A Chain A, 4-(aminoalkylamino)-3-benzimidazole-quinolinones As Potent
Chk1 Inhibitors
Length = 295
Score = 68.9 bits (167), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
LG+G +G V + + +A+K + E K E + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
+ + L EY L FD + ++ D ++ F+ ++ G++YLH +
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 124
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
+ HRD+K N+LLD++ N KISDFG+A F N E N++ GT Y++PE +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
+ DV+S G+++ +++ +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGE 205
>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1
pdb|4FTA|A Chain A, Crystal Structure Of The Chk1
pdb|4FTC|A Chain A, Crystal Structure Of The Chk1
pdb|4FTN|A Chain A, Crystal Structure Of The Chk1
pdb|4FTQ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 68.9 bits (167), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
LG+G +G V + + +A+K + E K E + L H N+V+ G
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
+ + L EY L FD + ++ D ++ F+ ++ G++YLH +
Sbjct: 74 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 123
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
+ HRD+K N+LLD++ N KISDFG+A F N E N++ GT Y++PE +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
+ DV+S G+++ +++ +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGE 204
>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70
Length = 613
Score = 68.9 bits (167), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 59/198 (29%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 26 LGQGGFGPVYKG--KLLDGQ-EIAIKRLSKSSGQG-IVEFKNEAKLIAKLQHTNLVRLLG 81
LG G FG V +G ++ Q ++AIK L + + + E EA+++ +L + +VRL+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 82 CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
Q +LV E L F+ K+E + ++ + G+ YL + +
Sbjct: 404 VC-QAEALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEKN---F 457
Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG--YMSPEYVMNGIV 199
+HR+L A N+LL ++ KISDFG+++ G ++ T R G + +PE +
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINFRKF 516
Query: 200 SMKSDVYSFGVLVLEIIS 217
S +SDV+S+GV + E +S
Sbjct: 517 SSRSDVWSYGVTMWEALS 534
>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54
pdb|2QHM|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2a
pdb|2QHN|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1a
pdb|3TKH|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S01
pdb|3TKI|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S25
Length = 323
Score = 68.6 bits (166), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
LG+G +G V + + +A+K + E K E + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
+ + L EY L FD + ++ D ++ F+ ++ G++YLH +
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 124
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
+ HRD+K N+LLD++ N KISDFG+A F N E N++ GT Y++PE +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
+ DV+S G+++ +++ +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGE 205
>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20
pdb|2HXL|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1
pdb|2HXQ|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2
pdb|2HY0|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 22
pdb|3F9N|A Chain A, Crystal Structure Of Chk1 Kinase In Complex With Inhibitor
38
Length = 322
Score = 68.6 bits (166), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
LG+G +G V + + +A+K + E K E + L H N+V+ G
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
+ + L EY L FD + ++ D ++ F+ ++ G++YLH +
Sbjct: 74 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 123
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
+ HRD+K N+LLD++ N KISDFG+A F N E N++ GT Y++PE +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
+ DV+S G+++ +++ +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGE 204
>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment
pdb|3H4J|A Chain A, Crystal Structure Of Pombe Ampk Kdaid Fragment
Length = 336
Score = 68.6 bits (166), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 54/197 (27%), Positives = 99/197 (50%), Gaps = 25/197 (12%)
Query: 26 LGQGGFGPV-----YKGKLLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLV 77
LG+G FG V YK + Q++A+K +S+ + + E + L+H +++
Sbjct: 17 LGEGSFGKVKLATHYKTQ----QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 78 RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
+L + ++V EY + D+ + K+ D +RF + I+ + Y H++
Sbjct: 73 KLYDVITTPTDIVMVIEYAGGELFDYIV--EKKRMTEDEGRRF--FQQIICAIEYCHRH- 127
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG 197
+++HRDLK N+LLDD +N KI+DFG++ + G+ Y +PE V+NG
Sbjct: 128 --KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS---CGSPNYAAPE-VING 181
Query: 198 --IVSMKSDVYSFGVLV 212
+ DV+S G+++
Sbjct: 182 KLYAGPEVDVWSCGIVL 198
>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native
pdb|3MFS|A Chain A, Cask-4m Cam Kinase Domain, Amppnp
pdb|3MFT|A Chain A, Cask-4m Cam Kinase Domain, Mn2+
pdb|3MFU|A Chain A, Cask-4m Cam Kinase Domain, Amppnp-Mn2+
Length = 351
Score = 68.6 bits (166), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 62/219 (28%), Positives = 101/219 (46%), Gaps = 23/219 (10%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIK-----RLSKSSGQGIVEFKNEAKLIAKLQHTNLVRL 79
+G+G F V + GQ+ A+K + + S G + K EA + L+H ++V L
Sbjct: 32 IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 80 LGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKK-RFNIIEGIVQGLLYLHKYSR 138
L G +V+E++ L F I + + + + + I++ L Y H +
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN- 150
Query: 139 LRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
+IHRD+K N+LL + N K+ DFG+A G + L A VGT +M+PE V
Sbjct: 151 --IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGR--VGTPHFMAPEVVK 206
Query: 196 NGIVSMKSDVYSFGVLVLEIISSKKNNGC---YDTERHL 231
DV+ GV++ ++S GC Y T+ L
Sbjct: 207 REPYGKPVDVWGCGVILFILLS-----GCLPFYGTKERL 240
>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1
pdb|4GH2|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 68.6 bits (166), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
LG+G +G V + + +A+K + E K E + L H N+V+ G
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
+ + L EY L FD + ++ D ++ F+ ++ G++YLH +
Sbjct: 74 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 123
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
+ HRD+K N+LLD++ N KISDFG+A F N E N++ GT Y++PE +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
+ DV+S G+++ +++ +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGE 204
>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38)
Length = 360
Score = 68.2 bits (165), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 26 NLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAGFVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone
Morp Protein Receptor Type-1b (Bmpr1b) In Complex With
Fkbp12 An 193189
pdb|3MDY|C Chain C, Crystal Structure Of The Cytoplasmic Domain Of The Bone
Morp Protein Receptor Type-1b (Bmpr1b) In Complex With
Fkbp12 An 193189
Length = 337
Score = 68.2 bits (165), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 23/209 (11%)
Query: 24 NRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
++G+G +G V+ GK G+++A+K + + E ++H N++ +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFR-ETEIYQTVLMRHENILGFIAAD 100
Query: 84 LQKG----ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK---- 135
++ + L+ +Y N SL +D K LD K + V GL +LH
Sbjct: 101 IKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 136 -YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF--GMNELEANTNRIVGTHGYMSPE 192
+ + HRDLK+ NIL+ I+D G+A F NE++ N VGT YM PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 193 YVMNGI------VSMKSDVYSFGVLVLEI 215
+ + + +D+YSFG+++ E+
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEV 245
>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Nuclear Substrate Mef2a
pdb|1LEZ|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Activator Mkk3b
Length = 360
Score = 68.2 bits (165), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 26 NLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With
Inhibitor Pg-892579
pdb|2GTN|A Chain A, Mutated Map Kinase P38 (mus Musculus) In Complex With
Inhbitor Pg-951717
Length = 348
Score = 68.2 bits (165), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 22 NLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 77
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 133
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 134 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 185
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain
In Complex With A Monocyclic Pyrazolone Inhibitor
Length = 360
Score = 68.2 bits (165), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 26 NLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAGFVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2OZA|B Chain B, Structure Of P38alpha Complex
pdb|3P78|A Chain A, P38 Inhibitor-Bound
pdb|3P79|A Chain A, P38 Inhibitor-Bound
pdb|3P7A|A Chain A, P38 Inhibitor-Bound
pdb|3P7B|A Chain A, P38 Inhibitor-Bound
pdb|3P7C|A Chain A, P38 Inhibitor-Bound
pdb|3P5K|A Chain A, P38 Inhibitor-Bound
Length = 366
Score = 68.2 bits (165), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 32 NLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 87
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 88 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 143
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 144 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 195
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With
Inhibitor Pg-874743
pdb|2GHM|A Chain A, Mutated Map Kinase P38 (Mus Musculus) In Complex With
Inhbitor Pg-895449
Length = 348
Score = 68.2 bits (165), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 22 NLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 77
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 133
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 134 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAGFVATRWYR 185
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk
Docking Partner
Length = 380
Score = 67.8 bits (164), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 46 NLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 101
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 157
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 158 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 209
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240
>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase
Length = 360
Score = 67.8 bits (164), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 26 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 190 APEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With
Ind E804
Length = 324
Score = 67.8 bits (164), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 24 NRLGQGGFGPVYKGK-LLDGQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLL 80
++LG+G + VYKGK L +A+K RL G + E L+ L+H N+V L
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 66
Query: 81 GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
+ LV+EYL +K L ++ D + K F + +++GL Y H R +
Sbjct: 67 DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLF--LFQLLRGLAYCH---RQK 120
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGI-V 199
V+HRDLK N+L++++ K++DFG+AR + + N +V T Y P+ ++
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYDNEVV-TLWYRPPDILLGSTDY 178
Query: 200 SMKSDVYSFGVLVLEIISSK 219
S + D++ G + E+ + +
Sbjct: 179 STQIDMWGVGCIFYEMATGR 198
>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655
pdb|1P38|A Chain A, The Structure Of The Map Kinase P38 At 2.1 Angstoms
Resolution
Length = 379
Score = 67.8 bits (164), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 45 NLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 100
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 156
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 157 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 208
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 209 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239
>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC7|D Chain D, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC8|A Chain A, Crystal Structure Of The Apo Erk5 Kinase Domain
pdb|4IC8|B Chain B, Crystal Structure Of The Apo Erk5 Kinase Domain
Length = 442
Score = 67.8 bits (164), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 15/226 (6%)
Query: 5 LKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSSG--QGIVEF 61
LK F D + +G G +G V + L GQ++AIK++ +
Sbjct: 42 LKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRT 101
Query: 62 KNEAKLIAKLQHTNLVRL---LGCSLQKGERLLVYEYLPNKSLDFF-IFDSSKKELLDWK 117
E K++ +H N++ + L ++ GE VY L D I SS+ L+
Sbjct: 102 LRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHV 161
Query: 118 KRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEA 177
+ F + +++GL Y+H +VIHRDLK SN+L+++ KI DFGMAR + E
Sbjct: 162 RYF--LYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEH 216
Query: 178 N--TNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKK 220
V T Y +PE +++ + D++S G + E+++ ++
Sbjct: 217 QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262
>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl
Amide Inhibitor
pdb|3IPH|A Chain A, Crystal Structure Of P38 In Complex With A Biphenylamide
Inhibitor
Length = 360
Score = 67.8 bits (164), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 26 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KXQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499
pdb|3FKO|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3668
pdb|3FLN|C Chain C, P38 Kinase Crystal Structure In Complex With R1487
Length = 372
Score = 67.8 bits (164), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 60/211 (28%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LSK Q I+ K E +L+ ++H
Sbjct: 38 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSKPF-QSIIHAKRTYRELRLLKHMKHE 93
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 94 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 149
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 150 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 201
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232
>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl
Amide Inhibitor
Length = 360
Score = 67.8 bits (164), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 26 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KXQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase
Length = 380
Score = 67.8 bits (164), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 46 NLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 101
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 157
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 158 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMXGXVATRWYR 209
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240
>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor
Length = 398
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 63/227 (27%), Positives = 109/227 (48%), Gaps = 17/227 (7%)
Query: 5 LKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKL-LDGQEIAIKRLSKSSGQGIVEFKN 63
LK F D + +G G +G V + L GQ++AIK++ ++ + K
Sbjct: 41 LKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIP-NAFDVVTNAKR 99
Query: 64 ---EAKLIAKLQHTNLVRL---LGCSLQKGERLLVYEYLPNKSLDFF-IFDSSKKELLDW 116
E K++ +H N++ + L ++ GE VY L D I SS+ L+
Sbjct: 100 TLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEH 159
Query: 117 KKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE 176
+ F + +++GL Y+H +VIHRDLK SN+L+++ KI DFGMAR + E
Sbjct: 160 VRYF--LYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAE 214
Query: 177 AN--TNRIVGTHGYMSPEYVMN-GIVSMKSDVYSFGVLVLEIISSKK 220
V T Y +PE +++ + D++S G + E+++ ++
Sbjct: 215 HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261
>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P-
Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl-
Pyridin-3-Yl)naphthalen-1-Yl]urea
pdb|3CTQ|A Chain A, Structure Of Map Kinase P38 In Complex With A
1-O-Tolyl-1,2, 3-Triazole-4-Carboxamide
Length = 348
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 22 NLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 77
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + +L D +F +I I++G
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCAKLTDDHVQF-LIYQILRG 133
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 134 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 185
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YA9|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YAA|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAA|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAB|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
pdb|2YAB|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
Length = 361
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/213 (27%), Positives = 107/213 (50%), Gaps = 24/213 (11%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
D + G LG G F V K + L + KR S++S +G+ E + E ++ +
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 71 LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
+ H N++ L + + +L+ E + L F+ ++KE L ++ + I+ I+ G+
Sbjct: 72 VLHPNIITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGV 128
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNP----KISDFGMARTFGMNELE--ANTNRIVG 184
YLH ++ H DLK NI+L D+ P K+ DFG+A +E+E I G
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-----HEIEDGVEFKNIFG 180
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +++PE V + +++D++S GV+ ++S
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213
>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195
Length = 365
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 31 NLSP---IGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 86
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 87 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 142
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 143 LKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTGYVATRWYR 194
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 55/190 (28%), Positives = 99/190 (52%), Gaps = 31/190 (16%)
Query: 25 RLGQGGFGPVYKGKLLD-GQEIAIKRL---SKSSGQGIVEFKNEAKLIAKLQHTNLVRLL 80
++GQG FG V+K + GQ++A+K++ ++ G I + E K++ L+H N+V L+
Sbjct: 25 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLI 83
Query: 81 GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKEL------------LDWKKRFNIIEGIVQ 128
K Y K+ + +FD + +L L KR +++ ++
Sbjct: 84 EICRTKAS-----PYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR--VMQMLLN 136
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM---NELEANTNRIVGT 185
GL Y+H R +++HRD+KA+N+L+ K++DFG+AR F + ++ NR+V T
Sbjct: 137 GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-T 192
Query: 186 HGYMSPEYVM 195
Y PE ++
Sbjct: 193 LWYRPPELLL 202
>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant
Length = 360
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 26 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex
With Dp802
Length = 354
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 26 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGXVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map
Kinase
Length = 360
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 26 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 17/201 (8%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLLGCS 83
LG+G G V + + +A+K + E K E + L H N+V+ G
Sbjct: 14 LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKEL----LDWKKRFNIIEGIVQGLLYLHKYSRL 139
+ + L EY L FD + ++ D ++ F+ ++ G++YLH +
Sbjct: 74 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 123
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
+ HRD+K N+LLD++ N KISDFG+A F N E N++ GT Y++PE +
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
+ DV+S G+++ +++ +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGE 204
>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The
Murine Receptor Tyrosine Kinase Tyro3 (Sky)
Length = 323
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 60/234 (25%), Positives = 110/234 (47%), Gaps = 20/234 (8%)
Query: 19 NFSPGNRLGQGGFGPVYKGKLL--DGQ--EIAIKRLSKS--SGQGIVEFKNEAKLIAKLQ 72
F+ G LG+G FG V + +L DG ++A+K L + I EF EA + +
Sbjct: 24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 73 HTNLVRLLGCSLQKGER------LLVYEYLPNKSLDFFIFDSSKKEL---LDWKKRFNII 123
H ++ +L+G SL+ + +++ ++ + L F+ S E L + +
Sbjct: 84 HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143
Query: 124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV 183
I G+ YL S IHRDL A N +L + M ++DFG++R +
Sbjct: 144 VDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASK 200
Query: 184 GTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKN--NGCYDTERHLNLVG 235
+++ E + + + ++ SDV++FGV + EI++ + G + E + L+G
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254
>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant
Length = 360
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 26 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In
Phosphorylated P38a And In Solution
Length = 370
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N +P +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 36 NLAP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 91
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 92 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 147
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 148 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 199
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 200 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230
>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant
Length = 360
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 26 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC
Length = 405
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 63/217 (29%), Positives = 108/217 (49%), Gaps = 19/217 (8%)
Query: 23 GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGI-VEFKNEAKLIAKLQHTNLVRLLG 81
G ++G+G +G VYK K DG++ L + G GI + E L+ +L+H N++ L
Sbjct: 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQK 85
Query: 82 CSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY-----LH 134
L +R L+++Y + F + K KK + G+V+ LLY +H
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIH 142
Query: 135 KYSRLRVIHRDLKASNILL----DDQMNPKISDFGMARTFG--MNELEANTNRIVGTHGY 188
V+HRDLK +NIL+ ++ KI+D G AR F + L A+ + +V T Y
Sbjct: 143 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL-ADLDPVVVTFWY 201
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEIISSKKNNGC 224
+PE ++ K+ D+++ G + E+++S+ C
Sbjct: 202 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 238
>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And
Drb
pdb|4EC9|A Chain A, Crystal Structure Of Full-Length Cdk9 In Complex With
Cyclin T
Length = 373
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 56/186 (30%), Positives = 102/186 (54%), Gaps = 23/186 (12%)
Query: 25 RLGQGGFGPVYKGKLLD-GQEIAIKRL---SKSSGQGIVEFKNEAKLIAKLQHTNLVRLL 80
++GQG FG V+K + GQ++A+K++ ++ G I + E K++ L+H N+V L+
Sbjct: 25 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLI 83
Query: 81 G-CSLQ-------KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
C + KG LV+++ + L + + K L KR +++ ++ GL Y
Sbjct: 84 EICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYY 140
Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM---NELEANTNRIVGTHGYM 189
+H R +++HRD+KA+N+L+ K++DFG+AR F + ++ NR+V T Y
Sbjct: 141 IH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYR 196
Query: 190 SPEYVM 195
PE ++
Sbjct: 197 PPELLL 202
>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3,
Tgme49_105860
Length = 467
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 37/213 (17%)
Query: 17 TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVE---FKNEAKLIAKLQ 72
+D + +LG G +G V K L G E AIK + KSS +E ++ +L
Sbjct: 3 SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 73 HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK-ELLD---WKKRFN------I 122
H N+++L YE+ +K + + + + EL D +++F+ I
Sbjct: 63 HPNIMKL-------------YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVI 109
Query: 123 IEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANT 179
++ ++ G YLHK++ ++HRDLK N+LL+ + KI DFG++ F E+
Sbjct: 110 MKQVLSGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKM 163
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLV 212
+GT Y++PE V+ K DV+S GV++
Sbjct: 164 KERLGTAYYIAPE-VLRKKYDEKCDVWSCGVIL 195
>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase
Length = 362
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 28 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 83
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 84 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 139
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 140 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 191
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A
Dihydroquinazolinone Inhibitor
pdb|1OUK|A Chain A, The Structure Of P38 Alpha In Complex With A
Pyridinylimidazole Inhibitor
pdb|1OUY|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydropyrido- Pyrimidine Inhibitor
pdb|1R39|A Chain A, The Structure Of P38alpha
pdb|1YQJ|A Chain A, Crystal Structure Of P38 Alpha In Complex With A Selective
Pyridazine Inhibitor
pdb|2OKR|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2OKR|D Chain D, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|B Chain B, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|1WFC|A Chain A, Structure Of Apo, Unphosphorylated, P38 Mitogen Activated
Protein Kinase P38 (P38 Map Kinase) The Mammalian
Homologue Of The Yeast Hog1 Protein
pdb|3DS6|A Chain A, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|B Chain B, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|C Chain C, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|D Chain D, P38 Complex With A Phthalazine Inhibitor
pdb|3FC1|X Chain X, Crystal Structure Of P38 Kinase Bound To
Pyrimido-Pyridazinone Inhibitor
pdb|3GFE|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridinone Inhibitor
pdb|3ITZ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridazine Inhibitor
pdb|3LHJ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridinone Inhibitor.
pdb|3ZYA|A Chain A, Human P38 Map Kinase In Complex With 2-Amino-Phenylamino-
Dibenzosuberone
pdb|3U8W|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Triazolopyridazinone Inhibitor
Length = 366
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 32 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 87
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 88 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 143
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 144 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 195
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase
Length = 367
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 33 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 88
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 144
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 145 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 196
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine
pdb|4AA5|A Chain A, P38alpha Map Kinase Bound To Cmpd 33
Length = 365
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 31 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 86
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 87 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 142
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 143 LKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTGYVATRWYR 194
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121
Length = 362
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 28 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 83
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 84 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 139
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 140 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 191
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|3HEC|A Chain A, P38 In Complex With Imatinib
pdb|3HEG|A Chain A, P38 In Complex With Sorafenib
Length = 348
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 22 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 77
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 133
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 134 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 185
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In
Complex With 4-[3-Methylsulfanylanilino]-6,7-
Dimethoxyquinazoline
pdb|1KV1|A Chain A, P38 Map Kinase In Complex With Inhibitor 1
pdb|1KV2|A Chain A, Human P38 Map Kinase In Complex With Birb 796
pdb|1WBO|A Chain A, Fragment Based P38 Inhibitors
pdb|1W7H|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W82|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W83|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W84|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1ZZ2|A Chain A, Two Classes Of P38alpha Map Kinase Inhibitors Having A
Common Diphenylether Core But Exhibiting Divergent
Binding Modes
pdb|1WBN|A Chain A, Fragment Based P38 Inhibitors
pdb|1WBS|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBT|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-based Lead Generation.
pdb|1WBV|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBW|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1ZYJ|A Chain A, Human P38 Map Kinase In Complex With Inhibitor 1a
pdb|2ZAZ|A Chain A, Crystal Structure Of P38 In Complex With 4-Anilino
Quinoline Inhibitor
pdb|2ZB0|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|2ZB1|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|3HL7|A Chain A, Crystal Structure Of Human P38alpha Complexed With Sd-0006
pdb|3HLL|A Chain A, Crystal Structure Of Human P38alpha Complexed With
Ph-797804
pdb|3HP2|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyridinone Compound
pdb|3HP5|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyrimidopyridazinone Compound
pdb|3KF7|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Triazolopyrimidine Compound
pdb|3MGY|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3ROC|A Chain A, Crystal Structure Of Human P38 Alpha Complexed With A
Pyrimidinone Compound
pdb|3RIN|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|4E5B|A Chain A, Structure Of P38a Map Kinase Without Bog
pdb|4E6A|A Chain A, P38a-Pia23 Complex
pdb|4E6C|A Chain A, P38a-perifosine Complex
pdb|4E8A|A Chain A, The Crystal Structure Of P38a Map Kinase In Complex With
Pia24
Length = 360
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 26 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea
pdb|2BAK|A Chain A, P38alpha Map Kinase Bound To Mpaq
pdb|4A9Y|A Chain A, P38alpha Map Kinase Bound To Cmpd 8
pdb|4AA0|A Chain A, P38alpha Map Kinase Bound To Cmpd 2
pdb|4AA4|A Chain A, P38alpha Map Kinase Bound To Cmpd 22
pdb|4AAC|A Chain A, P38alpha Map Kinase Bound To Cmpd 29
Length = 365
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 31 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 86
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 87 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 142
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 143 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 194
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|3MW1|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|2YIS|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase.
pdb|2YIW|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase
Length = 359
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 25 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 80
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 81 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 136
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 137 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 188
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 189 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219
>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376
pdb|3NNV|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp437
pdb|3NNW|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp802
Length = 354
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 26 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A
Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE
COMPLEX IN Solution
Length = 359
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 31 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 86
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 87 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 142
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 143 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 194
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
pdb|3E93|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
Length = 371
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 37 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 92
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 93 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 148
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 149 LKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTGYVATRWYR 200
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 201 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231
>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715
pdb|3ZSH|A Chain A, X-Ray Structure Of P38alpha Bound To Scio-469
pdb|3ZSI|A Chain A, X-Ray Structure Of P38alpha Bound To Vx-745
pdb|3ZS5|A Chain A, Structural Basis For Kinase Selectivity Of Three Clinical
P38alpha Inhibitors
Length = 362
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 28 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 83
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 84 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 139
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 140 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 191
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
Length = 349
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 23 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 78
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 79 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 134
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 135 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 186
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 187 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217
>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955
Length = 350
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 24 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 79
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 80 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 135
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 136 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 187
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 188 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218
>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole
Inhibitor
Length = 372
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 38 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 93
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 94 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 149
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 150 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 201
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232
>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-A
pdb|2FSM|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-B
Length = 367
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 60/211 (28%), Positives = 108/211 (51%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 33 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 88
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 144
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR +E+ V T Y
Sbjct: 145 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTA-DEMTG----YVATRWYR 196
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195
pdb|3FKL|A Chain A, P38 Kinase Crystal Structure In Complex With Ro9552
pdb|3FKN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro7125
pdb|3FL4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro5634
pdb|3FLQ|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((S)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin
pdb|3FLS|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((R)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin-7-One
pdb|3FLW|A Chain A, P38 Kinase Crystal Structure In Complex With Pamapimod
pdb|3FLY|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-Isopropylamino-8-Methyl-8h-Pyrido[2,
3- D]pyrimidin-7-One
pdb|3FLZ|A Chain A, P38 Kinase Crystal Structure In Complex With
8-Methyl-6-Phenoxy-2-
(Tetrahydro-Pyran-4-Ylamino)-8h-Pyrido[2,
3-D]pyrimidin-7-One
pdb|3FMH|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((R)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FMJ|A Chain A, P38 Kinase Crystal Structure In Complex With
4-(5-Methyl-3-Phenyl- Isoxazol-4-Yl)-Pyrimidin-2-Ylamine
pdb|3FMK|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((S)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FML|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6224
pdb|3FMM|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6226
pdb|3FMN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro2530
pdb|3FSF|A Chain A, P38 Kinase Crystal Structure In Complex With 3-(2,6-
Dichloro-Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-
Phenylamino]-
1-Methyl-3,4-Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3FSK|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6257
Length = 372
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 38 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 93
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 94 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 149
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 150 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 201
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232
>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A
Pyrrole-2- Carboxamide Inhibitor
Length = 371
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 37 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 92
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 93 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 148
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 149 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 200
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 201 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231
>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48
pdb|3GCU|B Chain B, Human P38 Map Kinase In Complex With Rl48
pdb|3HV4|A Chain A, Human P38 Map Kinase In Complex With Rl51
pdb|3HV4|B Chain B, Human P38 Map Kinase In Complex With Rl51
pdb|3HV5|A Chain A, Human P38 Map Kinase In Complex With Rl24
pdb|3HV5|B Chain B, Human P38 Map Kinase In Complex With Rl24
pdb|3HV6|A Chain A, Human P38 Map Kinase In Complex With Rl39
pdb|3HV7|A Chain A, Human P38 Map Kinase In Complex With Rl38
pdb|3HUC|A Chain A, Human P38 Map Kinase In Complex With Rl40
pdb|3LFA|A Chain A, Human P38 Map Kinase In Complex With Dasatinib
pdb|3QUE|A Chain A, Human P38 Map Kinase In Complex With Skepinone-L
pdb|3QUD|A Chain A, Human P38 Map Kinase In Complex With
2-Amino-Phenylamino-Benzophenone
pdb|3UVP|A Chain A, Human P38 Map Kinase In Complex With A Benzamide
Substituted Benzosuberone
pdb|3UVQ|A Chain A, Human P38 Map Kinase In Complex With A Dibenzosuberone
Derivative
pdb|4EH2|A Chain A, Human P38 Map Kinase In Complex With Np-F1 And Rl87
pdb|4EH3|A Chain A, Human P38 Map Kinase In Complex With Np-F2 And Rl87
pdb|4EH4|A Chain A, Human P38 Map Kinase In Complex With Np-F3 And Rl87
pdb|4EH5|A Chain A, Human P38 Map Kinase In Complex With Np-F4 And Rl87
pdb|4EH6|A Chain A, Human P38 Map Kinase In Complex With Np-F5 And Rl87
pdb|4EH7|A Chain A, Human P38 Map Kinase In Complex With Np-F6 And Rl87
pdb|4EH8|A Chain A, Human P38 Map Kinase In Complex With Np-F7 And Rl87
pdb|4EH9|A Chain A, Human P38 Map Kinase In Complex With Np-F11 And Rl87
pdb|4EHV|A Chain A, Human P38 Map Kinase In Complex With Np-F10 And Rl87
pdb|3UVR|A Chain A, Human P38 Map Kinase In Complex With Km064
pdb|4DLI|A Chain A, Human P38 Map Kinase In Complex With Rl87
pdb|4DLJ|A Chain A, Human P38 Map Kinase In Complex With Rl163
Length = 360
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 26 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2UV2|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To
4-(4-(
5-Cyclopropyl-1h-Pyrazol-3-Ylamino)-Quinazolin-2-
Ylamino)- Phenyl)-Acetonitrile
Length = 287
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 12/193 (6%)
Query: 29 GGFGPVYKGKLLDGQEIAI-KRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKG 87
G FG VYK + + +A K + S + + ++ E ++A H N+V+LL +
Sbjct: 21 GDFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 80
Query: 88 ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLK 147
++ E+ ++D + + + L + + + + L YLH ++IHRDLK
Sbjct: 81 NLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDN---KIIHRDLK 135
Query: 148 ASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM-----NGIVSMK 202
A NIL + K++DFG++ ++ + +GT +M+PE VM + K
Sbjct: 136 AGNILFTLDGDIKLADFGVSAKNTRTXIQ-RRDSFIGTPYWMAPEVVMCETSKDRPYDYK 194
Query: 203 SDVYSFGVLVLEI 215
+DV+S G+ ++E+
Sbjct: 195 ADVWSLGITLIEM 207
>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine
pdb|2YIX|A Chain A, Triazolopyridine Inhibitors Of P38
Length = 351
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 23 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 78
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 79 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 134
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 135 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 186
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 187 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217
>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex
pdb|2QD9|A Chain A, P38 Alpha Map Kinase Inhibitor Based On Heterobicyclic
Scaffolds
pdb|2RG5|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11b
pdb|2RG6|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11j
pdb|3C5U|A Chain A, P38 Alpha Map Kinase Complexed With A Benzothiazole Based
Inhibitor
pdb|3BV2|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 30
pdb|3BV3|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 2
pdb|3BX5|A Chain A, P38 Alpha Map Kinase Complexed With Bms-640994
pdb|3L8X|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Pyrimidine
Based Inhibitor
pdb|3NWW|A Chain A, P38 Alpha Kinase Complexed With A
2-Aminothiazol-5-Yl-Pyrimidine Based Inhibitor
pdb|3MVL|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVL|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVM|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3MVM|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3OCG|A Chain A, P38 Alpha Kinase Complexed With A 5-Amino-Pyrazole Based
Inhibitor
pdb|3S4Q|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Triazine Based
Inhibitor
Length = 366
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 32 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 87
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 88 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 143
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 144 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 195
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb
pdb|3MIA|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Atp-Bound
Human P-Tefb
Length = 351
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 56/186 (30%), Positives = 102/186 (54%), Gaps = 23/186 (12%)
Query: 25 RLGQGGFGPVYKGKLLD-GQEIAIKRL---SKSSGQGIVEFKNEAKLIAKLQHTNLVRLL 80
++GQG FG V+K + GQ++A+K++ ++ G I + E K++ L+H N+V L+
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLI 82
Query: 81 G-CSLQ-------KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
C + KG LV+++ + L + + K L KR +++ ++ GL Y
Sbjct: 83 EICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYY 139
Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM---NELEANTNRIVGTHGYM 189
+H R +++HRD+KA+N+L+ K++DFG+AR F + ++ NR+V T Y
Sbjct: 140 IH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYR 195
Query: 190 SPEYVM 195
PE ++
Sbjct: 196 PPELLL 201
>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l)
Activating Mutant
Length = 367
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 60/211 (28%), Positives = 108/211 (51%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 33 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 88
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 144
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR +E+ V T Y
Sbjct: 145 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTA-DEMTG----YVATRWYR 196
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a)
Activating Mutant
Length = 367
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 60/211 (28%), Positives = 108/211 (51%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 33 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 88
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 144
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR +E+ V T Y
Sbjct: 145 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTA-DEMTG----YVATRWYR 196
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1-
Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3-
Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide
Length = 380
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 46 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 101
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 157
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 158 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 209
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240
>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995
pdb|1BL7|A Chain A, The Complex Structure Of The Map Kinase P38SB220025
pdb|2EWA|A Chain A, Dual Binding Mode Of Pyridinylimidazole To Map Kinase P38
pdb|1A9U|A Chain A, The Complex Structure Of The Map Kinase P38SB203580
pdb|3HA8|A Chain A, The Complex Structure Of The Map Kinase P38COMPOUND 14B
Length = 379
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 45 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 100
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 156
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 157 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 208
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 209 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239
>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor
Length = 383
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 49 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 104
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 160
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 161 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 212
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 213 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243
>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
pdb|1H4L|B Chain B, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
Length = 292
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 57/200 (28%), Positives = 107/200 (53%), Gaps = 12/200 (6%)
Query: 25 RLGQGGFGPVYKGKLLDGQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQHTNLVRLLG 81
++G+G +G V+K K + EI A+KR+ +G+ E L+ +L+H N+VRL
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 82 CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
+ LV+E+ ++ L + FDS +L D + + + +++GL + H + V
Sbjct: 69 VLHSDKKLTLVFEFC-DQDLKKY-FDSCNGDL-DPEIVKSFLFQLLKGLGFCHSRN---V 122
Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG-IVS 200
+HRDLK N+L++ K++DFG+AR FG+ + + +V T Y P+ + + S
Sbjct: 123 LHRDLKPQNLLINRNGELKLADFGLARAFGI-PVRCYSAEVV-TLWYRPPDVLFGAKLYS 180
Query: 201 MKSDVYSFGVLVLEIISSKK 220
D++S G + E+ ++ +
Sbjct: 181 TSIDMWSAGCIFAELANAAR 200
>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From
Toxoplasma Gondii, 541.m00134, Kinase Domain
Length = 287
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 37/213 (17%)
Query: 17 TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVE---FKNEAKLIAKLQ 72
+D + +LG G +G V K L G E AIK + KSS +E ++ +L
Sbjct: 20 SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 73 HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK-ELLD---WKKRFN------I 122
H N+++L YE+ +K + + + + EL D +++F+ I
Sbjct: 80 HPNIMKL-------------YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVI 126
Query: 123 IEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANT 179
++ ++ G YLHK++ ++HRDLK N+LL+ + KI DFG++ F E+
Sbjct: 127 MKQVLSGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKM 180
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLV 212
+GT Y++PE V+ K DV+S GV++
Sbjct: 181 KERLGTAYYIAPE-VLRKKYDEKCDVWSCGVIL 212
>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|B Chain B, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|C Chain C, Crystal Structure Of The Human Cdkl1 Kinase Domain
Length = 311
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 57/198 (28%), Positives = 101/198 (51%), Gaps = 14/198 (7%)
Query: 25 RLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVE--FKNEAKLIAKLQHTNLVRLLG 81
++G+G +G V+K + D GQ +AIK+ +S +++ E +++ +L+H NLV LL
Sbjct: 10 KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 82 CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
+K LV+EY + L D ++ + + + +I +Q + + HK++
Sbjct: 70 VFRRKRRLHLVFEYCDHTVLH--ELDRYQRGVPEHLVK-SITWQTLQAVNFCHKHN---C 123
Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTF-GMNELEANTNRIVGTHGYMSPEYVMNGI-V 199
IHRD+K NIL+ K+ DFG AR G ++ + V T Y SPE ++
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE---VATRWYRSPELLVGDTQY 180
Query: 200 SMKSDVYSFGVLVLEIIS 217
DV++ G + E++S
Sbjct: 181 GPPVDVWAIGCVFAELLS 198
>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk
Docking Peptide
Length = 362
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 28 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 83
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 84 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 139
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 140 LKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR-----HTDDEMTGYVATRWYR 191
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With
Y- 27632
Length = 350
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 21/210 (10%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F +G G FG V K ++ G A+K L K Q +V+ K NE ++
Sbjct: 38 AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
+ + LV+L +V EY+P D F + RF + IV
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGG--DMFSHLRRIGRFSEPHARFYAAQ-IV 151
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
YLH L +I+RDLK N+L+D Q K++DFG A+ ++ T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPE 203
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase
pdb|2GNH|A Chain A, Pka Five Fold Mutant Model Of Rho-Kinase With H1152p
pdb|2GNI|A Chain A, Pka Fivefold Mutant Model Of Rho-Kinase With Inhibitor
Fasudil (Ha1077)
Length = 350
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 21/210 (10%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F +G G FG V K ++ G A+K L K Q +V+ K NE ++
Sbjct: 38 AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
+ + LV+L +V EY+P D F + RF + IV
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGG--DMFSHLRRIGRFSEPHARFYAAQ-IV 151
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
YLH L +I+RDLK N+L+D Q K++DFG A+ ++ T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPE 203
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydroquinolinone
pdb|1R3C|A Chain A, The Structure Of P38alpha C162s Mutant
pdb|2I0H|A Chain A, The Structure Of P38alpha In Complex With An
Arylpyridazinone
pdb|3GC7|A Chain A, The Structure Of P38alpha In Complex With A
Dihydroquinazolinone
pdb|3NEW|A Chain A, P38-Alpha Complexed With Compound 10
Length = 366
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 32 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 87
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 88 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 143
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 144 LKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR-----HTDDEMTGYVATRWYR 195
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1
pdb|3BLQ|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
ATP
pdb|3BLR|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
Flavopiridol
pdb|3MY1|A Chain A, Structure Of Cdk9CYCLINT1 IN COMPLEX WITH DRB
pdb|3LQ5|A Chain A, Structure Of Cdk9CYCLINT IN COMPLEX WITH S-Cr8
pdb|3TN8|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNH|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNI|A Chain A, Structure Of Cdk9CYCLIN T F241L
pdb|4BCH|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCI|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCJ|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 56/186 (30%), Positives = 102/186 (54%), Gaps = 23/186 (12%)
Query: 25 RLGQGGFGPVYKGKLLD-GQEIAIKRL---SKSSGQGIVEFKNEAKLIAKLQHTNLVRLL 80
++GQG FG V+K + GQ++A+K++ ++ G I + E K++ L+H N+V L+
Sbjct: 25 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLI 83
Query: 81 G-CSLQ-------KGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
C + KG LV+++ + L + + K L KR +++ ++ GL Y
Sbjct: 84 EICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYY 140
Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM---NELEANTNRIVGTHGYM 189
+H R +++HRD+KA+N+L+ K++DFG+AR F + ++ NR+V T Y
Sbjct: 141 IH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYR 196
Query: 190 SPEYVM 195
PE ++
Sbjct: 197 PPELLL 202
>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based
Inhibitor
Length = 383
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 49 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 104
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 160
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+AR + V T Y
Sbjct: 161 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMXGYVATRWYR 212
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 213 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243
>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1
pdb|3FPQ|B Chain B, Crystal Structure Of The Kinase Domain Of Wnk1
Length = 290
Score = 66.2 bits (160), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 33/210 (15%)
Query: 26 LGQGGFGPVYKGKLLDGQ--------EIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLV 77
+G+G F VYKG LD + E+ ++L+KS Q FK EA+ + LQH N+V
Sbjct: 34 IGRGSFKTVYKG--LDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEXLKGLQHPNIV 88
Query: 78 RLLGC--SLQKGER--LLVYEYLPNKSLDFFI--FDSSK-KELLDWKKRFNIIEGIVQGL 130
R S KG++ +LV E + +L ++ F K K L W ++ I++GL
Sbjct: 89 RFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQ------ILKGL 142
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNP-KISDFGMARTFGMNELEANTNRIVGTHGYM 189
+LH + +IHRDLK NI + KI D G+A + +A ++GT +
Sbjct: 143 QFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFX 197
Query: 190 SPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
+PE DVY+FG LE +S+
Sbjct: 198 APEXYEEK-YDESVDVYAFGXCXLEXATSE 226
>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain
Length = 332
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 70/271 (25%), Positives = 110/271 (40%), Gaps = 76/271 (28%)
Query: 19 NFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNL 76
+F P +G+GGFG V++ K +D AIKR+ + + E E K +AKL+H +
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 77 VRLLGCSLQ----KGERLLVYEYLPNKSLDFFIFDSS----------------------- 109
VR L+ K + + +L ++S D+ + S
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 110 ------------------KKELLDWKKR------------FNIIEGIVQGLLYLHKYSRL 139
K+ L DW R +I I + + +LH
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG-- 184
Query: 140 RVIHRDLKASNIL--LDDQMNPKISDFGMARTFGMNELE----------ANTNRIVGTHG 187
++HRDLK SNI +DD + K+ DFG+ +E E A VGT
Sbjct: 185 -LMHRDLKPSNIFFTMDDVV--KVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKL 241
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISS 218
YMSPE + S K D++S G+++ E++ S
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580
pdb|3GCQ|A Chain A, Human P38 Map Kinase In Complex With Rl45
pdb|3GCS|A Chain A, Human P38 Map Kinase In Complex With Sorafenib
pdb|3GCV|A Chain A, Human P38 Map Kinase In Complex With Rl62
pdb|3HV3|A Chain A, Human P38 Map Kinase In Complex With Rl49
pdb|3IW5|A Chain A, Human P38 Map Kinase In Complex With An Indole Derivative
pdb|3IW6|A Chain A, Human P38 Map Kinase In Complex With A Benzylpiperazin-
Pyrrol
pdb|3IW7|A Chain A, Human P38 Map Kinase In Complex With An Imidazo-Pyridine
pdb|3IW8|A Chain A, Structure Of Inactive Human P38 Map Kinase In Complex With
A Thiazole-Urea
pdb|3HUB|A Chain A, Human P38 Map Kinase In Complex With Scios-469
pdb|3L8S|A Chain A, Human P38 Map Kinase In Complex With Cp-547632
pdb|3LFB|A Chain A, Human P38 Map Kinase In Complex With Rl98
pdb|3LFC|A Chain A, Human P38 Map Kinase In Complex With Rl99
pdb|3LFD|A Chain A, Human P38 Map Kinase In Complex With Rl113
pdb|3LFE|A Chain A, Human P38 Map Kinase In Complex With Rl116
pdb|3LFF|A Chain A, Human P38 Map Kinase In Complex With Rl166
pdb|3PG3|A Chain A, Human P38 Map Kinase In Complex With Rl182
Length = 360
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 26 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KSQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DFG+ R + V T Y
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3ZGW|A Chain A, Crystal Structure Of Maternal Embryonic Leucine Zipper
Kinase (melk) In Complex With Amp-pnp
Length = 347
Score = 65.9 bits (159), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 54/191 (28%), Positives = 92/191 (48%), Gaps = 12/191 (6%)
Query: 26 LGQGGFGPV-YKGKLLDGQEIAIKRLSKSS-GQGIVEFKNEAKLIAKLQHTNLVRLLGCS 83
+G GGF V +L G+ +AIK + K++ G + K E + + L+H ++ +L
Sbjct: 18 IGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEALKNLRHQHICQLYHVL 77
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ +V EY P L F + S+ L + + R + IV + Y+H H
Sbjct: 78 ETANKIFMVLEYCPGGEL--FDYIISQDRLSEEETRV-VFRQIVSAVAYVHSQG---YAH 131
Query: 144 RDLKASNILLDDQMNPKISDFGM-ARTFGMNELEANTNRIVGTHGYMSPEYVM-NGIVSM 201
RDLK N+L D+ K+ DFG+ A+ G + T G+ Y +PE + +
Sbjct: 132 RDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQT--CCGSLAYAAPELIQGKSYLGS 189
Query: 202 KSDVYSFGVLV 212
++DV+S G+L+
Sbjct: 190 EADVWSMGILL 200
>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin.
pdb|2BFY|B Chain B, Complex Of Aurora-B With Incenp And Hesperidin
Length = 284
Score = 65.9 bits (159), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 15/222 (6%)
Query: 18 DNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSS--GQGIV-EFKNEAKLIAKLQH 73
D+F LG+G FG VY + + I A+K L KS +G+ + + E ++ + L+H
Sbjct: 14 DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 74 TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
N++R+ + L+ E+ P L + K D ++ +E + L Y
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGEL---YKELQKHGRFDEQRSATFMEELADALHYC 130
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
H+ +VIHRD+K N+L+ + KI+DFG + ++ + GT Y+ PE
Sbjct: 131 HER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPPEM 183
Query: 194 VMNGIVSMKSDVYSFGVLVLE-IISSKKNNGCYDTERHLNLV 234
+ K D++ GVL E ++ + TE H +V
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV 225
>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
Length = 321
Score = 65.9 bits (159), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 59/213 (27%), Positives = 107/213 (50%), Gaps = 24/213 (11%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
D + G LG G F V K + L + KR S++S +G+ E + E ++ +
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 71 LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
+ H N++ L + + +L+ E + L F+ ++KE L ++ + I+ I+ G+
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGV 128
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNP----KISDFGMARTFGMNELE--ANTNRIVG 184
YLH ++ H DLK NI+L D+ P K+ DFG+A +E+E I G
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-----HEIEDGVEFKNIFG 180
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +++PE V + +++D++S GV+ ++S
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213
>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3O8U|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 65.9 bits (159), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 26 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI D+G+AR + V T Y
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLAR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia
pdb|3GC0|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia In
Complex With Amp
Length = 329
Score = 65.5 bits (158), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 18/212 (8%)
Query: 14 AAATDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLS-KSSGQGIVEFK-NEAKLIAK 70
A + D + +LG+G +G VYK + + +AIKR+ + +G+ E L+ +
Sbjct: 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKE 89
Query: 71 LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
LQH N++ L L++EY N + D + + K F + ++ G+
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAENDLKKY--MDKNPDVSMRVIKSF--LYQLINGV 145
Query: 131 LYLHKYSRLRVIHRDLKASNILL---DDQMNP--KISDFGMARTFGMNELEANTNRIVGT 185
+ H SR R +HRDLK N+LL D P KI DFG+AR FG+ + T+ I+ T
Sbjct: 146 NFCH--SR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-PIRQFTHEII-T 200
Query: 186 HGYMSPEYVMNG-IVSMKSDVYSFGVLVLEII 216
Y PE ++ S D++S + E++
Sbjct: 201 LWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232
>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|D Chain D, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|E Chain E, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|F Chain F, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|G Chain G, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|H Chain H, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
Length = 321
Score = 65.5 bits (158), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 59/213 (27%), Positives = 107/213 (50%), Gaps = 24/213 (11%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
D + G LG G F V K + L + KR S++S +G+ E + E ++ +
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 71 LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
+ H N++ L + + +L+ E + L F+ ++KE L ++ + I+ I+ G+
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGV 128
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNP----KISDFGMARTFGMNELE--ANTNRIVG 184
YLH ++ H DLK NI+L D+ P K+ DFG+A +E+E I G
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-----HEIEDGVEFKNIFG 180
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +++PE V + +++D++S GV+ ++S
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213
>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|B Chain B, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|C Chain C, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|D Chain D, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2CKE|A Chain A, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|B Chain B, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|C Chain C, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|D Chain D, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
Length = 321
Score = 65.5 bits (158), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 59/213 (27%), Positives = 107/213 (50%), Gaps = 24/213 (11%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
D + G LG G F V K + L + KR S++S +G+ E + E ++ +
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 71 LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
+ H N++ L + + +L+ E + L F+ ++KE L ++ + I+ I+ G+
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGV 128
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNP----KISDFGMARTFGMNELE--ANTNRIVG 184
YLH ++ H DLK NI+L D+ P K+ DFG+A +E+E I G
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-----HEIEDGVEFKNIFG 180
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +++PE V + +++D++S GV+ ++S
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213
>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|E Chain E, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|C Chain C, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|B Chain B, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|F Chain F, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|D Chain D, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|H Chain H, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|G Chain G, Human Death-Associated Kinase Drp-1, Mutant S308d D40
Length = 321
Score = 65.5 bits (158), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 59/213 (27%), Positives = 107/213 (50%), Gaps = 24/213 (11%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
D + G LG G F V K + L + KR S++S +G+ E + E ++ +
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 71 LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
+ H N++ L + + +L+ E + L F+ ++KE L ++ + I+ I+ G+
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGV 128
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNP----KISDFGMARTFGMNELE--ANTNRIVG 184
YLH ++ H DLK NI+L D+ P K+ DFG+A +E+E I G
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-----HEIEDGVEFKNIFG 180
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +++PE V + +++D++S GV+ ++S
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213
>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With The Imidazo[1,2-B]pyridazine Inhibitor K00135
Length = 301
Score = 65.5 bits (158), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL- 84
+G+G +G V++G G+ +A+K S + + E L+H N++ + +
Sbjct: 16 VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIASDMT 73
Query: 85 ---QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH-----KY 136
+ L+ Y SL +D + LD I+ I GL +LH
Sbjct: 74 SRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMA--RTFGMNELEANTNRIVGTHGYMSPEYV 194
+ + HRDLK+ NIL+ I+D G+A + N+L+ N VGT YM+PE V
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE-V 188
Query: 195 MNGIVSM-------KSDVYSFGVLVLEIISSKKNNG 223
++ + + + D+++FG+++ E+ +NG
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224
>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2-
Aminopyridine Inhibitor
pdb|3MTF|B Chain B, Crystal Structure Of The Acvr1 Kinase In Complex With A 2-
Aminopyridine Inhibitor
pdb|3OOM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With The Imidazo[1,2-B]pyridazine Inhibitor K00507
pdb|3Q4U|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|B Chain B, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|C Chain C, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|D Chain D, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
Length = 301
Score = 65.5 bits (158), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL- 84
+G+G +G V++G G+ +A+K S + + E L+H N++ + +
Sbjct: 16 VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIASDMT 73
Query: 85 ---QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH-----KY 136
+ L+ Y SL +D + LD I+ I GL +LH
Sbjct: 74 SRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMA--RTFGMNELEANTNRIVGTHGYMSPEYV 194
+ + HRDLK+ NIL+ I+D G+A + N+L+ N VGT YM+PE V
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE-V 188
Query: 195 MNGIVSM-------KSDVYSFGVLVLEIISSKKNNG 223
++ + + + D+++FG+++ E+ +NG
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224
>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin
Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin
Length = 330
Score = 65.5 bits (158), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL- 84
+G+G +G V++G G+ +A+K S + + E L+H N++ + +
Sbjct: 45 VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIASDMT 102
Query: 85 ---QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH-----KY 136
+ L+ Y SL +D + LD I+ I GL +LH
Sbjct: 103 SRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMA--RTFGMNELEANTNRIVGTHGYMSPEYV 194
+ + HRDLK+ NIL+ I+D G+A + N+L+ N VGT YM+PE V
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE-V 217
Query: 195 MNGIVSM-------KSDVYSFGVLVLEIISSKKNNG 223
++ + + + D+++FG+++ E+ +NG
Sbjct: 218 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 253
>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|B Chain B, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|C Chain C, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|D Chain D, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|E Chain E, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|F Chain F, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|G Chain G, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|H Chain H, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
Length = 288
Score = 65.5 bits (158), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 59/213 (27%), Positives = 107/213 (50%), Gaps = 24/213 (11%)
Query: 18 DNFSPGNRLGQGGFGPVYKGK-----LLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAK 70
D + G LG G F V K + L + KR S++S +G+ E + E ++ +
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 71 LQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
+ H N++ L + + +L+ E + L F+ ++KE L ++ + I+ I+ G+
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGV 128
Query: 131 LYLHKYSRLRVIHRDLKASNILLDDQMNP----KISDFGMARTFGMNELE--ANTNRIVG 184
YLH ++ H DLK NI+L D+ P K+ DFG+A +E+E I G
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-----HEIEDGVEFKNIFG 180
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T +++PE V + +++D++S GV+ ++S
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213
>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5
pdb|2F57|B Chain B, Crystal Structure Of The Human P21-activated Kinase 5
Length = 317
Score = 65.5 bits (158), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 19/216 (8%)
Query: 11 QTIAAATDNFSPGN---------RLGQGGFGPV-YKGKLLDGQEIAIKRLSKSSGQGIVE 60
Q AA SPG+ ++G+G G V + G+++A+K++ Q
Sbjct: 29 QFRAALQLVVSPGDPREYLANFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL 88
Query: 61 FKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRF 120
NE ++ H N+V + L E +V E+L +L + + E ++
Sbjct: 89 LFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNE----EQIA 144
Query: 121 NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN 180
+ +++ L YLH VIHRD+K+ +ILL K+SDFG +++
Sbjct: 145 TVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQ--VSKEVPKRK 199
Query: 181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
+VGT +M+PE + + D++S G++V+E+I
Sbjct: 200 XLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMI 235
>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
A- 443654
Length = 351
Score = 65.1 bits (157), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K ++ G A+K L K Q +V+ K NE ++
Sbjct: 39 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 95
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
+ + LV+L +V EY+P + F ++ + RF +
Sbjct: 96 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQ- 150
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
IV YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + GT
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 202
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234
>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
pdb|2BVA|B Chain B, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 292
Score = 65.1 bits (157), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 18 DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 76
DNF ++G+G G V + G+ +A+K++ Q NE ++ QH N+
Sbjct: 23 DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 77 VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
V + L E +V E+L +L + + E ++ + ++Q L LH
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE----EQIAAVCLAVLQALSVLHAQ 135
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
VIHRD+K+ +ILL K+SDFG +++ +VGT +M+PE +
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISR 190
Query: 197 GIVSMKSDVYSFGVLVLEII 216
+ D++S G++V+E++
Sbjct: 191 LPYGPEVDIWSLGIMVIEMV 210
>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In
Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077)
pdb|1XH4|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|3BWJ|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Lead Compound Arc-1034
pdb|3KKV|A Chain A, Structure Of Pka With A Protein Kinase B-Selective
Inhibitor
Length = 350
Score = 65.1 bits (157), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K ++ G A+K L K Q +V+ K NE ++
Sbjct: 38 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
+ + LV+L +V EY+P + F ++ + RF +
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
IV YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 65.1 bits (157), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K ++ G A+K L K Q +V+ K NE ++
Sbjct: 38 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
+ + LV+L +V EY+P + F ++ + RF +
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
IV YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Pf-03758309
pdb|4APP|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With (S)-N-(5-(3-Benzyl-1-Methylpiperazine-4-
Carbonyl)-6,6-Dimethyl-1,4,5,6-Tetrahydropyrrolo(3,4-C)
Pyrazol-3-Yl)-3-Phenoxybenzamide
Length = 296
Score = 65.1 bits (157), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 18 DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 76
DNF ++G+G G V + G+ +A+K++ Q NE ++ QH N+
Sbjct: 27 DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 83
Query: 77 VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
V + L E +V E+L +L + + E ++ + ++Q L LH
Sbjct: 84 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE----EQIAAVCLAVLQALSVLHAQ 139
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
VIHRD+K+ +ILL K+SDFG +++ +VGT +M+PE +
Sbjct: 140 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISR 194
Query: 197 GIVSMKSDVYSFGVLVLEII 216
+ D++S G++V+E++
Sbjct: 195 LPYGPEVDIWSLGIMVIEMV 214
>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent
Protein Kinase Ii Gamma
Length = 336
Score = 65.1 bits (157), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 17/212 (8%)
Query: 10 FQTIAAAT---DNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLS--KSSGQGIVEFKN 63
FQ +A T D++ LG+G F V + K QE A K ++ K S + + +
Sbjct: 20 FQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLER 79
Query: 64 EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNII 123
EA++ L+H N+VRL ++G LV++ + L D +E + I
Sbjct: 80 EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCI 136
Query: 124 EGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANTN 180
I++ + ++H++ ++HRDLK N+LL + K++DFG+A E +A
Sbjct: 137 HQILESVNHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLAIEV-QGEQQAWFG 192
Query: 181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLV 212
GT GY+SPE + D+++ GV++
Sbjct: 193 -FAGTPGYLSPEVLRKDPYGKPVDIWACGVIL 223
>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Cgp74514a
pdb|2J0I|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 303
Score = 65.1 bits (157), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 18 DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 76
DNF ++G+G G V + G+ +A+K++ Q NE ++ QH N+
Sbjct: 34 DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 90
Query: 77 VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
V + L E +V E+L +L + + E ++ + ++Q L LH
Sbjct: 91 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE----EQIAAVCLAVLQALSVLHAQ 146
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
VIHRD+K+ +ILL K+SDFG +++ +VGT +M+PE +
Sbjct: 147 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISR 201
Query: 197 GIVSMKSDVYSFGVLVLEII 216
+ D++S G++V+E++
Sbjct: 202 LPYGPEVDIWSLGIMVIEMV 221
>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d)
Length = 290
Score = 65.1 bits (157), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 59/222 (26%), Positives = 112/222 (50%), Gaps = 34/222 (15%)
Query: 12 TIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAK 70
++ D+ P LG+G +G V K + + GQ +A+KR+ + V + + +L+
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-----RATVNSQEQKRLLMD 55
Query: 71 LQHTN-------LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRF--- 120
L + V G ++G+ + E + + SLD F K+++D +
Sbjct: 56 LDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPED 109
Query: 121 ---NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEA 177
I IV+ L +LH S+L VIHRD+K SN+L++ K+ DFG++ + ++++
Sbjct: 110 ILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS-GYLVDDVAK 166
Query: 178 NTNRIVGTHGYMSPEYVMNGI----VSMKSDVYSFGVLVLEI 215
+ + G YM+PE + + S+KSD++S G+ ++E+
Sbjct: 167 DID--AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206
>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors
pdb|2UZU|E Chain E, Pka Structures Of Indazole-Pyridine Series Of Akt
Inhibitors
pdb|2UZV|A Chain A, Pka Structures Of Indazole-pyridine Series Of Akt
Inhibitors
pdb|2UZW|E Chain E, Pka Structures Of Indazole-Pyridine Series Of Akt
Inhibitors
Length = 336
Score = 65.1 bits (157), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 25/213 (11%)
Query: 14 AAATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAK 66
A D F LG G FG V K ++ G A+K L K Q +V+ K NE +
Sbjct: 23 TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKR 79
Query: 67 LIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIE 124
++ + LV+L +V EY+P + F ++ + RF +
Sbjct: 80 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ 135
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
IV YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + G
Sbjct: 136 -IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCG 186
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 187 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 219
>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In
A Putative Auto-Inhibition State
Length = 340
Score = 65.1 bits (157), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 60/223 (26%), Positives = 109/223 (48%), Gaps = 34/223 (15%)
Query: 11 QTIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIA 69
Q D+ P LG+G +G V K + + GQ +A+KR+ + V + + +L+
Sbjct: 44 QNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-----RATVNSQEQKRLLM 98
Query: 70 KLQHTN-------LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRF-- 120
L + V G ++G+ + E + + SLD F K+++D +
Sbjct: 99 DLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPE 152
Query: 121 ----NIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE 176
I IV+ L +LH S+L VIHRD+K SN+L++ K+ DFG++ + ++ +
Sbjct: 153 DILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS-GYLVDSVA 209
Query: 177 ANTNRIVGTHGYMSPEYVMNGI----VSMKSDVYSFGVLVLEI 215
+ G YM+PE + + S+KSD++S G+ ++E+
Sbjct: 210 KTID--AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 250
>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In
Complex With A Consensus Peptide
Length = 301
Score = 65.1 bits (157), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 18 DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 76
DNF ++G+G G V + G+ +A+K++ Q NE ++ QH N+
Sbjct: 32 DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 88
Query: 77 VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
V + L E +V E+L +L + + E ++ + ++Q L LH
Sbjct: 89 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE----EQIAAVCLAVLQALSVLHAQ 144
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
VIHRD+K+ +ILL K+SDFG +++ +VGT +M+PE +
Sbjct: 145 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISR 199
Query: 197 GIVSMKSDVYSFGVLVLEII 216
+ D++S G++V+E++
Sbjct: 200 LPYGPEVDIWSLGIMVIEMV 219
>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632
pdb|2GNL|A Chain A, Pka Threefold Mutant Model Of Rho-Kinase With Inhibitor H-
1152p
Length = 350
Score = 65.1 bits (157), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F +G G FG V K ++ G A+K L K Q +V+ K NE ++
Sbjct: 38 AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
+ + LV+L +V EY+P + F ++ + RF +
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
IV YLH L +I+RDLK N+L+D Q K++DFG A+ ++ T + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In
Complex With P38 Map Kinase
Length = 360
Score = 65.1 bits (157), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 26 NLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI DF +AR + V T Y
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLAR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 65.1 bits (157), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 21/210 (10%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K ++ G A+K L K Q +V+ K NE ++
Sbjct: 38 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKEIEHTLNEKRI 94
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
+ + LV+L +V EY P + F + RF + IV
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFSEPHARFYAAQ-IV 151
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
YLH L +I+RDLK N+++D Q K++DFG+A+ ++ T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAK-----RVKGRTWXLCGTPE 203
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein
Kinase A (Pka)
pdb|1SZM|B Chain B, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein
Kinase A (Pka)
Length = 350
Score = 64.7 bits (156), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K ++ G A+K L K Q +V+ K NE ++
Sbjct: 38 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
+ + LV+L +V EY P + F + RF + IV
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFXEPHARFYAAQ-IV 151
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
YLH L +I+RDLK N+++D Q K++DFG A+ ++ T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPE 203
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
pdb|3DNE|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
Length = 350
Score = 64.7 bits (156), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K ++ G A+K L K Q +V+ K NE ++
Sbjct: 38 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
+ + LV+L +V EY+P + F ++ + RF +
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
IV YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 8
pdb|1XH5|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|1XH6|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|1XH8|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|2GFC|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
Length = 350
Score = 64.7 bits (156), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K ++ G A+K L K Q +V+ K NE ++
Sbjct: 38 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
+ + LV+L +V EY+P + F ++ + RF +
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
IV YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl)amide
pdb|2C1B|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
(4r,2s)-5'-(4-(4-Chlorobenzyloxy)pyrrolidin-2-
Ylmethanesulfonyl)isoquinoline
pdb|2VO7|A Chain A, Structure Of Pka Complexed With 4-(4-Chlorobenzyl)-1-(7h-
Pyrrolo(2,3-D)pyrimidin-4-Yl)piperidin-4-Ylamine
pdb|3AG9|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1012
pdb|3AG9|B Chain B, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1012
Length = 351
Score = 64.7 bits (156), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K ++ G A+K L K Q +V+ K NE ++
Sbjct: 39 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 95
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
+ + LV+L +V EY+P + F ++ + RF +
Sbjct: 96 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ- 150
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
IV YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + GT
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 202
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234
>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In
Complex With Staurosporine
pdb|1Q8T|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase
(Pka) In Complex With Rho-Kinase Inhibitor Y-27632
pdb|1Q8U|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In
Complex With Rho-Kinase Inhibitor H-1152p
pdb|1SVE|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 1
pdb|1SVG|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 4
pdb|1VEB|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 5
pdb|3E8C|A Chain A, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|B Chain B, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|C Chain C, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|D Chain D, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|E Chain E, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|F Chain F, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8E|A Chain A, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|B Chain B, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|E Chain E, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|I Chain I, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|L Chain L, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|P Chain P, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
Length = 350
Score = 64.7 bits (156), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K ++ G A+K L K Q +V+ K NE ++
Sbjct: 38 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
+ + LV+L +V EY+P + F ++ + RF +
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
IV YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
>pdb|2F7E|E Chain E, Pka Complexed With
(S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6-
Yl-Pyridin-3-Yloxymethyl-Etylamine
pdb|2F7X|E Chain E, Protein Kinase A Bound To
(s)-2-(1h-indol-3-yl)-1-[5-((e)-2-
Pyridin-4-yl-vinyl)-pyridin-3-yloxymethyl]-ethylamine
pdb|2F7Z|E Chain E, Protein Kinase A Bound To
(R)-1-(1h-Indol-3-Ylmethyl)-2-(2-
Pyridin-4-Yl-[1,7]naphtyridin-5-Yloxy)-Ehylamine
pdb|2OH0|E Chain E, Crystal Structure Of Protein Kinase A In Complex With
Pyridine-Pyrazolopyridine Based Inhibitors
pdb|2OJF|E Chain E, Crystal Structure Of Protein Kinase A In Complex With
Pyridine-Pyrazolopyridine Based Inhibitors
Length = 351
Score = 64.7 bits (156), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K ++ G A+K L K Q +V+ K NE ++
Sbjct: 39 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 95
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
+ + LV+L +V EY+P + F ++ + RF +
Sbjct: 96 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ- 150
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
IV YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + GT
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGT 202
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234
>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3DY7|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3E8N|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) Complexed With A Potent Inhibitor
Rdea119 And Mgatp
pdb|3V01|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions.
pdb|3V04|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions
Length = 341
Score = 64.7 bits (156), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 49/200 (24%), Positives = 99/200 (49%), Gaps = 11/200 (5%)
Query: 18 DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAKLQHTN 75
D+F + LG G G V+K + ++L + + + E +++ +
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 76 LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
+V G GE + E++ SLD + + + + + + +++GL YL +
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 122
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
+ +++HRD+K SNIL++ + K+ DFG++ +++ N VGT YMSPE +
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPERLQ 176
Query: 196 NGIVSMKSDVYSFGVLVLEI 215
S++SD++S G+ ++E+
Sbjct: 177 GTHYSVQSDIWSMGLSLVEM 196
>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4987655 And Mgamp-Pnp
pdb|3OS3|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4858061 And Mgatp
Length = 307
Score = 64.3 bits (155), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 50/202 (24%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 18 DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAKLQHTN 75
D+F + LG G G V+K + ++L + + + E +++ +
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 76 LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK--KELLDWKKRFNIIEGIVQGLLYL 133
+V G GE + E++ SLD + + + +++L + +++GL YL
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 120
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
+ + +++HRD+K SNIL++ + K+ DFG++ +++ N VGT YMSPE
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174
Query: 194 VMNGIVSMKSDVYSFGVLVLEI 215
+ S++SD++S G+ ++E+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEM 196
>pdb|4FIE|A Chain A, Full-Length Human Pak4
pdb|4FIE|B Chain B, Full-Length Human Pak4
Length = 423
Score = 64.3 bits (155), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 18 DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 76
DNF ++G+G G V + G+ +A+K++ Q NE ++ QH N+
Sbjct: 154 DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 210
Query: 77 VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
V + L E +V E+L +L + + E ++ + ++Q L LH
Sbjct: 211 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE----EQIAAVCLAVLQALSVLHAQ 266
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
VIHRD+K+ +ILL K+SDFG +++ +VGT +M+PE +
Sbjct: 267 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISR 321
Query: 197 GIVSMKSDVYSFGVLVLEII 216
+ D++S G++V+E++
Sbjct: 322 LPYGPEVDIWSLGIMVIEMV 341
>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer
Length = 395
Score = 64.3 bits (155), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 50/202 (24%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 18 DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAKLQHTN 75
D+F + LG G G V+K + ++L + + + E +++ +
Sbjct: 68 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 76 LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK--KELLDWKKRFNIIEGIVQGLLYL 133
+V G GE + E++ SLD + + + +++L + +++GL YL
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 182
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
+ + +++HRD+K SNIL++ + K+ DFG++ +++ N VGT YMSPE
Sbjct: 183 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 236
Query: 194 VMNGIVSMKSDVYSFGVLVLEI 215
+ S++SD++S G+ ++E+
Sbjct: 237 LQGTHYSVQSDIWSMGLSLVEM 258
>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp
pdb|3PP1|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgatp
Length = 328
Score = 64.3 bits (155), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 50/202 (24%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 18 DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAKLQHTN 75
D+F + LG G G V+K + ++L + + + E +++ +
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 76 LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK--KELLDWKKRFNIIEGIVQGLLYL 133
+V G GE + E++ SLD + + + +++L + +++GL YL
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 120
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
+ + +++HRD+K SNIL++ + K+ DFG++ +++ N VGT YMSPE
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174
Query: 194 VMNGIVSMKSDVYSFGVLVLEI 215
+ S++SD++S G+ ++E+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEM 196
>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|B Chain B, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|C Chain C, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
Length = 360
Score = 64.3 bits (155), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 26 LGQGGFGPVYKGKLLDGQEI-AIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
LG+G FG V +E+ AIK L K + E +++A L + L
Sbjct: 27 LGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLH 86
Query: 82 CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
Q +RL V EY+ L + I K + + F E I GL +LHK
Sbjct: 87 SCFQTVDRLYFVMEYVNGGDLMYHIQQVGK--FKEPQAVFYAAE-ISIGLFFLHKRG--- 140
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
+I+RDLK N++LD + + KI+DFGM + M+ + T GT Y++PE +
Sbjct: 141 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGV--TTREFCGTPDYIAPEIIAYQPYG 198
Query: 201 MKSDVYSFGVLVLEIISSK 219
D +++GVL+ E+++ +
Sbjct: 199 KSVDWWAYGVLLYEMLAGQ 217
>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound
Length = 322
Score = 64.3 bits (155), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 50/202 (24%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 18 DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAKLQHTN 75
D+F + LG G G V+K + ++L + + + E +++ +
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 76 LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK--KELLDWKKRFNIIEGIVQGLLYL 133
+V G GE + E++ SLD + + + +++L + +++GL YL
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 120
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
+ + +++HRD+K SNIL++ + K+ DFG++ +++ N VGT YMSPE
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174
Query: 194 VMNGIVSMKSDVYSFGVLVLEI 215
+ S++SD++S G+ ++E+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEM 196
>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3EQB|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
Length = 333
Score = 64.3 bits (155), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 50/202 (24%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 18 DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAKLQHTN 75
D+F + LG G G V+K + ++L + + + E +++ +
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 76 LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK--KELLDWKKRFNIIEGIVQGLLYL 133
+V G GE + E++ SLD + + + +++L + +++GL YL
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 120
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
+ + +++HRD+K SNIL++ + K+ DFG++ +++ N VGT YMSPE
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174
Query: 194 VMNGIVSMKSDVYSFGVLVLEI 215
+ S++SD++S G+ ++E+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEM 196
>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb
Length = 350
Score = 64.3 bits (155), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K ++ G A+K L K Q +V+ K NE ++
Sbjct: 38 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
+ + LV+L +V EY P + F + RF + IV
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFSEPHARFYAAQ-IV 151
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
YLH L +I+RDLK N+++D Q K++DFG A+ ++ T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPE 203
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNG|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNL|A Chain A, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|1UNL|B Chain B, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|3O0G|A Chain A, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
pdb|3O0G|B Chain B, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
Length = 292
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 56/200 (28%), Positives = 107/200 (53%), Gaps = 12/200 (6%)
Query: 25 RLGQGGFGPVYKGKLLDGQEI-AIKRLS-KSSGQGIVEFK-NEAKLIAKLQHTNLVRLLG 81
++G+G +G V+K K + EI A+KR+ +G+ E L+ +L+H N+VRL
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 82 CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
+ LV+E+ ++ L + FDS +L D + + + +++GL + H + V
Sbjct: 69 VLHSDKKLTLVFEFC-DQDLKKY-FDSCNGDL-DPEIVKSFLFQLLKGLGFCHSRN---V 122
Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG-IVS 200
+HRDLK N+L++ K+++FG+AR FG+ + + +V T Y P+ + + S
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVV-TLWYRPPDVLFGAKLYS 180
Query: 201 MKSDVYSFGVLVLEIISSKK 220
D++S G + E+ ++ +
Sbjct: 181 TSIDMWSAGCIFAELANAGR 200
>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With
Compound 1, Atp-Gs And Mg2p
pdb|3EQD|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Atp-Gs
And Mg2p
pdb|3EQF|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With K252a
And Mg2p
pdb|3EQG|A Chain A, X-ray Structure Of The Human Mitogen-activated Protein
Kinase Kinase 1 (mek1) In A Ternary Complex With Pd, Adp
And Mg2p
pdb|3EQH|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With U0126,
Adp And Mg2p
pdb|3EQI|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Adp And
Mg2p
Length = 360
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 50/202 (24%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 18 DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAKLQHTN 75
D+F + LG G G V+K + ++L + + + E +++ +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 76 LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK--KELLDWKKRFNIIEGIVQGLLYL 133
+V G GE + E++ SLD + + + +++L + +++GL YL
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 147
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
+ + +++HRD+K SNIL++ + K+ DFG++ +++ N VGT YMSPE
Sbjct: 148 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 201
Query: 194 VMNGIVSMKSDVYSFGVLVLEI 215
+ S++SD++S G+ ++E+
Sbjct: 202 LQGTHYSVQSDIWSMGLSLVEM 223
>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIF|B Chain B, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIG|A Chain A, Catalytic Domain Of Human Pak4
pdb|4FIG|B Chain B, Catalytic Domain Of Human Pak4
pdb|4FIH|A Chain A, Catalytic Domain Of Human Pak4 With Qkftglprqw Peptide
pdb|4FII|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIJ|A Chain A, Catalytic Domain Of Human Pak4
Length = 346
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 18 DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 76
DNF ++G+G G V + G+ +A+K++ Q NE ++ QH N+
Sbjct: 77 DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 133
Query: 77 VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
V + L E +V E+L +L + + E ++ + ++Q L LH
Sbjct: 134 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE----EQIAAVCLAVLQALSVLHAQ 189
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
VIHRD+K+ +ILL K+SDFG +++ +VGT +M+PE +
Sbjct: 190 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISR 244
Query: 197 GIVSMKSDVYSFGVLVLEII 216
+ D++S G++V+E++
Sbjct: 245 LPYGPEVDIWSLGIMVIEMV 264
>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
pdb|3MPA|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 26 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI FG+AR + V T Y
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLAR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
pdb|3GC9|B Chain B, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
Length = 370
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 54/206 (26%), Positives = 104/206 (50%), Gaps = 27/206 (13%)
Query: 26 LGQGGFGPV---YKGKLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHTNLVRL 79
+G G +G V Y +L Q++A+K+LS+ Q ++ + E +L+ L+H N++ L
Sbjct: 36 VGSGAYGSVCSAYDARL--RQKVAVKKLSRPF-QSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 80 L-----GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
L S++ + + L L+ + + L D +F ++ +++GL Y+H
Sbjct: 93 LDVFTPATSIEDFSEVYLVTTLMGADLNNIV---KSQALSDEHVQF-LVYQLLRGLKYIH 148
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
+IHRDLK SN+ +++ +I DFG+AR + + V T Y +PE +
Sbjct: 149 SAG---IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRWYRAPEIM 200
Query: 195 MNGI-VSMKSDVYSFGVLVLEIISSK 219
+N + + D++S G ++ E++ K
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLQGK 226
>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed
With A Specific Inhibitor Of Human P38 Map Kinase
Length = 380
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 57/219 (26%), Positives = 100/219 (45%), Gaps = 49/219 (22%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLV------ 77
+G+G +G V ++ +AIK++S Q + E K++ + +H N++
Sbjct: 51 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 78 ---------------RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNI 122
L+G L K LL ++L N + +F++
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYK---LLKTQHLSNDHICYFLYQ--------------- 152
Query: 123 IEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNR 181
I++GL Y+H + V+HRDLK SN+LL+ + KI DFG+AR +
Sbjct: 153 ---ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTE 206
Query: 182 IVGTHGYMSPEYVMNGIVSMKS-DVYSFGVLVLEIISSK 219
V T Y +PE ++N KS D++S G ++ E++S++
Sbjct: 207 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245
>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With
N-(4-chlorophenyl)-2-
((pyridin-4-ylmethyl)amino)benzamide
Length = 360
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 37/92 (40%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
+ +G+ +L S + IHRDL A NILL + KI DFG+AR N
Sbjct: 208 VARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
+M+PE + + I S KSDV+S+GVL+ EI S
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296
Score = 34.7 bits (78), Expect = 0.075, Method: Compositional matrix adjust.
Identities = 33/118 (27%), Positives = 55/118 (46%), Gaps = 15/118 (12%)
Query: 8 FDFQTIAAATDNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQGIVEF 61
+D A + G LG+G FG V + K + +A+K L + G E+
Sbjct: 17 YDASKWEFARERLKLGKSLGRGAFGKVVQASAFGIKKSPTCRTVAVKMLKE--GATASEY 74
Query: 62 K---NEAKLIAKL-QHTNLVRLLG-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELL 114
K E K++ + H N+V LLG C+ Q G +++ EY +L ++ SK++L
Sbjct: 75 KALMTELKILTHIGHHLNVVNLLGACTKQGGPLMVIVEYCKYGNLSNYL--KSKRDLF 130
>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN3|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN9|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4ANB|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs
Length = 301
Score = 63.5 bits (153), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 50/202 (24%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 18 DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAKLQHTN 75
D+F + LG G G V+K + ++L + + + E +++ +
Sbjct: 9 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 76 LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK--KELLDWKKRFNIIEGIVQGLLYL 133
+V G GE + E++ SLD + + + +++L + +++GL YL
Sbjct: 69 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 123
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
+ + +++HRD+K SNIL++ + K+ DFG++ ++ N VGT YMSPE
Sbjct: 124 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDEMANEFVGTRSYMSPER 177
Query: 194 VMNGIVSMKSDVYSFGVLVLEI 215
+ S++SD++S G+ ++E+
Sbjct: 178 LQGTHYSVQSDIWSMGLSLVEM 199
>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
pdb|3SLS|B Chain B, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
Length = 304
Score = 63.5 bits (153), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 50/202 (24%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 18 DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAKLQHTN 75
D+F + LG G G V+K + ++L + + + E +++ +
Sbjct: 25 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 76 LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK--KELLDWKKRFNIIEGIVQGLLYL 133
+V G GE + E++ SLD + + + +++L + +++GL YL
Sbjct: 85 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 139
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
+ + +++HRD+K SNIL++ + K+ DFG++ +++ N VGT YMSPE
Sbjct: 140 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 193
Query: 194 VMNGIVSMKSDVYSFGVLVLEI 215
+ S++SD++S G+ ++E+
Sbjct: 194 LQGTHYSVQSDIWSMGLSLVEM 215
>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3O8T|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg-Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 63.5 bits (153), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 26 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI D G+AR + V T Y
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLAR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered
N- Terminal Helix
pdb|1XHA|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 63.5 bits (153), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 21/210 (10%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K ++ G A+K L K Q +V+ K NE ++
Sbjct: 38 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKEIEHTLNEKRI 94
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
+ + LV+L +V EY P + F + RF + IV
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFSEPHARFYAAQ-IV 151
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
YLH L +I+RDLK N+++D Q +++DFG+A+ ++ T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAK-----RVKGRTWXLCGTPE 203
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2
pdb|4AE9|B Chain B, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2
Length = 343
Score = 63.5 bits (153), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 25/213 (11%)
Query: 14 AAATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAK 66
A D F LG G FG V K + G A+K L K Q +V+ K NE +
Sbjct: 30 TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK---QKVVKLKQIEHTLNEKR 86
Query: 67 LIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIE 124
++ + LV+L +V EY+P + F ++ + RF +
Sbjct: 87 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQ 142
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
IV YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + G
Sbjct: 143 -IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCG 193
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 194 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 226
>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|B Chain B, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|C Chain C, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|D Chain D, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|E Chain E, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|F Chain F, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|G Chain G, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|H Chain H, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|I Chain I, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|J Chain J, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|K Chain K, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|L Chain L, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|M Chain M, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|N Chain N, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|O Chain O, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|P Chain P, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|Q Chain Q, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|R Chain R, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|S Chain S, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|T Chain T, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|U Chain U, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|V Chain V, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|W Chain W, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|X Chain X, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
Length = 305
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 54/221 (24%), Positives = 100/221 (45%), Gaps = 23/221 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL- 84
+G+G +G V++G L G+ +A+K S Q + E L+H N++ + +
Sbjct: 16 VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFR-ETEIYNTVLLRHDNILGFIASDMT 73
Query: 85 ---QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH-----KY 136
+ L+ Y + SL +D +++ L+ + GL +LH
Sbjct: 74 SRNSSTQLWLITHYHEHGSL----YDFLQRQTLEPHLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 137 SRLRVIHRDLKASNILLDDQMNPKISDFGMA--RTFGMNELEANTNRIVGTHGYMSPEYV 194
+ + HRD K+ N+L+ + I+D G+A + G + L+ N VGT YM+PE +
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVL 189
Query: 195 MNGIVS------MKSDVYSFGVLVLEIISSKKNNGCYDTER 229
I + +D+++FG+++ EI NG + R
Sbjct: 190 DEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVEDYR 230
>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
pdb|1S9I|B Chain B, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
Length = 354
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 51/202 (25%), Positives = 102/202 (50%), Gaps = 15/202 (7%)
Query: 18 DNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIV--EFKNEAKLIAKLQHTN 75
D+F + LG G G V K + I ++L + + + E +++ +
Sbjct: 16 DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 76 LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSK--KELLDWKKRFNIIEGIVQGLLYL 133
+V G GE + E++ SLD + ++ + +E+L + +++GL YL
Sbjct: 76 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYL 130
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEY 193
+ + +++HRD+K SNIL++ + K+ DFG++ +++ N VGT YM+PE
Sbjct: 131 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMAPER 184
Query: 194 VMNGIVSMKSDVYSFGVLVLEI 215
+ S++SD++S G+ ++E+
Sbjct: 185 LQGTHYSVQSDIWSMGLSLVEL 206
>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit
(E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein
Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24)
Isoelectric Variant Ca) And Mn2+ Adenylyl
Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c
pdb|1CDK|B Chain B, Camp-Dependent Protein Kinase Catalytic Subunit
(E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein
Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24)
Isoelectric Variant Ca) And Mn2+ Adenylyl
Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c
Length = 350
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K + G A+K L K Q +V+ K NE ++
Sbjct: 38 AHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
+ + LV+L +V EY+P + F + RF + IV
Sbjct: 95 LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFYAAQ-IV 151
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPE 203
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3OBJ|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants In
Response To Inhibitor Binding
Length = 360
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 26 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI D G+AR + V T Y
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLAR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of
Camp-Dependent Protein Kinase And An Inhibitor Peptide
Displays An Open Conformation
Length = 350
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 25/212 (11%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K + G A+K L K Q +V+ K NE ++
Sbjct: 38 AHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
+ + LV+L +V EY+P + F ++ + RF +
Sbjct: 95 LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
IV YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit
Of Camp- Dependent Protein Kinase Reveal Open And Closed
Conformations
Length = 350
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 25/212 (11%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K + G A+K L K Q +V+ K NE ++
Sbjct: 38 AHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
+ + LV+L +V EY+P + F ++ + RF +
Sbjct: 95 LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
IV YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 11 (p38 Beta) In Complex With Nilotinib
Length = 348
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 54/206 (26%), Positives = 104/206 (50%), Gaps = 27/206 (13%)
Query: 26 LGQGGFGPV---YKGKLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHTNLVRL 79
+G G +G V Y +L Q++A+K+LS+ Q ++ + E +L+ L+H N++ L
Sbjct: 28 VGSGAYGSVCSAYDARL--RQKVAVKKLSRPF-QSLIHARRTYRELRLLKHLKHENVIGL 84
Query: 80 L-----GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
L S++ + + L L+ + + L D +F ++ +++GL Y+H
Sbjct: 85 LDVFTPATSIEDFSEVYLVTTLMGADLNNIV---KCQALSDEHVQF-LVYQLLRGLKYIH 140
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
+IHRDLK SN+ +++ +I DFG+AR + + V T Y +PE +
Sbjct: 141 SAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADEEMTGYVATRWYRAPEIM 192
Query: 195 MNGI-VSMKSDVYSFGVLVLEIISSK 219
+N + + D++S G ++ E++ K
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLQGK 218
>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
pdb|2JC6|C Chain C, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
Length = 334
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 28/213 (13%)
Query: 6 KIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGI-VEFKN 63
KIF+F+ LG G F V + G+ A+K + K + +G +N
Sbjct: 22 KIFEFKET------------LGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIEN 69
Query: 64 EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDS-SKKELLDWKKRFNI 122
E ++ K++H N+V L LV + + L FD +K K +
Sbjct: 70 EIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGEL----FDRIVEKGFYTEKDASTL 125
Query: 123 IEGIVQGLLYLHKYSRLRVIHRDLKASNILL---DDQMNPKISDFGMARTFGMNELEANT 179
I ++ + YLH R+ ++HRDLK N+L D++ ISDFG+++ G ++ +
Sbjct: 126 IRQVLDAVYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTA 182
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLV 212
GT GY++PE + S D +S GV+
Sbjct: 183 ---CGTPGYVAPEVLAQKPYSKAVDCWSIGVIA 212
>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h-
Purin-6-yl)-benzyl)-amine
pdb|2UVZ|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
C-Phenyl-C-(4-( 9h-Purin-6-Yl)-Phenyl)-Methylamine
pdb|2UW0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 6-(4-(4-(4-
Chloro-Phenyl)-Piperidin-4-Yl)-Phenyl)-9h-Purine
pdb|2UW3|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 5-Methyl-4-
Phenyl-1h-Pyrazole
pdb|2UW5|A Chain A, Structure Of Pka-Pkb Chimera Complexed With (R)-2-(4-
Chloro-Phenyl)-2-(4-1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW6|A Chain A, Structure Of Pka-Pkb Chimera Complexed With (S)-2-(4-
Chloro-Phenyl)-2-(4-1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW8|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 2-(4-Chloro-
Phenyl)-2-Phenyl-Ethylamine
pdb|2VNW|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
(1-(9h-Purin-6- Yl)piperidin-4-Yl)methanamine
pdb|2VNY|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
(1-(9h-Purin-6- Yl)piperidin-4-Yl)amine
pdb|2VO3|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4-
Chlorophenyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine
pdb|2VO6|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 4-(4-
Chlorobenzyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Ylamine
Length = 351
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 21/210 (10%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K ++ G A+K L K Q +V+ K NE ++
Sbjct: 39 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 95
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
+ + L +L +V EY P + F + RF + IV
Sbjct: 96 LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFXEPHARFYAAQ-IV 152
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
YLH L +I+RDLK N+++D Q K++DFG A+ ++ T + GT
Sbjct: 153 LTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPE 204
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAA 234
>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1
Length = 327
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 54/201 (26%), Positives = 100/201 (49%), Gaps = 16/201 (7%)
Query: 26 LGQGGFGPVYKGKLLDGQE----IAIKRLSKS----SGQGIVEFKNEAKLIAKLQHTNLV 77
LG+GG+G V++ + + G A+K L K+ + + K E ++ +++H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 78 RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
L+ G+ L+ EYL L F+ + ++ F + E I L +LH+
Sbjct: 85 DLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAE-ISMALGHLHQKG 141
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG 197
+I+RDLK NI+L+ Q + K++DFG+ + + T+ GT YM+PE +M
Sbjct: 142 ---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD--GTVTHXFCGTIEYMAPEILMRS 196
Query: 198 IVSMKSDVYSFGVLVLEIISS 218
+ D +S G L+ ++++
Sbjct: 197 GHNRAVDWWSLGALMYDMLTG 217
>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp
pdb|1Q62|A Chain A, Pka Double Mutant Model Of Pkb
Length = 350
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 25/212 (11%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K ++ G A+K L K Q +V+ K NE ++
Sbjct: 38 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
+ + LV+L +V EY P + F ++ + RF +
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
IV YLH L +I+RDLK N+++D Q +++DFG A+ ++ T + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3OBG|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants In
Response To Inhibitor Binding
pdb|3OC1|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 26/211 (12%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHT 74
N SP +G G +G V G +A+K+LS+ Q I+ K E +L+ ++H
Sbjct: 26 NLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 81
Query: 75 NLVRLLGC-----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ LL SL++ + + +L L+ + ++L D +F +I I++G
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRG 137
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYM 189
L Y+H +IHRDLK SN+ +++ KI D G+AR + V T Y
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLAR-----HTDDEMTGYVATRWYR 189
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE ++N + + D++S G ++ E+++ +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A60|B Chain B, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A61|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form Ii)
Length = 327
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 54/201 (26%), Positives = 100/201 (49%), Gaps = 16/201 (7%)
Query: 26 LGQGGFGPVYKGKLLDGQE----IAIKRLSKS----SGQGIVEFKNEAKLIAKLQHTNLV 77
LG+GG+G V++ + + G A+K L K+ + + K E ++ +++H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 78 RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
L+ G+ L+ EYL L F+ + ++ F + E I L +LH+
Sbjct: 85 DLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAE-ISMALGHLHQKG 141
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG 197
+I+RDLK NI+L+ Q + K++DFG+ + + +T GT YM+PE +M
Sbjct: 142 ---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYMAPEILMRS 196
Query: 198 IVSMKSDVYSFGVLVLEIISS 218
+ D +S G L+ ++++
Sbjct: 197 GHNRAVDWWSLGALMYDMLTG 217
>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit Calpha 2
pdb|4AE6|B Chain B, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit Calpha 2
Length = 343
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 25/213 (11%)
Query: 14 AAATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAK 66
A D F LG G FG V K + G A+K L K Q +V+ K NE +
Sbjct: 30 TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK---QKVVKLKQIEHTLNEKR 86
Query: 67 LIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIE 124
++ + LV+L +V EY+P + F ++ + RF +
Sbjct: 87 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ 142
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
IV YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + G
Sbjct: 143 -IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCG 193
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 194 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 226
>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
pdb|3GC8|B Chain B, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
Length = 370
Score = 62.8 bits (151), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 54/206 (26%), Positives = 104/206 (50%), Gaps = 27/206 (13%)
Query: 26 LGQGGFGPV---YKGKLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQHTNLVRL 79
+G G +G V Y +L Q++A+K+LS+ Q ++ + E +L+ L+H N++ L
Sbjct: 36 VGSGAYGSVCSAYDARL--RQKVAVKKLSRPF-QSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 80 L-----GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
L S++ + + L L+ + + L D +F ++ +++GL Y+H
Sbjct: 93 LDVFTPATSIEDFSEVYLVTTLMGADLNNIV---KCQALSDEHVQF-LVYQLLRGLKYIH 148
Query: 135 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
+IHRDLK SN+ +++ +I DFG+AR + + V T Y +PE +
Sbjct: 149 SAG---IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRWYRAPEIM 200
Query: 195 MNGI-VSMKSDVYSFGVLVLEIISSK 219
+N + + D++S G ++ E++ K
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLQGK 226
>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1039
pdb|3AGL|B Chain B, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1039
pdb|3VQH|A Chain A, Bromine Sad Partially Resolves Multiple Binding Modes For
Pka Inhibitor H-89
Length = 351
Score = 62.8 bits (151), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 25/212 (11%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K + G A+K L K Q +V+ K NE ++
Sbjct: 39 AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 95
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
+ + LV+L +V EY+P + F ++ + RF +
Sbjct: 96 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ- 150
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
IV YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + GT
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 202
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234
>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|B Chain B, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|C Chain C, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|D Chain D, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|E Chain E, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|F Chain F, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
Length = 285
Score = 62.8 bits (151), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 18/213 (8%)
Query: 18 DNFSPGNRLGQGGFGPVY-KGKLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTN 75
D F +LG G FG V+ + G E IK ++K Q +E + E +++ L H N
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 76 LVRLLGCSLQKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
++++ +V E L + + ++ + L +++ ++ L Y H
Sbjct: 82 IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 135 KYSRLRVIHRDLKASNILLDDQ--MNP-KISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
V+H+DLK NIL D +P KI DFG+A F +E N GT YM+P
Sbjct: 142 SQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNA---AGTALYMAP 195
Query: 192 EYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGC 224
E V V+ K D++S GV++ +++ GC
Sbjct: 196 E-VFKRDVTFKCDIWSAGVVMYFLLT-----GC 222
>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol
Length = 351
Score = 62.8 bits (151), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 25/212 (11%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K + G A+K L K Q +V+ K NE ++
Sbjct: 39 AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 95
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
+ + LV+L +V EY+P + F ++ + RF +
Sbjct: 96 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ- 150
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
IV YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + GT
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 202
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234
>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-670
pdb|3L9L|A Chain A, Crystal Structure Of Pka With Compound 36
pdb|3L9L|B Chain B, Crystal Structure Of Pka With Compound 36
pdb|3OOG|A Chain A, Human Camp-Dependent Protein Kinase In Complex With A
Small Fragment
pdb|3OVV|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3OWP|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3OXT|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3P0M|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3POO|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
Length = 351
Score = 62.8 bits (151), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 25/212 (11%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K + G A+K L K Q +V+ K NE ++
Sbjct: 39 AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 95
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
+ + LV+L +V EY+P + F ++ + RF +
Sbjct: 96 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQ- 150
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
IV YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + GT
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 202
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234
>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1
Reveals A Novel Autoinhibitory Conformation For A Dual
Kinase Protein
Length = 355
Score = 62.8 bits (151), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 105/211 (49%), Gaps = 18/211 (8%)
Query: 18 DNFSPGNRLGQGGFGPVYKGKLLDGQEI----AIKRLSKSS----GQGIVEFKNEAKLIA 69
+NF LG G +G V+ + + G + A+K L K++ + + E +++
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 70 KLQHTNLVRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ 128
++ + + L + Q +L L+ +Y+ L F S ++ + + + + E IV
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIYVGE-IVL 170
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
L +LHK L +I+RD+K NILLD + ++DFG+++ F +E E + GT Y
Sbjct: 171 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEY 226
Query: 189 MSPEYVMNGIVSMKS--DVYSFGVLVLEIIS 217
M+P+ V G D +S GVL+ E+++
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 257
>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase
Catalytic Subunit From Saccharomyces Cerevisiae
Length = 318
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 56/196 (28%), Positives = 94/196 (47%), Gaps = 15/196 (7%)
Query: 26 LGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGI--VEFKNEAKLIAKL-QHTNLVRLLG 81
LG G FG V+ + +G+ A+K L K + VE N+ +L+ + H ++R+ G
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 82 CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
+ ++ +Y+ L F + + +F E + L YLH +
Sbjct: 74 TFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYAAE-VCLALEYLHSKD---I 127
Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSM 201
I+RDLK NILLD + KI+DFG A+ + T + GT Y++PE V +
Sbjct: 128 IYRDLKPENILLDKNGHIKITDFGFAKY-----VPDVTYXLCGTPDYIAPEVVSTKPYNK 182
Query: 202 KSDVYSFGVLVLEIIS 217
D +SFG+L+ E+++
Sbjct: 183 SIDWWSFGILIYEMLA 198
>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDV|A Chain A, Structure Of Pka-Pkb Chimera Complexed With A-443654
pdb|2UVX|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 7-Azaindole
pdb|2UW4|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
2-(4-(5-Methyl- 1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW7|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|4AXA|A Chain A, Structure Of Pka-pkb Chimera Complexed With
(1s)-2-amino-1-(
4-chlorophenyl)-1-(4-(1h-pyrazol-4-yl)phenyl)ethan-1-ol
Length = 351
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 21/210 (10%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K ++ G A+K L K Q +V+ K NE ++
Sbjct: 39 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 95
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
+ + L +L +V EY P + F + RF + IV
Sbjct: 96 LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFSEPHARFYAAQ-IV 152
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
YLH L +I+RDLK N+++D Q K++DFG A+ ++ T + GT
Sbjct: 153 LTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPE 204
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAA 234
>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4-
Chlorophenyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine
Length = 351
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 21/210 (10%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K ++ G A+K L K Q +V+ K NE ++
Sbjct: 39 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 95
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
+ + L +L +V EY P + F + RF + IV
Sbjct: 96 LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFSEPHARFYAAQ-IV 152
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
YLH L +I+RDLK N+++D Q K++DFG A+ ++ T + GT
Sbjct: 153 LTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPE 204
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAA 234
>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
pdb|2VN9|B Chain B, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
Length = 301
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 17 TDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLS--KSSGQGIVEFKNEAKLIAKLQH 73
TD + LG+G F V + K+ GQE A K ++ K S + + + EA++ L+H
Sbjct: 3 TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 74 TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
N+VRL ++G LV++ + L D +E + I+ I++ + +
Sbjct: 63 PNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANTNR---IVGTHG 187
H ++HRDLK N+LL + K++DFG+A E++ + GT G
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLA-----IEVQGDQQAWFGFAGTPG 171
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLV 212
Y+SPE + D+++ GV++
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVIL 196
>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With
Nms-P937
pdb|4A4L|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
5-(2-Amino-Pyrimidin-4-Yl)-1h-Pyrrole Inhibitor
pdb|4A4O|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
2-
(2-Amino-Pyrimidin-4-Yl)-1,5,6,
7-Tetrahydro-Pyrrolopyridin- 4-One Inhibitor
Length = 311
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 55/198 (27%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRLSKSS----GQGIVEFKNEAKLIAKLQHTNLVRLLG 81
LG+GGF ++ D +E+ ++ S + E + L H ++V G
Sbjct: 25 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 82 CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
+V E +SL +K L + + R+ + IV G YLH R RV
Sbjct: 85 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 138
Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSM 201
IHRDLK N+ L++ + KI DFG+A + T + GT Y++PE + S
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 196
Query: 202 KSDVYSFGVLVLEIISSK 219
+ DV+S G ++ ++ K
Sbjct: 197 EVDVWSIGCIMYTLLVGK 214
>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue
pdb|2PMN|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp-Site
Inhibitor
pdb|2PMO|X Chain X, Crystal Structure Of Pfpk7 In Complex With Hymenialdisine
Length = 348
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 13/160 (8%)
Query: 60 EFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSL-----DFFIFDSSKKELL 114
+FKNE ++I +++ + G E ++YEY+ N S+ FF+ D + +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 115 DWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE 174
+ II+ ++ Y+H + + HRD+K SNIL+D K+SDFG + +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 175 LEANTNRIVGTHGYMSPEYVMN--GIVSMKSDVYSFGVLV 212
++ + GT+ +M PE+ N K D++S G+ +
Sbjct: 207 IKGSR----GTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242
>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
pdb|2JAM|B Chain B, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
Length = 304
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 56/191 (29%), Positives = 91/191 (47%), Gaps = 16/191 (8%)
Query: 26 LGQGGFGPVYKGKL-LDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
LG G F V+ K L G+ A+K + KS +NE ++ K++H N+V L
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 85 QKGERLLVYEYLPNKSLDFFIFDSS-KKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
LV + + L FD ++ + K +I+ ++ + YLH+ ++H
Sbjct: 77 STTHYYLVMQLVSGGEL----FDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVH 129
Query: 144 RDLKASNIL-LDDQMNPKISDFGMARTFGMNELEAN--TNRIVGTHGYMSPEYVMNGIVS 200
RDLK N+L L + N KI M FG++++E N + GT GY++PE + S
Sbjct: 130 RDLKPENLLYLTPEENSKI----MITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYS 185
Query: 201 MKSDVYSFGVL 211
D +S GV+
Sbjct: 186 KAVDCWSIGVI 196
>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2-
Phenylcyclopropyl)urea
Length = 293
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 25/204 (12%)
Query: 26 LGQGGFGPVYKG--KLLDGQEIAIKRLSKSSGQGIV---EFKNEAKLIAKLQHTNLVRLL 80
LG G FG V KG ++ + ++ K+ E EA ++ +L + +VR++
Sbjct: 35 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 81 G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
G C + +LV E L+ ++ + + D K ++ + G+ YL + +
Sbjct: 95 GICEAESW--MLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 147
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI-VGTHG-----YMSPEY 193
+HRDL A N+LL Q KISDFG+++ L A+ N THG + +PE
Sbjct: 148 -FVHRDLAARNVLLVTQHYAKISDFGLSKA-----LRADENYYKAQTHGKWPVKWYAPEC 201
Query: 194 VMNGIVSMKSDVYSFGVLVLEIIS 217
+ S KSDV+SFGVL+ E S
Sbjct: 202 INYYKFSSKSDVWSFGVLMWEAFS 225
>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Pyrazolylbenzimidazole Inhibitor 416
pdb|3VF9|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Thienopyrazolylindole Inhibitor 027
pdb|3TUC|A Chain A, Crystal Structure Of Syk Kinase Domain With
1-Benzyl-N-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-2-Oxo-1,
2-Dihydropyridine-3- Carboxamide
pdb|3TUD|A Chain A, Crystal Structure Of Syk Kinase Domain With
N-(4-Methyl-3-(8-Methyl-7-
Oxo-2-(Phenylamino)-7,8-Dihydropyrido[2,
3-D]pyrimidin-6-Yl)phenyl)-3- (Trifluoromethyl)benzamide
Length = 299
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 25/204 (12%)
Query: 26 LGQGGFGPVYKG--KLLDGQEIAIKRLSKSSGQGIV---EFKNEAKLIAKLQHTNLVRLL 80
LG G FG V KG ++ + ++ K+ E EA ++ +L + +VR++
Sbjct: 35 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 81 G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
G C + +LV E L+ ++ + + D K ++ + G+ YL + +
Sbjct: 95 GICEAESW--MLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 147
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI-VGTHG-----YMSPEY 193
+HRDL A N+LL Q KISDFG+++ L A+ N THG + +PE
Sbjct: 148 -FVHRDLAARNVLLVTQHYAKISDFGLSKA-----LRADENYYKAQTHGKWPVKWYAPEC 201
Query: 194 VMNGIVSMKSDVYSFGVLVLEIIS 217
+ S KSDV+SFGVL+ E S
Sbjct: 202 INYYKFSSKSDVWSFGVLMWEAFS 225
>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 311
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 55/198 (27%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRLSKSS----GQGIVEFKNEAKLIAKLQHTNLVRLLG 81
LG+GGF ++ D +E+ ++ S + E + L H ++V G
Sbjct: 25 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 82 CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
+V E +SL +K L + + R+ + IV G YLH R RV
Sbjct: 85 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 138
Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSM 201
IHRDLK N+ L++ + KI DFG+A + T + GT Y++PE + S
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 196
Query: 202 KSDVYSFGVLVLEIISSK 219
+ DV+S G ++ ++ K
Sbjct: 197 EVDVWSIGCIMYTLLVGK 214
>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
pdb|3MVJ|B Chain B, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
pdb|3MVJ|E Chain E, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
Length = 371
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K + G A+K L K Q +V+ K NE ++
Sbjct: 59 AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 115
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
+ + LV+L +V EY+P + F + RF + IV
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFYAAQ-IV 172
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + GT
Sbjct: 173 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPE 224
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 225 YLAPEIILSKGYNKAVDWWALGVLIYEMAA 254
>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In
Complex With A Selective Darpin
pdb|2V5Q|B Chain B, Crystal Structure Of Wild-type Plk-1 Kinase Domain In
Complex With A Selective Darpin
Length = 315
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 55/198 (27%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRLSKSS----GQGIVEFKNEAKLIAKLQHTNLVRLLG 81
LG+GGF ++ D +E+ ++ S + E + L H ++V G
Sbjct: 29 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 82 CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
+V E +SL +K L + + R+ + IV G YLH R RV
Sbjct: 89 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 142
Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSM 201
IHRDLK N+ L++ + KI DFG+A + T + GT Y++PE + S
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 200
Query: 202 KSDVYSFGVLVLEIISSK 219
+ DV+S G ++ ++ K
Sbjct: 201 EVDVWSIGCIMYTLLVGK 218
>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX
Length = 358
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
+G+G +G V L+ +AIK++S Q + E K++ + +H N++ +
Sbjct: 29 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ Y+ ++ ++ K + L + I++GL Y+H + V+H
Sbjct: 89 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 145
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
RDLK SN+LL+ + KI DFG+AR + V T Y +PE ++N K
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 203 S-DVYSFGVLVLEIISSK 219
S D++S G ++ E++S++
Sbjct: 206 SIDIWSVGCILAEMLSNR 223
>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN-
Dependent Protein Kinase Ii Delta In Complex With
Calmodulin
Length = 327
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 17 TDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLS--KSSGQGIVEFKNEAKLIAKLQH 73
TD + LG+G F V + K+ GQE A K ++ K S + + + EA++ L+H
Sbjct: 3 TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 74 TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
N+VRL ++G LV++ + L D +E + I+ I++ + +
Sbjct: 63 PNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANTNR---IVGTHG 187
H ++HRDLK N+LL + K++DFG+A E++ + GT G
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLA-----IEVQGDQQAWFGFAGTPG 171
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLV 212
Y+SPE + D+++ GV++
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVIL 196
>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e)
Length = 358
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
+G+G +G V L+ +AIK++S Q + E K++ + +H N++ +
Sbjct: 29 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ Y+ ++ ++ K + L + I++GL Y+H + V+H
Sbjct: 89 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 145
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
RDLK SN+LL+ + KI DFG+AR + V T Y +PE ++N K
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 203 S-DVYSFGVLVLEIISSK 219
S D++S G ++ E++S++
Sbjct: 206 SIDIWSVGCILAEMLSNR 223
>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Map Kinase Erk2
Length = 365
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
+G+G +G V L+ +AIK++S Q + E K++ + +H N++ +
Sbjct: 36 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ Y+ ++ ++ K + L + I++GL Y+H + V+H
Sbjct: 96 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 152
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
RDLK SN+LL+ + KI DFG+AR + V T Y +PE ++N K
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 212
Query: 203 S-DVYSFGVLVLEIISSK 219
S D++S G ++ E++S++
Sbjct: 213 SIDIWSVGCILAEMLSNR 230
>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In
Complex With
(4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin
2-Yl]amino}phenyl)acetic Acid
Length = 366
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
+G+G +G V L+ +AIK++S Q + E K++ + +H N++ +
Sbjct: 37 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ Y+ ++ ++ K + L + I++GL Y+H + V+H
Sbjct: 97 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 153
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
RDLK SN+LL+ + KI DFG+AR + V T Y +PE ++N K
Sbjct: 154 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 213
Query: 203 S-DVYSFGVLVLEIISSK 219
S D++S G ++ E++S++
Sbjct: 214 SIDIWSVGCILAEMLSNR 231
>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
pdb|3C9W|B Chain B, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
Length = 357
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
+G+G +G V L+ +AIK++S Q + E K++ + +H N++ +
Sbjct: 28 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ Y+ ++ ++ K + L + I++GL Y+H + V+H
Sbjct: 88 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 144
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
RDLK SN+LL+ + KI DFG+AR + V T Y +PE ++N K
Sbjct: 145 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 204
Query: 203 S-DVYSFGVLVLEIISSK 219
S D++S G ++ E++S++
Sbjct: 205 SIDIWSVGCILAEMLSNR 222
>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|2FYS|A Chain A, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|1ERK|A Chain A, Structure Of Signal-Regulated Kinase
pdb|3ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2SB220025
pdb|4ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2OLOMOUCINE
pdb|3QYI|A Chain A, Map Kinase Erk2 Complexed With
1,1-Dioxo-2,3-Dihydrothiophen-3-Yl Benzenesulfonate
Length = 364
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
+G+G +G V L+ +AIK++S Q + E K++ + +H N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ Y+ ++ ++ K + L + I++GL Y+H + V+H
Sbjct: 95 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
RDLK SN+LL+ + KI DFG+AR + V T Y +PE ++N K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 203 S-DVYSFGVLVLEIISSK 219
S D++S G ++ E++S++
Sbjct: 212 SIDIWSVGCILAEMLSNR 229
>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 18
pdb|3L9M|B Chain B, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 18
pdb|3L9N|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 27
Length = 351
Score = 62.4 bits (150), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K + G A+K L K Q +V+ K NE ++
Sbjct: 39 AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 95
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
+ + LV+L +V EY P + F ++ + RF +
Sbjct: 96 LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQ- 150
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
IV YLH L +I+RDLK N+++D Q K++DFG A+ ++ T + GT
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGT 202
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234
>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536
Length = 294
Score = 62.4 bits (150), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRLSKSS----GQGIVEFKNEAKLIAKLQHTNLVRLLG 81
LG+GGF ++ D +E+ ++ S + E + L H ++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 82 CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
+V E +SL +K L + + R+ + IV G YLH R RV
Sbjct: 83 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 136
Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR---IVGTHGYMSPEYVMNGI 198
IHRDLK N+ L++ + KI DFG+A ++E + R + GT Y++PE +
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKG 191
Query: 199 VSMKSDVYSFGVLVLEIISSK 219
S + DV+S G ++ ++ K
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGK 212
>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|3QYZ|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|4GT3|A Chain A, Atp-Bound Form Of The Erk2 Kinase
pdb|4GVA|A Chain A, Adp-Bound Form Of The Erk2 Kinase
Length = 364
Score = 62.4 bits (150), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
+G+G +G V L+ +AIK++S Q + E K++ + +H N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ Y+ ++ ++ K + L + I++GL Y+H + V+H
Sbjct: 95 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
RDLK SN+LL+ + KI DFG+AR + V T Y +PE ++N K
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 203 S-DVYSFGVLVLEIISSK 219
S D++S G ++ E++S++
Sbjct: 212 SIDIWSVGCILAEMLSNR 229
>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562
Length = 364
Score = 62.4 bits (150), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 12 TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
T+ N P QG Y L + +AIK+LS+ F+N+ AK
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKR 69
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
+ LV L+ C K L+ + P K+L+ F + D++ ++ LD ++
Sbjct: 70 AYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERM 128
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
++ ++ G+ +LH +IHRDLK SNI++ KI DFG+ART G + +
Sbjct: 129 SYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFM---M 182
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
V T Y +PE ++ D++S G ++ E++ K
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222
>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
pdb|1Y6B|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
Length = 366
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 19/169 (11%)
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
+ +G+ +L + + IHRDL A NILL ++ KI DFG+AR +
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGK 245
+M+PE + + + +++SDV+SFGVL+ EI S L Y +E
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------------LGASPYPGVKIDEEF 310
Query: 246 ALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPTMSDVASMLTN 293
L + T +PD T ++ +L C + + RPT S++ L N
Sbjct: 311 CRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 357
Score = 28.9 bits (63), Expect = 4.6, Method: Compositional matrix adjust.
Identities = 28/121 (23%), Positives = 53/121 (43%), Gaps = 10/121 (8%)
Query: 8 FDFQTIAAATDNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQG-IVE 60
+D D G LG+G FG V + K + +A+K L + +
Sbjct: 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 61 FKNEAKLIAKL-QHTNLVRLLG-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKK 118
+E K++ + H N+V LLG C+ G +++ E+ +L ++ S + E + +K
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKT 135
Query: 119 R 119
+
Sbjct: 136 K 136
>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Back Pocket Binder
Length = 368
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 19/169 (11%)
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
+ +G+ +L + + IHRDL A NILL ++ KI DFG+AR +
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGK 245
+M+PE + + + +++SDV+SFGVL+ EI S L Y +E
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------------LGASPYPGVKIDEEF 312
Query: 246 ALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPTMSDVASMLTN 293
L + T +PD T ++ +L C + + RPT S++ L N
Sbjct: 313 CRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 359
Score = 28.9 bits (63), Expect = 4.6, Method: Compositional matrix adjust.
Identities = 28/121 (23%), Positives = 53/121 (43%), Gaps = 10/121 (8%)
Query: 8 FDFQTIAAATDNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQG-IVE 60
+D D G LG+G FG V + K + +A+K L + +
Sbjct: 19 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 78
Query: 61 FKNEAKLIAKL-QHTNLVRLLG-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKK 118
+E K++ + H N+V LLG C+ G +++ E+ +L ++ S + E + +K
Sbjct: 79 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKT 137
Query: 119 R 119
+
Sbjct: 138 K 138
>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A
Benzolactam-Derived Inhibitor
Length = 333
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRLSKSS----GQGIVEFKNEAKLIAKLQHTNLVRLLG 81
LG+GGF ++ D +E+ ++ S + E + L H ++V G
Sbjct: 47 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 82 CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
+V E +SL +K L + + R+ + IV G YLH R RV
Sbjct: 107 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 160
Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR---IVGTHGYMSPEYVMNGI 198
IHRDLK N+ L++ + KI DFG+A ++E + R + GT Y++PE +
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKG 215
Query: 199 VSMKSDVYSFGVLVLEIISSK 219
S + DV+S G ++ ++ K
Sbjct: 216 HSFEVDVWSIGCIMYTLLVGK 236
>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like
Kinase 1
pdb|2OWB|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like
Kinase 1
pdb|3FC2|A Chain A, Plk1 In Complex With Bi6727
Length = 335
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRLSKSS----GQGIVEFKNEAKLIAKLQHTNLVRLLG 81
LG+GGF ++ D +E+ ++ S + E + L H ++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 82 CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
+V E +SL +K L + + R+ + IV G YLH R RV
Sbjct: 109 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 162
Query: 142 IHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNR---IVGTHGYMSPEYVMNGI 198
IHRDLK N+ L++ + KI DFG+A ++E + R + GT Y++PE +
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKG 217
Query: 199 VSMKSDVYSFGVLVLEIISSK 219
S + DV+S G ++ ++ K
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGK 238
>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2-
Phenylaminopyrimidines As Potent Inhibitors Of Spleen
Tyrosine Kinase (Syk)
Length = 291
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 25/204 (12%)
Query: 26 LGQGGFGPVYKG--KLLDGQEIAIKRLSKSSGQGIV---EFKNEAKLIAKLQHTNLVRLL 80
LG G FG V KG ++ + ++ K+ E EA ++ +L + +VR++
Sbjct: 33 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 81 G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
G C + +LV E L+ ++ + + D K ++ + G+ YL + +
Sbjct: 93 GICEAESW--MLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 145
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI-VGTHG-----YMSPEY 193
+HRDL A N+LL Q KISDFG+++ L A+ N THG + +PE
Sbjct: 146 -FVHRDLAARNVLLVTQHYAKISDFGLSKA-----LRADENYYKAQTHGKWPVKWYAPEC 199
Query: 194 VMNGIVSMKSDVYSFGVLVLEIIS 217
+ S KSDV+SFGVL+ E S
Sbjct: 200 INYYKFSSKSDVWSFGVLMWEAFS 223
>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 25/204 (12%)
Query: 26 LGQGGFGPVYKG--KLLDGQEIAIKRLSKSSGQGIV---EFKNEAKLIAKLQHTNLVRLL 80
LG G FG V KG ++ + ++ K+ E EA ++ +L + +VR++
Sbjct: 19 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 81 G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
G C + +LV E L+ ++ + + D K ++ + G+ YL + +
Sbjct: 79 GICEAESW--MLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 131
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI-VGTHG-----YMSPEY 193
+HRDL A N+LL Q KISDFG+++ L A+ N THG + +PE
Sbjct: 132 -FVHRDLAARNVLLVTQHYAKISDFGLSKA-----LRADENXYKAQTHGKWPVKWYAPEC 185
Query: 194 VMNGIVSMKSDVYSFGVLVLEIIS 217
+ S KSDV+SFGVL+ E S
Sbjct: 186 INYYKFSSKSDVWSFGVLMWEAFS 209
>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A
Novel Pyrrolopyrimidine Inhibitor
Length = 359
Score = 62.0 bits (149), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 19/169 (11%)
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
+ +G+ +L + + IHRDL A NILL ++ KI DFG+AR +
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGK 245
+M+PE + + + +++SDV+SFGVL+ EI S L Y +E
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------------LGASPYPGVKIDEEF 305
Query: 246 ALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPTMSDVASMLTN 293
L + T +PD T ++ +L C + + RPT S++ L N
Sbjct: 306 CRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352
Score = 28.9 bits (63), Expect = 4.7, Method: Compositional matrix adjust.
Identities = 28/121 (23%), Positives = 53/121 (43%), Gaps = 10/121 (8%)
Query: 8 FDFQTIAAATDNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQG-IVE 60
+D D G LG+G FG V + K + +A+K L + +
Sbjct: 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 71
Query: 61 FKNEAKLIAKL-QHTNLVRLLG-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKK 118
+E K++ + H N+V LLG C+ G +++ E+ +L ++ S + E + +K
Sbjct: 72 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKT 130
Query: 119 R 119
+
Sbjct: 131 K 131
>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
pdb|2R9S|B Chain B, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
Length = 356
Score = 62.0 bits (149), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 12 TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
T+ N P QG Y L + +AIK+LS+ F+N+ AK
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKR 62
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
+ LV L+ C K L+ + P K+L+ F + D++ ++ LD ++
Sbjct: 63 AYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERM 121
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
++ ++ G+ +LH +IHRDLK SNI++ KI DFG+ART G + +
Sbjct: 122 SYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFM---M 175
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
V T Y +PE ++ D++S G ++ E++ K
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain
pdb|1XBB|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Gleevec
pdb|1XBC|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Staurosporin
pdb|3FQE|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
Ym193306
pdb|3FQH|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQH|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQS|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
R406
pdb|4FL1|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
pdb|4FYN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
3-(8-{4-
[ethyl-(2-hydroxy-ethyl)-amino]-phenylamino}-imidazo[1,
2-a]pyrazin-5- Yl)-phenol
pdb|4FYO|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
N-{(s)-1-
[7-(3,4-dimethoxy-phenylamino)-thiazolo[5,
4-d]pyrimidin-5-yl]- Pyrrolidin-3-yl}-terephthalamic
Acid
pdb|4FZ6|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
[6-((s)-2-
Methyl-pyrrolidin-1-yl)-pyridin-2-yl]-(6-phenyl-
imidazo[1,2- B]pyridazin-8-yl)-amine
Length = 291
Score = 62.0 bits (149), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 25/204 (12%)
Query: 26 LGQGGFGPVYKG--KLLDGQEIAIKRLSKSSGQGIV---EFKNEAKLIAKLQHTNLVRLL 80
LG G FG V KG ++ + ++ K+ E EA ++ +L + +VR++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 81 G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
G C + +LV E L+ ++ + + D K ++ + G+ YL + +
Sbjct: 85 GICEAESW--MLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 137
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI-VGTHG-----YMSPEY 193
+HRDL A N+LL Q KISDFG+++ L A+ N THG + +PE
Sbjct: 138 -FVHRDLAARNVLLVTQHYAKISDFGLSKA-----LRADENYYKAQTHGKWPVKWYAPEC 191
Query: 194 VMNGIVSMKSDVYSFGVLVLEIIS 217
+ S KSDV+SFGVL+ E S
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFS 215
>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With
Compound A
Length = 356
Score = 62.0 bits (149), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 19/169 (11%)
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
+ +G+ +L + + IHRDL A NILL ++ KI DFG+AR +
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGK 245
+M+PE + + + +++SDV+SFGVL+ EI S L Y +E
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------------LGASPYPGVKIDEEF 303
Query: 246 ALELIDTTLHESCSPDEVTRCIHVGLL-CVQDKATDRPTMSDVASMLTN 293
L + T +PD T ++ +L C + + RPT S++ L N
Sbjct: 304 CRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 350
Score = 28.9 bits (63), Expect = 4.5, Method: Compositional matrix adjust.
Identities = 28/121 (23%), Positives = 53/121 (43%), Gaps = 10/121 (8%)
Query: 8 FDFQTIAAATDNFSPGNRLGQGGFGPVYKG------KLLDGQEIAIKRLSKSSGQG-IVE 60
+D D G LG+G FG V + K + +A+K L + +
Sbjct: 10 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 69
Query: 61 FKNEAKLIAKL-QHTNLVRLLG-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKK 118
+E K++ + H N+V LLG C+ G +++ E+ +L ++ S + E + +K
Sbjct: 70 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKT 128
Query: 119 R 119
+
Sbjct: 129 K 129
>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
pdb|3ZUV|C Chain C, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
Length = 364
Score = 62.0 bits (149), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
+G+G +G V L+ +AIK++S Q + E K++ + +H N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ Y+ ++ ++ K + L + I++GL Y+H + V+H
Sbjct: 95 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
RDLK SN+LL+ + KI DFG+AR + V T Y +PE ++N K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 211
Query: 203 S-DVYSFGVLVLEIISSK 219
S D++S G ++ E++S++
Sbjct: 212 SIDIWSVGCILAEMLSNR 229
>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A Sulfonamidopyrazine Piperidine Inhibitor
pdb|4DFN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
An Adamantylpyrazine Inhibitor
Length = 274
Score = 62.0 bits (149), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 25/204 (12%)
Query: 26 LGQGGFGPVYKG--KLLDGQEIAIKRLSKSSGQGIV---EFKNEAKLIAKLQHTNLVRLL 80
LG G FG V KG ++ + ++ K+ E EA ++ +L + +VR++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 81 G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
G C + +LV E L+ ++ + + D K ++ + G+ YL + +
Sbjct: 75 GICEAESW--MLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 127
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI-VGTHG-----YMSPEY 193
+HRDL A N+LL Q KISDFG+++ L A+ N THG + +PE
Sbjct: 128 -FVHRDLAARNVLLVTQHYAKISDFGLSKA-----LRADENYYKAQTHGKWPVKWYAPEC 181
Query: 194 VMNGIVSMKSDVYSFGVLVLEIIS 217
+ S KSDV+SFGVL+ E S
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFS 205
>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2
Length = 365
Score = 62.0 bits (149), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
+G+G +G V L+ +AIK++S Q + E K++ + +H N++ +
Sbjct: 36 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ Y+ ++ ++ K + L + I++GL Y+H + V+H
Sbjct: 96 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 152
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
RDLK SN+LL+ + KI DFG+AR + V T Y +PE ++N K
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 212
Query: 203 S-DVYSFGVLVLEIISSK 219
S D++S G ++ E++S++
Sbjct: 213 SIDIWSVGCILAEMLSNR 230
>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836
Length = 273
Score = 62.0 bits (149), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 25/204 (12%)
Query: 26 LGQGGFGPVYKG--KLLDGQEIAIKRLSKSSGQGIV---EFKNEAKLIAKLQHTNLVRLL 80
LG G FG V KG ++ + ++ K+ E EA ++ +L + +VR++
Sbjct: 13 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 81 G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
G C + +LV E L+ ++ + + D K ++ + G+ YL + +
Sbjct: 73 GICEAESW--MLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 125
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI-VGTHG-----YMSPEY 193
+HRDL A N+LL Q KISDFG+++ L A+ N THG + +PE
Sbjct: 126 -FVHRDLAARNVLLVTQHYAKISDFGLSKA-----LRADENYYKAQTHGKWPVKWYAPEC 179
Query: 194 VMNGIVSMKSDVYSFGVLVLEIIS 217
+ S KSDV+SFGVL+ E S
Sbjct: 180 INYYKFSSKSDVWSFGVLMWEAFS 203
>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|B Chain B, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|C Chain C, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|D Chain D, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
Length = 316
Score = 62.0 bits (149), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 59/217 (27%), Positives = 106/217 (48%), Gaps = 34/217 (15%)
Query: 17 TDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTN 75
D+ P LG+G +G V K + + GQ A+KR+ + V + + +L+ L +
Sbjct: 33 ADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRI-----RATVNSQEQKRLLXDLDISX 87
Query: 76 -------LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRF------NI 122
V G ++G+ + E L + SLD F K+++D + I
Sbjct: 88 RTVDCPFTVTFYGALFREGDVWICXE-LXDTSLDKFY-----KQVIDKGQTIPEDILGKI 141
Query: 123 IEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI 182
IV+ L +LH S+L VIHRD+K SN+L++ K DFG++ + ++++ + +
Sbjct: 142 AVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGIS-GYLVDDVAKDID-- 196
Query: 183 VGTHGYMSPEYVMNGI----VSMKSDVYSFGVLVLEI 215
G Y +PE + + S+KSD++S G+ +E+
Sbjct: 197 AGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIEL 233
>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp
Site Inhibitor
Length = 301
Score = 62.0 bits (149), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 41/216 (18%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
+G+G FG V++GK G+E+A+K S + + E L+H N++ + +
Sbjct: 12 IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADNK 69
Query: 86 KG----ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNI-IEGIVQ-------GLLYL 133
+ LV +Y + SL D+ R+ + +EG+++ GL +L
Sbjct: 70 DNGTWTQLWLVSDYHEHGSL------------FDYLNRYTVTVEGMIKLALSTASGLAHL 117
Query: 134 H-----KYSRLRVIHRDLKASNILLDDQMNPKISDFGMA--RTFGMNELEANTNRIVGTH 186
H + + HRDLK+ NIL+ I+D G+A + ++ N VGT
Sbjct: 118 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 177
Query: 187 GYMSPEYVMNGIVSMK-------SDVYSFGVLVLEI 215
YM+PE V++ ++MK +D+Y+ G++ EI
Sbjct: 178 RYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 212
>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 62.0 bits (149), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 25/204 (12%)
Query: 26 LGQGGFGPVYKG--KLLDGQEIAIKRLSKSSGQGIV---EFKNEAKLIAKLQHTNLVRLL 80
LG G FG V KG ++ + ++ K+ E EA ++ +L + +VR++
Sbjct: 19 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 81 G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
G C + +LV E L+ ++ + + D K ++ + G+ YL + +
Sbjct: 79 GICEAESW--MLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 131
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI-VGTHG-----YMSPEY 193
+HRDL A N+LL Q KISDFG+++ L A+ N THG + +PE
Sbjct: 132 -FVHRDLAARNVLLVTQHYAKISDFGLSKA-----LRADENYYKAQTHGKWPVKWYAPEC 185
Query: 194 VMNGIVSMKSDVYSFGVLVLEIIS 217
+ S KSDV+SFGVL+ E S
Sbjct: 186 INYYKFSSKSDVWSFGVLMWEAFS 209
>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX
Length = 361
Score = 62.0 bits (149), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 22/202 (10%)
Query: 42 GQEIAIK-----RLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL 96
GQ+ A+K + + S G + K EA + L+H ++V LL G +V+E++
Sbjct: 51 GQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFM 110
Query: 97 PNKSLDFFIFDSSKKELLDWKK-RFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD 155
L F I + + + + + I++ L Y H + +IHRD+K +LL
Sbjct: 111 DGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLAS 167
Query: 156 QMNP---KISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLV 212
+ N K+ FG+A G + L A VGT +M+PE V DV+ GV++
Sbjct: 168 KENSAPVKLGGFGVAIQLGESGLVAGGR--VGTPHFMAPEVVKREPYGKPVDVWGCGVIL 225
Query: 213 LEIISSKKNNGC---YDTERHL 231
++S GC Y T+ L
Sbjct: 226 FILLS-----GCLPFYGTKERL 242
>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2
Length = 364
Score = 62.0 bits (149), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
+G+G +G V L+ +AIK++S Q + E K++ + +H N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ Y+ ++ ++ K + L + I++GL Y+H + V+H
Sbjct: 95 RAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
RDLK SN+LL+ + KI DFG+AR + V T Y +PE ++N K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 203 S-DVYSFGVLVLEIISSK 219
S D++S G ++ E++S++
Sbjct: 212 SIDIWSVGCILAEMLSNR 229
>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2
Length = 364
Score = 62.0 bits (149), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
+G+G +G V L+ +AIK++S Q + E K++ + +H N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ Y+ ++ ++ K + L + I++GL Y+H + V+H
Sbjct: 95 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
RDLK SN+LL+ + KI DFG+AR + V T Y +PE ++N K
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 203 S-DVYSFGVLVLEIISSK 219
S D++S G ++ E++S++
Sbjct: 212 SIDIWSVGCILAEMLSNR 229
>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form
pdb|3C0G|B Chain B, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form
pdb|3C0H|A Chain A, Cask Cam-Kinase Domain- Amppnp Complex, P1 Form
pdb|3C0H|B Chain B, Cask Cam-Kinase Domain- Amppnp Complex, P1 Form
pdb|3C0I|A Chain A, Cask Cam-Kinase Domain- 3'-Amp Complex, P212121 Form
Length = 351
Score = 62.0 bits (149), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 51/185 (27%), Positives = 86/185 (46%), Gaps = 14/185 (7%)
Query: 42 GQEIAIK-----RLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL 96
GQ+ A+K + + S G + K EA + L+H ++V LL G +V+E++
Sbjct: 49 GQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFM 108
Query: 97 PNKSLDFFIFDSSKKELLDWKK-RFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDD 155
L F I + + + + + I++ L Y H + +IHRD+K +LL
Sbjct: 109 DGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLAS 165
Query: 156 QMNP---KISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLV 212
+ N K+ FG+A G + L A VGT +M+PE V DV+ GV++
Sbjct: 166 KENSAPVKLGGFGVAIQLGESGLVAGGR--VGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
Query: 213 LEIIS 217
++S
Sbjct: 224 FILLS 228
>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human
Tgf- Beta Type I Receptor
pdb|3GXL|A Chain A, Alk-5 Kinase Complex With Gw857175
pdb|3HMM|A Chain A, Structure Of Alk5 + Gw855857
Length = 303
Score = 61.6 bits (148), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 41/216 (18%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
+G+G FG V++GK G+E+A+K S + + E L+H N++ + +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADNK 68
Query: 86 KG----ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNI-IEGIVQ-------GLLYL 133
+ LV +Y + SL D+ R+ + +EG+++ GL +L
Sbjct: 69 DNGTWTQLWLVSDYHEHGSL------------FDYLNRYTVTVEGMIKLALSTASGLAHL 116
Query: 134 H-----KYSRLRVIHRDLKASNILLDDQMNPKISDFGMA--RTFGMNELEANTNRIVGTH 186
H + + HRDLK+ NIL+ I+D G+A + ++ N VGT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 187 GYMSPEYVMNGIVSMK-------SDVYSFGVLVLEI 215
YM+PE V++ ++MK +D+Y+ G++ EI
Sbjct: 177 RYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 211
>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine
Mutation At Position 52
Length = 364
Score = 61.6 bits (148), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 51/198 (25%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
+G+G +G V L+ +AI+++S Q + E K++ + +H N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ Y+ ++ ++ K + L + I++GL Y+H + V+H
Sbjct: 95 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
RDLK SN+LL+ + KI DFG+AR + V T Y +PE ++N K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 203 S-DVYSFGVLVLEIISSK 219
S D++S G ++ E++S++
Sbjct: 212 SIDIWSVGCILAEMLSNR 229
>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|D Chain D, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|F Chain F, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|H Chain H, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1IAS|A Chain A, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|B Chain B, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|C Chain C, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|D Chain D, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|E Chain E, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|3FAA|A Chain A, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|B Chain B, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|C Chain C, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|D Chain D, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|E Chain E, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3KCF|A Chain A, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|B Chain B, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|C Chain C, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|D Chain D, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|E Chain E, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|2X7O|A Chain A, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|B Chain B, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|C Chain C, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|D Chain D, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|E Chain E, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
Length = 342
Score = 61.6 bits (148), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 41/216 (18%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
+G+G FG V++GK G+E+A+K S + + E L+H N++ + +
Sbjct: 50 IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADNK 107
Query: 86 KG----ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNI-IEGIVQ-------GLLYL 133
+ LV +Y + SL D+ R+ + +EG+++ GL +L
Sbjct: 108 DNGTWTQLWLVSDYHEHGSL------------FDYLNRYTVTVEGMIKLALSTASGLAHL 155
Query: 134 H-----KYSRLRVIHRDLKASNILLDDQMNPKISDFGMA--RTFGMNELEANTNRIVGTH 186
H + + HRDLK+ NIL+ I+D G+A + ++ N VGT
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
Query: 187 GYMSPEYVMNGIVSMK-------SDVYSFGVLVLEI 215
YM+PE V++ ++MK +D+Y+ G++ EI
Sbjct: 216 RYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 250
>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3-
Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine
pdb|2WOU|A Chain A, Alk5 In Complex With
4-((4-((2,6-Dimethyl-3-Pyridyl)oxy)-2-
Pyridyl)amino)benzenesulfonamide
Length = 306
Score = 61.6 bits (148), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 41/216 (18%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
+G+G FG V++GK G+E+A+K S + + E L+H N++ + +
Sbjct: 14 IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADNK 71
Query: 86 KG----ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNI-IEGIVQ-------GLLYL 133
+ LV +Y + SL D+ R+ + +EG+++ GL +L
Sbjct: 72 DNGTWTQLWLVSDYHEHGSL------------FDYLNRYTVTVEGMIKLALSTASGLAHL 119
Query: 134 H-----KYSRLRVIHRDLKASNILLDDQMNPKISDFGMA--RTFGMNELEANTNRIVGTH 186
H + + HRDLK+ NIL+ I+D G+A + ++ N VGT
Sbjct: 120 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 179
Query: 187 GYMSPEYVMNGIVSMK-------SDVYSFGVLVLEI 215
YM+PE V++ ++MK +D+Y+ G++ EI
Sbjct: 180 RYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 214
>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With
Inhibitor
Length = 326
Score = 61.6 bits (148), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 41/216 (18%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
+G+G FG V++GK G+E+A+K S + + E L+H N++ + +
Sbjct: 37 IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADNK 94
Query: 86 KG----ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNI-IEGIVQ-------GLLYL 133
+ LV +Y + SL D+ R+ + +EG+++ GL +L
Sbjct: 95 DNGTWTQLWLVSDYHEHGSL------------FDYLNRYTVTVEGMIKLALSTASGLAHL 142
Query: 134 H-----KYSRLRVIHRDLKASNILLDDQMNPKISDFGMA--RTFGMNELEANTNRIVGTH 186
H + + HRDLK+ NIL+ I+D G+A + ++ N VGT
Sbjct: 143 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 202
Query: 187 GYMSPEYVMNGIVSMK-------SDVYSFGVLVLEI 215
YM+PE V++ ++MK +D+Y+ G++ EI
Sbjct: 203 RYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 237
>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542
Length = 309
Score = 61.6 bits (148), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 41/216 (18%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
+G+G FG V++GK G+E+A+K S + + E L+H N++ + +
Sbjct: 17 IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADNK 74
Query: 86 KG----ERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNI-IEGIVQ-------GLLYL 133
+ LV +Y + SL D+ R+ + +EG+++ GL +L
Sbjct: 75 DNGTWTQLWLVSDYHEHGSL------------FDYLNRYTVTVEGMIKLALSTASGLAHL 122
Query: 134 H-----KYSRLRVIHRDLKASNILLDDQMNPKISDFGMA--RTFGMNELEANTNRIVGTH 186
H + + HRDLK+ NIL+ I+D G+A + ++ N VGT
Sbjct: 123 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 182
Query: 187 GYMSPEYVMNGIVSMK-------SDVYSFGVLVLEI 215
YM+PE V++ ++MK +D+Y+ G++ EI
Sbjct: 183 RYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 217
>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57
Length = 360
Score = 61.6 bits (148), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 51/198 (25%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
+G+G +G V ++ +AIK++S Q + E K++ + +H N++ +
Sbjct: 31 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ Y+ ++ ++ K + L + I++GL Y+H + V+H
Sbjct: 91 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 147
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
RDLK SN+LL+ + KI DFG+AR + V T Y +PE ++N K
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 203 S-DVYSFGVLVLEIISSK 219
S D++S G ++ E++S++
Sbjct: 208 SIDIWSVGCILAEMLSNR 225
>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 635
Score = 61.6 bits (148), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 25/204 (12%)
Query: 26 LGQGGFGPVYKG--KLLDGQEIAIKRLSKSSGQGIV---EFKNEAKLIAKLQHTNLVRLL 80
LG G FG V KG ++ + ++ K+ E EA ++ +L + +VR++
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 81 G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
G C + +LV E L+ ++ + + D K ++ + G+ YL + +
Sbjct: 437 GICEAESW--MLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 489
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI-VGTHG-----YMSPEY 193
+HRDL A N+LL Q KISDFG+++ L A+ N THG + +PE
Sbjct: 490 -FVHRDLAARNVLLVTQHYAKISDFGLSKA-----LRADENYYKAQTHGKWPVKWYAPEC 543
Query: 194 VMNGIVSMKSDVYSFGVLVLEIIS 217
+ S KSDV+SFGVL+ E S
Sbjct: 544 INYYKFSSKSDVWSFGVLMWEAFS 567
>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 636
Score = 61.6 bits (148), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 25/204 (12%)
Query: 26 LGQGGFGPVYKG--KLLDGQEIAIKRLSKSSGQGIV---EFKNEAKLIAKLQHTNLVRLL 80
LG G FG V KG ++ + ++ K+ E EA ++ +L + +VR++
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 81 G-CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
G C + +LV E L+ ++ + + D K ++ + G+ YL + +
Sbjct: 438 GICEAESW--MLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 490
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRI-VGTHG-----YMSPEY 193
+HRDL A N+LL Q KISDFG+++ L A+ N THG + +PE
Sbjct: 491 -FVHRDLAARNVLLVTQHYAKISDFGLSKA-----LRADENYYKAQTHGKWPVKWYAPEC 544
Query: 194 VMNGIVSMKSDVYSFGVLVLEIIS 217
+ S KSDV+SFGVL+ E S
Sbjct: 545 INYYKFSSKSDVWSFGVLMWEAFS 568
>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4FMQ|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 61.2 bits (147), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 51/198 (25%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
+G+G +G V ++ +AIK++S Q + E K++ + +H N++ +
Sbjct: 33 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ Y+ ++ ++ K + L + I++GL Y+H + V+H
Sbjct: 93 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 149
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
RDLK SN+LL+ + KI DFG+AR + V T Y +PE ++N K
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 203 S-DVYSFGVLVLEIISSK 219
S D++S G ++ E++S++
Sbjct: 210 SIDIWSVGCILAEMLSNR 227
>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium
Dependent Protein Kinase Cgd7_1840 In Presence Of
Indirubin E804
Length = 277
Score = 61.2 bits (147), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 58/195 (29%), Positives = 92/195 (47%), Gaps = 18/195 (9%)
Query: 24 NRLGQGGFGPVYKGKLLDGQEI--AIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
N +G+G +G V K + G I A K++ K + + FK E +++ L H N++RL
Sbjct: 15 NTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 73
Query: 82 CSLQKGERLLVYEYLPNKSLDFFIFDS-SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
+ LV E L F+ K + I++ ++ + Y HK L
Sbjct: 74 TFEDNTDIYLVMELCTGGEL----FERVVHKRVFRESDAARIMKDVLSAVAYCHK---LN 126
Query: 141 VIHRDLKASNILL--DDQMNP-KISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG 197
V HRDLK N L D +P K+ DFG+A F ++ VGT Y+SP+ V+ G
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK---VGTPYYVSPQ-VLEG 182
Query: 198 IVSMKSDVYSFGVLV 212
+ + D +S GV++
Sbjct: 183 LYGPECDEWSAGVMM 197
>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With
Inhibitor Jnj- 7706621
pdb|3AMB|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With
Inhibitor Vx- 680
Length = 351
Score = 61.2 bits (147), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 21/210 (10%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K + G A+K L K Q +V+ K NE ++
Sbjct: 39 AHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 95
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
+ LV+L +V EY P + F + RF + IV
Sbjct: 96 QQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEM--FSHLRRIGRFSEPHARFYAAQ-IV 152
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
YLH L +I+RDLK N+L+D Q K++DFG A+ ++ T + GT
Sbjct: 153 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPE 204
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAA 234
>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75
pdb|4FV1|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek4
pdb|4FV2|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek5
pdb|4FV3|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek6
pdb|4FV4|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek7
pdb|4FV5|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek9
pdb|4FV8|A Chain A, Crystal Structure Of The Erk2 Complexed With E63
pdb|4FV9|A Chain A, Crystal Structure Of The Erk2 Complexed With E71
pdb|4G6N|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 61.2 bits (147), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 51/198 (25%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
+G+G +G V ++ +AIK++S Q + E K++ + +H N++ +
Sbjct: 31 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ Y+ ++ ++ K + L + I++GL Y+H + V+H
Sbjct: 91 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 147
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
RDLK SN+LL+ + KI DFG+AR + V T Y +PE ++N K
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 203 S-DVYSFGVLVLEIISSK 219
S D++S G ++ E++S++
Sbjct: 208 SIDIWSVGCILAEMLSNR 225
>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A
Pyrazolopyridazine Derivative
pdb|3W55|A Chain A, The Structure Of Erk2 In Complex With Fr148083
Length = 368
Score = 61.2 bits (147), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 51/198 (25%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
+G+G +G V ++ +AIK++S Q + E K++ + +H N++ +
Sbjct: 39 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ Y+ ++ ++ K + L + I++GL Y+H + V+H
Sbjct: 99 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 155
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
RDLK SN+LL+ + KI DFG+AR + V T Y +PE ++N K
Sbjct: 156 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 215
Query: 203 S-DVYSFGVLVLEIISSK 219
S D++S G ++ E++S++
Sbjct: 216 SIDIWSVGCILAEMLSNR 233
>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule
Inhibitor
Length = 368
Score = 61.2 bits (147), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 51/198 (25%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
+G+G +G V ++ +AIK++S Q + E K++ + +H N++ +
Sbjct: 31 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ Y+ ++ ++ K + L + I++GL Y+H + V+H
Sbjct: 91 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 147
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
RDLK SN+LL+ + KI DFG+AR + V T Y +PE ++N K
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 203 S-DVYSFGVLVLEIISSK 219
S D++S G ++ E++S++
Sbjct: 208 SIDIWSVGCILAEMLSNR 225
>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H89 Protein
Kinase Inhibitor N-[2-
(4-Bromocinnamylamino)ethyl]-5-Isoquinoline
pdb|1YDR|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H7 Protein
Kinase Inhibitor 1-(5-
Isoquinolinesulfonyl)-2-Methylpiperazine
pdb|1YDS|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H8 Protein
Kinase Inhibitor [n-(2-Methylamino)ethyl]-5-
Isoquinolinesulfonamide
Length = 350
Score = 61.2 bits (147), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 25/212 (11%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K ++ G A+K L K Q +V+ K NE ++
Sbjct: 38 AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
+ + LV+L +V EY+ + F ++ + RF +
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
IV YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk
Inhibitor For The Prevention Of Ischemia-Reperfusion
Injury
pdb|3TTI|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-930, An Orally
Active Anti-Fibrotic Jnk Inhibitor
Length = 464
Score = 61.2 bits (147), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 12 TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
T+ N P QG Y L + +AIK+LS+ F+N+ AK
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKR 107
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
+ LV L+ C K L+ + P K+L+ F + D++ ++ LD ++
Sbjct: 108 AYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 166
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
++ ++ G+ +LH +IHRDLK SNI++ KI DFG+ART G + +
Sbjct: 167 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 220
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
V T Y +PE ++ D++S G ++ E++ K
Sbjct: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMQ|A Chain A, The Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMU|A Chain A, The Crystal Structure Of Jnk3 In Complex With A
Phenantroline Inhibitor
pdb|1PMV|A Chain A, The Structure Of Jnk3 In Complex With A
Dihydroanthrapyrazole Inhibitor
Length = 364
Score = 61.2 bits (147), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 12 TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
T+ N P QG Y L + +AIK+LS+ F+N+ AK
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKR 70
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
+ LV L+ C K L+ + P K+L+ F + D++ ++ LD ++
Sbjct: 71 AYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 129
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
++ ++ G+ +LH +IHRDLK SNI++ KI DFG+ART G + +
Sbjct: 130 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 183
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
V T Y +PE ++ D++S G ++ E++ K
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223
>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|B Chain B, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|D Chain D, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
Length = 294
Score = 61.2 bits (147), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 58/195 (29%), Positives = 92/195 (47%), Gaps = 18/195 (9%)
Query: 24 NRLGQGGFGPVYKGKLLDGQEI--AIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
N +G+G +G V K + G I A K++ K + + FK E +++ L H N++RL
Sbjct: 32 NTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 90
Query: 82 CSLQKGERLLVYEYLPNKSLDFFIFDS-SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
+ LV E L F+ K + I++ ++ + Y HK L
Sbjct: 91 TFEDNTDIYLVMELCTGGEL----FERVVHKRVFRESDAARIMKDVLSAVAYCHK---LN 143
Query: 141 VIHRDLKASNILL--DDQMNP-KISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG 197
V HRDLK N L D +P K+ DFG+A F ++ VGT Y+SP+ V+ G
Sbjct: 144 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK---VGTPYYVSPQ-VLEG 199
Query: 198 IVSMKSDVYSFGVLV 212
+ + D +S GV++
Sbjct: 200 LYGPECDEWSAGVMM 214
>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3
Length = 355
Score = 61.2 bits (147), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 12 TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
T+ N P QG Y L + +AIK+LS+ F+N+ AK
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKR 62
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
+ LV L+ C K L+ + P K+L+ F + D++ ++ LD ++
Sbjct: 63 AYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 121
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
++ ++ G+ +LH +IHRDLK SNI++ KI DFG+ART G + +
Sbjct: 122 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 175
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
V T Y +PE ++ D++S G ++ E++ K
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious
Tri-Substituted Thiophene Based Jnk Inhibitor
Length = 363
Score = 61.2 bits (147), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 12 TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
T+ N P QG Y L + +AIK+LS+ F+N+ AK
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKR 69
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
+ LV L+ C K L+ + P K+L+ F + D++ ++ LD ++
Sbjct: 70 AYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 128
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
++ ++ G+ +LH +IHRDLK SNI++ KI DFG+ART G + +
Sbjct: 129 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 182
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
V T Y +PE ++ D++S G ++ E++ K
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222
>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3
Length = 356
Score = 61.2 bits (147), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 12 TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
T+ N P QG Y L + +AIK+LS+ F+N+ AK
Sbjct: 15 TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKR 63
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
+ LV L+ C K L+ + P K+L+ F + D++ ++ LD ++
Sbjct: 64 AYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 122
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
++ ++ G+ +LH +IHRDLK SNI++ KI DFG+ART G + +
Sbjct: 123 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 176
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
V T Y +PE ++ D++S G ++ E++ K
Sbjct: 177 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216
>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With
N,n-dimethyl-4-(4-
Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide
pdb|2OJI|A Chain A, Crystal Structure Of Erk2 In Complex With
N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2OJJ|A Chain A, Crystal Structure Of Erk2 In Complex With (S)-N-(1-(3-
Chloro-4-Fluorophenyl)-2-Hydroxyethyl)-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|3I5Z|A Chain A, Crystal Structure Of Erk2 Bound To
(S)-N-(2-Hydroxy-1-Phenylethyl)-4-
(5-Methyl-2-(Phenylamino)pyrimidin-4-Yl)-1h-Pyrrole-2-
Carboxamide
pdb|3I60|A Chain A, Crystal Structure Of Erk2 Bound To
(s)-4-(2-(2-chlorophenylamino)-5-
Methylpyrimidin-4-yl)-n-(2-hydroxy-1-phenylethyl)-1h-
pyrrole-2- Carboxamide
Length = 380
Score = 60.8 bits (146), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 51/198 (25%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
+G+G +G V ++ +AIK++S Q + E K++ + +H N++ +
Sbjct: 51 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ Y+ ++ ++ K + L + I++GL Y+H + V+H
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 167
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
RDLK SN+LL+ + KI DFG+AR + V T Y +PE ++N K
Sbjct: 168 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 227
Query: 203 S-DVYSFGVLVLEIISSK 219
S D++S G ++ E++S++
Sbjct: 228 SIDIWSVGCILAEMLSNR 245
>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide
pdb|4H39|A Chain A, Crystal Structure Of Jnk3 In Complex With Jip1 Peptide
pdb|4H3B|A Chain A, Crystal Structure Of Jnk3 In Complex With Sab Peptide
pdb|4H3B|C Chain C, Crystal Structure Of Jnk3 In Complex With Sab Peptide
Length = 356
Score = 60.8 bits (146), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 12 TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
T+ N P QG Y L + +AIK+LS+ F+N+ AK
Sbjct: 15 TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKR 63
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
+ LV L+ C K L+ + P K+L+ F + D++ ++ LD ++
Sbjct: 64 AYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 122
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
++ ++ G+ +LH +IHRDLK SNI++ KI DFG+ART G + +
Sbjct: 123 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 176
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
V T Y +PE ++ D++S G ++ E++ K
Sbjct: 177 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216
>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-{3-Cyano-6-[3-(1-
Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2,
3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide
pdb|2O2U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Cyano-4,5,6,7-
Tetrahydro-1-Benzothien-2-Yl)-2-Fluorobenzamide
pdb|2ZDT|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|2ZDU|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|3DA6|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Methyl-
4-(3-(2-(Methylamino)pyrimidin-4-Yl)pyridin-2-Yloxy)
Naphthalen-1-Yl)-1h-Benzo[d]imidazol-2-Amine
pdb|2WAJ|A Chain A, Crystal Structure Of Human Jnk3 Complexed With A
1-Aryl-3,4- Dihydroisoquinoline Inhibitor
pdb|3V6R|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6R|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
Length = 364
Score = 60.8 bits (146), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 12 TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
T+ N P QG Y L + +AIK+LS+ F+N+ AK
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKR 69
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
+ LV L+ C K L+ + P K+L+ F + D++ ++ LD ++
Sbjct: 70 AYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 128
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
++ ++ G+ +LH +IHRDLK SNI++ KI DFG+ART G + +
Sbjct: 129 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 182
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
V T Y +PE ++ D++S G ++ E++ K
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222
>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2P33|A Chain A, Synthesis And Sar Of Aminopyrimidines As Novel C-Jun N-
Terminal Kinase (Jnk) Inhibitors
pdb|3CGF|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3CGO|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3G90|X Chain X, Jnk-3 Bound To
(Z)-5-Fluoro-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)
Methyl)-3-(Hydroxyimino)indolin-2-One
pdb|3G9N|A Chain A, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Phenylindolin-2-One
pdb|3G9L|X Chain X, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Styrylindolin-2-One
Length = 365
Score = 60.8 bits (146), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 12 TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
T+ N P QG Y L + +AIK+LS+ F+N+ AK
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKR 70
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
+ LV L+ C K L+ + P K+L+ F + D++ ++ LD ++
Sbjct: 71 AYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 129
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
++ ++ G+ +LH +IHRDLK SNI++ KI DFG+ART G + +
Sbjct: 130 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 183
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
V T Y +PE ++ D++S G ++ E++ K
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223
>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94
pdb|4G6O|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 51/198 (25%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
+G+G +G V ++ +AIK++S Q + E K++ + +H N++ +
Sbjct: 31 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ Y+ ++ ++ K + L + I++GL Y+H + V+H
Sbjct: 91 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 147
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
RDLK SN+LL+ + KI DFG+AR + V T Y +PE ++N K
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 203 S-DVYSFGVLVLEIISSK 219
S D++S G ++ E++S++
Sbjct: 208 SIDIWSVGCILAEMLSNR 225
>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And
Thiazole Based Inhibitors Of Jnk For The Treatment Of
Neurodegenerative Diseases
pdb|3OY1|A Chain A, Highly Selective C-Jun N-Terminal Kinase (Jnk) 2 And 3
Inhibitors With In Vitro Cns-Like Pharmacokinetic
Properties
Length = 362
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 12 TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
T+ N P QG Y L + +AIK+LS+ F+N+ AK
Sbjct: 20 TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKR 68
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
+ LV L+ C K L+ + P K+L+ F + D++ ++ LD ++
Sbjct: 69 AYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 127
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
++ ++ G+ +LH +IHRDLK SNI++ KI DFG+ART G + +
Sbjct: 128 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 181
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
V T Y +PE ++ D++S G ++ E++ K
Sbjct: 182 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221
>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O17|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O2M|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
pdb|3O2M|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
Length = 370
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 64/223 (28%), Positives = 102/223 (45%), Gaps = 36/223 (16%)
Query: 12 TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
T+ N P QG Y L + +AIK+LS+ F+N+ AK
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKR 69
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
+ LV L+ C K L+ + P KSL+ F + D++ ++ LD ++
Sbjct: 70 AYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 128
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG---MNELE 176
++ ++ G+ +LH +IHRDLK SNI++ KI DFG+ART G M E E
Sbjct: 129 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPE 185
Query: 177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
V T Y +PE ++ D++S G ++ E++ K
Sbjct: 186 ------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222
>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino(
Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6-
Difluoro-Phenyl)-Amide)
Length = 349
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 17/202 (8%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLDGQE-IAIKRLSKSSGQGIVEFKNEAKLIAKLQH 73
A +D F + LG+G VY+ K Q+ A+K L K+ + IV + E ++ +L H
Sbjct: 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIV--RTEIGVLLRLSH 107
Query: 74 TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDS-SKKELLDWKKRFNIIEGIVQGLLY 132
N+++L E LV E + L FD +K + + ++ I++ + Y
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGEL----FDRIVEKGYYSERDAADAVKQILEAVAY 163
Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANTNRIVGTHGYM 189
LH+ ++HRDLK N+L KI+DFG+++ + E + + GT GY
Sbjct: 164 LHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSK---IVEHQVLMKTVCGTPGYC 217
Query: 190 SPEYVMNGIVSMKSDVYSFGVL 211
+PE + + D++S G++
Sbjct: 218 APEILRGCAYGPEVDMWSVGII 239
>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With
Mgamp-Pnp
Length = 423
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 12 TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
T+ N P QG Y L + +AIK+LS+ F+N+ AK
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKR 107
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
+ LV L+ C K L+ + P K+L+ F + D++ ++ LD ++
Sbjct: 108 AYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 166
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
++ ++ G+ +LH +IHRDLK SNI++ KI DFG+ART G + +
Sbjct: 167 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 220
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
V T Y +PE ++ D++S G ++ E++ K
Sbjct: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 30/217 (13%)
Query: 12 TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
T+ N P QG Y L + +AIK+LS+ F+N+ AK
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKR 69
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
+ LV L+ C K L+ + P KSL+ F + D++ ++ LD ++
Sbjct: 70 AYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERM 128
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
++ ++ G+ +LH +IHRDLK SNI++ KI DFG+ART G + +
Sbjct: 129 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 182
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
V T Y +PE ++ D++S G ++ E+I
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In
Complex With Ca2+ And Amppnp
Length = 494
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 42/212 (19%)
Query: 25 RLGQGGFGPVYKGK-LLDGQEIAIK-----RLSKSSGQGIVEFKNEAKLIAKLQHTNLVR 78
+LG G +G V + + E AIK +S SS ++E E ++ L H N+++
Sbjct: 44 KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE---EVAVLKLLDHPNIMK 100
Query: 79 LLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK-ELLD---WKKRFN------IIEGIVQ 128
L Y++ +K + + + K EL D + +FN II+ ++
Sbjct: 101 L-------------YDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLS 147
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANTNRIVGT 185
G+ YLHK++ ++HRDLK N+LL+ + KI DFG++ F E + +GT
Sbjct: 148 GVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKMKERLGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE V+ K DV+S GV++ +++
Sbjct: 202 AYYIAPE-VLRKKYDEKCDVWSIGVILFILLA 232
>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-293 In Complex With Atp
Length = 293
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 55/193 (28%), Positives = 92/193 (47%), Gaps = 16/193 (8%)
Query: 26 LGQGGFGPVYKGKLLDGQE-IAIKRLSKSSGQGIV-EFKNEAKLIAKLQHTNLVRLLGCS 83
LG G F V + Q+ +AIK ++K + +G +NE ++ K++H N+V L
Sbjct: 26 LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDS-SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
G L+ + + L FD +K + +I ++ + YLH L ++
Sbjct: 86 ESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIV 138
Query: 143 HRDLKASNIL---LDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
HRDLK N+L LD+ ISDFG+++ M + + + GT GY++PE +
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 200 SMKSDVYSFGVLV 212
S D +S GV+
Sbjct: 196 SKAVDCWSIGVIA 208
>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And
Potent Inhibitors For Akt: Synthesis And Sar Studies
Length = 337
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 25/213 (11%)
Query: 14 AAATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAK 66
A D F LG G FG V K + G A+K L K Q +V+ K NE +
Sbjct: 24 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKR 80
Query: 67 LIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIE 124
++ + LV+L +V EY+ + F ++ + RF +
Sbjct: 81 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQ 136
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
IV YLH L +I+RDLK N+L+D+Q +++DFG A+ ++ T + G
Sbjct: 137 -IVLTFEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAK-----RVKGRTWXLCG 187
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 188 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 220
>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map
Kinase Jnk1
Length = 370
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 30/217 (13%)
Query: 12 TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
T+ N P QG Y L + +AIK+LS+ F+N+ AK
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKR 69
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
+ LV L+ C K L+ + P KSL+ F + D++ ++ LD ++
Sbjct: 70 AYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERM 128
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
++ ++ G+ +LH +IHRDLK SNI++ KI DFG+ART G + +
Sbjct: 129 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFM---M 182
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
V T Y +PE ++ D++S G ++ E+I
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol
pdb|4FUY|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek2
pdb|4FV0|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek3
Length = 360
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 51/198 (25%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
+G+G +G V ++ +AIK++S Q + E K++ + +H N++ +
Sbjct: 31 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ Y+ ++ ++ K + L + I++GL Y+H + V+H
Sbjct: 91 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 147
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
RDLK SN+LL+ + KI DFG+AR + V T Y +PE ++N K
Sbjct: 148 RDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 203 S-DVYSFGVLVLEIISSK 219
S D++S G ++ E++S++
Sbjct: 208 SIDIWSVGCILAEMLSNR 225
>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase,
Kinase: An Active Protein Kinase Complexed With
Nucleotide, Substrate-Analogue And Product
Length = 298
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 58/232 (25%), Positives = 103/232 (44%), Gaps = 26/232 (11%)
Query: 3 RDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEF 61
RD + + +N+ P LG+G V + +E A+K + + G
Sbjct: 2 RDAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAE 61
Query: 62 KNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK-ELLDW---- 116
+ + A L+ +++R + + YE + F +FD KK EL D+
Sbjct: 62 EVQELREATLKEVDILRKVSGHPNIIQLKDTYE---TNTFFFLVFDLMKKGELFDYLTEK 118
Query: 117 -----KKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG 171
K+ I+ +++ + LHK L ++HRDLK NILLDD MN K++DFG +
Sbjct: 119 VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175
Query: 172 MNELEANTNRIVGTHGYMSPEYVMNGI------VSMKSDVYSFGVLVLEIIS 217
E + GT Y++PE + + + D++S GV++ +++
Sbjct: 176 PGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224
>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor
Length = 358
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 12 TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
T+ N P QG Y L + +AIK+LS+ F+N+ AK
Sbjct: 15 TVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKR 63
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
+ LV L+ C K L+ + P KSL+ F + D++ ++ LD ++
Sbjct: 64 AYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 122
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
++ ++ G+ +LH +IHRDLK SNI++ KI DFG+ART G + +
Sbjct: 123 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 176
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
V T Y +PE ++ D++S G ++ E++ K
Sbjct: 177 TPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216
>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDR|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With The Inhibitor
A- 443654
pdb|2UW9|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|2X39|A Chain A, Structure Of
4-Amino-N-(4-Chlorobenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidine-4-Carboxamide Bound To Pkb
pdb|2XH5|A Chain A, Structure Of 4-(4-Tert-Butylbenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidin-4-Amine Bound To Pkb
Length = 342
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 14/214 (6%)
Query: 26 LGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
LG+G FG V + G+ A+K L K + + E++++ +H L L
Sbjct: 18 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-ALK 76
Query: 82 CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
+ Q +RL V EY L F + S ++ + + RF E IV L YLH
Sbjct: 77 YAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYLHSRD--- 130
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
V++RD+K N++LD + KI+DFG+ + G+++ A GT Y++PE + +
Sbjct: 131 VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISD-GATMKXFCGTPEYLAPEVLEDNDYG 188
Query: 201 MKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
D + GV++ E++ + D ER L+
Sbjct: 189 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 222
>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2IWI|B Chain B, Crystal Structure Of The Human Pim2 In Complex With A
Ruthenium Organometallic Ligand Ru1
Length = 312
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 74/283 (26%), Positives = 127/283 (44%), Gaps = 55/283 (19%)
Query: 23 GNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKLQ--- 72
G LG+GGFG V+ G +L D ++AIK + ++ G + E L+ K+
Sbjct: 36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG 95
Query: 73 -HTNLVRLLGC-SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKR--FNIIEGIVQ 128
H ++RLL Q+G L++ LP + D F + + K L + R F + +Q
Sbjct: 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQ--DLFDYITEKGPLGEGPSRCFFGQVVAAIQ 153
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMN-PKISDFGMARTFGMNELEANTNRIVGTHG 187
H +SR V+HRD+K NIL+D + K+ DFG + E T+ GT
Sbjct: 154 -----HCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSG---ALLHDEPYTD-FDGTRV 203
Query: 188 YMSPEYV-MNGIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKA 246
Y PE++ + ++ + V+S G+L+ +++ C D +
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMV-------CGDIPFE--------------RD 242
Query: 247 LELIDTTLH--ESCSPDEVTRCIHVGLLCVQDKATDRPTMSDV 287
E+++ LH SPD C + C+ K + RP++ ++
Sbjct: 243 QEILEAELHFPAHVSPD----CCALIRRCLAPKPSSRPSLEEI 281
>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
pdb|4FG8|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
Length = 315
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 55/193 (28%), Positives = 92/193 (47%), Gaps = 16/193 (8%)
Query: 26 LGQGGFGPVYKGKLLDGQE-IAIKRLSKSSGQGIV-EFKNEAKLIAKLQHTNLVRLLGCS 83
LG G F V + Q+ +AIK ++K + +G +NE ++ K++H N+V L
Sbjct: 26 LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDS-SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
G L+ + + L FD +K + +I ++ + YLH L ++
Sbjct: 86 ESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIV 138
Query: 143 HRDLKASNIL---LDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
HRDLK N+L LD+ ISDFG+++ M + + + GT GY++PE +
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 200 SMKSDVYSFGVLV 212
S D +S GV+
Sbjct: 196 SKAVDCWSIGVIA 208
>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide
Substrate Complex: Kinase Substrate Recognition
Length = 277
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 22/131 (16%)
Query: 103 FFIFDSSKK-ELLDW---------KKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNIL 152
F +FD KK EL D+ K+ I+ +++ + LHK L ++HRDLK NIL
Sbjct: 87 FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENIL 143
Query: 153 LDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGI------VSMKSDVY 206
LDD MN K++DFG + E + GT Y++PE + + + D++
Sbjct: 144 LDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMW 200
Query: 207 SFGVLVLEIIS 217
S GV++ +++
Sbjct: 201 STGVIMYTLLA 211
>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By
Mutational Studies
Length = 298
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 58/232 (25%), Positives = 103/232 (44%), Gaps = 26/232 (11%)
Query: 3 RDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEF 61
RD + + +N+ P LG+G V + +E A+K + + G
Sbjct: 2 RDAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAE 61
Query: 62 KNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK-ELLDW---- 116
+ + A L+ +++R + + YE + F +FD KK EL D+
Sbjct: 62 EVQELREATLKEVDILRKVSGHPNIIQLKDTYE---TNTFFFLVFDLMKKGELFDYLTEK 118
Query: 117 -----KKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG 171
K+ I+ +++ + LHK L ++HRDLK NILLDD MN K++DFG +
Sbjct: 119 VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175
Query: 172 MNELEANTNRIVGTHGYMSPEYVMNGI------VSMKSDVYSFGVLVLEIIS 217
E + GT Y++PE + + + D++S GV++ +++
Sbjct: 176 PGE---KLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224
>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer
Length = 319
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 61/281 (21%), Positives = 120/281 (42%), Gaps = 33/281 (11%)
Query: 23 GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
G +G+G FG VY G+ I + + + + + FK E + +H N+V +G
Sbjct: 38 GELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 83 SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
+ ++ ++L + D+ K +LD K I + IV+G+ YLH ++
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---IL 152
Query: 143 HRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGY---MSPEYVMN--- 196
H+DLK+ N+ D+ I+DFG+ G+ + +++ +G+ ++PE +
Sbjct: 153 HKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 197 ------GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKALELI 250
S SDV++ G + E+ + T+ ++ W G ++
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYEL---HAREWPFKTQPAEAII------WQMGTGMK-- 260
Query: 251 DTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASML 291
L + E++ + L C + +RPT + + ML
Sbjct: 261 -PNLSQIGMGKEISDIL---LFCWAFEQEERPTFTKLMDML 297
>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine
Inhibitor
Length = 369
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 12 TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
T+ N P QG Y L + +AIK+LS+ F+N+ AK
Sbjct: 26 TVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKR 74
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
+ LV L+ C K L+ + P KSL+ F + D++ ++ LD ++
Sbjct: 75 AYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 133
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
++ ++ G+ +LH +IHRDLK SNI++ KI DFG+ART G + +
Sbjct: 134 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 187
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
V T Y +PE ++ D++S G ++ E++ K
Sbjct: 188 TPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227
>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FG9|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FGB|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I Apo Form
Length = 320
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 55/193 (28%), Positives = 92/193 (47%), Gaps = 16/193 (8%)
Query: 26 LGQGGFGPVYKGKLLDGQE-IAIKRLSKSSGQGIV-EFKNEAKLIAKLQHTNLVRLLGCS 83
LG G F V + Q+ +AIK ++K + +G +NE ++ K++H N+V L
Sbjct: 26 LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDS-SKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVI 142
G L+ + + L FD +K + +I ++ + YLH L ++
Sbjct: 86 ESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIV 138
Query: 143 HRDLKASNIL---LDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIV 199
HRDLK N+L LD+ ISDFG+++ M + + + GT GY++PE +
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 200 SMKSDVYSFGVLV 212
S D +S GV+
Sbjct: 196 SKAVDCWSIGVIA 208
>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B
(pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3
Peptide
Length = 337
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 14/214 (6%)
Query: 26 LGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
LG+G FG V + G+ A+K L K + + E++++ +H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-ALK 71
Query: 82 CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
+ Q +RL V EY L F + S ++ + + RF E IV L YLH
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYLHSRD--- 125
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
V++RD+K N++LD + KI+DFG+ + G+++ A GT Y++PE + +
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISD-GATMKXFCGTPEYLAPEVLEDNDYG 183
Query: 201 MKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
D + GV++ E++ + D ER L+
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|D Chain D, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 51/198 (25%), Positives = 95/198 (47%), Gaps = 7/198 (3%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
+G+G +G V ++ +AIK++S Q + E K++ +H N++ +
Sbjct: 33 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ Y+ ++ ++ K + L + I++GL Y+H + V+H
Sbjct: 93 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 149
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
RDLK SN+LL+ + KI DFG+AR + V T Y +PE ++N K
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 203 S-DVYSFGVLVLEIISSK 219
S D++S G ++ E++S++
Sbjct: 210 SIDIWSVGCILAEMLSNR 227
>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
pdb|1MRY|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
Length = 339
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 14/214 (6%)
Query: 26 LGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
LG+G FG V + G+ A+K L K + + E++++ +H L L
Sbjct: 16 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-ALK 74
Query: 82 CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
+ Q +RL V EY L F + S ++ + + RF E IV L YLH
Sbjct: 75 YAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYLHSRD--- 128
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
V++RD+K N++LD + KI+DFG+ + G+++ A GT Y++PE + +
Sbjct: 129 VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISD-GATMKTFCGTPEYLAPEVLEDNDYG 186
Query: 201 MKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
D + GV++ E++ + D ER L+
Sbjct: 187 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 220
>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit
Of Camp- Dependent Protein Kinase In Complex With Sp20
And Amp-Pnp
pdb|4DFZ|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit
Of Camp- Dependent Protein Kinase In Complex With Sp20
Length = 350
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K + G A+K L K Q +V+ K NE ++
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
+ + LV+L +V EY+ + F ++ + RF +
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
IV YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The
Catalytic Subunit Of Camp-Dependent Protein Kinase
pdb|3TNP|C Chain C, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
pdb|3TNP|F Chain F, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
pdb|3TNQ|B Chain B, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
Length = 350
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K + G A+K L K Q +V+ K NE ++
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
+ + LV+L +V EY+ + F ++ + RF +
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
IV YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of
Camp-Dependent Protein Kinase
Length = 345
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 25/213 (11%)
Query: 14 AAATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAK 66
A D F LG G FG V K + G A+K L K Q +V+ K NE +
Sbjct: 32 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKR 88
Query: 67 LIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIE 124
++ + LV+L +V EY+ + F ++ + RF +
Sbjct: 89 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFYAAQ 144
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
IV YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + G
Sbjct: 145 -IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCG 195
Query: 185 THGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
T Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 196 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 228
>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory
Subunit Of Protein Kinase A That Represents The
Inhibited State
pdb|2CPK|E Chain E, Crystal Structure Of The Catalytic Subunit Of Cyclic
Adenosine Monophosphate-Dependent Protein Kinase
pdb|4DG0|E Chain E, Crystal Structure Of Myristoylated Wt Catalytic Subunit Of
Camp- Dependent Protein Kinase In Complex With Sp20 And
Amp-Pnp
pdb|4DG2|E Chain E, Crystal Structure Of Myristoylated Wt Catalytic Subunit Of
Camp- Dependent Protein Kinase In Complex With Sp20
pdb|4DH1|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With Low Mg2+, Atp And Ip20
pdb|4DH3|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Atp And Ip20
pdb|4DH5|A Chain A, Room Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Adp,
Phosphate, And Ip20
pdb|4DH7|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Amp-pnp And
Ip20'
pdb|4DH8|A Chain A, Room Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Amp-pnp And
Ip20
Length = 350
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K + G A+K L K Q +V+ K NE ++
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
+ + LV+L +V EY+ + F ++ + RF +
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
IV YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
pdb|1UKI|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
Length = 369
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 30/217 (13%)
Query: 12 TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
T+ N P QG Y L + +AIK+LS+ F+N+ AK
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKR 69
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
+ LV L+ C K L+ + P KSL+ F + D++ ++ LD ++
Sbjct: 70 AYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 128
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
++ ++ G+ +LH +IHRDLK SNI++ KI DFG+ART G + +
Sbjct: 129 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 182
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
V T Y +PE ++ D++S G ++ E+I
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic
Subunit Of Camp-Dependent Protein Kinase Complexed With
A Peptide Inhibitor And Detergent
Length = 350
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K + G A+K L K Q +V+ K NE ++
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
+ + LV+L +V EY+ + F ++ + RF +
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFAEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
IV YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 371
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 30/217 (13%)
Query: 12 TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
T+ N P QG Y L + +AIK+LS+ F+N+ AK
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKR 70
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
+ LV L+ C K L+ + P KSL+ F + D++ ++ LD ++
Sbjct: 71 AYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 129
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
++ ++ G+ +LH +IHRDLK SNI++ KI DFG+ART G + +
Sbjct: 130 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 183
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
V T Y +PE ++ D++S G ++ E+I
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 220
>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors
pdb|2G01|B Chain B, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors
pdb|2GMX|A Chain A, Selective Aminopyridine-Based C-Jun N-Terminal Kinase
Inhibitors With Cellular Activity
pdb|2GMX|B Chain B, Selective Aminopyridine-Based C-Jun N-Terminal Kinase
Inhibitors With Cellular Activity
pdb|2H96|A Chain A, Discovery Of Potent, Highly Selective, And Orally
Bioavailable Pyridine Carboxamide C-Jun Nh2-Terminal
Kinase Inhibitors
pdb|2H96|B Chain B, Discovery Of Potent, Highly Selective, And Orally
Bioavailable Pyridine Carboxamide C-Jun Nh2-Terminal
Kinase Inhibitors
pdb|2NO3|A Chain A, Novel 4-Anilinopyrimidines As Potent Jnk1 Inhibitors
pdb|2NO3|B Chain B, Novel 4-Anilinopyrimidines As Potent Jnk1 Inhibitors
Length = 370
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 64/223 (28%), Positives = 102/223 (45%), Gaps = 36/223 (16%)
Query: 12 TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
T+ N P QG Y L + +AIK+LS+ F+N+ AK
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKR 69
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
+ LV L+ C K L+ + P KSL+ F + D++ ++ LD ++
Sbjct: 70 AYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 128
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG---MNELE 176
++ ++ G+ +LH +IHRDLK SNI++ KI DFG+ART G M E E
Sbjct: 129 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPE 185
Query: 177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
V T Y +PE ++ D++S G ++ E++ K
Sbjct: 186 ------VVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222
>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat
Length = 332
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 28/212 (13%)
Query: 7 IFDFQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQE-IAIKRLSKSSGQGIV-EFKNE 64
I+DF+ + LG G F V + Q+ +AIK ++K + +G +NE
Sbjct: 19 IYDFRDV------------LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENE 66
Query: 65 AKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDS-SKKELLDWKKRFNII 123
++ K++H N+V L G L+ + + L FD +K + +I
Sbjct: 67 IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLI 122
Query: 124 EGIVQGLLYLHKYSRLRVIHRDLKASNIL---LDDQMNPKISDFGMARTFGMNELEANTN 180
++ + YLH L ++HRDLK N+L LD+ ISDFG+++ M + + +
Sbjct: 123 FQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLS 176
Query: 181 RIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLV 212
GT GY++PE + S D +S GV+
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIA 208
>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B
Akt By Hydrophobic Motif Phosphorylation
pdb|1GZO|A Chain A, Structure Of Protein Kinase B Unphosphorylated
Length = 315
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 14/214 (6%)
Query: 26 LGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
LG+G FG V + G+ A+K L K + + E++++ +H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-ALK 71
Query: 82 CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
+ Q +RL V EY L F + S ++ + + RF E IV L YLH
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYLHSRD--- 125
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
V++RD+K N++LD + KI+DFG+ + G+++ A GT Y++PE + +
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISD-GATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 201 MKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
D + GV++ E++ + D ER L+
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d
With Gsk3 Peptide And Amp-Pnp
Length = 336
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 14/214 (6%)
Query: 26 LGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
LG+G FG V + G+ A+K L K + + E++++ +H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-ALK 71
Query: 82 CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
+ Q +RL V EY L F + S ++ + + RF E IV L YLH
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYLHSRD--- 125
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
V++RD+K N++LD + KI+DFG+ + G+++ A GT Y++PE + +
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISD-GATMKXFCGTPEYLAPEVLEDNDYG 183
Query: 201 MKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
D + GV++ E++ + D ER L+
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine
Kinase
pdb|3FZP|A Chain A, Crystal Structure Of Pyk2 Complexed With Atpgs
pdb|3FZR|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-431396
pdb|3FZS|A Chain A, Crystal Structure Of Pyk2 Complexed With Birb796
pdb|3FZT|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-4618433
pdb|3H3C|A Chain A, Crystal Structure Of Pyk2 In Complex With Sulfoximine-
Substituted Trifluoromethylpyrimidine Analog
pdb|3ET7|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-2318841
Length = 277
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 55/202 (27%), Positives = 98/202 (48%), Gaps = 14/202 (6%)
Query: 26 LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLL 80
LG+G FG VY+G + G++I A+K K E F +EA ++ L H ++V+L+
Sbjct: 16 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 81 GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
G +++ ++ E P L ++ + +K L K ++ +Q + +
Sbjct: 76 GI-IEEEPTWIIMELYPYGELGHYL-ERNKNSL----KVLTLVLYSLQICKAMAYLESIN 129
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTF-GMNELEANTNRIVGTHGYMSPEYVMNGIV 199
+HRD+ NIL+ K+ DFG++R + +A+ R+ +MSPE +
Sbjct: 130 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRF 187
Query: 200 SMKSDVYSFGVLVLEIISSKKN 221
+ SDV+ F V + EI+S K
Sbjct: 188 TTASDVWMFAVCMWEILSFGKQ 209
>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E87|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3D0E|A Chain A, Crystal Structure Of Human Akt2 In Complex With Gsk690693
pdb|3D0E|B Chain B, Crystal Structure Of Human Akt2 In Complex With Gsk690693
Length = 335
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 14/214 (6%)
Query: 26 LGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
LG+G FG V + G+ A+K L K + + E++++ +H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-ALK 71
Query: 82 CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
+ Q +RL V EY L F + S ++ + + RF E IV L YLH
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYLHSRD--- 125
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
V++RD+K N++LD + KI+DFG+ + G+++ A GT Y++PE + +
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISD-GATMKXFCGTPEYLAPEVLEDNDYG 183
Query: 201 MKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
D + GV++ E++ + D ER L+
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain
Length = 335
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 14/214 (6%)
Query: 26 LGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
LG+G FG V + G+ A+K L K + + E++++ +H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-ALK 71
Query: 82 CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
+ Q +RL V EY L F + S ++ + + RF E IV L YLH
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYLHSRD--- 125
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
V++RD+K N++LD + KI+DFG+ + G+++ A GT Y++PE + +
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISD-GATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 201 MKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
D + GV++ E++ + D ER L+
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent
Protein Kinase With Unphosphorylated Turn Motif
Length = 371
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 21/210 (10%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K + G A+K L K Q +V+ K NE ++
Sbjct: 59 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 115
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
+ + LV+L +V EY+ + F + RF + IV
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFXEPHARFYAAQ-IV 172
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + GT
Sbjct: 173 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPE 224
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 225 YLAPEIILSKGYNKAVDWWALGVLIYEMAA 254
>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 386
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 30/217 (13%)
Query: 12 TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
T+ N P QG Y L + +AIK+LS+ F+N+ AK
Sbjct: 23 TVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKR 71
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
+ LV L+ C K L+ + P KSL+ F + D++ ++ LD ++
Sbjct: 72 AYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 130
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
++ ++ G+ +LH +IHRDLK SNI++ KI DFG+ART G + +
Sbjct: 131 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVP- 186
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
V T Y +PE ++ D++S G ++ E+I
Sbjct: 187 --FVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 221
>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 30/217 (13%)
Query: 12 TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
T+ N P QG Y L + +AIK+LS+ F+N+ AK
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKR 69
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
+ LV L+ C K L+ + P KSL+ F + D++ ++ LD ++
Sbjct: 70 AYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 128
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
++ ++ G+ +LH +IHRDLK SNI++ KI DFG+ART G + +
Sbjct: 129 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M 182
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
V T Y +PE ++ D++S G ++ E+I
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A
Natural Jnk1 Inhibitor
Length = 379
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 30/217 (13%)
Query: 12 TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL 71
T+ N P QG Y L + +AIK+LS+ F+N+ AK
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKR 69
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDWKKR 119
+ LV L+ C K L+ + P KSL+ F + D++ ++ LD ++
Sbjct: 70 AYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 128
Query: 120 FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANT 179
++ ++ G+ +LH +IHRDLK SNI++ KI DFG+ART G + + T
Sbjct: 129 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MT 183
Query: 180 NRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
+V T Y +PE ++ D++S G ++ E+I
Sbjct: 184 PEVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine
Kinase 2 Beta (ptk2b)
Length = 281
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 55/202 (27%), Positives = 98/202 (48%), Gaps = 14/202 (6%)
Query: 26 LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLL 80
LG+G FG VY+G + G++I A+K K E F +EA ++ L H ++V+L+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 81 GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
G +++ ++ E P L ++ + +K L K ++ +Q + +
Sbjct: 80 GI-IEEEPTWIIMELYPYGELGHYL-ERNKNSL----KVLTLVLYSLQICKAMAYLESIN 133
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTF-GMNELEANTNRIVGTHGYMSPEYVMNGIV 199
+HRD+ NIL+ K+ DFG++R + +A+ R+ +MSPE +
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRF 191
Query: 200 SMKSDVYSFGVLVLEIISSKKN 221
+ SDV+ F V + EI+S K
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQ 213
>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And
Regulatory (Ri{alpha}) Subunits Of Pka
Length = 350
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K + G A+K L K Q +V+ K NE ++
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
+ + LV+L +V EY+ + F ++ + RF +
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
IV YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLAGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma
pdb|1CM8|B Chain B, Phosphorylated Map Kinase P38-Gamma
Length = 367
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 53/213 (24%), Positives = 102/213 (47%), Gaps = 41/213 (19%)
Query: 26 LGQGGFGPVYKGKLLDGQ---EIAIKRLSKSSGQGIVEFK--NEAKLIAKLQHTNLVRLL 80
+G G +G V +DG+ ++AIK+L + + + E +L+ ++H N++ LL
Sbjct: 33 VGSGAYGAVCSA--VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 81 GCSLQKGERLLVYEYLPNKSLDFF-------------IFDSSKKELLDWKKRFNIIEGIV 127
+ P+++LD F + K E L + ++ ++
Sbjct: 91 DV------------FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML 138
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
+GL Y+H +IHRDLK N+ +++ KI DFG+AR + ++ V T
Sbjct: 139 KGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMXGXVVTRW 190
Query: 188 YMSPEYVMNGIVSMKS-DVYSFGVLVLEIISSK 219
Y +PE ++N + ++ D++S G ++ E+I+ K
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 51/198 (25%), Positives = 95/198 (47%), Gaps = 7/198 (3%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGCS 83
+G+G +G V ++ +AIK++S Q + E K++ +H N++ +
Sbjct: 33 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
+ Y+ ++ ++ K + L + I++GL Y+H + V+H
Sbjct: 93 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 149
Query: 144 RDLKASNILLDDQMNPKISDFGMARTFGMNELEAN-TNRIVGTHGYMSPEYVMNGIVSMK 202
RDLK SN+LL+ + KI DFG+AR + V T Y +PE ++N K
Sbjct: 150 RDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 203 S-DVYSFGVLVLEIISSK 219
S D++S G ++ E++S++
Sbjct: 210 SIDIWSVGCILAEMLSNR 227
>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate
Peptide And Inhibitor
pdb|3CQW|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate
Peptide And Inhibitor
pdb|3MV5|A Chain A, Crystal Structure Of Akt-1-Inhibitor Complexes
pdb|3MVH|A Chain A, Crystal Structure Of Akt-1-Inhibitor Complexes
Length = 342
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 13/214 (6%)
Query: 26 LGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
LG+G FG V K G+ A+K L K + + E +++ +H L L
Sbjct: 18 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT-ALK 76
Query: 82 CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
S Q +RL V EY L F + S ++ + + RF E IV L YLH S
Sbjct: 77 YSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSALDYLH--SEKN 131
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
V++RDLK N++LD + KI+DFG+ + G+ + A GT Y++PE + +
Sbjct: 132 VVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKD-GATMKXFCGTPEYLAPEVLEDNDYG 189
Query: 201 MKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
D + GV++ E++ + D E+ L+
Sbjct: 190 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 223
>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a
pdb|4H1M|A Chain A, Crystal Structure Of Pyk2 With The Indole 10c
Length = 293
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 55/202 (27%), Positives = 98/202 (48%), Gaps = 14/202 (6%)
Query: 26 LGQGGFGPVYKGKLLD--GQEI--AIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLVRLL 80
LG+G FG VY+G + G++I A+K K E F +EA ++ L H ++V+L+
Sbjct: 32 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 81 GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
G +++ ++ E P L ++ + +K L K ++ +Q + +
Sbjct: 92 GI-IEEEPTWIIMELYPYGELGHYL-ERNKNSL----KVLTLVLYSLQICKAMAYLESIN 145
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTF-GMNELEANTNRIVGTHGYMSPEYVMNGIV 199
+HRD+ NIL+ K+ DFG++R + +A+ R+ +MSPE +
Sbjct: 146 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRF 203
Query: 200 SMKSDVYSFGVLVLEIISSKKN 221
+ SDV+ F V + EI+S K
Sbjct: 204 TTASDVWMFAVCMWEILSFGKQ 225
>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796
pdb|3NPC|B Chain B, Crystal Structure Of Jnk2 Complexed With Birb796
Length = 364
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 63/234 (26%), Positives = 107/234 (45%), Gaps = 40/234 (17%)
Query: 10 FQTIAAATDNFSPGNR------LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK 62
F ++ A F+ R +G G G V + G +A+K+LS+ F+
Sbjct: 10 FYSVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP-------FQ 62
Query: 63 NEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL- 113
N+ AK + LV LL C K L+ + P K+L+ F + D++ ++
Sbjct: 63 NQTH--AKRAYRELV-LLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI 119
Query: 114 ---LDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF 170
LD ++ ++ ++ G+ +LH +IHRDLK SNI++ KI DFG+ART
Sbjct: 120 HMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 176
Query: 171 GMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSKKNNGC 224
N + V T Y +PE ++ + D++S G ++ E++ GC
Sbjct: 177 CTNFM---MTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELV-----KGC 222
>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp-
Dependent Protein Kinase Complexed With A Substrate
Peptide, Adp And Detergent
Length = 350
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K + G A+K L K Q +V+ K NE ++
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
+ + LV+L +V EY+ + F ++ + RF +
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
IV YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent
Protein Kinase
Length = 350
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 21/210 (10%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K + G A+K L K Q +V+ K NE ++
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
+ + LV+L +V EY+ + F + RF + IV
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARFYAAQ-IV 151
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPE 203
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor
pdb|3OCB|B Chain B, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor
pdb|3OW4|A Chain A, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|3OW4|B Chain B, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|3QKK|A Chain A, Spirochromane Akt Inhibitors
pdb|3QKL|A Chain A, Spirochromane Akt Inhibitors
pdb|3QKM|A Chain A, Spirocyclic Sulfonamides As Akt Inhibitors
pdb|4EKK|A Chain A, Akt1 With Amp-Pnp
pdb|4EKK|B Chain B, Akt1 With Amp-Pnp
pdb|4EKL|A Chain A, Akt1 With Gdc0068
Length = 341
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 13/214 (6%)
Query: 26 LGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
LG+G FG V K G+ A+K L K + + E +++ +H L L
Sbjct: 17 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT-ALK 75
Query: 82 CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
S Q +RL V EY L F + S ++ + + RF E IV L YLH S
Sbjct: 76 YSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSALDYLH--SEKN 130
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
V++RDLK N++LD + KI+DFG+ + G+ + A GT Y++PE + +
Sbjct: 131 VVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKD-GATMKXFCGTPEYLAPEVLEDNDYG 188
Query: 201 MKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
D + GV++ E++ + D E+ L+
Sbjct: 189 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 222
>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To
Hydroxyfasudil
Length = 351
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K + G A+K L K Q +V+ K NE ++
Sbjct: 39 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 95
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
+ + LV+L +V EY+ + F ++ + RF +
Sbjct: 96 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQ- 150
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
IV YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + GT
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 202
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234
>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of
Camp-Dependent Protein Kinase And Adenosine Further
Defines Conformational Flexibility
pdb|1BX6|A Chain A, Crystal Structure Of The Potent Natural Product Inhibitor
Balanol In Complex With The Catalytic Subunit Of Camp-
Dependent Protein Kinase
Length = 350
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K + G A+K L K Q +V+ K NE ++
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
+ + LV+L +V EY+ + F ++ + RF +
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
IV YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit
Of Camp- Dependent Protein Kinase
Length = 350
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K + G A+K L K Q +V+ K NE ++
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
+ + LV+L +V EY+ + F ++ + RF +
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
IV YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant
Catalytic Subunit Of Camp-Dependent Protein Kinase
Complexed With The Peptide Inhibitor Pki(5-24) And
Adenosine
pdb|1JLU|E Chain E, Crystal Structure Of The Catalytic Subunit Of
Camp-dependent Protein Kinase Complexed With A
Phosphorylated Substrate Peptide And Detergent
pdb|1RE8|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 2
pdb|1REJ|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 1
pdb|1REK|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 8
pdb|2QVS|E Chain E, Crystal Structure Of Type Iia Holoenzyme Of Camp-Dependent
Protein Kinase
pdb|3FJQ|E Chain E, Crystal Structure Of Camp-Dependent Protein Kinase
Catalytic Subunit Alpha In Complex With Peptide
Inhibitor Pki Alpha (6-25)
pdb|3IDB|A Chain A, Crystal Structure Of (108-268)riib:c Holoenzyme Of Camp-
Dependent Protein Kinase
pdb|3IDC|A Chain A, Crystal Structure Of (102-265)riib:c Holoenzyme Of Camp-
Dependent Protein Kinase
pdb|3O7L|D Chain D, Crystal Structure Of Phospholamban (1-19):pka
C-Subunit:amp-Pnp:mg2+ Complex
pdb|3OW3|A Chain A, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|1ATP|E Chain E, 2.2 Angstrom Refined Crystal Structure Of The Catalytic
Subunit Of Camp-Dependent Protein Kinase Complexed With
Mnatp And A Peptide Inhibitor
pdb|4DIN|A Chain A, Novel Localization And Quaternary Structure Of The Pka Ri
Beta Holoenzyme
Length = 350
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K + G A+K L K Q +V+ K NE ++
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
+ + LV+L +V EY+ + F ++ + RF +
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
IV YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|B Chain B, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|C Chain C, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|D Chain D, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|E Chain E, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|F Chain F, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|G Chain G, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|H Chain H, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|I Chain I, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|J Chain J, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|K Chain K, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|L Chain L, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|M Chain M, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|N Chain N, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
Length = 448
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 80/313 (25%), Positives = 129/313 (41%), Gaps = 70/313 (22%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-----QHTNLVRLL 80
LG G G V G+ +A+KR+ +++F + A + KL H N++R
Sbjct: 41 LGYGSSGTVVFQGSFQGRPVAVKRM-------LIDFCDIALMEIKLLTESDDHPNVIRYY 93
Query: 81 GCSLQKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFN---IIEGIVQGLLYLHKY 136
CS L + L N +L D + E L +K +N ++ I G+ +LH
Sbjct: 94 -CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS- 151
Query: 137 SRLRVIHRDLKASNILL--------DDQMNPK-----ISDFGMARTF--GMNELEANTNR 181
L++IHRDLK NIL+ D Q + ISDFG+ + G N N
Sbjct: 152 --LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 209
Query: 182 IVGTHGYMSPEYVMNGI---VSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAW 238
GT G+ +PE + ++ D++S G + I+S K+ R N++ +
Sbjct: 210 PSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIF 269
Query: 239 QLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMAL 298
L DE+ +C+H L + ATD ++ M+ +D +
Sbjct: 270 SL--------------------DEM-KCLHDRSLIAE--ATDL-----ISQMIDHDPLKR 301
Query: 299 PTP----RQPAFF 307
PT R P F+
Sbjct: 302 PTAMKVLRHPLFW 314
>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex
With N-(4-
(5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h-
Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide
Length = 446
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 13/214 (6%)
Query: 26 LGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
LG+G FG V K G+ A+K L K + + E +++ +H L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT-ALK 214
Query: 82 CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
S Q +RL V EY L F + S ++ + + RF E IV L YLH S
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSALDYLH--SEKN 269
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
V++RDLK N++LD + KI+DFG+ + G+ + A GT Y++PE + +
Sbjct: 270 VVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKD-GATMKTFCGTPEYLAPEVLEDNDYG 327
Query: 201 MKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
D + GV++ E++ + D E+ L+
Sbjct: 328 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 361
>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363
Length = 340
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 13/214 (6%)
Query: 26 LGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
LG+G FG V K G+ A+K L K + + E +++ +H L L
Sbjct: 16 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT-ALK 74
Query: 82 CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
S Q +RL V EY L F + S ++ + + RF E IV L YLH S
Sbjct: 75 YSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSALDYLH--SEKN 129
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
V++RDLK N++LD + KI+DFG+ + G+ + A GT Y++PE + +
Sbjct: 130 VVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKD-GATMKXFCGTPEYLAPEVLEDNDYG 187
Query: 201 MKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
D + GV++ E++ + D E+ L+
Sbjct: 188 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 221
>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein
Kinase Catalytic Subunit
pdb|1J3H|B Chain B, Crystal Structure Of Apoenzyme Camp-Dependent Protein
Kinase Catalytic Subunit
Length = 350
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K + G A+K L K Q +V+ K NE ++
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
+ + LV+L +V EY+ + F ++ + RF +
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
IV YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLXGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|B Chain B, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|C Chain C, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|D Chain D, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|E Chain E, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|F Chain F, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|G Chain G, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|H Chain H, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|I Chain I, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|J Chain J, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|K Chain K, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|L Chain L, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|M Chain M, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|N Chain N, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3SDM|A Chain A, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|B Chain B, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|C Chain C, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|D Chain D, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|E Chain E, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|F Chain F, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|G Chain G, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
Length = 448
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 80/313 (25%), Positives = 129/313 (41%), Gaps = 70/313 (22%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-----QHTNLVRLL 80
LG G G V G+ +A+KR+ +++F + A + KL H N++R
Sbjct: 41 LGYGSSGTVVFQGSFQGRPVAVKRM-------LIDFCDIALMEIKLLTESDDHPNVIRYY 93
Query: 81 GCSLQKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFN---IIEGIVQGLLYLHKY 136
CS L + L N +L D + E L +K +N ++ I G+ +LH
Sbjct: 94 -CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS- 151
Query: 137 SRLRVIHRDLKASNILL--------DDQMNPK-----ISDFGMARTF--GMNELEANTNR 181
L++IHRDLK NIL+ D Q + ISDFG+ + G N N
Sbjct: 152 --LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 209
Query: 182 IVGTHGYMSPEYVMNGI---VSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAW 238
GT G+ +PE + ++ D++S G + I+S K+ R N++ +
Sbjct: 210 PSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIF 269
Query: 239 QLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMAL 298
L DE+ +C+H L + ATD ++ M+ +D +
Sbjct: 270 SL--------------------DEM-KCLHDRSLIAE--ATDL-----ISQMIDHDPLKR 301
Query: 299 PTP----RQPAFF 307
PT R P F+
Sbjct: 302 PTAMKVLRHPLFW 314
>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric
Inhibitor
Length = 446
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 13/214 (6%)
Query: 26 LGQGGFGPVYKGK-LLDGQEIAIKRLSKS---SGQGIVEFKNEAKLIAKLQHTNLVRLLG 81
LG+G FG V K G+ A+K L K + + E +++ +H L L
Sbjct: 159 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT-ALK 217
Query: 82 CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
S Q +RL V EY L F + S ++ + + RF E IV L YLH S
Sbjct: 218 YSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSALDYLH--SEKN 272
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
V++RDLK N++LD + KI+DFG+ + G+ + A GT Y++PE + +
Sbjct: 273 VVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKD-GATMKTFCGTPEYLAPEVLEDNDYG 330
Query: 201 MKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
D + GV++ E++ + D E+ L+
Sbjct: 331 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 364
>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
pdb|2ZOQ|B Chain B, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
Length = 382
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 52/201 (25%), Positives = 100/201 (49%), Gaps = 13/201 (6%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLV---RLL 80
+G+G +G V + +AIK++S Q + E +++ + +H N++ +L
Sbjct: 51 IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 81 GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
S + R + Y+ ++ ++ K + L + I++GL Y+H +
Sbjct: 111 RASTLEAMRDV---YIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSAN--- 164
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGM-NELEANTNRIVGTHGYMSPEYVMNGIV 199
V+HRDLK SN+L++ + KI DFG+AR ++ V T Y +PE ++N
Sbjct: 165 VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKG 224
Query: 200 SMKS-DVYSFGVLVLEIISSK 219
KS D++S G ++ E++S++
Sbjct: 225 YTKSIDIWSVGCILAEMLSNR 245
>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From
Par-3
Length = 396
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 44/147 (29%), Positives = 74/147 (50%), Gaps = 8/147 (5%)
Query: 73 HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
H LV L C + V EY+ L F + +++L + RF E I L Y
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNY 168
Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
LH+ +I+RDLK N+LLD + + K++D+GM + G+ + T+ GT Y++PE
Sbjct: 169 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDT-TSTFCGTPNYIAPE 223
Query: 193 YVMNGIVSMKSDVYSFGVLVLEIISSK 219
+ D ++ GVL+ E+++ +
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMAGR 250
>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical
Protein Kinase C-Iota
Length = 364
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 44/147 (29%), Positives = 74/147 (50%), Gaps = 8/147 (5%)
Query: 73 HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
H LV L C + V EY+ L F + +++L + RF E I L Y
Sbjct: 80 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNY 136
Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
LH+ +I+RDLK N+LLD + + K++D+GM + G+ + T+ GT Y++PE
Sbjct: 137 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDT-TSXFCGTPNYIAPE 191
Query: 193 YVMNGIVSMKSDVYSFGVLVLEIISSK 219
+ D ++ GVL+ E+++ +
Sbjct: 192 ILRGEDYGFSVDWWALGVLMFEMMAGR 218
>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase
Length = 353
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 36/212 (16%)
Query: 24 NRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK--NEAKLIAKLQHTNLVRLL 80
+G G +G V G+++AIK+LS+ I + E L+ +QH N++ LL
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 81 GCSLQKGERLLVYEYLPNKSL----DFFI----FDSSKKELLDWK----KRFNIIEGIVQ 128
+ P SL DF++ + ++++ K K ++ +++
Sbjct: 90 DV------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLK 137
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
GL Y+H V+HRDLK N+ +++ KI DFG+AR +A V T Y
Sbjct: 138 GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWY 189
Query: 189 MSPEYVMNGI-VSMKSDVYSFGVLVLEIISSK 219
+PE +++ + + D++S G ++ E+++ K
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
>pdb|4EXU|A Chain A, Mapk13, Inactive Form
pdb|4EYJ|A Chain A, Mapk13 Complex With Inhibitor
pdb|4EYM|A Chain A, Mapk13 Complex With Inhibitor
Length = 371
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 53/203 (26%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 24 NRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK--NEAKLIAKLQHTNLVRLL 80
+G G +G V G+++AIK+LS+ I + E L+ +QH N++ LL
Sbjct: 48 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 107
Query: 81 GCSLQKGERLLVYEYLPNKSLDFFIFDSSK---KELLDWKKRFNIIEGIVQGLLYLHKYS 137
Y++ + F D K E + K ++ ++ +++GL Y+H
Sbjct: 108 DVFTPASSLRNFYDFY--LVMPFMQTDLQKIMGMEFSEEKIQY-LVYQMLKGLKYIHSAG 164
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG 197
V+HRDLK N+ +++ KI DFG+AR +A V T Y +PE +++
Sbjct: 165 ---VVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILSW 216
Query: 198 I-VSMKSDVYSFGVLVLEIISSK 219
+ + D++S G ++ E+++ K
Sbjct: 217 MHYNQTVDIWSVGCIMAEMLTGK 239
>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737
Length = 364
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 57/229 (24%), Positives = 99/229 (43%), Gaps = 48/229 (20%)
Query: 12 TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAK----- 66
T+ N P QG Y L + +AIK+LS+ F+N+
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTHAKRAY 71
Query: 67 ----LIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL- 113
L+ + H N++ LL + P K+L+ F + D++ ++
Sbjct: 72 RELVLMKXVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVI 119
Query: 114 ---LDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF 170
LD ++ ++ ++ G+ +LH +IHRDLK SNI++ KI DFG+ART
Sbjct: 120 QMELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA 176
Query: 171 GMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
G + + V T Y +PE ++ D++S G ++ E++ K
Sbjct: 177 GTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222
>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8W|B Chain B, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|B Chain B, Crystal Structure Of Pkciota Kinase Domain
Length = 345
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 44/147 (29%), Positives = 74/147 (50%), Gaps = 8/147 (5%)
Query: 73 HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
H LV L C + V EY+ L F + +++L + RF E I L Y
Sbjct: 69 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNY 125
Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
LH+ +I+RDLK N+LLD + + K++D+GM + G+ + T+ GT Y++PE
Sbjct: 126 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDT-TSXFCGTPNYIAPE 180
Query: 193 YVMNGIVSMKSDVYSFGVLVLEIISSK 219
+ D ++ GVL+ E+++ +
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAGR 207
>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent
Protein Kinase With Unphosphorylated Activation Loop
pdb|4DFY|E Chain E, Crystal Structure Of R194a Mutant Of Camp-Dependent
Protein Kinase With Unphosphorylated Activation Loop
Length = 371
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 21/210 (10%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K + G A+K L K Q +V+ K NE ++
Sbjct: 59 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 115
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
+ + LV+L +V EY+ + F + RF + IV
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARFYAAQ-IV 172
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + GT
Sbjct: 173 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGATWTLCGTPE 224
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 225 YLAPEIILSKGYNKAVDWWALGVLIYEMAA 254
>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent
Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In
Complex With Sto-609
Length = 298
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 52/169 (30%), Positives = 88/169 (52%), Gaps = 36/169 (21%)
Query: 58 IVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYL--PNKSLDFFIFD-------- 107
I + E ++ KL H N+V+L+ E L PN+ + +F+
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLV-------------EVLDDPNEDHLYMVFELVNQGPVM 126
Query: 108 --SSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG 165
+ K L + + RF + +++G+ YLH ++IHRD+K SN+L+ + + KI+DFG
Sbjct: 127 EVPTLKPLSEDQARF-YFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 166 MARTF-GMNELEANTNRIVGTHGYMSPEYV--MNGIVSMKS-DVYSFGV 210
++ F G + L +NT VGT +M+PE + I S K+ DV++ GV
Sbjct: 183 VSNEFKGSDALLSNT---VGTPAFMAPESLSETRKIFSGKALDVWAMGV 228
>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
pdb|3OZ6|B Chain B, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
Length = 388
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 55/221 (24%), Positives = 104/221 (47%), Gaps = 34/221 (15%)
Query: 25 RLGQGGFGPVYKG-KLLDGQEIAIKRLS---KSSGQGIVEFKNEAKLIAKLQHTNLVRLL 80
+LG+G +G V+K G+ +A+K++ ++S F+ L H N+V LL
Sbjct: 16 KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLL 75
Query: 81 GCSLQKGER--LLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSR 138
+R LV++Y+ + + +L+ + ++ +++ + YLH
Sbjct: 76 NVLRADNDRDVYLVFDYMETD-----LHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG- 129
Query: 139 LRVIHRDLKASNILLDDQMNPKISDFGMARTF------------GMNELEANTN------ 180
++HRD+K SNILL+ + + K++DFG++R+F +NE N +
Sbjct: 130 --LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187
Query: 181 -RIVGTHGYMSPEYVMNGIVSMKS-DVYSFGVLVLEIISSK 219
V T Y +PE ++ K D++S G ++ EI+ K
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|B Chain B, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|C Chain C, A Novel Small Molecule Apkc Inhibitor
Length = 349
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 44/147 (29%), Positives = 74/147 (50%), Gaps = 8/147 (5%)
Query: 73 HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
H LV L C + V EY+ L F + +++L + RF E I L Y
Sbjct: 65 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNY 121
Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
LH+ +I+RDLK N+LLD + + K++D+GM + G+ + T+ GT Y++PE
Sbjct: 122 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDT-TSXFCGTPNYIAPE 176
Query: 193 YVMNGIVSMKSDVYSFGVLVLEIISSK 219
+ D ++ GVL+ E+++ +
Sbjct: 177 ILRGEDYGFSVDWWALGVLMFEMMAGR 203
>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For
Catalysis And Regulation Of Non-conventional Splicing
pdb|2RIO|B Chain B, Structure Of The Dual Enzyme Ire1 Reveals The Basis For
Catalysis And Regulation Of Non-conventional Splicing
Length = 434
Score = 58.5 bits (140), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 81/317 (25%), Positives = 132/317 (41%), Gaps = 74/317 (23%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-----QHTNLVRLL 80
LG G G V G+ +A+KR+ +++F + A + KL H N++R
Sbjct: 23 LGYGSSGTVVFQGSFQGRPVAVKRM-------LIDFCDIALMEIKLLTESDDHPNVIRYY 75
Query: 81 GCSLQKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFN---IIEGIVQGLLYLHKY 136
CS L + L N +L D + E L +K +N ++ I G+ +LH
Sbjct: 76 -CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS- 133
Query: 137 SRLRVIHRDLKASNILL--------DDQMNPK-----ISDFGMARTF--GMNELEANTNR 181
L++IHRDLK NIL+ D Q + ISDFG+ + G + N N
Sbjct: 134 --LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 182 IVGTHGYMSPEYV--MNGIVSMKS-----DVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
GT G+ +PE + N + + + D++S G + I+S K+ R N++
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 251
Query: 235 GYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND 294
+ L DE+ +C+H L + ATD ++ M+ +D
Sbjct: 252 RGIFSL--------------------DEM-KCLHDRSLIAE--ATDL-----ISQMIDHD 283
Query: 295 TMALPTP----RQPAFF 307
+ PT R P F+
Sbjct: 284 PLKRPTAMKVLRHPLFW 300
>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2
pdb|3E7O|B Chain B, Crystal Structure Of Jnk2
Length = 360
Score = 58.5 bits (140), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 35/226 (15%)
Query: 10 FQTIAAATDNFSPGNR------LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFK 62
F ++ A F+ R +G G G V + G +A+K+LS+ F+
Sbjct: 8 FYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP-------FQ 60
Query: 63 NEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL- 113
N+ AK + LV LL C K L+ + P K+L+ F + D++ ++
Sbjct: 61 NQTH--AKRAYRELV-LLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI 117
Query: 114 ---LDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF 170
LD ++ ++ ++ G+ +LH +IHRDLK SNI++ KI DFG+ART
Sbjct: 118 HMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 174
Query: 171 GMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
N + V T Y +PE ++ D++S G ++ E++
Sbjct: 175 STNFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELV 217
>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 58.5 bits (140), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 48/226 (21%)
Query: 12 TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAK----- 66
T+ N P QG Y L + +AIK+LS+ F+N+
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTHAKRAY 71
Query: 67 ----LIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL- 113
L+ + H N++ LL + P KSL+ F + D++ ++
Sbjct: 72 RELVLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVI 119
Query: 114 ---LDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF 170
LD ++ ++ ++ G+ +LH +IHRDLK SNI++ KI DFG+ART
Sbjct: 120 QMELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA 176
Query: 171 GMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
G + + V T Y +PE ++ D++S GV++ E+I
Sbjct: 177 GTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMI 219
>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|B Chain B, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|C Chain C, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALO|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Ternary Complex With Amp-Pnp And P38 Peptide
pdb|3VUT|A Chain A, Crystal Structures Of Non-Phosphorylated Map2k4
pdb|3VUT|B Chain B, Crystal Structures Of Non-Phosphorylated Map2k4
Length = 327
Score = 58.5 bits (140), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 63/244 (25%), Positives = 107/244 (43%), Gaps = 37/244 (15%)
Query: 5 LKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN 63
LKI Q ++ +G+G +G V K GQ +A+KR+ + V+ K
Sbjct: 9 LKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-----RSTVDEKE 63
Query: 64 EAKLIAKLQ-------HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIF------DSSK 110
+ +L+ L +V+ G ++G+ + E + F+ + D
Sbjct: 64 QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIP 123
Query: 111 KELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF 170
+E+L I V+ L +L + L++IHRD+K SNILLD N K+ DFG++
Sbjct: 124 EEILG-----KITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGIS--- 173
Query: 171 GMNELEANTNRIVGTHGYMSPEYVMNGI----VSMKSDVYSFGVLVLEIISSK----KNN 222
G R G YM+PE + ++SDV+S G+ + E+ + + K N
Sbjct: 174 GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233
Query: 223 GCYD 226
+D
Sbjct: 234 SVFD 237
>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka
C-Subunit:amp-Pnp:mg2+ Complex
Length = 350
Score = 58.2 bits (139), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K + G A+K L K Q +V+ K NE ++
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
+ + LV+L +V EY+ + F ++ + RF +
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
IV YLH L +I+RDLK N+++D Q +++DFG A+ ++ T + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ E+ +
Sbjct: 202 PEYLAPEIIISKGYNKAVDWWALGVLIYEMAA 233
>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774
Length = 355
Score = 58.2 bits (139), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 36/223 (16%)
Query: 12 TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLI 68
T+ N P QG Y L + +AIK+LS+ Q K E L+
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPF-QNQTHAKRAYRELVLM 77
Query: 69 AKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL----LDW 116
+ H N++ LL + P K+L+ F + D++ ++ LD
Sbjct: 78 KXVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDH 125
Query: 117 KKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELE 176
++ ++ ++ G+ +LH +IHRDLK SNI++ KI DFG+ART G + +
Sbjct: 126 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFM- 181
Query: 177 ANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
V T Y +PE ++ D++S G ++ E++ K
Sbjct: 182 --MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222
>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent
Protein Kinase Reveals Unexpected Apoenzyme Conformation
pdb|1SYK|B Chain B, Crystal Structure Of E230q Mutant Of Camp-Dependent
Protein Kinase Reveals Unexpected Apoenzyme Conformation
Length = 350
Score = 58.2 bits (139), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K + G A+K L K Q +V+ K NE ++
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
+ + LV+L +V EY+ + F ++ + RF +
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
IV YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++PE +++ + D ++ GVL+ ++ +
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYQMAA 233
>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map
Kinase Jnk1
Length = 370
Score = 58.2 bits (139), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 48/226 (21%)
Query: 12 TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAK----- 66
T+ N P QG Y L + +AIK+LS+ F+N+
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVVAAYDAIL--ERNVAIKKLSRP-------FQNQTHAKRAY 71
Query: 67 ----LIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL- 113
L+ + H N++ LL + P KSL+ F + D++ ++
Sbjct: 72 RELVLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVI 119
Query: 114 ---LDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF 170
LD ++ ++ ++ G+ +LH +IHRDLK SNI++ KI DFG+ART
Sbjct: 120 QMELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA 176
Query: 171 GMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
G + + V T Y +PE ++ D++S GV++ E+I
Sbjct: 177 GTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMI 219
>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain
pdb|2F2U|B Chain B, Crystal Structure Of The Rho-Kinase Kinase Domain
pdb|2H9V|A Chain A, Structural Basis For Induced-Fit Binding Of Rho-Kinase To
The Inhibitor Y27632
Length = 402
Score = 58.2 bits (139), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 20/201 (9%)
Query: 26 LGQGGFGPVYKGKLLDGQEI-AIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
+G+G FG V + Q++ A+K LSK + F E + I ++ V L C
Sbjct: 83 IGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 142
Query: 83 SLQKGERL-LVYEYLPNKSLDFFI--FDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
+ Q + L +V EY+P L + +D +K W K + + +L L +
Sbjct: 143 AFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFYT-----AEVVLALDAIHSM 193
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM---- 195
+IHRD+K N+LLD + K++DFG + + + VGT Y+SPE +
Sbjct: 194 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM-VHCDTAVGTPDYISPEVLKSQGG 252
Query: 196 NGIVSMKSDVYSFGVLVLEII 216
+G + D +S GV + E++
Sbjct: 253 DGYYGRECDWWSVGVFLFEML 273
>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
pdb|1KOB|B Chain B, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
Length = 387
Score = 58.2 bits (139), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 54/199 (27%), Positives = 93/199 (46%), Gaps = 19/199 (9%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
LG G FG V++ + G+ K ++ KNE ++ +L H L+ L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 85 QKGERLLVYEYLPNKSLDFFIFDSSKKELLDWK----KRFNIIEGIVQGLLYLHKYSRLR 140
K E +L+ E+L L FD E D+K + N + +GL ++H++S
Sbjct: 119 DKYEMVLILEFLSGGEL----FDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS--- 169
Query: 141 VIHRDLKASNILLDDQM--NPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGI 198
++H D+K NI+ + + + KI DFG+A +E+ T T + +PE V
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT---TATAEFAAPEIVDREP 226
Query: 199 VSMKSDVYSFGVLVLEIIS 217
V +D+++ GVL ++S
Sbjct: 227 VGFYTDMWAIGVLGYVLLS 245
>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|C Chain C, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|D Chain D, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|E Chain E, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|F Chain F, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
Length = 384
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 18 DNFSPGNRLGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVEFKN---EAKLIAKLQH 73
D+F +G+G FG V + D +++ A+K ++K E +N E +++ L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 74 TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSS--KKELLDWKKRFNIIEGIVQGLL 131
LV L + + +V + L L + + + K+E + K F I +V L
Sbjct: 75 PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETV---KLF--ICELVMALD 129
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
YL R+IHRD+K NILLD+ + I+DF +A M E + GT YM+P
Sbjct: 130 YLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIA---AMLPRETQITTMAGTKPYMAP 183
Query: 192 EYVMN---GIVSMKSDVYSFGVLVLEIISSKK 220
E + S D +S GV E++ ++
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis
Length = 394
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 52/203 (25%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKN-EAKLIAKLQHTNLVRLLGCSL 84
+G G FG V++ KL++ E+AIK++ + FKN E +++ ++H N+V L
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKVLQDK-----RFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 85 QKGERL------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSR 138
G++ LV EY+P + K+ + + +++ L Y+H
Sbjct: 103 SNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS--- 159
Query: 139 LRVIHRDLKASNILLDDQMNP-KISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG 197
+ + HRD+K N+LLD K+ DFG A+ E N + I + Y +PE +
Sbjct: 160 IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG--EPNVSXICSRY-YRAPELIFGA 216
Query: 198 I-VSMKSDVYSFGVLVLEIISSK 219
+ D++S G ++ E++ +
Sbjct: 217 TNYTTNIDIWSTGCVMAELMQGQ 239
>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor,
Sr- 3451
Length = 353
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 14/212 (6%)
Query: 12 TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLI 68
T+ N P QG Y L + +AIK+LS+ Q K E L+
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPF-QNQTHAKRAYRELVLM 77
Query: 69 AKLQHTNLVRLLGC-SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIV 127
+ H N++ LL + QK YL + +D + + EL D ++ ++ ++
Sbjct: 78 KXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-DHERMSYLLYQML 136
Query: 128 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHG 187
G+ +LH +IHRDLK SNI++ KI DFG+ART G + + V T
Sbjct: 137 CGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFM---MTPYVVTRY 190
Query: 188 YMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
Y +PE ++ D++S G ++ E++ K
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222
>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|B Chain B, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|C Chain C, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|D Chain D, Structure Of Human Phosphorylase Kinase, Gamma 2
Length = 365
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 38/136 (27%), Positives = 70/136 (51%), Gaps = 22/136 (16%)
Query: 98 NKSLDFFIFDSSKK-ELLDW---------KKRFNIIEGIVQGLLYLHKYSRLRVIHRDLK 147
+ S F +FD +K EL D+ K+ +I+ +++ + +LH + ++HRDLK
Sbjct: 171 SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLK 227
Query: 148 ASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGI------VSM 201
NILLDD M ++SDFG + E + GT GY++PE + +
Sbjct: 228 PENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGK 284
Query: 202 KSDVYSFGVLVLEIIS 217
+ D+++ GV++ +++
Sbjct: 285 EVDLWACGVILFTLLA 300
>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1
Length = 361
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 22/202 (10%)
Query: 17 TDNFSPGNRLGQGGFGPVYKGKLLDGQE----IAIKRLSKSSGQGIVE-FKNEAKLIAKL 71
+D + +G G FG +L+ ++ +A+K + + G+ I E K E L
Sbjct: 17 SDRYELVKDIGSGNFG---VARLMRDKQSNELVAVKYIER--GEKIDENVKREIINHRSL 71
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
+H N+VR L +V EY L I ++ + + + RF + ++ G+
Sbjct: 72 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARF-FFQQLISGVS 128
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNP--KISDFGMARTFGMNELEANTNRIVGTHGYM 189
Y H ++V HRDLK N LLD P KI DFG +++ + L + VGT Y+
Sbjct: 129 YCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGTPAYI 182
Query: 190 SPEYVMNGIVSMK-SDVYSFGV 210
+PE ++ K +DV+S GV
Sbjct: 183 APEVLLKKEYDGKVADVWSCGV 204
>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|B Chain B, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|D Chain D, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|E Chain E, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
Length = 371
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 29/210 (13%)
Query: 25 RLGQGGFGPVYKGKLLDGQ---EIAIKRLSKSSGQGIVEFKNEAKL-IAKLQHTNLVRLL 80
RLG+G FG V++ + D Q + A+K++ + F+ E + A L +V L
Sbjct: 100 RLGRGSFGEVHR--MEDKQTGFQCAVKKVR------LEVFRAEELMACAGLTSPRIVPLY 151
Query: 81 GCSLQKGERLLVY-EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
G ++++G + ++ E L SL + ++ L + + ++GL YLH SR
Sbjct: 152 G-AVREGPWVNIFMELLEGGSLGQLV---KEQGCLPEDRALYYLGQALEGLEYLH--SR- 204
Query: 140 RVIHRDLKASNILLD-DQMNPKISDFGMARTF---GMNELEANTNRIVGTHGYMSPEYVM 195
R++H D+KA N+LL D + + DFG A G+ + + I GT +M+PE V+
Sbjct: 205 RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVL 264
Query: 196 NGIVSMKSDVYSFGVLVLEIISSKKNNGCY 225
K DV+S ++L ++ NGC+
Sbjct: 265 GRSCDAKVDVWSSCCMMLHML-----NGCH 289
>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid-
Regulated Kinase 1 In Complex With Amp-Pnp
pdb|3HDM|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 1
pdb|3HDN|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 2
Length = 373
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 23/201 (11%)
Query: 26 LGQGGFGPVYKGKLLDGQEI--AIKRLSKSSGQGIVEFKNEAKLIAK-------LQHTNL 76
+G+G FG V + +E+ A+K L K + I++ K E ++++ ++H L
Sbjct: 46 IGKGSFGKVLLARH-KAEEVFYAVKVLQK---KAILKKKEEKHIMSERNVLLKNVKHPFL 101
Query: 77 VRLLGCSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
V L S Q ++L V +Y+ L F ++ L+ + RF E I L YLH
Sbjct: 102 VGL-HFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAE-IASALGYLHS 157
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
L +++RDLK NILLD Q + ++DFG+ + E + T+ GT Y++PE +
Sbjct: 158 ---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNSTTSTFCGTPEYLAPEVLH 212
Query: 196 NGIVSMKSDVYSFGVLVLEII 216
D + G ++ E++
Sbjct: 213 KQPYDRTVDWWCLGAVLYEML 233
>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3)
Length = 350
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 25/208 (12%)
Query: 25 RLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGC 82
RLG+G FG V++ K G + A+K++ + F+ E A L +V L G
Sbjct: 79 RLGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYG- 131
Query: 83 SLQKGERLLVY-EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
++++G + ++ E L SL I + L + + ++GL YLH R+
Sbjct: 132 AVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---RI 185
Query: 142 IHRDLKASNILLD-DQMNPKISDFGMARTF---GMNELEANTNRIVGTHGYMSPEYVMNG 197
+H D+KA N+LL D + DFG A G+ + + I GT +M+PE VM
Sbjct: 186 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 245
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCY 225
K D++S ++L ++ NGC+
Sbjct: 246 PCDAKVDIWSSCCMMLHML-----NGCH 268
>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit
Of Camp- Dependent Protein Kinase
Length = 350
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 25/212 (11%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K + G A+K L K Q +V+ K NE ++
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
+ + LV+L +V EY+ + F ++ + RF +
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
IV YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
Y++P +++ + D ++ GVL+ E+ +
Sbjct: 202 PEYLAPAIILSKGYNKAVDWWALGVLIYEMAA 233
>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6
pdb|3UDB|B Chain B, Crystal Structure Of Snrk2.6
pdb|3UDB|C Chain C, Crystal Structure Of Snrk2.6
pdb|3UDB|D Chain D, Crystal Structure Of Snrk2.6
pdb|3UDB|E Chain E, Crystal Structure Of Snrk2.6
pdb|3UDB|F Chain F, Crystal Structure Of Snrk2.6
Length = 317
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 16/199 (8%)
Query: 17 TDNFSPGNRLGQGGFGPVYKGKLLDGQE-IAIKRLSKSSGQGIVE-FKNEAKLIAKLQHT 74
+D + +G G FG + E +A+K + + G+ I E K E L+H
Sbjct: 18 SDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIER--GEKIDENVKREIINHRSLRHP 75
Query: 75 NLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLH 134
N+VR L +V EY L I ++ + + + RF + ++ G+ Y H
Sbjct: 76 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARF-FFQQLISGVSYAH 132
Query: 135 KYSRLRVIHRDLKASNILLDDQMNP--KISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
++V HRDLK N LLD P KI+DFG ++ + L + VGT Y++PE
Sbjct: 133 A---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKA---SVLHSQPKSAVGTPAYIAPE 186
Query: 193 YVMNGIVSMK-SDVYSFGV 210
++ K +DV+S GV
Sbjct: 187 VLLKKEYDGKVADVWSCGV 205
>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin
pdb|3LJ0|B Chain B, Ire1 Complexed With Adp And Quercetin
pdb|3LJ1|A Chain A, Ire1 Complexed With Cdk12 INHIBITOR III
pdb|3LJ1|B Chain B, Ire1 Complexed With Cdk12 INHIBITOR III
pdb|3LJ2|A Chain A, Ire1 Complexed With Jak Inhibitor I
pdb|3LJ2|B Chain B, Ire1 Complexed With Jak Inhibitor I
Length = 434
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 81/317 (25%), Positives = 131/317 (41%), Gaps = 74/317 (23%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-----QHTNLVRLL 80
LG G G V G+ +A+KR+ +++F + A + KL H N++R
Sbjct: 23 LGYGSSGTVVFQGSFQGRPVAVKRM-------LIDFCDIALMEIKLLTESDDHPNVIRYY 75
Query: 81 GCSLQKGERLLVYEYLPNKSL-DFFIFDSSKKELLDWKKRFN---IIEGIVQGLLYLHKY 136
CS L + L N +L D + E L +K +N ++ I G+ +LH
Sbjct: 76 -CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS- 133
Query: 137 SRLRVIHRDLKASNILL--------DDQMNPK-----ISDFGMARTF--GMNELEANTNR 181
L++IHRDLK NIL+ D Q + ISDFG+ + G N N
Sbjct: 134 --LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 191
Query: 182 IVGTHGYMSPEYV--MNGIVSMKS-----DVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
GT G+ +PE + N + + + D++S G + I+S K+ R N++
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 251
Query: 235 GYAWQLWNEGKALELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTND 294
+ L DE+ +C+H L + ATD ++ M+ +D
Sbjct: 252 RGIFSL--------------------DEM-KCLHDRSLIAE--ATDL-----ISQMIDHD 283
Query: 295 TMALPTP----RQPAFF 307
+ PT R P F+
Sbjct: 284 PLKRPTAMKVLRHPLFW 300
>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The
Kinase Domain Of Focal Adhesion Kinase With A
Phosphorylated Activation Loop
Length = 276
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 50/199 (25%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 23 GNRLGQGGFGPVYKGKLLDGQE----IAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLV 77
G +G+G FG V++G + + +AIK + + E F EA + + H ++V
Sbjct: 15 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 78 RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
+L+G + + ++ E L F+ +K LD + L YL
Sbjct: 75 KLIGV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK- 130
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG 197
R +HRD+ A N+L+ K+ DFG++R + + ++ +M+PE +
Sbjct: 131 --RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTXXKASKGKLPIKWMAPESINFR 187
Query: 198 IVSMKSDVYSFGVLVLEII 216
+ SDV+ FGV + EI+
Sbjct: 188 RFTSASDVWMFGVCMWEIL 206
>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6
pdb|3UC4|B Chain B, The Crystal Structure Of Snf1-Related Kinase 2.6
Length = 362
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 22/202 (10%)
Query: 17 TDNFSPGNRLGQGGFGPVYKGKLLDGQE----IAIKRLSKSSGQGIV-EFKNEAKLIAKL 71
+D + +G G FG +L+ ++ +A+K + + G+ I K E L
Sbjct: 18 SDRYELVKDIGSGNFG---VARLMRDKQSNELVAVKYIER--GEKIAANVKREIINHRSL 72
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
+H N+VR L +V EY L I ++ + + + RF + ++ G+
Sbjct: 73 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARF-FFQQLISGVS 129
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNP--KISDFGMARTFGMNELEANTNRIVGTHGYM 189
Y H ++V HRDLK N LLD P KI DFG +++ + L + VGT Y+
Sbjct: 130 YCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGTPAYI 183
Query: 190 SPEYVMNGIVSMK-SDVYSFGV 210
+PE ++ K +DV+S GV
Sbjct: 184 APEVLLKKEYDGKVADVWSCGV 205
>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik)
pdb|4DN5|B Chain B, Crystal Structure Of Nf-kb-inducing Kinase (nik)
Length = 356
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 29/210 (13%)
Query: 25 RLGQGGFGPVYKGKLLDGQ---EIAIKRLSKSSGQGIVEFKNEAKL-IAKLQHTNLVRLL 80
RLG+G FG V++ + D Q + A+K++ + F+ E + A L +V L
Sbjct: 81 RLGRGSFGEVHR--MEDKQTGFQCAVKKVR------LEVFRAEELMACAGLTSPRIVPLY 132
Query: 81 GCSLQKGERLLVY-EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
G ++++G + ++ E L SL + ++ L + + ++GL YLH SR
Sbjct: 133 G-AVREGPWVNIFMELLEGGSLGQLV---KEQGCLPEDRALYYLGQALEGLEYLH--SR- 185
Query: 140 RVIHRDLKASNILLD-DQMNPKISDFGMARTF---GMNELEANTNRIVGTHGYMSPEYVM 195
R++H D+KA N+LL D + + DFG A G+ + + I GT +M+PE V+
Sbjct: 186 RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVL 245
Query: 196 NGIVSMKSDVYSFGVLVLEIISSKKNNGCY 225
K DV+S ++L ++ NGC+
Sbjct: 246 GRSCDAKVDVWSSCCMMLHML-----NGCH 270
>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map
Kinase Jnk1
Length = 370
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 48/226 (21%)
Query: 12 TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAK----- 66
T+ N P QG Y L + +AIK+LS+ F+N+
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTHAKRAY 71
Query: 67 ----LIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL- 113
L+ + H N++ LL + P KSL+ F + D++ ++
Sbjct: 72 RELVLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVI 119
Query: 114 ---LDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF 170
LD ++ ++ ++ G+ +LH +IHRDLK SNI++ KI DFG+ART
Sbjct: 120 QMELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA 176
Query: 171 GMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
G + + V T Y +PE ++ D++S G ++ E+I
Sbjct: 177 GTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2ETM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2IJM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
pdb|2IJM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
Length = 281
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 23 GNRLGQGGFGPVYKGKLLDGQE----IAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLV 77
G +G+G FG V++G + + +AIK + + E F EA + + H ++V
Sbjct: 17 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 76
Query: 78 RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
+L+G + + ++ E L F+ +K LD + L YL
Sbjct: 77 KLIGV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK- 132
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTF-GMNELEANTNRIVGTHGYMSPEYVMN 196
R +HRD+ A N+L+ K+ DFG++R +A+ ++ +M+PE +
Sbjct: 133 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINF 188
Query: 197 GIVSMKSDVYSFGVLVLEII 216
+ SDV+ FGV + EI+
Sbjct: 189 RRFTSASDVWMFGVCMWEIL 208
>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A
Methanesulfonamide Diaminopyrimidine Inhibitor
Length = 276
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 23 GNRLGQGGFGPVYKGKLLDGQE----IAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLV 77
G +G+G FG V++G + + +AIK + + E F EA + + H ++V
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 78 RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
+L+G + + ++ E L F+ +K LD + L YL
Sbjct: 72 KLIGV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK- 127
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTF-GMNELEANTNRIVGTHGYMSPEYVMN 196
R +HRD+ A N+L+ K+ DFG++R +A+ ++ +M+PE +
Sbjct: 128 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINF 183
Query: 197 GIVSMKSDVYSFGVLVLEII 216
+ SDV+ FGV + EI+
Sbjct: 184 RRFTSASDVWMFGVCMWEIL 203
>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 23 GNRLGQGGFGPVYKGKLLDGQE----IAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLV 77
G +G+G FG V++G + + +AIK + + E F EA + + H ++V
Sbjct: 15 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 78 RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
+L+G + + ++ E L F+ +K LD + L YL
Sbjct: 75 KLIGV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK- 130
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTF-GMNELEANTNRIVGTHGYMSPEYVMN 196
R +HRD+ A N+L+ K+ DFG++R +A+ ++ +M+PE +
Sbjct: 131 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINF 186
Query: 197 GIVSMKSDVYSFGVLVLEII 216
+ SDV+ FGV + EI+
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206
>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And
Kinase Domains Of Focal Adhesion Kinase.
pdb|2JKQ|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 23 GNRLGQGGFGPVYKGKLLDGQE----IAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLV 77
G +G+G FG V++G + + +AIK + + E F EA + + H ++V
Sbjct: 15 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 78 RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
+L+G + + ++ E L F+ +K LD + L YL
Sbjct: 75 KLIGV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK- 130
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTF-GMNELEANTNRIVGTHGYMSPEYVMN 196
R +HRD+ A N+L+ K+ DFG++R +A+ ++ +M+PE +
Sbjct: 131 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINF 186
Query: 197 GIVSMKSDVYSFGVLVLEII 216
+ SDV+ FGV + EI+
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206
>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
pdb|4EBV|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
Length = 304
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 23 GNRLGQGGFGPVYKGKLLDGQE----IAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLV 77
G +G+G FG V++G + + +AIK + + E F EA + + H ++V
Sbjct: 43 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 102
Query: 78 RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
+L+G + + ++ E L F+ +K LD + L YL
Sbjct: 103 KLIGV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK- 158
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTF-GMNELEANTNRIVGTHGYMSPEYVMN 196
R +HRD+ A N+L+ K+ DFG++R +A+ ++ +M+PE +
Sbjct: 159 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINF 214
Query: 197 GIVSMKSDVYSFGVLVLEII 216
+ SDV+ FGV + EI+
Sbjct: 215 RRFTSASDVWMFGVCMWEIL 234
>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 2-(aminothiazoly)phenol (cmp2)
Length = 336
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 25/208 (12%)
Query: 25 RLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGC 82
R+G+G FG V++ K G + A+K++ + F+ E A L +V L G
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYG- 117
Query: 83 SLQKGERLLVY-EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
++++G + ++ E L SL I + L + + ++GL YLH R+
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---RI 171
Query: 142 IHRDLKASNILLD-DQMNPKISDFGMARTF---GMNELEANTNRIVGTHGYMSPEYVMNG 197
+H D+KA N+LL D + DFG A G+ + + I GT +M+PE VM
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCY 225
K D++S ++L ++ NGC+
Sbjct: 232 PCDAKVDIWSSCCMMLHML-----NGCH 254
>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 48/226 (21%)
Query: 12 TIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAK----- 66
T+ N P QG Y L + +AIK+LS+ F+N+
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTHAKRAY 71
Query: 67 ----LIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFF--------IFDSSKKEL- 113
L+ + H N++ LL + P KSL+ F + D++ ++
Sbjct: 72 RELVLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVI 119
Query: 114 ---LDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTF 170
LD ++ ++ ++ G+ +LH +IHRDLK SNI++ KI DFG+ART
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA 176
Query: 171 GMNELEANTNRIVGTHGYMSPEYVMNGIVSMKSDVYSFGVLVLEII 216
G + + V T Y +PE ++ D++S G ++ E+I
Sbjct: 177 GTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak)
pdb|4I4F|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With An Allosteric Binding Pyrazolobenzothiazine
Compound
Length = 281
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 23 GNRLGQGGFGPVYKGKLLDGQE----IAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLV 77
G +G+G FG V++G + + +AIK + + E F EA + + H ++V
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 78 RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
+L+G + + ++ E L F+ +K LD + L YL
Sbjct: 80 KLIGV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK- 135
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTF-GMNELEANTNRIVGTHGYMSPEYVMN 196
R +HRD+ A N+L+ K+ DFG++R +A+ ++ +M+PE +
Sbjct: 136 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINF 191
Query: 197 GIVSMKSDVYSFGVLVLEII 216
+ SDV+ FGV + EI+
Sbjct: 192 RRFTSASDVWMFGVCMWEIL 211
>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase
(nik)
pdb|4G3C|B Chain B, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase
(nik)
pdb|4G3E|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 6-alkynylindoline (cmp1)
pdb|4G3E|B Chain B, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 6-alkynylindoline (cmp1)
Length = 352
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 25/208 (12%)
Query: 25 RLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEFK-NEAKLIAKLQHTNLVRLLGC 82
R+G+G FG V++ K G + A+K++ + F+ E A L +V L G
Sbjct: 81 RVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYG- 133
Query: 83 SLQKGERLLVY-EYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRV 141
++++G + ++ E L SL I + L + + ++GL YLH R+
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---RI 187
Query: 142 IHRDLKASNILLD-DQMNPKISDFGMARTF---GMNELEANTNRIVGTHGYMSPEYVMNG 197
+H D+KA N+LL D + DFG A G+ + + I GT +M+PE VM
Sbjct: 188 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 247
Query: 198 IVSMKSDVYSFGVLVLEIISSKKNNGCY 225
K D++S ++L ++ NGC+
Sbjct: 248 PCDAKVDIWSSCCMMLHML-----NGCH 270
>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
pdb|3PXK|B Chain B, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
Length = 282
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 23 GNRLGQGGFGPVYKGKLLDGQE----IAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLV 77
G +G+G FG V++G + + +AIK + + E F EA + + H ++V
Sbjct: 18 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 77
Query: 78 RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
+L+G + + ++ E L F+ +K LD + L YL
Sbjct: 78 KLIGV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK- 133
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTF-GMNELEANTNRIVGTHGYMSPEYVMN 196
R +HRD+ A N+L+ K+ DFG++R +A+ ++ +M+PE +
Sbjct: 134 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINF 189
Query: 197 GIVSMKSDVYSFGVLVLEII 216
+ SDV+ FGV + EI+
Sbjct: 190 RRFTSASDVWMFGVCMWEIL 209
>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of
Camp-Dependent Protein Kinase
Length = 350
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 25/212 (11%)
Query: 15 AATDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFK------NEAKL 67
A D F LG G FG V K + G A+K L K Q +V+ K NE ++
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRI 94
Query: 68 IAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKK--ELLDWKKRFNIIEG 125
+ + LV+L +V EY+ + F ++ + RF +
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQ- 149
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
IV YLH L +I+RDLK N+L+D Q +++DFG A+ ++ T + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGT 201
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIIS 217
++PE +++ + D ++ GVL+ E+ +
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle
Protein Titin
pdb|1TKI|B Chain B, Autoinhibited Serine Kinase Domain Of The Giant Muscle
Protein Titin
Length = 321
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 46/200 (23%), Positives = 94/200 (47%), Gaps = 22/200 (11%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQ 85
LG+G FG V++ ++ + + K G V K E ++ +H N++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 86 KGERLLVYEYLPNKSLDFF------IFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
E ++++E++ LD F F+ +++E++ + + + + L +LH ++
Sbjct: 73 MEELVMIFEFISG--LDIFERINTSAFELNEREIVSY------VHQVCEALQFLHSHN-- 122
Query: 140 RVIHRDLKASNILLDDQMNP--KISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNG 197
+ H D++ NI+ + + KI +FG AR + N + Y +PE +
Sbjct: 123 -IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHD 178
Query: 198 IVSMKSDVYSFGVLVLEIIS 217
+VS +D++S G LV ++S
Sbjct: 179 VVSTATDMWSLGTLVYVLLS 198
>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
pdb|2JKO|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 23 GNRLGQGGFGPVYKGKLLDGQE----IAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLV 77
G +G+G FG V++G + + +AIK + + E F EA + + H ++V
Sbjct: 15 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 78 RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
+L+G + + ++ E L F+ +K LD + L YL
Sbjct: 75 KLIGV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK- 130
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTF-GMNELEANTNRIVGTHGYMSPEYVMN 196
R +HRD+ A N+L+ K+ DFG++R +A+ ++ +M+PE +
Sbjct: 131 --RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINF 186
Query: 197 GIVSMKSDVYSFGVLVLEII 216
+ SDV+ FGV + EI+
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206
>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 23 GNRLGQGGFGPVYKGKLLDGQE----IAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLV 77
G +G+G FG V++G + + +AIK + + E F EA + + H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 78 RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
+L+G + + ++ E L F+ +K LD + L YL
Sbjct: 455 KLIGV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK- 510
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTF-GMNELEANTNRIVGTHGYMSPEYVMN 196
R +HRD+ A N+L+ K+ DFG++R +A+ ++ +M+PE +
Sbjct: 511 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINF 566
Query: 197 GIVSMKSDVYSFGVLVLEII 216
+ SDV+ FGV + EI+
Sbjct: 567 RRFTSASDVWMFGVCMWEIL 586
>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3
Length = 361
Score = 55.1 bits (131), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 18/200 (9%)
Query: 17 TDNFSPGNRLGQGGFG--PVYKGKLLDGQEIAIKRLSKSSGQGIVE-FKNEAKLIAKLQH 73
+D + +G G FG + + KL + +A+K + + G I E + E L+H
Sbjct: 19 SDRYDFVKDIGSGNFGVARLMRDKLTK-ELVAVKYIER--GAAIDENVQREIINHRSLRH 75
Query: 74 TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYL 133
N+VR L ++ EY L I ++ + + + RF + ++ G+ Y
Sbjct: 76 PNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGR--FSEDEARF-FFQQLLSGVSYC 132
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNP--KISDFGMARTFGMNELEANTNRIVGTHGYMSP 191
H +++ HRDLK N LLD P KI DFG +++ + L + VGT Y++P
Sbjct: 133 HS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGTPAYIAP 186
Query: 192 EYVMNGIVSMK-SDVYSFGV 210
E ++ K +DV+S GV
Sbjct: 187 EVLLRQEYDGKIADVWSCGV 206
>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains.
pdb|2J0K|B Chain B, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 54.7 bits (130), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 23 GNRLGQGGFGPVYKGKLLDGQE----IAIKRLSKSSGQGIVE-FKNEAKLIAKLQHTNLV 77
G +G+G FG V++G + + +AIK + + E F EA + + H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 78 RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
+L+G + + ++ E L F+ +K LD + L YL
Sbjct: 455 KLIGV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK- 510
Query: 138 RLRVIHRDLKASNILLDDQMNPKISDFGMARTF-GMNELEANTNRIVGTHGYMSPEYVMN 196
R +HRD+ A N+L+ K+ DFG++R +A+ ++ +M+PE +
Sbjct: 511 --RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINF 566
Query: 197 GIVSMKSDVYSFGVLVLEII 216
+ SDV+ FGV + EI+
Sbjct: 567 RRFTSASDVWMFGVCMWEIL 586
>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase
pdb|3ZUT|B Chain B, The Structure Of Ost1 (D160a) Kinase
Length = 362
Score = 54.7 bits (130), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 22/202 (10%)
Query: 17 TDNFSPGNRLGQGGFGPVYKGKLLDGQE----IAIKRLSKSSGQGIVE-FKNEAKLIAKL 71
+D + +G G FG +L+ ++ +A+K + + G+ I E K E L
Sbjct: 18 SDRYELVKDIGSGNFG---VARLMRDKQSNELVAVKYIER--GEKIDENVKREIINHRSL 72
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
+H N+VR L +V EY L I ++ + + + RF + ++ G+
Sbjct: 73 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARF-FFQQLISGVS 129
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNP--KISDFGMARTFGMNELEANTNRIVGTHGYM 189
Y H ++V HRDLK N LLD P KI FG +++ + L + VGT Y+
Sbjct: 130 YCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKS---SVLHSQPKSTVGTPAYI 183
Query: 190 SPEYVMNGIVSMK-SDVYSFGV 210
+PE ++ K +DV+S GV
Sbjct: 184 APEVLLKKEYDGKVADVWSCGV 205
>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
pdb|2BUJ|B Chain B, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
Length = 317
Score = 54.3 bits (129), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 59/225 (26%), Positives = 98/225 (43%), Gaps = 34/225 (15%)
Query: 24 NRLGQGGFGPV-YKGKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLG- 81
+LG+GGF V L DG A+KR+ Q E + EA + H N++RL+
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 82 CSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIE---------GIVQGLLY 132
C ++G + + LP FF + E+ K + N + GI +GL
Sbjct: 95 CLRERGAKHEAWLLLP-----FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIV--------G 184
+H HRDLK +NILL D+ P + D G ++ +E + +
Sbjct: 150 IHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH-VEGSRQALTLQDWAAQRC 205
Query: 185 THGYMSPEYV---MNGIVSMKSDVYSFGVLVLEIISSKKNNGCYD 226
T Y +PE + ++ ++DV+S G ++ ++ + G YD
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE---GPYD 247
>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|B Chain B, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|C Chain C, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|D Chain D, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
Length = 432
Score = 54.3 bits (129), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 53/228 (23%), Positives = 105/228 (46%), Gaps = 23/228 (10%)
Query: 19 NFSPGNRLGQGGFGP-VYKGKLLDGQEIAIKRLSKSSGQGIVEFKN-EAKLIAKL-QHTN 75
+F P + LG G G VY+G + D +++A+KR+ F + E +L+ + +H N
Sbjct: 25 SFCPKDVLGHGAEGTIVYRG-MFDNRDVAVKRILPEC----FSFADREVQLLRESDEHPN 79
Query: 76 LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
++R C+ + + + L +L ++ L + +++ GL +LH
Sbjct: 80 VIRYF-CTEKDRQFQYIAIELCAATLQEYVEQKDFAHL--GLEPITLLQQTTSGLAHLHS 136
Query: 136 YSRLRVIHRDLKASNILLD-----DQMNPKISDFGMARTFGMNELE-ANTNRIVGTHGYM 189
L ++HRDLK NIL+ ++ ISDFG+ + + + + + GT G++
Sbjct: 137 ---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 190 SPEYVMNGI---VSMKSDVYSFGVLVLEIISSKKNNGCYDTERHLNLV 234
+PE + + D++S G + +IS + +R N++
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL 241
>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex
With Gold
pdb|3ZUU|B Chain B, The Structure Of Ost1 (D160a, S175d) Kinase In Complex
With Gold
Length = 362
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 22/202 (10%)
Query: 17 TDNFSPGNRLGQGGFGPVYKGKLLDGQE----IAIKRLSKSSGQGIVE-FKNEAKLIAKL 71
+D + +G G FG +L+ ++ +A+K + + G+ I E K E L
Sbjct: 18 SDRYELVKDIGSGNFG---VARLMRDKQSNELVAVKYIER--GEKIDENVKREIINHRSL 72
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
+H N+VR L +V EY L I ++ + + + RF + ++ G+
Sbjct: 73 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARF-FFQQLISGVS 129
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNP--KISDFGMARTFGMNELEANTNRIVGTHGYM 189
Y H ++V HRDLK N LLD P KI FG +++ + L + VGT Y+
Sbjct: 130 YCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKS---SVLHSQPKDTVGTPAYI 183
Query: 190 SPEYVMNGIVSMK-SDVYSFGV 210
+PE ++ K +DV+S GV
Sbjct: 184 APEVLLKKEYDGKVADVWSCGV 205
>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B
(STK17B)
pdb|3LM5|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B
(STK17B) IN Complex With Quercetin
Length = 327
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 16/201 (7%)
Query: 25 RLGQGGFGPVYKG-KLLDGQEIAIKRLSKSS-GQGI-VEFKNEAKLIAKLQHT-NLVRLL 80
LG+G F V + GQE A K L K GQ E +E ++ + ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 81 GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
E +L+ EY + F + E++ +I+ I++G+ YLH+ +
Sbjct: 96 EVYENTSEIILILEYAAGGEI-FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--- 151
Query: 141 VIHRDLKASNILLDDQMNP----KISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMN 196
++H DLK NILL + P KI DFGM+R G I+GT Y++PE +
Sbjct: 152 IVHLDLKPQNILLSS-IYPLGDIKIVDFGMSRKIGH---ACELREIMGTPEYLAPEILNY 207
Query: 197 GIVSMKSDVYSFGVLVLEIIS 217
++ +D+++ G++ +++
Sbjct: 208 DPITTATDMWNIGIIAYMLLT 228
>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha
Complex
pdb|2WTK|F Chain F, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha
Complex
Length = 305
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 53/216 (24%), Positives = 96/216 (44%), Gaps = 36/216 (16%)
Query: 23 GNRLGQGGFGPVYKGKLLDGQEIAIKRLSKSS-------GQGIVEFKNEAKLIAKLQHTN 75
G+ LG+G +G V ++LD + + + + G K E +L+ +L+H N
Sbjct: 10 GDLLGEGSYGKV--KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKN 67
Query: 76 LVRLLGC--SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDW--KKRFNIIEG------ 125
+++L+ + +K + +V EY +E+LD +KRF + +
Sbjct: 68 VIQLVDVLYNEEKQKMYMVMEYC----------VCGMQEMLDSVPEKRFPVCQAHGYFCQ 117
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
++ GL YLH ++H+D+K N+LL KIS G+A + G+
Sbjct: 118 LIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGS 174
Query: 186 HGYMSPEYVMNGI---VSMKSDVYSFGVLVLEIISS 218
+ PE + NG+ K D++S GV + I +
Sbjct: 175 PAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTG 209
>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein
Kinase C Beta Ii
Length = 674
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
I GL +L +I+RDLK N++LD + + KI+DFGM + + + T GT
Sbjct: 451 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKXFCGT 505
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
Y++PE + D ++FGVL+ E+++ +
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors
Length = 273
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 69/292 (23%), Positives = 120/292 (41%), Gaps = 43/292 (14%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
+ G LG GGFG VY G ++ D +AIK + K E N E L+ K+
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 72 Q--HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
+ ++RLL + +L+ E P D F F + + L + R + +++
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 122
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
+ + H V+HRD+K NIL+D ++ K+ DFG + GT Y
Sbjct: 123 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 175
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
PE++ +S V+S G+L+ +++ G E ++G G+
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC-----GDIPFEHDEEIIG--------GQVF 222
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP 299
+ S + C H+ C+ + +DRPT ++ + + LP
Sbjct: 223 ------FRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 264
>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase
(ttk)
pdb|3GFW|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase
(Ttk) In Complex With A Pyrolo-Pyridin Ligand
Length = 313
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 47/189 (24%), Positives = 93/189 (49%), Gaps = 12/189 (6%)
Query: 10 FQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIK--RLSKSSGQGIVEFKNEAKL 67
FQ+++ +S ++G GG V++ Q AIK L ++ Q + ++NE
Sbjct: 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 68 IAKLQ-HTN-LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEG 125
+ KLQ H++ ++RL + +Y + ++D + KK + W+++ + +
Sbjct: 80 LNKLQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKN 135
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
+++ + +H++ ++H DLK +N L+ D M K+ DFG+A + + VGT
Sbjct: 136 MLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGT 191
Query: 186 HGYMSPEYV 194
YM PE +
Sbjct: 192 VNYMPPEAI 200
>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 7 Activated Mutant (S287d, T291d)
Length = 318
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 33/100 (33%), Positives = 56/100 (56%), Gaps = 10/100 (10%)
Query: 125 GIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVG 184
IV+ L YL + + VIHRD+K SNILLD++ K+ DFG++ G + +R G
Sbjct: 132 AIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGIS---GRLVDDKAKDRSAG 186
Query: 185 THGYMSPEYV-----MNGIVSMKSDVYSFGVLVLEIISSK 219
YM+PE + +++DV+S G+ ++E+ + +
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase
(Ttk) In Complex With A Pyrimido-Diazepin Ligand
Length = 313
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 47/189 (24%), Positives = 93/189 (49%), Gaps = 12/189 (6%)
Query: 10 FQTIAAATDNFSPGNRLGQGGFGPVYKGKLLDGQEIAIK--RLSKSSGQGIVEFKNEAKL 67
FQ+++ +S ++G GG V++ Q AIK L ++ Q + ++NE
Sbjct: 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 68 IAKLQ-HTN-LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEG 125
+ KLQ H++ ++RL + +Y + ++D + KK + W+++ + +
Sbjct: 80 LNKLQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKN 135
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
+++ + +H++ ++H DLK +N L+ D M K+ DFG+A + + VGT
Sbjct: 136 MLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVKDSQVGT 191
Query: 186 HGYMSPEYV 194
YM PE +
Sbjct: 192 VNYMPPEAI 200
>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And
Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1)
Length = 311
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 32/205 (15%)
Query: 24 NRLGQGGFGPVYKGKLL-DGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL-------QHTN 75
+RLG G +G V+K + DG+ A+KR S S +G K+ A+ +A++ QH
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGP---KDRARKLAEVGSHEKVGQHPC 118
Query: 76 LVRLLGCSLQKGERLLVYEYLPNKSLDFFI--FDSSKKELLDWKKRFNIIEGIVQGLLYL 133
VRL + ++G L + L SL + +S E W + + L +L
Sbjct: 119 CVRLEQ-AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVW----GYLRDTLLALAHL 173
Query: 134 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGM---ARTFGMNELEANTNRIVGTHGYMS 190
H ++H D+K +NI L + K+ DFG+ T G E++ R YM+
Sbjct: 174 HSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPR------YMA 224
Query: 191 PEYVMNGIVSMKSDVYSFGVLVLEI 215
PE ++ G +DV+S G+ +LE+
Sbjct: 225 PE-LLQGSYGTAADVFSLGLTILEV 248
>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With
Ly333531
Length = 312
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 69/292 (23%), Positives = 120/292 (41%), Gaps = 43/292 (14%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
+ G LG GGFG VY G ++ D +AIK + K E N E L+ K+
Sbjct: 37 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 72 QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
+ ++RLL + +L+ E P D F F + + L + R + +++
Sbjct: 97 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 154
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
+ + H V+HRD+K NIL+D ++ K+ DFG + GT Y
Sbjct: 155 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 207
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
PE++ +S V+S G+L+ +++ G E ++G G+
Sbjct: 208 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC-----GDIPFEHDEEIIG--------GQVF 254
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP 299
+ S + C H+ C+ + +DRPT ++ + + LP
Sbjct: 255 ------FRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 296
>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C
Beta Ii Complexed With A Bisindolylmaleimide Inhibitor
pdb|2I0E|B Chain B, Structure Of Catalytic Domain Of Human Protein Kinase C
Beta Ii Complexed With A Bisindolylmaleimide Inhibitor
Length = 353
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 126 IVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGT 185
I GL +L +I+RDLK N++LD + + KI+DFGM + + + T GT
Sbjct: 130 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKXFCGT 184
Query: 186 HGYMSPEYVMNGIVSMKSDVYSFGVLVLEIISSK 219
Y++PE + D ++FGVL+ E+++ +
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Pyrrolo[2,3- A]carbazole Ligand
pdb|3QF9|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Furan- Thiazolidinedione Ligand
pdb|4GW8|A Chain A, Human Proto-Oncogene Serine Threonine Kinase (Pim1) In
Complex With A Consensus Peptide And Leucettine L41
Length = 313
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 69/292 (23%), Positives = 120/292 (41%), Gaps = 43/292 (14%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
+ G LG GGFG VY G ++ D +AIK + K E N E L+ K+
Sbjct: 38 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 72 QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
+ ++RLL + +L+ E P D F F + + L + R + +++
Sbjct: 98 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 155
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
+ + H V+HRD+K NIL+D ++ K+ DFG + GT Y
Sbjct: 156 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 208
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
PE++ +S V+S G+L+ +++ G E ++G G+
Sbjct: 209 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC-----GDIPFEHDEEIIG--------GQVF 255
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP 299
+ S + C H+ C+ + +DRPT ++ + + LP
Sbjct: 256 ------FRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 297
>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand I
pdb|3CY2|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand Ii
Length = 314
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 69/292 (23%), Positives = 120/292 (41%), Gaps = 43/292 (14%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
+ G LG GGFG VY G ++ D +AIK + K E N E L+ K+
Sbjct: 38 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 72 QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
+ ++RLL + +L+ E P D F F + + L + R + +++
Sbjct: 98 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 155
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
+ + H V+HRD+K NIL+D ++ K+ DFG + GT Y
Sbjct: 156 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 208
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
PE++ +S V+S G+L+ +++ G E ++G G+
Sbjct: 209 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC-----GDIPFEHDEEIIG--------GQVF 255
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP 299
+ S + C H+ C+ + +DRPT ++ + + LP
Sbjct: 256 ------FRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 297
>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its
Consensus Peptide Pimtide
pdb|2BZJ|A Chain A, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru3
pdb|2BZK|B Chain B, Crystal Structure Of The Human Pim1 In Complex With Amppnp
And Pimtide
pdb|2C3I|B Chain B, Crystal Structure Of Human Pim1 In Complex With
Imidazopyridazin I
pdb|2BZH|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2OI4|X Chain X, Crystal Structure Of Human Pim1 In Complex With
Fluorinated Ruthenium Pyridocarbazole
pdb|3BWF|A Chain A, Crystal Structure Of The Human Pim1 In Complex With An
Osmium Compound
Length = 313
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 69/292 (23%), Positives = 120/292 (41%), Gaps = 43/292 (14%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
+ G LG GGFG VY G ++ D +AIK + K E N E L+ K+
Sbjct: 37 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 72 QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
+ ++RLL + +L+ E P D F F + + L + R + +++
Sbjct: 97 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 154
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
+ + H V+HRD+K NIL+D ++ K+ DFG + GT Y
Sbjct: 155 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 207
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
PE++ +S V+S G+L+ +++ G E ++G G+
Sbjct: 208 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC-----GDIPFEHDEEIIG--------GQVF 254
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP 299
+ S + C H+ C+ + +DRPT ++ + + LP
Sbjct: 255 ------FRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 296
>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
pdb|2I6L|B Chain B, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
Length = 320
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 53/212 (25%), Positives = 102/212 (48%), Gaps = 26/212 (12%)
Query: 26 LGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLVRLLGCSL 84
LG GG G V+ D + +AIK++ + Q + E K+I +L H N+V++
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 85 QKGERL--------------LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGL 130
G +L +V EY+ + + LL+ R + + +++GL
Sbjct: 79 PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVL----EQGPLLEEHARLFMYQ-LLRGL 133
Query: 131 LYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMN-ELEANTNRIVGTHGY 188
Y+H + V+HRDLK +N+ ++ + + KI DFG+AR + + + + + T Y
Sbjct: 134 KYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWY 190
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEIISSK 219
SP +++ K+ D+++ G + E+++ K
Sbjct: 191 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Naphtho-Difuran Ligand
Length = 313
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 69/292 (23%), Positives = 119/292 (40%), Gaps = 43/292 (14%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
+ G LG GGFG VY G ++ D +AIK + K E N E L+ K+
Sbjct: 38 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 72 QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
+ ++RLL + +L+ E P D F F + + L + R + +++
Sbjct: 98 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 155
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
+ + H V+HRD+K NIL+D ++ K+ DFG + GT Y
Sbjct: 156 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 208
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
PE++ +S V+S G+L+ +++ G E ++G G+
Sbjct: 209 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC-----GDIPFEHDEEIIG--------GQVF 255
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP 299
+ S C H+ C+ + +DRPT ++ + + LP
Sbjct: 256 ------FRQRVS----XECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 297
>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase
(gak)
pdb|3LL6|B Chain B, Crystal Structure Of The Human Cyclin G Associated Kinase
(gak)
Length = 337
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 59/238 (24%), Positives = 97/238 (40%), Gaps = 35/238 (14%)
Query: 3 RDLKIFDFQTIAAATDNFSPGNRLGQGGFGPVYKGK-LLDGQEIAIKRLSKSSGQGIVEF 61
RD F QT+ L +GGF VY+ + + G+E A+KRL + +
Sbjct: 13 RDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAI 72
Query: 62 KNEAKLIAKLQ-HTNLVRLLGCS--------LQKGERLLVYEYLPNKSLDFFIFDSSKKE 112
E + KL H N+V+ + + E LL+ E + ++F S+
Sbjct: 73 IQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP 132
Query: 113 LLDWKKRFNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGM 172
L I + + ++H+ + +IHRDLK N+LL +Q K+ DFG A T
Sbjct: 133 L-SCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISH 190
Query: 173 ---------------NELEANTNRIVGTHGYMSPEYV---MNGIVSMKSDVYSFGVLV 212
E+ NT T Y +PE + N + K D+++ G ++
Sbjct: 191 YPDYSWSAQRRALVEEEITRNT-----TPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243
>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261
pdb|2BZI|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru2
Length = 313
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 69/292 (23%), Positives = 119/292 (40%), Gaps = 43/292 (14%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
+ G LG GGFG VY G ++ D +AIK + K E N E L+ K+
Sbjct: 37 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 72 QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
+ ++RLL + +L+ E P D F F + + L + R + +++
Sbjct: 97 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 154
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
+ + H V+HRD+K NIL+D ++ K+ DFG + GT Y
Sbjct: 155 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 207
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
PE++ +S V+S G+L+ +++ G E ++G G+
Sbjct: 208 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC-----GDIPFEHDEEIIG--------GQVF 254
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP 299
+ S C H+ C+ + +DRPT ++ + + LP
Sbjct: 255 ------FRQRVS----XECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 296
>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo
Form)
pdb|4FVQ|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain
(Mg-Atp-Bound Form)
Length = 289
Score = 52.0 bits (123), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 69/244 (28%), Positives = 110/244 (45%), Gaps = 30/244 (12%)
Query: 26 LGQGGFGPVYKG--------KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLV 77
LGQG F ++KG L E+ +K L K+ F A +++KL H +LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 78 RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
G + E +LV E++ SLD ++ + + WK +E Q +H
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK-----LEVAKQLAAAMHFLE 130
Query: 138 RLRVIHRDLKASNILL---DDQM--NP---KISDFGMARTFGMNELEANTNRIVGTHGYM 189
+IH ++ A NILL +D+ NP K+SD G++ T ++ RI ++
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL--QERI----PWV 184
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
PE + N +++ +D +SFG + EI S K D++R L QL KA
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQL-PAPKAA 243
Query: 248 ELID 251
EL +
Sbjct: 244 ELAN 247
>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And
The Jnk Inhibitor V
Length = 314
Score = 52.0 bits (123), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 69/292 (23%), Positives = 119/292 (40%), Gaps = 43/292 (14%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
+ G LG GGFG VY G ++ D +AIK + K E N E L+ K+
Sbjct: 38 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 72 QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
+ ++RLL + +L+ E P D F F + + L + R + +++
Sbjct: 98 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 155
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
+ + H V+HRD+K NIL+D ++ K+ DFG + GT Y
Sbjct: 156 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 208
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
PE++ +S V+S G+L+ +++ G E ++G G+
Sbjct: 209 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC-----GDIPFEHDEEIIG--------GQVF 255
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP 299
+ S C H+ C+ + +DRPT ++ + + LP
Sbjct: 256 ------FRQRVS----XECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 297
>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant
V617f (Mg- Atp-Bound Form)
Length = 289
Score = 52.0 bits (123), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 29/226 (12%)
Query: 26 LGQGGFGPVYKG--------KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNLV 77
LGQG F ++KG L E+ +K L K+ F A +++KL H +LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 78 RLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYS 137
G E +LV E++ SLD ++ + + WK +E Q +H
Sbjct: 76 LNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWK-----LEVAKQLAWAMHFLE 130
Query: 138 RLRVIHRDLKASNILL---DDQM--NP---KISDFGMARTFGMNELEANTNRIVGTHGYM 189
+IH ++ A NILL +D+ NP K+SD G++ T ++ RI ++
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL--QERI----PWV 184
Query: 190 SPEYVMNGI-VSMKSDVYSFGVLVLEIIS-SKKNNGCYDTERHLNL 233
PE + N +++ +D +SFG + EI S K D++R L
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF 230
>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major
pdb|3E3P|B Chain B, Glycogen Synthase Kinase From Leishmania Major
Length = 360
Score = 52.0 bits (123), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 31/217 (14%)
Query: 18 DNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKSSGQGIVEFKNEAKLI----AKLQ 72
D F GQG FG V GK G +AIK++ + F+N I A L
Sbjct: 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-----RFRNRELQIMQDLAVLH 77
Query: 73 HTNLVRLLGCSLQKGER-------LLVYEYLPNK----SLDFFIFDSSKKELLDWKKRFN 121
H N+V+L GER +V EY+P+ +++ + +L F
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 122 IIEGIVQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP-KISDFGMARTFGMNELEANTN 180
+I I G L+L + V HRD+K N+L+++ K+ DFG A+ ++ E N
Sbjct: 138 LIRSI--GCLHL---PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK--LSPSEPNVA 190
Query: 181 RIVGTHGYMSPEYVM-NGIVSMKSDVYSFGVLVLEII 216
I + Y +PE + N + D++S G + E++
Sbjct: 191 YICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMM 226
>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine
pdb|1YI3|A Chain A, Crystal Structure Of Pim-1 Bound To Ly294002
pdb|1YI4|A Chain A, Structure Of Pim-1 Bound To Adenosine
Length = 273
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
+ G LG GGFG VY G ++ D +AIK + K E N E L+ K+
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 72 Q--HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
+ ++RLL + +L+ E P D F F + + L + R + +++
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 122
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
+ + H V+HRD+K NIL+D ++ K+ DFG + GT Y
Sbjct: 123 VRHCHNXG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 175
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
PE++ +S V+S G+L+ +++
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 204
>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution
pdb|1XR1|A Chain A, Crystal Structure Of Hpim-1 Kinase In Complex With Amp-Pnp
At 2.1 A Resolution
Length = 300
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
+ G LG GGFG VY G ++ D +AIK + K E N E L+ K+
Sbjct: 24 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 72 QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
+ ++RLL + +L+ E P D F F + + L + R + +++
Sbjct: 84 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 141
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
+ + H V+HRD+K NIL+D ++ K+ DFG + GT Y
Sbjct: 142 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 194
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
PE++ +S V+S G+L+ +++
Sbjct: 195 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 223
>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
pdb|3UTO|B Chain B, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
Length = 573
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 47/203 (23%), Positives = 88/203 (43%), Gaps = 11/203 (5%)
Query: 18 DNFSPGNRLGQGGFGPVYK-GKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 76
D++ LG G FG V++ + G A K + + E + ++ L+H L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 77 VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
V L E +++YE++ L + D K D + + + +GL ++H+
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMHEN 274
Query: 137 SRLRVIHRDLKASNILLDDQMNP--KISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
+ +H DLK NI+ + + K+ DFG+ + + + GT + +PE
Sbjct: 275 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVA 328
Query: 195 MNGIVSMKSDVYSFGVLVLEIIS 217
V +D++S GVL ++S
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLS 351
>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa
Length = 300
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
+ G LG GGFG VY G ++ D +AIK + K E N E L+ K+
Sbjct: 24 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 72 QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
+ ++RLL + +L+ E P D F F + + L + R + +++
Sbjct: 84 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 141
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
+ + H V+HRD+K NIL+D ++ K+ DFG + GT Y
Sbjct: 142 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 194
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
PE++ +S V+S G+L+ +++
Sbjct: 195 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 223
>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor
Length = 276
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
+ G LG GGFG VY G ++ D +AIK + K E N E L+ K+
Sbjct: 8 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 67
Query: 72 Q--HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
+ ++RLL + +L+ E P D F F + + L + R + +++
Sbjct: 68 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 125
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
+ + H V+HRD+K NIL+D ++ K+ DFG + GT Y
Sbjct: 126 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 178
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
PE++ +S V+S G+L+ +++
Sbjct: 179 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 207
>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain
Length = 313
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
+ G LG GGFG VY G ++ D +AIK + K E N E L+ K+
Sbjct: 37 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 72 QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
+ ++RLL + +L+ E P D F F + + L + R + +++
Sbjct: 97 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 154
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
+ + H V+HRD+K NIL+D ++ K+ DFG + GT Y
Sbjct: 155 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 207
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
PE++ +S V+S G+L+ +++
Sbjct: 208 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 236
>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|B Chain B, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|C Chain C, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|D Chain D, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
Length = 273
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
+ G LG GGFG VY G ++ D +AIK + K E N E L+ K+
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 72 Q--HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
+ ++RLL + +L+ E P D F F + + L + R + +++
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 122
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
+ + H V+HRD+K NIL+D ++ K+ DFG + GT Y
Sbjct: 123 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 175
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
PE++ +S V+S G+L+ +++
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 204
>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target
Of Aberrant Somatic Hypermutations In Diffuse Large Cell
Lymphoma
pdb|1YXT|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amppnp
pdb|1YXU|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|B Chain B, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|C Chain C, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|D Chain D, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXV|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
3,4-Dihydroxy-1- Methylquinolin-2(1h)-One
pdb|1YXX|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
(3e)-3-[(4- Hydroxyphenyl)imino]-1h-Indol-2(3h)-One
pdb|2O3P|A Chain A, Crystal Structure Of Pim1 With Quercetin
pdb|2O63|A Chain A, Crystal Structure Of Pim1 With Myricetin
pdb|2O64|A Chain A, Crystal Structure Of Pim1 With Quercetagetin
pdb|2O65|A Chain A, Crystal Structure Of Pim1 With Pentahydroxyflavone
Length = 293
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
+ G LG GGFG VY G ++ D +AIK + K E N E L+ K+
Sbjct: 9 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 72 Q--HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
+ ++RLL + +L+ E P D F F + + L + R + +++
Sbjct: 69 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 126
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
+ + H V+HRD+K NIL+D ++ K+ DFG + GT Y
Sbjct: 127 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 179
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
PE++ +S V+S G+L+ +++
Sbjct: 180 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 208
>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From
Crystallographic Fragment Screen
Length = 301
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
+ G LG GGFG VY G ++ D +AIK + K E N E L+ K+
Sbjct: 25 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 72 QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
+ ++RLL + +L+ E P D F F + + L + R + +++
Sbjct: 85 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 142
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
+ + H V+HRD+K NIL+D ++ K+ DFG + GT Y
Sbjct: 143 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 195
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
PE++ +S V+S G+L+ +++
Sbjct: 196 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 224
>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From
Crystallographic Fragment Screen
Length = 301
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
+ G LG GGFG VY G ++ D +AIK + K E N E L+ K+
Sbjct: 25 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 72 QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
+ ++RLL + +L+ E P D F F + + L + R + +++
Sbjct: 85 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 142
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
+ + H V+HRD+K NIL+D ++ K+ DFG + GT Y
Sbjct: 143 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 195
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
PE++ +S V+S G+L+ +++
Sbjct: 196 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 224
>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R01|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R02|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R04|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3VBQ|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBT|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBV|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBW|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBX|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBY|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VC4|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
Length = 299
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
+ G LG GGFG VY G ++ D +AIK + K E N E L+ K+
Sbjct: 10 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 72 QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
+ ++RLL + +L+ E P D F F + + L + R + +++
Sbjct: 70 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 127
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
+ + H V+HRD+K NIL+D ++ K+ DFG + GT Y
Sbjct: 128 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 180
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
PE++ +S V+S G+L+ +++
Sbjct: 181 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 209
>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JY0|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JYA|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
Length = 294
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
+ G LG GGFG VY G ++ D +AIK + K E N E L+ K+
Sbjct: 10 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 72 QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
+ ++RLL + +L+ E P D F F + + L + R + +++
Sbjct: 70 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 127
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
+ + H V+HRD+K NIL+D ++ K+ DFG + GT Y
Sbjct: 128 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 180
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
PE++ +S V+S G+L+ +++
Sbjct: 181 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 209
>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated
Protein Kinase And Immunoglobulin Domains
Length = 491
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 47/203 (23%), Positives = 88/203 (43%), Gaps = 11/203 (5%)
Query: 18 DNFSPGNRLGQGGFGPVYK-GKLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQHTNL 76
D++ LG G FG V++ + G A K + + E + ++ L+H L
Sbjct: 51 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 77 VRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKY 136
V L E +++YE++ L + D K D + + + +GL ++H+
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMHEN 168
Query: 137 SRLRVIHRDLKASNILLDDQMNP--KISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
+ +H DLK NI+ + + K+ DFG+ + + + GT + +PE
Sbjct: 169 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVA 222
Query: 195 MNGIVSMKSDVYSFGVLVLEIIS 217
V +D++S GVL ++S
Sbjct: 223 EGKPVGYYTDMWSVGVLSYILLS 245
>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From
Crystallographic Fragment Screen
pdb|2XIZ|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-3 From
Crystallographic Fragment Screen
pdb|2XJ1|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inibitor
pdb|2XJ2|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inhibitor
Length = 301
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
+ G LG GGFG VY G ++ D +AIK + K E N E L+ K+
Sbjct: 25 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 72 QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
+ ++RLL + +L+ E P D F F + + L + R + +++
Sbjct: 85 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 142
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
+ + H V+HRD+K NIL+D ++ K+ DFG + GT Y
Sbjct: 143 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 195
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
PE++ +S V+S G+L+ +++
Sbjct: 196 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 224
>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With
4-(4-
Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One
pdb|3T9I|A Chain A, Pim1 Complexed With A Novel 3,6-Disubstituted Indole At
2.6 Ang Resolution
Length = 328
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
+ G LG GGFG VY G ++ D +AIK + K E N E L+ K+
Sbjct: 52 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 72 QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
+ ++RLL + +L+ E P D F F + + L + R + +++
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 169
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
+ + H V+HRD+K NIL+D ++ K+ DFG + GT Y
Sbjct: 170 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 222
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
PE++ +S V+S G+L+ +++
Sbjct: 223 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 251
>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With
Inhibitor
pdb|3BGP|A Chain A, Human Pim-1 Complexed With A Benzoisoxazole Inhibitor Vx1
pdb|3BGQ|A Chain A, Human Pim-1 Kinase In Complex With An Triazolo Pyridazine
Inhibitor Vx2
pdb|3BGZ|A Chain A, Human Pim-1 Kinase In Complex With Diphenyl Indole
Inhibitor Vx3
Length = 333
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
+ G LG GGFG VY G ++ D +AIK + K E N E L+ K+
Sbjct: 57 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 116
Query: 72 QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
+ ++RLL + +L+ E P D F F + + L + R + +++
Sbjct: 117 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 174
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
+ + H V+HRD+K NIL+D ++ K+ DFG + GT Y
Sbjct: 175 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 227
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
PE++ +S V+S G+L+ +++
Sbjct: 228 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 256
>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
pdb|4ALW|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
Length = 328
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
+ G LG GGFG VY G ++ D +AIK + K E N E L+ K+
Sbjct: 52 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 72 QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
+ ++RLL + +L+ E P D F F + + L + R + +++
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 169
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
+ + H V+HRD+K NIL+D ++ K+ DFG + GT Y
Sbjct: 170 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 222
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
PE++ +S V+S G+L+ +++
Sbjct: 223 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 251
>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of
P27kip1 Carboxy-Terminal Peptide
Length = 320
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
+ G LG GGFG VY G ++ D +AIK + K E N E L+ K+
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 72 QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
+ ++RLL + +L+ E P D F F + + L + R + +++
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 161
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
+ + H V+HRD+K NIL+D ++ K+ DFG + GT Y
Sbjct: 162 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 214
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
PE++ +S V+S G+L+ +++
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 243
>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small
Molecule Inhibitor
pdb|3UMX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indol-3-Yl)methylene]-7-(Azepan-1-Ylmethyl)-6-
Hydroxybenzofuran- 3(2h)-One
pdb|4ENX|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
Inhibitor (2e,5z)-2-
(2-Chlorophenylimino)-5-(4-Hydroxy-3-
Nitrobenzylidene)thiazolidin-4- One
pdb|4ENY|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
(2e,5z)-2-(2-
Chlorophenylimino)-5-(4-Hydroxy-3-
Methoxybenzylidene)thiazolidin-4- One
pdb|3UMW|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indazol-3-Yl)methylene]-6-Methoxy-7-(Piperazin-1-
Ylmethyl)benzofuran- 3(2h)-One
Length = 298
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 67/292 (22%), Positives = 118/292 (40%), Gaps = 43/292 (14%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
+ G LG GGFG VY G ++ D +AIK + K E N E L+ K+
Sbjct: 10 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 72 QH--TNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
+ ++RLL + +L+ E P D F F + + L + R + +++
Sbjct: 70 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 127
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
+ + H V+HRD+K NIL+D ++ K+ DFG + GT Y
Sbjct: 128 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 180
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEIISSKKNNGCYDTERHLNLVGYAWQLWNEGKAL 247
PE++ +S V+S G+L+ +++ C D + + +
Sbjct: 181 SPPEWIRYHRYHGRSAAVWSLGILLYDMV-------CGDIP------------FEHDEEI 221
Query: 248 ELIDTTLHESCSPDEVTRCIHVGLLCVQDKATDRPTMSDVASMLTNDTMALP 299
+ S + C H+ C+ + +DRPT ++ + + LP
Sbjct: 222 IRGQVFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 269
>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With
Sb203580
Length = 362
Score = 50.8 bits (120), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 22/209 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIV-----------EFKNEAKLIAKLQHT 74
+ G +G V G +G +AIKR+ + G E +L+ H
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 75 NLVRLLGCSLQKGERLLVYEYLPNKSL--DFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
N++ L + E + YL + + D ++ ++ + + I+ GL
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHV 149
Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
LH+ V+HRDL NILL D + I DF +AR + +AN V Y +PE
Sbjct: 150 LHEAG---VVHRDLHPGNILLADNNDITICDFNLARE---DTADANKTHYVTHRWYRAPE 203
Query: 193 YVMN--GIVSMKSDVYSFGVLVLEIISSK 219
VM G + D++S G ++ E+ + K
Sbjct: 204 LVMQFKGFTKL-VDMWSAGCVMAEMFNRK 231
>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546
Length = 308
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
+ G LG GGFG VY G ++ D +AIK + K E N E L+ K+
Sbjct: 32 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 91
Query: 72 Q--HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
+ ++RLL + +L+ E P D F F + + L + R + +++
Sbjct: 92 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEA 149
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
+ + H V+HRD+K NIL+D ++ K+ DFG + GT Y
Sbjct: 150 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 202
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
PE++ +S V+S G+L+ +++
Sbjct: 203 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 231
>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs
Resolution)
Length = 362
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 22/209 (10%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIKRLSKSSGQGIV-----------EFKNEAKLIAKLQHT 74
+ G +G V G +G +AIKR+ + G E +L+ H
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 75 NLVRLLGCSLQKGERLLVYEYLPNKSL--DFFIFDSSKKELLDWKKRFNIIEGIVQGLLY 132
N++ L + E + YL + + D ++ ++ + + I+ GL
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHV 149
Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
LH+ V+HRDL NILL D + I DF +AR + +AN V Y +PE
Sbjct: 150 LHEAG---VVHRDLHPGNILLADNNDITICDFNLARE---DTADANKTHYVTHRWYRAPE 203
Query: 193 YVMN--GIVSMKSDVYSFGVLVLEIISSK 219
VM G + D++S G ++ E+ + K
Sbjct: 204 LVMQFKGFTKL-VDMWSAGCVMAEMFNRK 231
>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With Atp
pdb|3HMO|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With The Inhibitor Staurosporine
pdb|3HMP|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With A Quinazolin Ligand Compound 4
Length = 342
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 50/208 (24%), Positives = 99/208 (47%), Gaps = 23/208 (11%)
Query: 20 FSPGNRLGQGGFGPVYKGKLLDGQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQ-HTN- 75
+S ++G GG V++ Q AIK L ++ Q + ++NE + KLQ H++
Sbjct: 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 76 LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
++RL + +Y + ++D + KK + W+++ + + +++ + +H+
Sbjct: 118 IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQ 173
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM 195
+ ++H DLK +N L+ D M K+ DFG+A + + VGT YM PE +
Sbjct: 174 HG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 229
Query: 196 NGIVSMKS-----------DVYSFGVLV 212
+ S ++ DV+S G ++
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCIL 257
>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|B Chain B, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|C Chain C, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|D Chain D, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3TV7|A Chain A, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|B Chain B, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|C Chain C, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|D Chain D, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TWJ|A Chain A, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|B Chain B, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|C Chain C, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|D Chain D, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
Length = 410
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 20/201 (9%)
Query: 26 LGQGGFGPVYKGKLLDGQEI-AIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
+G+G FG V + +++ A+K LSK + F E + I ++ V L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 83 SLQKGERL-LVYEYLPNKSLDFFI--FDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
+ Q L +V EY+P L + +D +K W RF E +V L +H +
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WA-RFYTAE-VVLALDAIHS---M 187
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM---- 195
IHRD+K N+LLD + K++DFG E + VGT Y+SPE +
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN-KEGMVRCDTAVGTPDYISPEVLKSQGG 246
Query: 196 NGIVSMKSDVYSFGVLVLEII 216
+G + D +S GV + E++
Sbjct: 247 DGYYGRECDWWSVGVFLYEML 267
>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe
Complex Structure
pdb|2V55|C Chain C, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe
Complex Structure
Length = 406
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 20/201 (9%)
Query: 26 LGQGGFGPVYKGKLLDGQEI-AIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
+G+G FG V + +++ A+K LSK + F E + I ++ V L
Sbjct: 82 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 141
Query: 83 SLQKGERL-LVYEYLPNKSLDFFI--FDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
+ Q L +V EY+P L + +D +K W RF E +V L +H +
Sbjct: 142 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WA-RFYTAE-VVLALDAIHS---M 192
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM---- 195
IHRD+K N+LLD + K++DFG E + VGT Y+SPE +
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN-KEGMVRCDTAVGTPDYISPEVLKSQGG 251
Query: 196 NGIVSMKSDVYSFGVLVLEII 216
+G + D +S GV + E++
Sbjct: 252 DGYYGRECDWWSVGVFLYEML 272
>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil
pdb|2ESM|B Chain B, Crystal Structure Of Rock 1 Bound To Fasudil
pdb|2ETK|A Chain A, Crystal Structure Of Rock 1 Bound To Hydroxyfasudil
pdb|2ETK|B Chain B, Crystal Structure Of Rock 1 Bound To Hydroxyfasudil
pdb|2ETR|A Chain A, Crystal Structure Of Rock I Bound To Y-27632
pdb|2ETR|B Chain B, Crystal Structure Of Rock I Bound To Y-27632
pdb|3D9V|A Chain A, Crystal Structure Of Rock I Bound To H-1152p A Di-
Methylated Variant Of Fasudil
pdb|3D9V|B Chain B, Crystal Structure Of Rock I Bound To H-1152p A Di-
Methylated Variant Of Fasudil
pdb|3NCZ|A Chain A, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|B Chain B, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|C Chain C, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|D Chain D, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NDM|A Chain A, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|B Chain B, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|C Chain C, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|D Chain D, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
Length = 415
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 20/201 (9%)
Query: 26 LGQGGFGPVYKGKLLDGQEI-AIKRLSKSS--GQGIVEFKNEAKLIAKLQHTNLVRLLGC 82
+G+G FG V + +++ A+K LSK + F E + I ++ V L
Sbjct: 82 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 141
Query: 83 SLQKGERL-LVYEYLPNKSLDFFI--FDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRL 139
+ Q L +V EY+P L + +D +K W RF E +V L +H +
Sbjct: 142 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WA-RFYTAE-VVLALDAIHS---M 192
Query: 140 RVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM---- 195
IHRD+K N+LLD + K++DFG E + VGT Y+SPE +
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN-KEGMVRCDTAVGTPDYISPEVLKSQGG 251
Query: 196 NGIVSMKSDVYSFGVLVLEII 216
+G + D +S GV + E++
Sbjct: 252 DGYYGRECDWWSVGVFLYEML 272
>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715
Length = 317
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 45/179 (25%), Positives = 88/179 (49%), Gaps = 12/179 (6%)
Query: 20 FSPGNRLGQGGFGPVYKGKLLDGQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQ-HTN- 75
+S ++G GG V++ Q AIK L ++ Q + ++NE + KLQ H++
Sbjct: 14 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 73
Query: 76 LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
++RL + +Y + ++D + KK + W+++ + + +++ + +H+
Sbjct: 74 IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQ 129
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
+ ++H DLK +N L+ D M K+ DFG+A + + VGT YM PE +
Sbjct: 130 HG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 184
>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain
pdb|2HW6|B Chain B, Crystal Structure Of Mnk1 Catalytic Domain
Length = 307
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 50/207 (24%), Positives = 92/207 (44%), Gaps = 21/207 (10%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLVRLLGCS 83
LG+G + V L +G+E A+K + K +G E + + + Q + N++ L+
Sbjct: 21 LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFF 80
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
LV+E L S+ I K++ + ++ ++ + L +LH + H
Sbjct: 81 EDDTRFYLVFEKLQGGSILAHI---QKQKHFNEREASRVVRDVAAALDFLHTKG---IAH 134
Query: 144 RDLKASNILLD--DQMNP-KISDFGMARTFGMNE-----LEANTNRIVGTHGYMSPEYV- 194
RDLK NIL + ++++P KI DF + +N G+ YM+PE V
Sbjct: 135 RDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVE 194
Query: 195 ----MNGIVSMKSDVYSFGVLVLEIIS 217
+ D++S GV++ ++S
Sbjct: 195 VFTDQATFYDKRCDLWSLGVVLYIMLS 221
>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2-
Yl)amino]benzamide
Length = 320
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 47/182 (25%), Positives = 85/182 (46%), Gaps = 18/182 (9%)
Query: 20 FSPGNRLGQGGFGPVYKGKLLDGQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQ-HTN- 75
+S ++G GG V++ Q AIK L ++ Q + ++NE + KLQ H++
Sbjct: 10 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 69
Query: 76 LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRF---NIIEGIVQGLLY 132
++RL + +Y + ++D + KK + W+++ N++E +
Sbjct: 70 IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV------ 120
Query: 133 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPE 192
H + ++H DLK +N L+ D M K+ DFG+A + + VGT YM PE
Sbjct: 121 -HTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 178
Query: 193 YV 194
+
Sbjct: 179 AI 180
>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain
Length = 343
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 45/179 (25%), Positives = 88/179 (49%), Gaps = 12/179 (6%)
Query: 20 FSPGNRLGQGGFGPVYKGKLLDGQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQ-HTN- 75
+S ++G GG V++ Q AIK L ++ Q + ++NE + KLQ H++
Sbjct: 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 76 LVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHK 135
++RL + +Y + ++D + KK + W+++ + + +++ + +H+
Sbjct: 71 IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQ 126
Query: 136 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYV 194
+ ++H DLK +N L+ D M K+ DFG+A + + VGT YM PE +
Sbjct: 127 HG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1
Catalytic Domain Apo Form
Length = 390
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 49/203 (24%), Positives = 97/203 (47%), Gaps = 23/203 (11%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQ-HTN-LVRLL 80
++G GG V++ Q AIK L ++ Q + ++NE + KLQ H++ ++RL
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 81 GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
+ +Y + ++D + KK + W+++ + + +++ + +H++
Sbjct: 123 DYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQHG--- 175
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
++H DLK +N L+ D M K+ DFG+A + + VGT YM PE + + S
Sbjct: 176 IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 234
Query: 201 MKS-----------DVYSFGVLV 212
++ DV+S G ++
Sbjct: 235 RENGKSKSKISPKSDVWSLGCIL 257
>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation
Length = 293
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 19 NFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN------EAKLIAKL 71
+ G LG GGFG VY G ++ D +AIK + K E N E L+ K+
Sbjct: 9 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 72 Q--HTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
+ ++RLL + +L+ E + D F F + + L + R + +++
Sbjct: 69 SSGFSGVIRLLDWFERPDSFVLILERM-EPVQDLFDFITERGALQEELAR-SFFWQVLEA 126
Query: 130 LLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARTFGMNELEANTNRIVGTHGY 188
+ + H V+HRD+K NIL+D ++ K+ DFG + GT Y
Sbjct: 127 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 179
Query: 189 MSPEYVMNGIVSMKS-DVYSFGVLVLEII 216
PE++ +S V+S G+L+ +++
Sbjct: 180 SPPEWIRYHRYHGRSAAVWSLGILLYDMV 208
>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g
pdb|2HW7|A Chain A, Crystal Structure Of Mnk2-D228g In Complex With
Staurosporine
Length = 316
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLVRLLGCS 83
LG+G V L+ QE A+K + K G E +++ + Q H N++ L+
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
++ LV+E + S+ I K+ + + +++ + L +LH + H
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIH---KRRHFNELEASVVVQDVASALDFLHNKG---IAH 134
Query: 144 RDLKASNILLD--DQMNP-KISDFGMARTFGMNELEANTNRI--------VGTHGYMSPE 192
RDLK NIL + +Q++P KI DFG+ +N + + I G+ YM+PE
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFGLGSGIKLN---GDCSPISTPELLTPCGSAEYMAPE 191
Query: 193 YV-----MNGIVSMKSDVYSFGVLVLEIIS 217
V I + D++S GV++ ++S
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLS 221
>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|B Chain B, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|C Chain C, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|D Chain D, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|E Chain E, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|F Chain F, Crystal Structure Of Human Pas Kinase Bound To Adp
Length = 335
Score = 48.9 bits (115), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 56/226 (24%), Positives = 101/226 (44%), Gaps = 24/226 (10%)
Query: 6 KIFDFQTIAAA----TDNFSPGNRLGQGGFGPVYKGKLLD-GQEIAIKRLSKS------- 53
K + + +AA + +S + LG G FG V+ + +E+ +K + K
Sbjct: 8 KAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCW 67
Query: 54 -SGQGIVEFKNEAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKE 112
+ + E ++++++H N++++L +G LV E LD F F +
Sbjct: 68 IEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEK-HGSGLDLFAF-IDRHP 125
Query: 113 LLDWKKRFNIIEGIVQGLLYLHKYSRLR-VIHRDLKASNILLDDQMNPKISDFGMARTFG 171
LD I +V + YL RL+ +IHRD+K NI++ + K+ DFG A
Sbjct: 126 RLDEPLASYIFRQLVSAVGYL----RLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181
Query: 172 MNELEANTNRIVGTHGYMSPEYVM-NGIVSMKSDVYSFGVLVLEII 216
+L GT Y +PE +M N + +++S GV + ++
Sbjct: 182 RGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224
>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei,
Pb000659.00.0
pdb|3N9X|B Chain B, Crystal Structure Of Map Kinase From Plasmodium Berghei,
Pb000659.00.0
Length = 432
Score = 48.9 bits (115), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 63/244 (25%), Positives = 118/244 (48%), Gaps = 48/244 (19%)
Query: 10 FQTI--AAATDNFSPGNRLGQGGFGPVYKGKLLDGQE-IAIKRLSKSSGQGIVEFKN--- 63
FQ I DN+ + +G+G +G VY + ++ +AIK++++ + +++ K
Sbjct: 16 FQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILR 74
Query: 64 EAKLIAKLQHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNII 123
E ++ +L+ ++RL + + LL ++ L + I DS K+L +K +
Sbjct: 75 EITILNRLKSDYIIRLYDLII--PDDLLKFDEL---YIVLEIADSDLKKL--FKTPIFLT 127
Query: 124 EGIVQGLLY--------LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFG---- 171
E ++ +LY +H+ +IHRDLK +N LL+ + K+ DFG+ART
Sbjct: 128 EEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184
Query: 172 ---MNELEAN--------------TNRIVGTHGYMSPEYVMNGIVSMKS-DVYSFGVLVL 213
+N+LE N T+ +V T Y +PE ++ KS D++S G +
Sbjct: 185 TNIVNDLEENEEPGPHNKNLKKQLTSHVV-TRWYRAPELILLQENYTKSIDIWSTGCIFA 243
Query: 214 EIIS 217
E+++
Sbjct: 244 ELLN 247
>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182
Length = 353
Score = 48.5 bits (114), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 17 TDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN--EAKLIAKLQH 73
+ +F + LG+G +G V G+ +AIK++ + + + + E K++ +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKH 68
Query: 74 TNLVRLLGC----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ + S + + + + L L I S + L D ++ I + + +
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI---STQMLSDDHIQYFIYQTL-RA 124
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL--------EANTNR 181
+ LH + VIHRDLK SN+L++ + K+ DFG+AR + ++
Sbjct: 125 VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 182 IVGTHGYMSPEYVMNGI-VSMKSDVYSFGVLVLEI 215
V T Y +PE ++ S DV+S G ++ E+
Sbjct: 182 XVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3
Length = 353
Score = 48.5 bits (114), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 17 TDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN--EAKLIAKLQH 73
+ +F + LG+G +G V G+ +AIK++ + + + + E K++ +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKH 68
Query: 74 TNLVRLLGC----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ + S + + + + L L I S + L D ++ I + + +
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI---STQMLSDDHIQYFIYQTL-RA 124
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNEL--------EANTNR 181
+ LH + VIHRDLK SN+L++ + K+ DFG+AR + ++
Sbjct: 125 VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 182 IVGTHGYMSPEYVMNGI-VSMKSDVYSFGVLVLEI 215
V T Y +PE ++ S DV+S G ++ E+
Sbjct: 182 YVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7
pdb|2B9I|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Msg5
pdb|2B9J|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Far1
pdb|2F49|A Chain A, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2F49|B Chain B, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2FA2|A Chain A, Crystal Structure Of Fus3 Without A Peptide From Ste5
pdb|2FA2|B Chain B, Crystal Structure Of Fus3 Without A Peptide From Ste5
Length = 353
Score = 48.1 bits (113), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 53/217 (24%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 17 TDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN--EAKLIAKLQH 73
+ +F + LG+G +G V G+ +AIK++ + + + + E K++ +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKH 68
Query: 74 TNLVRLLGC----SLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQG 129
N++ + S + + + + L L I S + L D ++ I + + +
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI---STQMLSDDHIQYFIYQTL-RA 124
Query: 130 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTN--------- 180
+ LH + VIHRDLK SN+L++ + K+ DFG+AR ++E A+ +
Sbjct: 125 VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTGQQSGM 179
Query: 181 -RIVGTHGYMSPEYVMNGI-VSMKSDVYSFGVLVLEI 215
V T Y +PE ++ S DV+S G ++ E+
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha
(Mrck Alpha)
Length = 437
Score = 47.8 bits (112), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 51/201 (25%), Positives = 90/201 (44%), Gaps = 17/201 (8%)
Query: 26 LGQGGFGPVYKGKLLDGQEI-AIKRLSKSSGQGIVE---FKNEAKLIAKLQHTNLVRLLG 81
+G+G FG V KL + ++ A+K L+K E F+ E ++ + + L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-GDSKWITTLH 140
Query: 82 CSLQKGERL-LVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
+ Q L LV +Y L + + L + RF + E ++ + +L
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYLAEMVIA----IDSVHQLH 195
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVM----- 195
+HRD+K NIL+D + +++DFG M + ++ VGT Y+SPE +
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKL-MEDGTVQSSVAVGTPDYISPEILQAMEGG 254
Query: 196 NGIVSMKSDVYSFGVLVLEII 216
G + D +S GV + E++
Sbjct: 255 KGRYGPECDWWSLGVCMYEML 275
>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a
Mutant In Complex With Sp600125 Inhibitor
Length = 390
Score = 47.8 bits (112), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 48/203 (23%), Positives = 96/203 (47%), Gaps = 23/203 (11%)
Query: 25 RLGQGGFGPVYKGKLLDGQEIAIK--RLSKSSGQGIVEFKNEAKLIAKLQ-HTN-LVRLL 80
++G GG V++ Q AIK L ++ Q + ++NE + KLQ H++ ++RL
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 81 GCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLR 140
+ +Y + ++D + KK + W+++ + + +++ + +H++
Sbjct: 123 DYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQHG--- 175
Query: 141 VIHRDLKASNILLDDQMNPKISDFGMARTFGMNELEANTNRIVGTHGYMSPEYVMNGIVS 200
++H DLK +N L+ D M K+ DFG+A + + VG YM PE + + S
Sbjct: 176 IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 201 MKS-----------DVYSFGVLV 212
++ DV+S G ++
Sbjct: 235 RENGKSKSKISPKSDVWSLGCIL 257
>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii,
25.M01780 Or Tgme49_007820
Length = 458
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 55/244 (22%), Positives = 108/244 (44%), Gaps = 37/244 (15%)
Query: 18 DNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKN---EAKLIAKLQH 73
D + + +G G +G V + L+ + +AIK++ + + +++ K E ++ +L H
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNH 111
Query: 74 TNLVRLLGCSLQKGERLL--VYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLL 131
++V++L + K +Y L DF + L + + ++ ++ G+
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIK-TLLYNLLVGVK 170
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARTFGMNE----------LEANTNR 181
Y+H ++HRDLK +N L++ + K+ DFG+ART E E + N
Sbjct: 171 YVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 182 I---------------VGTHGYMSPEYV-MNGIVSMKSDVYSFGVLVLEIISSKKNNGCY 225
+ V T Y +PE + + + DV+S G + E+++ K N Y
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287
Query: 226 DTER 229
+R
Sbjct: 288 HADR 291
>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From
Cryptosporidium Parvum, Cgd7_40
Length = 345
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 63/240 (26%), Positives = 99/240 (41%), Gaps = 60/240 (25%)
Query: 26 LGQGGFGPVYKGKLLDGQEIAIK--------RLSKSSGQGIVEFKNEAKLIAKLQHTNLV 77
+GQG +G V ++ Q AI+ ++ + + + + K E +L+ KL H N+
Sbjct: 34 IGQGSYGVVRVA--IENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91
Query: 78 RLLGCSLQKGERLLVYE-----YLPNKSLDFFIFDSSKK--------------------- 111
RL + LV E +L +K L+ FI DS+ K
Sbjct: 92 RLYEVYEDEQYICLVMELCHGGHLLDK-LNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150
Query: 112 --------ELLDWKKR----FNIIEGIVQGLLYLHKYSRLRVIHRDLKASNILL--DDQM 157
E LD+ +R NI+ I L YLH + HRD+K N L +
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSF 207
Query: 158 NPKISDFGMARTF---GMNELEANTNRIVGTHGYMSPEYV--MNGIVSMKSDVYSFGVLV 212
K+ DFG+++ F E T + GT +++PE + N K D +S GVL+
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTK-AGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain
Length = 316
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 53/210 (25%), Positives = 95/210 (45%), Gaps = 27/210 (12%)
Query: 26 LGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKLQ-HTNLVRLLGCS 83
LG+G V L+ QE A+K + K G E +++ + Q H N++ L+
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 84 LQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQGLLYLHKYSRLRVIH 143
++ LV+E + S+ I K+ + + +++ + L +LH + H
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIH---KRRHFNELEASVVVQDVASALDFLHNKG---IAH 134
Query: 144 RDLKASNILLD--DQMNP-KISDFGMARTFGMNELEANTNRI--------VGTHGYMSPE 192
RDLK NIL + +Q++P KI DF + +N + + I G+ YM+PE
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLN---GDCSPISTPELLTPCGSAEYMAPE 191
Query: 193 YV-----MNGIVSMKSDVYSFGVLVLEIIS 217
V I + D++S GV++ ++S
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLS 221
>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839
pdb|2IO6|A Chain A, Wee1 Kinase Complexed With Inhibitor Pd330961
Length = 287
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 45/145 (31%), Positives = 69/145 (47%), Gaps = 14/145 (9%)
Query: 17 TDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL---- 71
T F ++G G FG V+K K LDG AIKR SK G V+ +N + +
Sbjct: 8 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 66
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ--- 128
QH+++VR + L+ EY SL I S ++ + K + + ++Q
Sbjct: 67 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI--SENYRIMSYFKEAELKDLLLQVGR 124
Query: 129 GLLYLHKYSRLRVIHRDLKASNILL 153
GL Y+H S ++H D+K SNI +
Sbjct: 125 GLRYIHSMS---LVHMDIKPSNIFI 146
>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770
Length = 285
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 45/145 (31%), Positives = 69/145 (47%), Gaps = 14/145 (9%)
Query: 17 TDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL---- 71
T F ++G G FG V+K K LDG AIKR SK G V+ +N + +
Sbjct: 6 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 64
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ--- 128
QH+++VR + L+ EY SL I S ++ + K + + ++Q
Sbjct: 65 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI--SENYRIMSYFKEAELKDLLLQVGR 122
Query: 129 GLLYLHKYSRLRVIHRDLKASNILL 153
GL Y+H S ++H D+K SNI +
Sbjct: 123 GLRYIHSMS---LVHMDIKPSNIFI 144
>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396
pdb|3BIZ|A Chain A, Wee1 Kinase Complex With Inhibitor Pd331618
pdb|3CQE|A Chain A, Wee1 Kinase Complex With Inhibitor Pd074291
pdb|3CR0|A Chain A, Wee1 Kinase Complex With Inhibitor Pd259_809
Length = 287
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 46/151 (30%), Positives = 70/151 (46%), Gaps = 14/151 (9%)
Query: 17 TDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL---- 71
T F ++G G FG V+K K LDG AIKR SK G V+ +N + +
Sbjct: 8 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 66
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ--- 128
QH+++VR + L+ EY SL I S ++ + K + + ++Q
Sbjct: 67 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI--SENYRIMSYFKEAELKDLLLQVGR 124
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNP 159
GL Y+H S ++H D+K SNI + P
Sbjct: 125 GLRYIHSMS---LVHMDIKPSNIFISRTSIP 152
>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed
With Inhibitor Pd0407824
Length = 289
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 46/151 (30%), Positives = 70/151 (46%), Gaps = 14/151 (9%)
Query: 17 TDNFSPGNRLGQGGFGPVYKG-KLLDGQEIAIKRLSKSSGQGIVEFKNEAKLIAKL---- 71
T F ++G G FG V+K K LDG AIKR SK G V+ +N + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 68
Query: 72 QHTNLVRLLGCSLQKGERLLVYEYLPNKSLDFFIFDSSKKELLDWKKRFNIIEGIVQ--- 128
QH+++VR + L+ EY SL I S ++ + K + + ++Q
Sbjct: 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI--SENYRIMSYFKEAELKDLLLQVGR 126
Query: 129 GLLYLHKYSRLRVIHRDLKASNILLDDQMNP 159
GL Y+H S ++H D+K SNI + P
Sbjct: 127 GLRYIHSMS---LVHMDIKPSNIFISRTSIP 154
>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A
Specific Inhibitor
pdb|2W7X|A Chain A, Cellular Inhibition Of Checkpoint Kinase 2 And
Potentiation Of Cytotoxic Drugs By Novel Chk2 Inhibitor
Pv1019
pdb|2YIQ|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1322
pdb|2YIR|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1352
pdb|2YIT|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Pv1162, A Novel Inhibitor
pdb|2YCQ|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1115
pdb|2YCS|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Pv788
Length = 323
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 40/138 (28%), Positives = 63/138 (45%), Gaps = 22/138 (15%)
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANTNRIVGTHGY 188
YLH+ +IHRDLK N+LL Q KI+DFG ++ G L + GT Y
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTY 182
Query: 189 MSPEYVMN---GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHL---------NLVGY 236
++PE +++ + D +S GV++ +S + T+ L N +
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 242
Query: 237 AWQLWNEGKALELIDTTL 254
W +E KAL+L+ L
Sbjct: 243 VWAEVSE-KALDLVKKLL 259
>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In
Complex With Inhibitor Pv1533
Length = 322
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 40/138 (28%), Positives = 63/138 (45%), Gaps = 22/138 (15%)
Query: 132 YLHKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARTFGMNELEANTNRIVGTHGY 188
YLH+ +IHRDLK N+LL Q KI+DFG ++ G L + GT Y
Sbjct: 128 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTY 181
Query: 189 MSPEYVMN---GIVSMKSDVYSFGVLVLEIISSKKNNGCYDTERHL---------NLVGY 236
++PE +++ + D +S GV++ +S + T+ L N +
Sbjct: 182 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 241
Query: 237 AWQLWNEGKALELIDTTL 254
W +E KAL+L+ L
Sbjct: 242 VWAEVSE-KALDLVKKLL 258
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.319 0.136 0.398
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 10,191,190
Number of Sequences: 62578
Number of extensions: 430197
Number of successful extensions: 3556
Number of sequences better than 100.0: 1000
Number of HSP's better than 100.0 without gapping: 849
Number of HSP's successfully gapped in prelim test: 235
Number of HSP's that attempted gapping in prelim test: 1116
Number of HSP's gapped (non-prelim): 1139
length of query: 340
length of database: 14,973,337
effective HSP length: 99
effective length of query: 241
effective length of database: 8,778,115
effective search space: 2115525715
effective search space used: 2115525715
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.8 bits)
S2: 52 (24.6 bits)